xvEPA
         United States
         Environmental Protection
         Agency	
            Prevention, Pesticides
            And Toxic Substances
            (7508W)	
EPA 738-R-97-006
February 1998
Reregistration
Eligibility Decision (RED)

Metribuzin

-------

-------
                     United States
                     Environmental Protection
                     Agency	
                                   Prevention, Pesticides
                                   And Toxic Substances
                                   (7508W)	
EPA-738-F-96-006
February 1998
ฉERA   R.E.D.  FACTS
                     Metribuzin
         Pesticide
   Re registration
                  All pesticides sold or distributed in the United States must be
              registered by EPA, based on scientific studies showing that they can be
              used without posing unreasonable risks to people or the environment.
              Because of advances in scientific knowledge, the law requires that
              pesticides which were first registered before November 1, 1984, be
              reregistered to ensure that they meet today's more stringent standards.
                      In evaluating pesticides for reregistration, EPA obtains and
              reviews a complete set of studies from pesticide producers, describing the
              human health and environmental effects of each pesticide. The Agency
              edevelops any mitigation measures or regulatory controls needed to
              effectively reduce each pesticide's risks. EPA then reregisters pesticides
              that can be used without posing unreasonable risks to human health or the
              environment.
                  When a pesticide is eligible for reregistration, EPA explains the basis
              for its decision in a Reregistration Eligibility Decision (RED) document.
              This fact sheet summarizes the information in the RED document for
              reregistration case 0181, metribuzin.

                  Metribuzin is a herbicide used to selectively control certain broadleaf
              weeds and grassy weed species on a wide range of sites including vegetable
              and field crops, turf grasses (recreational areas), and non-crop areas.
              Formulations include wettable powder, emulsifiable concentrate, water
              dispersible granules (dry flowable), and flowable concentrate. Metribuzin
              is applied by various methods including aerial, chemigation, and ground
              application.

Regulatory       Metribuzin was first registered as a pesticide in the U.S. in 1973.
    History   EPA issued a Registration  Standard for metribuzin in July 1985 (PB86-
              174216). Data Call-Ins (DCIs) were issued in 1991 and 1995 requiring
              additional product chemistry, environmental fate and groundwater, and
              ecological effects data. Currently 86 metribuzin products are registered.
                   On August 3,  1996, the Food Quality Protection Act of 1996 (FQPA)
              was signed into law. FQPA amends both the Federal Food, Drug, and
              Cosmetic Act (FFDCA), and the Federal Insecticide, Fungicide, and
              Rodenticide Act (FIFRA). The FQPA amendments went into effect
              immediately and were considered during this reregistration decision.
       Use Profile

-------
Human  Health
  Assessment
Toxicity
     In studies using laboratory animals, metribuzin generally has been
shown to be of low acute toxicity. It is slightly toxic by the oral and
inhalation routes and has been placed in Toxicity Category III (the second
lowest of four categories) for this effect. It is practically non-toxic by the
dermal route of exposure and has been placed in Toxicity Category IV (the
lowest of four categories).
     A 21-day dermal toxicity study and a 21-day inhalation toxicity study
were used to assess subchronic toxicity.  In the dermal toxicity study,
minimal systemic changes were noted at the highest dose level and no
dermal irritation was noted at any dose level. In the inhalation study,
systemic toxicity was observed at 720 mg/m3 air (0.720 mg/L), and was
based on clinical signs of toxicity, increased liver enzyme activities, and
increased organ weights.  Results of three developmental toxicity studies
and one reproduction study suggest that although metribuzin is not
considered a developmental toxicant it is associated with developmental
toxicity effects. There was a lack of evidence for carcinogenicity in the
following studies: 1) a mouse study in which there were no increases in
tumor incidences at dosing levels up to 438 mg/kg/day for males and 567
mg/kg/day for females; 2) a rat study in which the observed pituitary
adenomas and carcinomas were not statistically significant at dosing levels
up to 14.36 mg/kg/day for males and 20.38 mg/kg/day for females; and 3)
another rat study which indicated no evidence for carcinogenicity at dosing
levels up to 42.2 mg/kg/day for males and 53.6 mg/kg/day for females.
Available data also suggest that metribuzin is not mutagenic.
Dietary Exposure
     People may be exposed to residues of metribuzin through the diet.
Tolerances were reassessed for metribuzin and three of its primary
metabolites. Tolerances have been established in 40 CFR 180.332 for the
following commodities:  asparagus; barley, grain; barley, straw; carrots;
corn, fodder; corn, forage; grass; grass, hay; lentils  (dried); lentils, forage;
peas; peas (dried), peas, forage; peas, vine hay; sainfoin, hay; soybeans;
soybeans, forage; soybeans, hay; sugarcane; tomatoes; wheat forage; wheat,
grain; and wheat straw. Additional  confirmatory information are needed
before several established tolerances for animal commodities can be
reassessed.  When these tolerances for animal commodities are reassessed,
a separate dietary exposure assessment will be made.
Occupational  Exposure
     Based on current use patterns, handlers (mixers, loaders, and
applicators) may be exposed to metribuzin during and after normal use of
liquid, wettable powder, and dry-flowable formulations.  Since minimal
systemic changes were noted at the highest dose level in a 21-day dermal
toxicity study, a short-term or intermediate term dermal risk assessment was

-------
not required. However, an inhalation risk assessment is required based on
clinical signs of toxicity, increased liver enzyme activities, and increased
organ weights observed in a 21-day inhalation study.  Based on the use
patterns and potential exposures, ten exposure scenarios for handlers were
identified and assessed for metribuzin.
Human  Risk Assessment
     Metribuzin generally is of low acute toxicity, and although it does
show developmental effects in animal studies, it is not considered  a
developmental toxicant. It has been classified as a Group D chemical, not
classifiable as to human carcinogenicity. Many food and feed crop uses are
registered; however, dietary exposure to metribuzin residues in food and
feed are not of concern.  Also, the cancer risk posed to the general
population is not of concern.
     Of greater concern is the inhalation exposure risk posed to metribuzin
handlers, particularly mixers/loaders/applicators, and field workers. This
concern was identified for mixing and loading wettable powders for aerial
and chemigation applications at 6 Ibs active ingredient (ai)/acre.  Exposure
and risk to workers will be mitigated by the use of PPE required by the
WPS, as well as additional risk mitigation measures described below. Post-
application reentry workers will be required to observe a 12-hour  Restricted
Entry Interval.
      The Agency has reassessed metribuzin food and feed related
tolerances under the standards of the FQPA and determined that, based on
available information, there is a reasonable certainty that no harm will result
to infants and children or to the  general population from aggregate exposure
to metribuzin residues. The only type of exposures evaluated were dietary
and drinking water routes, since significant non-occupational exposures are
unlikely with metribuzin use.
      The Agency believes that the acute and chronic total dietary (food
source and drinking water source) risks from metribuzin are minimal. The
total acute dietary (food and drinking water source) risk assessment was
performed for the sub-population females (13+ years). The MOE was 1200
(rounded to two significant digits). Metribuzin's acute dietary MOE greatly
exceeds  100; therefore, the Agency considers the MOE to be sufficiently
protective for acute total dietary risk.
      EPA has also assessed the chronic dietary risk posed by metribuzin.
For the overall U.S. population  and 22 subgroups, exposure from all current
metribuzin tolerances represents 36% of the Reference Dose (RfD), or
amount believed  not to cause adverse effects if consumed daily over a 70-
year lifetime. 1% of the RfD is reserved for exposure to residues  of
metribuzin in drinking water; therefore, the total chronic dietary risk is 37%
of the RfD for the general population. The exposure level of residues of
metribuzin in food commodities in the most highly exposed subgroup,
children (1-6 years), is 75% of the RfD. For this subgroup, 4% of the RfD

-------
is reserved for exposure to residues of metribuzin in drinking water;
therefore, total chronic dietary risk is 79% of the RfD. It appears that total
chronic dietary risk from food and drinking water sources is low.
     EPA does not have, at this time, available data to determine whether
metribuzin has a common mechanism of toxicity with other substances or
how to include this pesticide in a cumulative risk assessment.  Unlike other
pesticides for which EPA has followed a cumulative risk approach based on
a common mechanism of toxicity, metribuzin does not appear to produce a
toxic metabolite produced by other substances. For the purposes of this
tolerance action, therefore, EPA has not assumed that metribuzin has a
common mechanism of toxicity with other substances.
Environmental Assessment
     An evaluation of the estimated exposure of metribuzin to the
environment and the toxicity of metribuzin to nontarget organisms is
required to assess the potential risk to the environment posed by metribuzin
use.
 Exposure of metribuzin to the environment is assessed by reviewing fate
lab and field tests, and estimating terrestrial residues and aquatic
concentrations with the use of models. Toxicity of metribuzin to nontarget
organisms is extrapolated from lab studies conducted on a few species of
birds, mammals, aquatic organisms, and plants.
Environmental Fate
     Based on available data, the primary routes of degradation of
metribuzin and its primary degradates are microbial metabolism and
photolytic degradation on soil. These compounds will be available for
leaching to ground water and runoff to surface water in many use
conditions because they are not volatile. Once in ground water, metribuzin
is expected to persist due to its stability to hydrolysis and the lack of light
penetration. Conversely, residues of metribuzin are not likely to persist in
clear, well-mixed, shallow surface water with good light penetration since
parent metribuzin degrades rapidly by aqueous photolysis.
Ecological Effects
     Laboratory study results indicate that metribuzin is moderately toxic
to avian species on an acute oral basis, practically non-toxic to avian
species on a subacute dietary basis, slightly toxic to small mammals on an
acute oral basis, practically non-toxic to bees on an acute contact basis,
slightly toxic to practically non-toxic to freshwater fish on an acute basis,
moderately to slightly toxic to aquatic invertebrates on an acute basis,
slightly toxic to estuarine/marine fish and invertebrates on an acute basis,
and highly toxic to nontarget plants.
Ecological Effects Risk Assessment
     There is potential acute and chronic risk concern for avian species,
including endangered species, for metribuzin application rates of 4 pounds

-------
Risk Mitigation
Additional Data
        Required
(lb) active ingredient (ai) per acre or higher. Also acute and chronic risks
are likely for mammalian species, including endangered species, for rates of
1 lb ai/acre or higher.  Additionally, risks are likely for nontarget terrestrial
and aquatic plant species, including endangered species, for rates of 0.5 lb
ai/acre or higher.
     Although presently there are ground water advisories on metribuzin
product labels, the Agency is still concerned with potential ground water
contamination from metribuzin use.  Data currently available to the Agency
indicate that metribuzin and its degradates are very mobile and highly
persistent, and thus have the potential to contaminate ground water and
surface water; however, the persistence of parent metribuzin in surface
water may be lessened by its susceptibility to photolytic degradation.
Metribuzin use could adversely affect ground-water quality, especially in
vulnerable areas. Detections have been reported in the "Pesticides in
Ground Water Database" (EPA, 1992) and other studies. These ground
water contamination concerns are enhanced by metribuzin's widespread use
patterns.

     To lessen the risks to birds, mammals, and nontarget plants posed by
metribuzin, EPA is taking the following risk mitigation measures.
o prohibiting aerial application on asparagus and tomatoes;
o reducing the application rate of metribuzin being applied to sugarcane via
aerial and chemigation methods from 6.0 lb ai/acre to 2.0 lb ai/acre;
o adding specific spray drift labeling requirements.
      To lessen the potential risks to humans posed by metribuzin, EPA is
taking the following risk mitigation measures.
o reducing the application rate of metribuzin being applied to sugarcane via
 aerial and chemigation methods from 6.0 lb ai/acre to 2.0 lb ai/acre;
o prohibiting the use of low-pressure or high volume hand wand equipment.
      To reduce the likelihood of metribuzin and its primary degradates
contaminating ground and surface water, EPA is taking the following risk
mitigation actions.
ฐ specifying on the label Best Management Practices;
o determining areas that are vulnerable to ground-water contamination by
metribuzin and recommending risk mitigation measures.

      EPA is requiring the following additional generic studies for
metribuzin to confirm its regulatory assessments and conclusions:
 1) magnitude of residue studies (alfalfa and field corn trials, and field
rotational crop studies, additional field trials for field corn and potatoes, and
data for wheat aspirated grain fractions; 2) processing studies for  sugarcane
and wheat; 3) certified limits (GLN 62-2) and analytical methods to verify

-------
                        certified limits (GLN 62-3) for three impurities related to the active
                        ingredient in the 90% technical; 4) storage stability data for animal
                        commodity samples from the previously evaluated poultry and ruminant
                        feeding studies; 5) confined rotational crop and field rotational crop studies;
                        and 6) additional ground water information.
                             The Agency also is requiring product-specific data including product
                        chemistry and acute toxicity studies, revised Confidential Statements of
                        Formula (CSFs), and revised labeling for reregistration.

Product Labeling        All metribuzin end-use products must comply with EPA's current
           Changes   pesticide product labeling requirements and with the following. For a
          Red uired   comprehensive list of labeling requirements, please see the metribuzin RED
                        document.
                             o For tomatoes and asparagus uses: "Aerial application is
                             prohibited."
                             o For aerial application on sugarcane: "To assure that spray will not
                             adversely affect adjacent sensitive nontarget plant, apply this product
                             by aircraft at a minimum upwind distance of 400 ft from sensitive
                             plants."
                             o For all uses:  "Low-pressure and high volume hand wand
                             equipment is prohibited."
                             o For the aerial and chemigation application methods of metribuzin
                             on sugarcane: A "maximum application rate of 2.0 Ib ai/acre" is
                             specified.
                             o Specific spray drift label requirements are added.
                             o Best Management Practices to help reduce ground and surface
                             water contamination.
        Regulatory
       Conclusion
          For More
       Information
     The use of currently registered products containing metribuzin in
accordance with approved labeling will not pose unreasonable risks or
adverse effects to humans or the environment. Therefore, all uses of these
products are eligible for reregistration under the conditions specified in this
RED.
     Metribuzin products will be reregistered once the required product-
specific data, revised Confidential Statements of Formula, and revised
labeling are received and accepted by EPA.

     EPA is requesting public comments on the Reregistration Eligibility
Decision (RED) document for metribuzin during a 60-day time period, as
announced in a Notice of Availability published in the Federal Register. To
obtain a copy of the RED document or to submit written comments, please
contact the Pesticide Docket, Public Information and Record Integrity

-------
Branch, Informantion Resources and Services Division (7506C), Office of
Pesticide Programs (OPP), US EPA, Washington, DC 20460, telephone
703-305-5805.
     Electronic copies of the RED and this fact sheet are available on the
Internet. See http://www.epa.gov/REDs.
     Printed copies of the RED and fact sheet can be obtained from EPA's
National Center for Environmental Publications and Information
(EPA/NCEPI), PO Box 42419, Cincinnati, OH 45242-2419, telephone 1-
800-490-9198; fax 513-489-8695.
     Following the comment period, the metribuzin RED document also
will be available from the National Technical Information Service (NTIS),
5285 Port Royal Road, Springfield, VA 22161, telephone 703-487-4650.
     For more information about EPA's pesticide reregistration program,
the metribuzin RED, or reregistration of individual products containing
metribuzin, please contact the Special Review and Reregistration Division
(7508W), OPP, US EPA, Washington, DC 20460, telephone 703-308-8000.
     For information about the health effects of pesticides, or for assistance
in recognizing and managing pesticide poisoning symptoms, please contact
the National Pesticides Telecommunications Network (NPTN).  Call toll-
free 1-800-858-7378, from 6:30 am to 4:30 pm Pacific Time, or 9:30 am to
7:30 pm Eastern Standard Time, seven days a week.

-------

-------
        '
                   UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

                                     WASHINGTON, D.C.  20460
                                                                            OFFICE OF
                                                                       PREVENTION, PESTICIDES
                                                                       AND TOXIC SUBSTANCES
                                                 i s
CERTIFIED MATT,
Dear Registrant:

       I am pleased to announce that the Environmental Protection Agency has completed its
reregistration eligibility review and decisions on the pesticide chemical case metribuzin which
includes the active ingredients 4-amino-6(l,l-dimethylethyl)-3-(methylthio)-l,2,4-triazin-5(4H)-
one. The enclosed Reregistration Eligibility Decision (RED), which was approved on
May 20,1997 contains the Agency's evaluation of the data base of these chemicals, its
conclusions of the potential human health and environmental risks of the current product uses,
and its decisions and conditions under which these uses and products will be eligible for
reregistration. The RED includes the data and labeling requirements for products for
reregistration. It also includes requirements for additional data (generic) on the active
ingredients to confirm the risk assessments.

       To assist you with a proper response, read the enclosed document entitled "Summary of
Instructions for Responding to the RED." This summary also  refers to other enclosed documents
which include further instructions. You must follow all instructions and submit complete and
timely responses.  The first set of required responses is due  90 days from the receipt of this
letter. The second set of required responses is due 8 months from the date of this letter.
Complete and timely responses will avoid the Agency taking the enforcement action of
suspension against your products.

       Please note that the Food Quality Protection Act of 1996 (FQPA) became effective on
August 3,1996, amending portions of both pesticide law (FIFRA) and the food and drug law
(FFDCA).  This RED takes into account, to the extent currently possible, the new safety standard
set by FQPA for establishing and reassessing tolerances.  However, it should be noted that in
continuing to make reregistration determinations during the early stages of FQPA
implementation, EPA recognizes that it will be necessary to make decisions relating to FQPA
before the implementation process is complete. In making these early case-by-case decisions,
EPA does not intend to set broad precedents for the application of FQPA. Rather, these early
determinations will be made on a case-by-case basis and will not bind EPA as it proceeds with
further policy development and any rulemaking that may be required.

-------
       If EPA determines, as a result of this later implementation process, that any of the
determinations described in this RED are no longer appropriate, the Agency will pursue whatever
action may be appropriate, including but not limited to reconsideration of any portion of this
RED.

If you have questions on the product specific data requirements or wish to meet with the Agency,
please contact the Special Review and Reregistration Division representative Jean Holmes (703)
308-8008.  Address any questions on required generic data to the Special Review and
Reregistration Division representative Michael Goodis (703) 308-8157.
                                                                     director
                                                             !. Review and
                                                        ^registration Division
Enclosures

-------
              SUMMARY OF INSTRUCTIONS FOR RESPONDING TO
              THE REREGISTRATION ELIGIBILITY DECISION (RED)

1.  DATA CALL-IN (PCD OR "90-DAY RESPONSE"-If generic data are required for
reregistration, a DCI letter will be enclosed describing such data. If product specific data are
required, a DCI letter will be enclosed listing such requirements.  If both generic and product
specific data are required, a combined Generic and Product Specific DCI letter will be enclosed
describing such data. However, if you are an end-use product registrant only and have been
granted a generic data exemption (GDE) by EPA, you are being sent only the product specific
response forms (2 forms) with the RED. Registrants responsible for generic data are being sent
response forms for both generic and product specific data requirements (4 forms). You must
submit the appropriate response forms (following the instructions provided) within 90
days of the receipt of this RED/DCI letter; otherwise, your product may be suspended.

2.  TIME EXTENSIONS AND DATA WAIVER REOUESTS-No time extension requests
will be granted for the 90-day response. Time extension requests may be submitted only with
respect to actual data submissions.  Requests for time extensions for product specific data should
be submitted in the 90-day response.  Requests for data waivers must be submitted as part of the
90-day response.  All data waiver and time extension requests must be accompanied by a full
justification.  All waivers and time extensions must be granted by EPA hi order to go into effect.

3.  APPLICATION FOR REREGISTRATION OR "8-MONTH RESPONSE"-You must
submit the following items for each product within eight months of the date of this letter
(RED issuance date).

       a. Application for Reregistration (EPA Form 8570-1). Use only an original
application form.  Mark it "Application for Reregistration."  Send your Application for
Reregistration (along with the other forms listed in b-e below) to the address listed hi item 5.

       b. Five copies of draft labeling which complies with the RED and current regulations
and requirements.  Only make labeling changes which are required by the RED and current
regulations (40 CFR 156.10) and policies. Submit any other amendments (such as formulation
changes, or labeling changes not related to reregistration) separately.  You may, but are not
required to, delete uses which the RED says are ineligible for reregistration. For further labeling
guidance, refer to the labeling section of the EPA publication "General Information on Applying
for Registration in the U.S., Second Edition, August 1992" (available from the National
Technical Information Service, publication #PB92-221811; telephone number 703-487-4650).

       c. Generic or Product Specific Data. Submit all data in a format which complies with
PR Notice 86-5, and/or submit citations of data already submitted and give the EPA identifier
(MRID) numbers. Before citing these studies, you must make sure that they meet the
Agency's acceptance criteria (attached to the DCI).

       d. Two copies of the Confidential Statement of Formula (CSF) for each basic and
each alternate formulation. The labeling and CSF which you submit  for each product must
comply with P.R. Notice 91-2 by declaring the active ingredient as the nominal concentration.

-------
You have two options for submitting a CSF: (1) accept the standard certified limits (see 40 CFR
ง158.175) or (2) provide certified limits that are supported by the analysis of five batches. If
you choose the second option, you must submit or cite the data for the five batches along with a
certification statement as described in 40 CFR ง158.175(e).  A copy of the CSF is enclosed;
follow the instructions on its back.

      e. Certification With Respect to Data Compensation Requirements. Complete and
sign EPA form 8570-31 for each product.

4. COMMENTS IN RESPONSE TO FEDERAL REGISTER NOTICE-Comments
pertaining to the content of the RED may be submitted to the address shown in the Federal
Register Notice which announces the availability of this RED.

5. WHERE TO SEND PRODUCT SPECIFIC PCI RESPONSES (90-DAY) AND
APPLICATIONS FOR REREGISTRATION (8-MONTH RESPONSES)

BvU.S.Mail:

      Document Processing Desk (RED-SRRD-PRB)
      Office of Pesticide Programs (7504C)
      EPA, 401 M St. S.W.
      Washington, D.C. 20460-0001

Bv express:

      Document Processing Desk (RED-SRRD-PRB)
      Office of Pesticide Programs (7504C)
      Room 266A, Crystal Mall 2
      1921 Jefferson Davis Hwy.
      Arlington, VA 22202

6. EPA'S REVIEWS-EPA will screen all submissions for completeness; those which are not
complete will be returned with a request for corrections. EPA will try to respond to data waiver
and time extension requests within 60 days. EPA will also try to respond to all 8-month
submissions with a final reregistration determination within 14 months after the RED has been
issued.

-------
REREGISTRATION ELIGIBILITY DECISION

                  Metribuzin

                    LIST A

                  CASE 0181
            ENVIRONMENTAL PROTECTION AGENCY
              OFFICE OF PESTICIDE PROGRAMS
         SPECIAL REVIEW AND REREGISTRATION DIVISION

-------

-------
                         TABLE OF CONTENTS
METRIBUZIN REREGISTRATION ELIGIBILITY DECISION TEAM	i

ABSTRACT	iv

I.     INTRODUCTION	1

II.    CASE OVERVIEW	2
      A.    Chemical Overview	2
      B.    Use Profile	3
      C.    Estimated Usage of Pesticide	5
      D.    Data Requirements	7
      E.    Regulatory History		.7

in.   SCIENCE ASSESSMENT	7
      A.    Physical Chemistry Assessment	7
      B.    Human Health Assessment	8
            1.     Toxicology Assessment	8
                  a.    Acute Toxicity	8
                  b.    Subchronic Toxicity	9
                  c.    Chronic toxicity and Carcinogenicity.	10
                  d.    Developmental Toxicity	12
                  e.    Reproductive Toxicity	13
                  f.    Mutagenicity	14
                  g.    Metabolism	15
                  h.    Dose-Response Assessment	15
            2.     Exposure Assessment	19
                  a.    Dietary Exposure	20
                  b.    Drinking Water Exposure	29
                  c.    Occupational Exposure	32
            3.     Risk Assessment	39
                  a.    Dietary Risk	39
                  b.    Drinking Water Risk	40
                  c.    Occupational Risk	41
                  d.    Food Quality Protection Act (FQPA) Considerations	48
      C.    Environmental Assessment	56
            1.     Ecological Toxicity Data	56
                  a.    Toxicity to Terrestrial Animals	56
                  b.    Toxicity to Aquatic Animals	58
                  c.    Toxicity to Plants	63
            2.     Environmental Fate	66
                  a.    Environmental Fate Assessment	66

-------
                  b.     Environmental Fate and Transport	67
                  c.     Water Resources	70
            3.     Exposure and Risk Characterization	76
                  a.     Ecological Exposure and Risk Characterization.	76
                  b.     Water Resources Risk Implication for Human Health ... 93

IV.   RISK MANAGEMENT AND REREGISTRATION DECISION	98
      A.    Determination of Eligibility	98
      B.    Determination of Eligibility	99
            1.     Eligibility Decision	99
            2.     Eligible and Ineligible Uses  	99
      C.    Regulatory Position.	99
            1.     Food Quality Protection Act Consideration	100
            2.     Tolerance Reassessment	101
            3.     Tolerance Revocations and Import Tolerances	107
            4.     Summary of Risk Management Decisions	108
            5.     Endangered Species Statement	110
            6.     Occupational Labeling Rationale	110
            7.     Spray Drift Advisory 	114

V.    ACTIONS REQUIRED OF REGISTRANTS	115
      A.    Manufacturing-Use Products	115
            1.     Additional Generic Data Requirements	115
            2.     Labeling Requirements for Manufacturing-Use Products	115
      B.    End-Use Products	116
            1.     Additional Product-Specific Data Requirements	116
            2.     Labeling Requirements for End-Use Products	."... 116
                  a.     Worker Protection Standard	116
                  b.    .Occupational/Residential Labeling	117
                  c.     Environmental Hazard Statements	120
                  d.     Application Restrictions	120
                  e.     Application Rates  	121
      C.    Spray Drift Labeling  	121
      D.    Existing Stocks	125

VL   APPENDICES	127
      APPENDIX A.    Table of Use Patterns Subject to Reregistration	127
      APPENDIX B.    Table of the Generic Data Requirements and Studies
                        Used to Make the Reregistration Decision	128
      APPENDIX C.    Citations Considered to be Part of the Data Base
                        Supporting the Reregistration of Metribuzin	143
      APPENDIX D.    Combined Generic and Product Specific Data Call-In .. 164
            Attachment 1.     Chemical Status Sheets	185
            Attachment 2.     Combined Generic and Product Specific Data
                              Call-in Response Forms (Form A inserts)

-------
                       Plus Instructions	187
      Attachment 3.    Generic and Product Specific Requirement Status
                       and Registrant's Response Forms (Form B inserts)
                       and Instructions	191
      Attachment 4.    EPA Batching of End-Use Products for Meeting
                       Data Requirements for Reregistration	199
      Attachment 5.    List of AH Registrants Sent This Data Call-In
                       (insert) Notice	206
      Attachment 6.    Cost Share, Data Compensation Forms,
                       Confidential Statement of Formula Form
                       and Instructions	207
APPENDIX  E.          List of Available Related Documents	215

-------

-------
METRIBUZIN REREGISTRATION ELIGIBILITY DECISION TEAM
Office of Pesticide Programs:

Biolosical and Economic Analysis Assessment
Jim Saulmon
Art Grube
Margaret Cogdell
Biological Analysis Branch
Economic Analysis Branch
L.U.I.S. Project
Environmental Fate and Effects Risk Assessment
Mary Powell
Kay Montague
Jim Breithaupt
Estella Waldman
Henry Nelson

Health Effects Risk Assessment

Kathryn Boyle
John Leahy
Sue Hummel
Brian Steinwand
Stephen C. Dapson

Registration Support

Vickie Walters
Mark Perry

Risk Management

Jean Holmes
Science Analysis and Coordination Staff
Ecological Effects Branch
Environmental Fate and Groundwater Branch
Environmental Fate and Groundwater Branch
Environmental Fate and Groundwater Branch
Risk Characterization and Analysis
Occupational and Residential Exposure Branch
Registration and Support Chemistry Branch
Science Analysis Branch
Toxicology Branch II
Fungicide-Herbicide Branch
Registration Support Branch
Planning and Reregistration Branch

-------

-------
            GLOSSARY OF TERMS AND ABBREVIATIONS

ADI           Acceptable Daily Intake.  A now defunct term for reference dose (RfD).
AE            Acid Equivalent
a.i.            Active Ingredient
ARC           Anticipated Residue Contribution
CAS           Chemical Abstracts Service
CI             Cation
CNS           Central Nervous System
CSF           Confidential Statement of Formula
DFR           Dislodgeable Foliar Residue
ORES          Dietary Risk Evaluation System
D WEL         Drinking Water Equivalent Level (DWEL) The D WEL represents a medium specific (i.e. drinking
               water) lifetime exposure at which adverse, non carcinogenic health effects are not anticipated to
               occur.
EEC           Estimated Environmental Concentration. The estimated pesticide concentration in an environment,
               such as a terrestrial ecosystem.
EP            End-Use Product
EPA           U.S. Environmental Protection Agency
FAO/WHO     Food and Agriculture Organization/World Health Organization
FDA           Food and Drug Administration
FIFRA         Federal Insecticide, Fungicide, and Rodenticide Act
FFDCA        Federal Food, Drug, and Cosmetic Act
FQPA          Food Quality Protection Act
FOB           Functional Observation Battery
GLC           Gas Liquid Chromatography
GM           Geometric Mean
GRAS          Generally Recognized as Safe as Designated by FDA
HA            Health Advisory (HA). The HA values are used as informal guidance to municipalities and other
               organizations when emergency spills or contamination situations occur.
HOT           Highest Dose Tested
LCi0           Median Lethal Concentration. A statistically derived concentration of a substance that can b e
               expected to cause death in 50% of test animals. It is usually expressed as the weight of substance
               per weight or volume of water, air or feed, e.g., mg/1, mg/kg or ppm.
LD50           Median Lethal Dose. A statistically derived single dose that can be expected to cause death in 50%
               of the test animals when administered by the route indicated (oral, dermal, inhalation). It i s
               expressed as a weight of substance per unit weight of animal, e.g., mg/kg.
LDlo           Lethal Dose-low. Lowest Dose at which lethality occurs.
LEL           Lowest Effect Level
LOG           Level of Concern
LOD           Limit of Detection
LOEL          Lowest Observed Effect Level
MATC         Maximum Acceptable Toxicant Concentration
MCLG         Maximum Contaminant Level Goal (MCLG) The MCLG is used by the Agency to regulat e
               contaminants in drinking water under the Safe Drinking Water Act.
Hg/g           Micrograms Per Gram
yt/g/L           Micrograms per liter
mg/L           Milligrams Per Liter
MOE           Margin of Exposure
MP            Manufacturing-Use Product
MPI           Maximum Permissible Intake
MRJD          Master Record Identification (number). EPA's system of recording and tracking studies submitted.
                                                 11

-------

-------
            GLOSSARY OF TERMS AND ABBREVIATIONS

N/A           Not Applicable
NOEC         No Observable Effect Concentration
NPDES        National Pollutant Discharge Elimination System
NOEL         No Observed Effect Level
NOAEL        No Observed Adverse Effect Level
OP            Organophosphate
OPP           Office of Pesticide Programs
Pa             pascal, the pressure exerted by a force of one newton acting on an area of one square meter.
PADI          Provisional Acceptable Daily Intake
PAG           Pesticide Assessment Guideline
PAM          Pesticide Analytical Method
PHED         Pesticide Handler's Exposure Data
PHI           Preharvest Interval
ppb           Parts Per Billion
PPE           Personal Protective Equipment
ppm           Parts Per Million
PRN           Pesticide Registration Notice
Q*,            The Carcinogenic Potential of a Compound, Quantified by the EPA's Cancer Risk Model
RBC           Red Blood Cell
RED           Reregistration Eligibility Decision
REI           Restricted Entry Interval
RfD           Reference Dose
RS            Registration Standard
RUP           Restricted Use Pesticide
SLN           Special Local Need (Registrations Under Section 24 (c) of FIFRA)
TC            Toxic Concentration. The concentration at which a substance produces a toxic effect.
TD            Toxic Dose. The dose at which a substance produces a toxic effect
TEP           Typical End-Use Product
TGAI         Technical Grade Active Ingredient
TLC           Thin Layer Chromatography
TMRC         Theoretical Maximum Residue Contribution
torr           A unit of pressure needed to support a column of mercury 1 mm high under standard conditions.
WP           Wettable Powder
WPS          Worker Protection Standard
                                                111

-------

-------
ABSTRACT

       The U. S. Environmental Protection Agency has completed its reregistration eligibility
decision for the pesticide metribuzin. This decision includes a comprehensive reassessment of
the required target data and the use patterns of currently registered products.  This decision
considered the requirements of the recently enacted "Food Quality Protection Act of 1996" which
amended the Federal Food, Drug, and Cosmetic Act and the Federal Insecticide, Fungicide and
Rodenticide Act, the two Federal statutes that provide the framework for pesticide regulation in
the United States. FQPA became effective immediately upon signature and all reregistration
eligibility decisions (REDs) signed subsequent to August 3,1996 are accordingly being evaluated
under the new standards imposed by FQPA.

       Metribuzin is a herbicide used on a wide range of sites, including vegetable and field
crops, turf grasses (recreational areas), and non-crop areas, to selectively control certain broadleaf
weeds and grassy weed species.  The Agency has concluded under FIFRA that all uses, as
prescribed in this document, will not cause unreasonable risks to humans or the environment and
therefore, all products are eligible  for reregistration.  To mitigate potential health risks to
mixer/loader/applicators, the Agency has accepted risk mitigation measures proposed by  the
technical registrant, Bayer Corporation, requiring the removal of certain application methods
from the label and application rate reductions. Also, measures to reduce environmental risks to
birds, mammals, and non-target plants include the removal of certain application methods from
the label,  application rate reductions, and spray drift label requirements.  Certain product
chemistry and residue chemistry data are being required to be submitted to confirm the Agency's
risk assessment and conclusions.

       In establishing or reassessing tolerances, FQPA requires the Agency to consider aggregate
exposures to pesticide residues, including all anticipated dietary exposures and other-exposures
for which there is reliable information, as well as the potential for cumulative effect from a
pesticide and other compounds with  a common mechanism of toxicity. The Act further directs
EPA to consider the potential for increased susceptibility of infants and children to the toxic
effects of pesticide residue.

       The Agency does not have at this time,  available data to determine whether metribuzin
has a common mechanism of toxicity with other substances or how to include this pesticide in
a cumulative risk assessment. Unlike other pesticides for which EPA has followed a cumulative
risk approach based on a common mechanism of toxicity, metribuzin does not appear to produce
a toxic metabolite produced by other  substances.  For the purposes of this tolerance  action,
therefore, EPA has not assumed that metribuzin has a common mechanism of toxicity with other
substances.

       The Agency has reassessed metribuzin food and feed related tolerances under  the
standards of FQPA and determined that, based on available information, there is a reasonable
certainty  that no harm will result to  infants and children or to the general population from
                                           IV

-------
aggregate exposure to metribuzin residues.  The only type of exposures evaluated were dietary
and drinking water routes, since  significant non-occupational exposures are unlikely with
metribuzin use.

       Before reregistering products containing metribuzin, the Agency is requiring that product
specific data, revised Confidential  Statements  of Formula (CSF), and revised labeling be
submitted within eight months of the issuance of this document for all products containing
metribuzin. The product specific data include product chemistry for each registration and acute
toxiciry testing. After reviewing all these data and any revised labels and finding them acceptable
in accordance with section 3(c)(5) of FIFRA, the Agency will reregister a product.  However,
those products which bear uses of this or any other active ingredients which have not been
determined to be eligible for reregistration will be reregistered only when such uses and active
ingredients are determined to be eligible for reregistration.

-------
I.
INTRODUCTION
       In 1988, the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) was amended
to accelerate the reregistration of products with active ingredients registered prior to November
1, 1984. The amended Act provides a schedule for the reregistration process to be completed in
nine years. There are five phases to the reregistration process. The first four phases of the process
focus on identification of data requirements to support the reregistration of an active ingredient
and the generation and submission of data to fulfill the requirements. The fifth phase is a review
by the U.S. Environmental Protection Agency (referred to as "the Agency") of all data submitted
to support reregistration.

       FIFRA Section 4(g)(2)(A) states that in Phase 5  "the Administrator shall determine
whether pesticides containing such active ingredient are eligible for reregistration" before calling
in data on products and either reregistering products or taking  "other appropriate regulatory
action." Thus, reregistration involves a thorough review of the scientific data base underlying a
pesticide's registration. The purpose of the Agency's review is to reassess the potential hazards
arising from the currently registered uses of the pesticide, to determine the need for additional
data on health and environmental effects, and to determine whether the pesticide meets the "no
unreasonable adverse effects" criterion of FIFRA.

       On August 3,1996, the Food Quality Protection Act of 1996 (FQPA) (Public Law 104-
170) was signed into law.  FQPA amends both the Federal  Food, Drug,  and Cosmetic Act
(FFDCA), 21 U.S.C. 301 et seq., and  the Federal Insecticide, Fungicide, and Rodenticide Act
(FIFRA), 7 U.S.C. 136 et seq. The FQPA amendments went into effect immediately. As a result,
EPA is embarking on an intensive process, including consultation with registrants, States, and
other interested stakeholders, to make decisions on the new policies and procedures that will be
appropriate as a result of enactment of FQPA.  This process will include  a more in depth analysis
of the new safety standard and how it should be applied to both food and non-food pesticide
applications.  The FQPA did not, however, amend any of the existing reregistration deadlines in
Section 4 of FIFRA. The Agency will therefore continue its ongoing reregistration program
while it continues to determine how best to implement FQPA.

       This document presents the Agency's decision regarding the reregistration eligibility of
the registered uses of metribuzin including the risk to infants and children for any potential
dietary, drinking water, dermal, inhalation  or other oral exposures, and cumulative effects as
stipulated under the FQPA. The document consists of six sections. Section I  is the introduction.
Section II describes metribuzin, its uses, data requirements and  regulatory history. Section III
discusses the human health and environmental assessment based on  the data available to the
Agency. Section IV presents the reregistration decision for metribuzin. Section V discusses the
reregistration requirements for metribuzin. Finally, Section VI is the Appendices which support
this Reregistration Eligibility Decision. Additional details concerning the Agency's review of
applicable data are available on request.

-------
II.    CASE OVERVIEW

      A.    Chemical Overview

            The following active ingredient is covered by this Reregistration Eligibility
      Decision:
            Common Name:
Metribuzin
      •     Chemical Name:
4-amino-6-(l,l-dimethylethyl)-3-
(methylthio)-1,2,4-triazin-5 (4H)-one
            Chemical Family:
Triazinone
            CAS Registry Number:
21087-64-9
            OPP Chemical Code:
101101
      •     Empirical Formula
            and Structure:
                               H,C
            Molecular Weight:
214.28
            Trade and Other Names:
Sencor, Lexone, Preview
      •     Basic Manufacturer:
Bayer Corporation

-------
B.    Use Profile

      The following is information on the currently registered uses with an overview of
use sites and application methods.  A detailed table of these uses of metribuzin is in
Appendix A.

      For Metribuzin:

      Type of Pesticide: Herbicide

      Mode of Action: Inhibits electron transport in photosynthesis

      Use Sites:

      TERRESTRIAL FOOD CROP

      Grain Crops: Wheat

      Miscellaneous Vegetables: Asparagus

      Root Crop Vegetables:  Carrot (including tops)

      TERRESTRIAL FOOD+FEED CROP

      Agricultural Uncultivated Areas: Agricultural fallow/idleland

      Fruiting Vegetables:  Tomato

      Grain Crops: Barley, Corn (Field), Wheat

      Groups of Agricultural Crops Which Cross Established Crop Groupings:  Corn,
      Peas, Soybeans

      Root Crop Vegetables:  Potato (White/Irish)

       Seed and Pod Vegetables: Garbanzos (including chick peas), Lentils, Peas (Dried-
      Type, Field, Pigeon)

       Sugar Crops:  Sugarcane

      TERRESTRIAL FEED CROP

      Forage Grasses: Barley, Bermudagrass, Bluegrass, Grass Forage/Fodder/Hay,

-------
Timothy, Wheat

Forage Legumes and Other Nongrass Forage Crops: Alfalfa, Lentils, Sainfoin

TERRESTRIAL NON-FOOD CROP

Groups of Agricultural Crops Which Cross Established Crop Groupings: Grasses
grown for seed

Nonagricultural Uncultivated Areas:  Nonagricultural uncultivated areas/soils,
recreational areas

TERRESTRIAL NON-FOOD

Ornamental Lawns and Turf: Ornamental Lawns and turf (No residential uses)

Target Pests:

Broadleaves: annual polemonium, ageratum,  ameranth, beggarweed,  bristly
starbur,  buffalobur, buttercup,  bedstraw,  carpetweed, chickweed,  clover,
cocklebur, coffeeweed, common ragweed, com cockle, Carolina geranium, cutleaf
evening  primrose,  dandelion, dayflower, dock,  dogfennel, falseflax, field
bindweed, field pennycress, filaree, fireweed, flixweed, Florida pusley, fumitory,
galinsoga,  gromwell, haloe koa,  henbit, hialoa, hophornbeam copperleaf,
horsenettle,  horseweed, Jacob's  ladder, jimsonweed, knotweed, kochia,
ladysthumb, lambsquarters, London rocket, mallow, marestail, meadow salsify,
mexicanweed,  minerslettuce, morningglory,  mustard,  nettleleaf  goosefoot,
parsley-piert, pepperweed, pigweed, pineappleweed, prickly lettuce,  purple
deadnettle, purslane,  rattlebox,  redweed, red tassel-flower,  red sorrel, sand
catchfly, sensitiveplant, sesbania,  shepherdspurse, sicklepod, spurred  anoda,
smartweed, snapweed, speedwell,  spurge, spurweed, sunflower, thistle, toadflax,
velvetleaf, white campion, wild buckwheat, wild poinsettia, yellow rocket;

Grasses: alexandergrass, barnyardgrass, barley, bluegrass, broadleaf panicum,
browntop millet, brome, cheat, crabgrass, crowfootgrass, fall panicum, field
sandbur, foxtail, guineagrass, Italian ryegrass, johnsongrass, junglerice, littleseed
canarygrass, quackgrass, rabbitfoot polypogon, radiate fingergrass, rescuegrass,
ricegrass, spring whitlowgrass, signalgrass, volunteer wheat, wild oat, windgrass,
wiregrass

-------
      Formulation Types Registered:
      TECHNICAL GRADE ACTIVE INGREDIENT
      SOLID
      MANUFACTURING PRODUCT
      WETTABLE POWDER
      END USE PRODUCT
      EMULSIFIABLE CONCENTRATE
      FLOWABLE CONCENTRATE
90.00%
50.00%
14.00 to 15.00%
41.00%
      WATER DISPERSIBLE GRANULES (DRY
      FLOWABLE)
      WETTABLE POWDER
64.30% to 75.00%
50.00% to 70.00%
      Method and Rates of Application:
      (Please refer to Appendix A for site/use rate combinations.)

            Equipment -

      Aircraft (fixed-wing and helicopter); Center pivot irrigation; Ground; Low
      pressure ground sprayer; Power sprayer; Sprayer; Sprinkler irrigation

            Method and Rate -

      Band treatment; Broadcast; Chemigation; Conservation tillage; Directed spray;
      Low volume spray (concentrate); Soil band treatment; Soil broadcast treatment;
      Soil incorporated treatment; Spot treatment; Spray
      At  planting; Dormant;  Early postemergence; Early  preplant; Early spring;
      Established plantings; Fall; Fallow; Foliar; Late spring; Layby; Post-final harvest;
      Postemergence; Postharvest; Postplant; Preemergence; Preplant; Preplant Spring);
      Pretransplant (Spring)

C.    Estimated Usage of Pesticide

      This section summarizes the best estimates available for the pesticide uses of
metribuzin. These estimates are derived from a variety of published and proprietary
sources available to the Agency. The data, reported on an aggregate and site (crop) basis,
reflect annual fluctuations in use patterns as well as the variability in using data from
various information sources. The table below summarizes metrobuzin use on agricultural
crops by site.

-------
          Table 1
                      Metribuzin Usage
tit*
Corn
Barley
Wheat
Sorghum
Lentils
Peas, Dry
Peas, Green
Alfalfa
Hay, Other
Potatoes
Soybeans
Sugarcane
Grasses &
Turf
Asparagus
Carrots
Tomatoes
Sainfoin
Acre*
(000)
Planted
76,200
8,200
71,500
11,600
130
170
320
24,800
36,000
1,400
59,300
900

90
100
450
NO
DATA
Acres Treated
(000)
Likely
Average
180
5
400
1
<1
60
15
200
10
830
6,540
90
30
25
5
110

Likely
Max
290
10
500
4
<1
100
30
340
30
920
11,540
140
60
50
10
130

Lb AX Applied
(000)
Likely
Average
30
3
65
1

15
4
110
4
430
1,980
90
30
25
1
60

Likely
Max
80
15
80
3

25
7
200
12
550
3,690
180
60
51
2
80

Application Rates
Ib ai/#
acre/yr
0.2
0.6
0.2
0.6

0.3
0.2
0.6
0.4
0.5
0.3
1.0
1.0
1.1
0.2
0.5

appl Ib
/year
1.0
1.0
1.0
1.0

1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0

ai/
A
app
1
0.2
0.6
0.2
0.6

0.3
0.2
0.6
0.4
0.5
0.3
1.0
1.0
1.1
0.2
0.5

States of Most
and % of Usage
States
IA 99%
WA UT 85%
WA OR 92%
LA 90%

ID WA 90%
WA OR 92%
WA OR UT ID
86%
NJ WA 85%
ID WA WI ME
77%
OH IL IN IA
66%
LA FL 100%

WA CA 81%
MN WI 81%
FL OH MI IN
78%

Usage
in Tnes<







MT MI

FL OR
MO MI




TN PA

 NOTES
 Calculations of the above numbers may not appear to agree because  they are displayed as rounded.


 % of each crop treated with metribuzin is 1% or less, except for soybeans.  The   likely average % of soybeans treated
is 11% and the  likely maximum % of soybeans treated is 20%.

-------
 NO DATA =  This site is NOT covered by EPA data sources.
 'Usage data primarily covers 1990  - 1994 for most sites and as early as 1987 for some sites.
 Likely averages are based on weighted averages of data with  most recent years and more reliable data weighted more.
Early years are   weighted very low.
 Likely maximums are an amount above which the  actual usage is unlikely to be.
 Application rates are calculated  from likely averages or are based on typical rather than maximum rates.
 SOURCES:  EPA data, USDA, and National Center  for Food and Agricultural Policy

                D.     Data Requirements

                       Data requested in the July 1985 Registration Standard for metribuzin included
                 studies on product chemistry, residue  chemistry, toxicology,  ecological effects, and
                 environmental fate. These data were required to support the uses listed in the Registration
                 Standard. Data Call-Ins were issued for metribuzin in 1991 and 1995 requiring additional
                 product chemistry, environmental fate and groundwater, and ecological effects data.  The
                 ecological effects, environmental fate and groundwater data have been submitted to the
                 Agency and reviewed. The residue chemistry data have been initiated by the registrant
                 but have not been completed. Appendix B includes all data requirements identified by
                 the Agency for currently registered uses needed to support reregistration.

                 E.     Regulatory History

                       Metribuzin was registered in the United States in 1973 for use as a herbicide. In
                 July, 1985, a Registration Standard (NTIS # PB86-174216) was issued for metribuzin.
                 The Registration Standard  required submission of additional  data in the  areas of
                 toxicology, product and residue chemistry, ecological effects, and environmental fate and
                 groundwater.  The Standard also classified metribuzin as "Restricted Use" based on
                 potential for groundwater contamination and possible carcinogenic effects.   This
                 classification was deleted six months after it was instituted, following the evaluation of
                 additional data submitted by the registrant, Miles, now Bayer Corporation, clarifying
                 carcinogenicity effects. This Reregistration Eligibility Decision evaluates data submitted
                 in response to the Registration Standard and subsequent data call-ins.

          III.    SCIENCE ASSESSMENT

                 A.     Physical Chemistry Assessment

                        IDENTIFICATION OF ACTIVE INGREDIENT

                        Metribuzin is a white crystalline solid with a melting point of about 126 ฐC.  Pure
                 metribuzin is soluble in water at 1200 ppm, and soluble in dimethylformamide (178 g/100
                 g), chloroform (85 g/100 g), acetone (82 g/100 g), ethyl acetate (47 g/100 g), methanol
                 (35 g/100 g), ethanol (19 g/100 g), toluene (12 g/100 g), xylene (9 g/100 g), and n-hexane
                 (0.2 g/100 g).

-------
       MANUFACTURING-USE PRODUCTS

       As of 7/29/96 there were two metribuzin manufacturing-use products (MPs)
registered to Bayer Corporation: a 90% technical (EPA Reg. No. 3125-270) and a 50%
formulation intermediate (FI) (EPA Reg. No. 3125-305). The formulation intermediate
is a wettable powder end-use product (EP).

       Physical Chemistry Assessment  -

       All pertinent data requirements are satisfied for the metribuzin 50% FI. (Some of
the 50% FI data requirements are fulfilled by data for the technical source product.)  Data
remain outstanding for the 90% T for GLNs 62-2 and 62-3 for the three manufacturing
process impurities.  The Agency has concerns that the three manufacturing impurities,
which are structurally related to metribuzin and are present at greater than 0.1% in the
product, could be of toxicological concern. The registrant must either demonstrate that
these impurities are not toxicologically significant, or provide upper certified limits.  In
addition, the label claim of 90% is not in agreement with the nominal concentration of the
active ingredient Per PR Notice 91 -2, dated 5/2/91, the label claim for the product must
reflect the nominal concentration of the active ingredient.

       The registrant must submit the outstanding data for the 90% T for GLNs 62-2 and
62-3 concerning the three manufacturing process impurities, and certify that the suppliers
of beginning materials and the manufacturing processes for the metribuzin MPs have not
changed since the  last  comprehensive  product chemistry review.   If changes  have
occurred, then the registrant must submit complete updated product chemistry data
packages.

B.     Human Health Assessment

       1.     Toxicology Assessment

             The toxicological data base on metribuzin is adequate and will support
       reregistration eligibility.

             a.     Acute Toxicity
       Table 2 summarizes the acute toxicity and toxicity categories  of metribuzin.

-------
Table 2:  Acute Toxicity Data
GLN
No.
ง81-1
ง81-2
ง81-3
ง81-4
ง81-5
ง81-6
Study
Acute Oral - rat
Acute Dermal - rabbit
Acute Inhalation - rat
Primary Eye Irritation
- rabbit
Primary Skin
Irritation - rabbit
Dermal Sensitization -
guinea pig
% a.i.
Technical
Technical
92.6%
Technical
Technical
93.5%
MRID
00106158
00106149
00157524
00106158
00106158
41555101
Results
LD50 =
m = 2.3 g/kg
f= 2.2 g/kg
LD,n>20g/kg
LC,0>0.648-mg/L
• not an eye irritant
PIS = 0.33/8.0
not a dermal irritant
Not a dermal sensitizer
Category
III
IV
III '
IV
IV
NA
       * Note: Data pertaining to acute eye irritation, dermal irritation, and dermal sensitization are not required to
       support the reregistration of the TGAI. These data are presented only for informational purposes.

              Acute toxicity studies with metribuzin indicate low toxicity. The LD50 in an acute
       dermal study with rabbits was greater than 20 g/kg, no systemic toxicity and no mortality
       was noted.  An acute inhalation toxicity study in rats, using the maximum obtainable
       concentration of technical metribuzin as dust, found the LC50 was greater than 0.648
       mg/L. Metribuzin was not an eye irritant in a primary eye irritation test in rabbits.  In a
       primary dermal irritation study, metribuzin produced very slight irritation on rabbit skin.
        Metribuzin was found not to produce a dermal sensitization reaction in guinea pigs under
       conditions of the study.

                     b.    Subchronic Toxicity

                           In a  21-day dermal toxicity study,  New Zealand rabbits of the
                     HCrNZW strain from Interfauna UK Limited, Huntingdon, England were
                     exposed to either 0, 40, 200 or 1000 mg/kg/day of metribuzin (DIG 1468,
                     technical 94.0% a.L; batch 238603171). The treatment area on the backs
                     and flanks of the rabbits was a shaved area approximately 11 x 12 cm.
                     The solution of metribuzin was applied to  4-ply gauze dressings which
                     were held in place with adhesive strapping tape for 6 hours. At the end of
                     6 hours, the dressing and strapping were removed and the treatment area
                     washed with soap and water. The rabbits were treated only on working
                     days (i.e., 5 consecutive days each week) for 3 weeks. No dermal irritation
                     was noted.  No animals died during the study.  High  dose males and
                     females had a dose-related increase in cholesterol.  T3 (triiodothyronine)
                     was decreased in all males, but statistically significant only at the high

-------
dose.  There was a statistically significant increase in N-demethylase and
cytochrome P450 activities in high dose males.  Thus, the systemic toxicity
NOEL is 200 mg/kg/day. The systemic toxicity LOEL is 1000 mg/kg/day
based on increased plasma cholesterol and liver enzyme activities.  Due to
the lack of dermal irritation, the dermal Noel is equal to or greater than
1000  mg/kg/day and the  dermal toxicity LOEL is greater than  1000
mg/kg/day. (GLN 82-2; MRID 43970701).

      In a 21-day inhalation toxicity study Wistar TNO/W 74 albino rats
from Winkelmann, Borchen were exposed to metribuzin (DIG 1468,  98.2
and 93.1% a.i.) in Ethanol-lutrol 1:1 (polyethylene glycol 400) at analytical
doses ranging from 32 to 720 mg metribuzin/m3 air.  A control group of
males and females  was exposed to the  ethanol-lutrol.  The animals'
conditions of exposure ensured that aerosols could only be inhaled.
Groups (10 males and 10 females) were  exposed to the aerosols daily for
six hours.  Systemic toxicity related to treatment with metribuzin was
noted in the  high exposure level as increased clinical signs of toxicity
(disturbed behavior which was comprised of animals appearing apathetic
and with ungroomed coat), increased N-demethylase, O-demethylase, and
cytochrome P-450 activities along with increased  liver weights, which
indicate increased activity in the liver. Body weight gains were decreased
in all treated groups.  However, these decreases were not dose related, the
decreases were of great variability, and  did not appear to be  of any
toxicological significance. There were increased absolute  and relative
thyroid weights. For systemic toxicity, the NOEL is 219 mg/m3 air (0.219
mg/L). The LOEL is 720 mg/m3 air (0.720 mg/L) based on clinical signs
of toxicity, increased liver enzyme activities, and increased organ weights
(GLN 82-4; MRID 00153706).

      Two subchronic 90 day feeding studies in rats and one in dogs (an
unvalidated Industrial Biotest Study) were conducted. However, they were
classified as unacceptable due to multiple  deficiencies.  These  studies were
not required to be repeated since the chronic toxicity study was acceptable.

c.    Chronic toxicity and Carcinogenicity

      In a two year chronic toxicity study, Beagle dogs from Appleton
Kennels, England received either 0, 25,  100, or 1500 ppm (0, 0.82, 3.44,
or 55.65  mg/kg/day for males; 0,  0.84,  3.56, or 55.3 mg/kg/day for
females) of metribuzin (BAY 94 337 technical 99.5% a.L, batch 1603/71)
in the diet. Toxicity was noted at the high dose in the form of mortality
(75%  of the 1500 ppm group) along with decreased body weight, increased
relative liver  weight and changes in liver and kidney function (increased
                      10

-------
SGOT and SGPT levels, increased ornithine-carbamyl transferase levels,
increased BSP retention, increased alkaline phosphatase, increased total
protein in blood and urine, increased urea, decreased creatinine, increased
blood sugar and increased cholesterol). For chronic toxicity the NOEL is
100 ppm (3.44 mg/kg/day in males, 3.56 mg/kg/day in females) and the
systemic toxicity LOEL is 1500 ppm (55.65 mg/kg/day for males, 55.3
mg/kg/day in females) based on  mortality,  decreased  body  weight,
increased liver weights and changes in clinical chemistry parameters (GLN
83-lb; MRID 00061260).

       In a  combined chronic toxicity and  carcinogenicity study
metribuzin (BAY 94 337 technical 99.5% a.i.; batch 1603/71) was fed to
Wistar rats from Winkelmann, Kirchborchem, Kreis Paderborn for two
years at doses of 0, 25, 35, 100, or 300 ppm (0, 1.3, 1.87, 5.27, or 14.36
mg/kg/day in males; 0, 1.68, 2.28, 6.53, or 20.38 mg/kg/day in females).
Toxicity was noted at the high dose as decreased body weight gain along
with pathological changes in the liver, kidneys, uterus, and mammary
glands. Pituitary adenomas and carcinomas were observed; however, this
was not considered to be statistically significant when compared to the
historical control data.  For chronic toxicity the NOEL is 100 ppm (5.27
mg/kg/day in males and 6.53 mg/kg/day in females).  The LOEL is 300
ppm (14.36 mg/kg/day in males, 20.38  mg/kg/day in females) based on
decreased body weight gain and pathological changes in the liver, kidneys,
uterus, and mammary glands. There was no evidence of carcinogenicity
in either sex (MRID 00061261).

       In a  repeat combined chronic feeding/carcinogenicity study,
metribuzin (93.0% a.i.; Batch 77-297-50) was fed to Fischer 344 rats from
Charles River Laboratories, Raleigh, NC  at doses of 0, 30, 300, or 900
ppm  (0, 1.3, 13.8, or  42.2 mg/kg/day in males; 0, 1.6, 17.7, or  53.6
mg/kg/day in females) for either 52 or 104 weeks. Toxicity was noted at
300 ppm and above based on decreased  body weight gain in females;
increased thyroid weight and thyroid/body weight ratio in males, increased
liver weight  and liver/body weight ratio in males and females. At the
lowest dose, there were statistically significant changes in thyroxine (T4)
and triiodothyronine  (T3) levels, but no other systemic effects were
observed.  The OPP/HED RfD Committee determined that the  1.3
mg/kg/day dose level (males) should be considered as the NOEL since the
effects at the 1.3 mg/kg/day dose were  considered to be of marginal
biological significance.  This conclusion was based primarily on the
knowledge that metribuzin is a liver enzyme inducer and that the rat has
no other compensatory mechanism to re-establish normal levels of thyroid
hormones other than to increase thyroid production of these hormones, the
                       11

-------
effect  observed  at the lowest dose was considered a  compensatory
homeostatic response and not a toxic effect.  There was no evidence of
carcinogenicity and there was no increase in tumor incidence. For chronic
toxicity, the NOEL is 30 ppm (1.3 mg/kg/day in males and 1.6 mg/kg/day
in females) and the LOEL is 300 ppm (13.8 mg/kg/day in males and 17.7
mg/kg/day in females) based on decreased body weight gains in females,
increased thyroid weights  in males, and increased liver weights in males
and females (GLN 83-5; MRID 42672501).

       In a carcinogenicity study, dietary doses of 0, 200, 800, or 3200
ppm (0,  25, 111,  or  438 mg/kg/day  for males; 0, 35, 139, or 567
mg/kg/day for females) metribuzin (92.9% a.i.) were given to GDI mice
from Charles River Laboratories for two years.  Systemic toxicity was
noted at the high dose as increased liver weights along with decreased
hemoglobin and hematocrit values.  This study demonstrated that under
these test conditions metribuzin does not increase the incidence of tumors
in mice.  For chronic toxicity, the NOEL is 800 ppm (111 mg/kg/day in
males, 139  mg/kg/day in females)  and the  LOEL is 3200 ppm (438
mg/kg/day for males, 567 mg/kg/day for females) based on increased liver
weights and decreased hematological parameters (GLN 83-2;  MRID
00087795).

d.     Developmental Toxicity

       In a developmental toxicity (teratology) study, metribuzin (92.6%
a.i.; Batch No. 77-297-50)  was administered in doses of 0, 25, 70, or 200
mg/kg/day by gavage on gestation days 6-18 to pregnant Charles River
CrhCD BR rats from Charles River Breeding Laboratories, Portage, MI.
Maternal toxicity was  shown at all dose levels as reduced body weight
gain,  reduced mean  gravid  uterine  weights,  and decreased  food
consumption. The mid (70 mg/kg/day)  and high (200 mg/kg/day) doses
showed an effect on the thyroid gland as demonstrated by reduced T4
levels. At the high dose there was also increased thyroid weight. The
maternal toxicity NOEL  is  less than 25 mg/kg/day and the  maternal
toxicity LOEL is equal to or  less than 25 mg/kg/day. For developmental
toxicity, the NOEL is 70 mg/kg/day and the LOEL is 200 mg/kg/day based
on decreased fetal body weight and reduced ossification or unossified skull
bones, ribs, vertebrae, sternebrae, pelvic bones, and appendages (GLN 83-
3a; MRID 00163802).
       In a developmental toxicity (teratology) study, American Dutch
rabbits from Langshaw Farms, Augusta, MI were given 0, 10, 30, or 85
mg/kg/day  of metribuzin  (92.7% a.i.; Batch 77-297-50) by gavage on
gestation days 6-18. Maternal toxicity  was noted at 30 mg/kg/day and
                     12

-------
above based on decreased maternal body weight gains on gestation days
18-28 at the mid dose level and decreased body weight gains, decreased
food consumption and decreased food efficiency on gestation days 7-19 at
the high dose level.  Developmental toxicity was noted at the high dose in
the form of an increased incidence of irregular spinous processes.  For
maternal toxicity,  the NOEL  is 10  mg/kg/day and the LOEL is 30
mg/kg/day,  based  on decreased weight gain on  days 18-28.    The
developmental toxicity NOEL  is 30 mg/kg/day and the developmental
toxicity LOEL is 85 mg/kg/day based on an increase incidence of irregular
spinous processes (GLN 83-3b; MRID 41249201).

       In a repeat developmental toxicity (teratology) study, New Zealand
white rabbits were given 0, 15, 45, or 135 mg/kg/day of metribuzin by
gavage on gestation days 6-18. Maternal systemic toxicity was noted at 45
mg/kg/day, as reduced body weight gain, and reduced food and water
intake. Additionally, at 135 mg/kg/day there was an increased incidence
of abortions and decreased body weights. For maternal toxicity, the NOEL
is 15 mg/kg/day and the LOEL is 45 mg/kg/day based on reduced body
weight gains  and reduced  food   and  water  consumption.    The
developmental toxicity NOEL  is 15 mg/kg/day and the developmental
toxicity LOEL is 45 mg/kg/day based on decreased fetal body weights,
increased number of runts and increased incidence of extra and partial ribs.
(GLN 83-3b; MRID 00087796).

       Based on the results of the existing studies, at this time metribuzin
is not considered to be a developmental toxin.  The developmental toxicity
observed in these studies occurred at or above doses that induced maternal
toxicity.

e.     Reproductive Toxicity

       In a two-generation reproduction  study, Crl:CD BR rats from
Charles River Breeding Laboratories, Portage, MI received in the feed 0,
30, 150,  or 750 ppm (approximately 0, 1.5, 7.5, and 37.5 mg/kg/day by
standard conversion factors) metribuzin (Sencorฎ  technical 92.6% a.L;
batch 77-297-50) . Systemic toxicity in both the parental animals and the
pups was noted at the mid dose as slightly decreased body weights in the
F1 high and the F2 mid and high dose pups.  The Fj females had decreased
body weight gains during the gestation period for mid and high doses; F0
and F[  females had increased body  weight during  lactation and
hypertrophy of hepatocytes in high dose males and mid and high dose
females.  The parental/offspring systemic toxicity NOEL is 1.5 mg/kg/day
and the parental/offspring systemic toxicity LOEL is 7.5 mg/kg/day based
                      13

-------
on decreased body weights and body weight gains and hypertrophy of the
hepatocytes (GLN 83-4; MRID 40838401).

f.      Mutagenicity

       Metribuzin was non-mutagenic in bacterial mutation assay systems
both  with and without metabolic  activation,  using  strains of SL
tvphimurium (TA1535, TA1537, TA98, and TA100), B. subtilus (NIG17
and NIG45), and E. coli (WP2 her) using concentrations of 0.2 to 2000
ug/plate of metribuzin  (technical Sencorฎ 93.7% a.i.).  The negative
control was DMSO. The positive controls were AAF, AF-2, 9-AA, NTG,
2-NF, and BP.  (MRID# 00086770; 00109254).

       No evidence of mutagenicity was seen in an in vitro CHO/HGPRT
assay when tested at doses ranging from 50-200 ug/mL with S-9 activation
and at doses ranging from  600-1000 ug/mL with out activation.  The
positive control was ethyl methane sulfonate and benzo(a)pyrene.  The
negative control was acetone (MRID 00157527).

       In  the preliminary screening cytotoxicity tests for an in vitro
Chinese hamster ovary (CHO) cell test severe cytotoxicity was observed
at doses equal to or greater than 1750 ug/ml without activation and at
doses equal to or greater than 584 ug/ml with S9 activation. For the study
the non-activated doses using a 20 hour harvest were 199, 299, 399,  499
or 598 ug/mL. The S9 activated doses using a 10 hour harvest were 37.5
or 50.0 ug/mL; and using a 20 hour harvest were 50.1, 100, 150, or  200
ug/mL. The positive control was mitomycin C and cyclophosphamide.
The negative control was ethanol.  No  statistically significant or dose-
related increases in aberration frequency were observed with nonactivated
metribuzin.  However, in the presence of S9 activation there was an
increase in chromosome and chromatid breaks, triradials, and quadriradials
which indicates that metribuzin is possibly an in vitro clastogen.  There is
no evidence of mutagenicity in the in vivo tests; therefore, the increase is
not considered to be of concern.  The  study was not repeated (MRID
42555102).

       A series of three in vivo tests for dominant lethal mutations in
NMRI mice  was performed.  Males were given 300 mg of metribuzin
(Sencorฎ 99.5% a.i.) by gavage and then mated with undosed females in
two of the tests. Females were given 300 mg/kg metribuzin, and were then
mated with untreated males.  On gestation day 14 females were sacrificed
and examined for the number of corporal lutea, viable implantation sites,
and dead  implants.  No statistically significant differences were noted
                      14

-------
(MRID 00086766).

      In an in vivo cytogenetic study, metribuzin at doses of 100 mg/kg
body weight failed to induce chromosomal aberrations hi Chinese hamster
spermatogonia (MRID 00086765).

      When tested at dose levels of 0.007 to 200 ug/ml, metribuzin did
not induce unscheduled DNA synthesis in rat primary hepatocytes. The
positive control was DMBA, and the negative control was ethanol or
DMSO. (MRID 00157526).

      These studies taken together satisfy GLN 84.

g.    Metabolism

      Metabolism studies in Wistar rats from Charles River Breeding
Laboratory, Inc., (Boston, MA.) using a single low dose (5 mg/kg) of I4C-
metribuzin (98.4-99.4% a.L; SA = 20.8 mCi/nmol), a single high dose
(500mg/kg) of 14C-metribuzin, and multidoses of 5 mg/kg unlabeled
metribuzin (99.0% a.L;  Lot# 51025) for 14 days followed by a  single
radiolabeled dose of 5 mg/kg were performed. No significant differences
were detected in the rates and routes of I4C-elimination between male and
female rats in either the low or high dose single administration group. The
studies indicated that metribuzin was rapidly excreted in the urine and
feces, with a plateau being reached at 48 hours for all single dose groups
excepting 72 hours for the high dose female feces. From 27.3 to 43.4% of
the radiolabel was found in the urine and from 55.8 to 71.5% in feces at 96
hours. Very small amounts of metribuzin were found in the blood at 96
hours. The high dose group had higher tissue levels, as expected, with the
GI tract having higher levels.  Sixteen metabolites of which 12 could be
identified were found in the urine. Very small amounts of the parent were
recovered. Many of the same metabolites were found in the feces. The
most prevalent metabolite in bom urine and feces was DA-N-Ac-Cys. The
metabolism of metribuzin in rats appears  to involve  deamination,
dethioalkylation, hydroxylation of the t-butyl side chain and conjugation.
(MRID 40255503).

h.    Dose-Response Assessment

      The OPP/HED RfD Peer Review Committee comprehensively
evaluates the toxicological database for a  pesticide chemical and
establishes the RfD for the chemical.  It also operates as  the Agency's
quality  assurance unit with respect to the acceptance or rejection of
                      15

-------
toxicological data for regulatory purposes; and determines whether a
chemical has been sufficiently tested to evaluate its carcinogenic potential
and  its effects on developmental or reproductive parameters.   The
OPP/HED RfD Peer Review Committee refers chemicals as necessary to
the  OPP/HED Cancer Peer  Review Committee  and/or  OPP/HED
Developmental and Reproductive Effects Peer Review Committee.

       The OPP/HED Toxicity Endpoints Selection Committee (TESC)
considers the available toxicology data for a pesticide chemical and
performs the dose-response assessment by  determining which of the
toxicological endpoints (if any) should be used in evaluating:  1) an acute
dietary risk  assessment, 2) a short-term occupational or residential
exposure  (1 to  7 days)  risk assessment, 3)  an  intermediate-term
occupational or residential exposure (1 week  to several months) risk
assessment, and 4) a chronic  (non-cancer) occupational or residential
exposure risk assessment.

       A NOEL is selected for use in calculating the MOE. TESC selects
the best toxicological study that most closely matches the duration of the
exposure of interest and the route of exposure.  For occupational or
residential scenarios, exposure is most likely via the  dermal and/or
inhalation route.  Therefore, the most appropriate toxicological endpoint
is provided by a dermal or inhalation toxicity study. If adequate dermal or
inhalation studies are not available, then an oral study may be identified for
use hi risk assessment. The NOEL from the oral study would need to be
adjusted by the dermal exposure factor to reflect the dermal exposure that
occurs in an occupational scenario.  If an appropriate study cannot be
identified (i.e., no effect occurs during the duration of exposure), the risk
assessment cannot be performed because the hazard that would be used in
the equation risk = hazard x exposure does not exist.

       1.     Reference Dose (Rfd)

       The OPP/HED RfD Committee  recommended that an RfD be
established on the basis of a two-year feeding study in rats (MRID
42672501). Increased absolute and relative weight of thyroid, decreased
lung weight in females, statistically significant increases in blood levels of
thyroxine (T4) and statistically significant decreases in blood levels of
triiodothyronine (T3) were observed at 30 ppm (1.3 mg/kg/day for males
and 1.6 mg/kg/day in females). However, as previously stated, the effects
observed at the lowest dose tested were considered to be of marginal
biological significance.  Therefore, the RfD Committee determined that the
dose of 30 ppm (1.3 in males) should be considered as a NOEL.  An
                       16

-------
uncertainty factor (UF) of 100 was applied to account for the inter-species
extrapolation and intra-species variability.  On this basis, the RfD was
calculated to be 0.013 mg/kg/day. It was also recommended to use the
reproductive toxicity  study (MRID 40838401)  with a NOEL  of 1.5
mg/kg/day as a co-critical study.

       The OPP/HED RfD Peer Review Committee met on January 5,
1995, to discuss the weight of the evidence on metribuzin's carcinogenic
potential, and to determine if review to the OPP/HED Cancer Peer Review
Committee was appropriate. The Committee determined that referral was
not warranted. Metribuzin was classified as Group D, not classifiable as
to human carcinogenicity. The Committee based this classification on the
lack of evidence for carcinogenicity in the following studies:  1) a mouse
study in which there were no increases in tumor incidences at dosing levels
up to 438 mg/kg/day for males and 567 mg/kg/day for females (MRID
00087795); 2) a 1974 (MRID 00061261) rat study (SPF Wistar rats) in
which the observed pituitary adenomas  and  carcinomas  were not
statistically significant at dosing levels up to 14.36 mg/kg/day for males
and 20.38 mg/kg/day for females; and 3) a 1993 (MRID 42672501) rat
study (Fischer [CDF(F-344)/BR] rats) which indicated no evidence for
carcinogenicity at dosing levels up to 42.2 mg/kg/day for males and 53.6
mg/kg/day for females.

       2.    Toxicological Endpoint Selection for Use in Human
             Risk Assessment

             (a)  Dermal Absorption Factor

             No  acceptable  dermal  absorption data are  available;
             therefore, a default assumption of 100% is used in this
             assessment..

             (b) Acute Dietary Assessment (one day)

             This risk assessment is required. The NOEL to be used for
             calculating the  MOE is 15  mg/kg/day from  an  oral
             developmental toxicity study in rabbits (MRID 00087796).
             (The LOEL was 45 mg/kg/day based  on decreased fetal
             body weight, increased number  of runts, and increased
             incidence of extra and partial ribs.)  The NOEL from a
             developmental   toxicity  study was  selected for  this
             assessment since the possibility exists that the exhibited
             effects could be caused by  a one-day  exposure.   The
                      17.

-------
      Agency considers an MOE of 100 to be acceptable when
      the NOEL is taken from an animal study.

      (c) Chronic Dietary

      The  RfD  is  the  traditionally  accepted  endpoint  for
      calculating a chronic dietary assessment.

      (d)   Short Term  (1  to  7 days) Occupational Dermal
      Assessment
              and
      Intermediate Term (1 week to several months) Occupational
      Dermal Assessment

      These risk assessments are not required.  In the 21-day
dermal toxicity study in  rabbits  (MRID 43970701) minimal
systemic changes were noted at the 1000 mg/kg/day. However, no
dermal irritation was noted at any dose level.  Since the dermal
NOEL is equal to or greater than 1000 mg/kg/day (highest dose
tested), the 21-day dermal study does not support performing a
short term or intermediate term DERMAL risk assessment.

      (e)  Short Term  (1 to 7 days) Occupational Inhalation
      Assessment
              and
      Intermediate Term (1 week to several months) Occupational
      Inhalation Assessment

      These risk assessments are required. The NOEL to be used
for calculating the MOE is 219 mg/m3 from a 21-day inhalation
toxicity study (MRID 00153706). (The LOEL is 720 mg/m3 (0.720
mg/L) based on clinical signs of toxicity, increased liver enzyme
activities and increased organ weights).

      Route-to-route extrapolation was used to convert the animal
inhalation concentration into a mg/kg  dose by the following
equation:

(•mg/L/dav)CAVRWDฅAF)   = mg/kg/day
      BW
where:

mg/L/day = 0.219 mg/L/day from the 21-day inhalation toxicity
               18

-------
             study

             A = absorption of inhaled material  = l(i.e., 100%, which is a
             default assumption used by the Agency)

             RV = 8.46 L/hr = mean liters of air respired per hour by the rat

             D = 6 hr = daily duration of exposure during the 21-day study

             AF = 1 = default animal activity factor

             BW = 0.190 kg = mean rat weight

          f0.219ฅlฅ8.46ฅ6)m   = 58.5 mg/kg/day
                    (0.190)

                The Agency considers a MOE equal to or greater than 100 to be
             sufficiently protective when the NOEL is taken from an animal
             study.
             3.
      WHO
2.
The  Joint FAO/WHO Meeting on Pesticide Residues has not
evaluated metribuzin.

Exposure Assessment
      The residue chemistry data base for metribuzin is now substantially
complete for reregistration purposes.  A reasonable dietary risk assessment of
metribuzin can be performed using the available residue data. The need for
additional/revised tolerances or revisions to exposure assessments will be made
upon review of any new data.

      The Residue Chemistry Chapter of the Reregistration Standard was issued
12/20/84. As previously stated, the Metribuzin Reregistration Standard Guidance
Document was issued 6/85  and the Reregistration Standard Update was issued
4/10/90.  These documents summarized the regulatory conclusions based on the
available residue chemistry data and  specified the additional data required for
reregistration  purposes.  Several data submissions have been received and
evaluated since the Update; a few submissions are still under review.

      The Agency has recently updated the Livestock Feeds Table (Table II of
the Pesticide Assessment Guidelines, Subdivision O, Residue Chemistry, issued
                             19

-------
September 1995). Any new data requirements as a result of Table II changes are
being imposed at the issuance of the RED.  The need for additional tolerances
and/or revisions to exposure/risk assessments will be made upon receipt of the
required data.

       New alfalfa and field corn trials, and field rotational crop studies need to
be submitted as confirmatory data. These studies  have been initiated by the
registrant. Tolerances for these commodities will be reassessed once the data have
been submitted and reviewed.

       The available data for alfalfa forage and hay are insufficient to completely
support the established tolerances on these commodities because of inadequate
geographic representation of data. The western growing region is not represented,
and the states for which residue data are adequate (e.g., states where tests were
conducted  according to the parameters of registered metribuzin uses on alfalfa)
represent less than one-fourth of the 1988 U.S.  alfalfa hay production.  The
tolerances  may be revised once confirmatory data, which is in  progress,  is
submitted and reviewed.

       a.     Dietary Exposure

             GLN 171-4 (a): Plant Metabolism

             The  qualitative nature of  the residue  in plants is adequately
       understood based on upgraded soybean and  wheat  metabolism studies
       which are supported by  supplemental alfalfa, potato, sugarcane, and
       tomato metabolism data. The residues of concern in plants are metribuzin
       and its triazinone metabolites.

             The  metabolism of metribuzin in plants occurs  via deamination
       and/or dethiomethylation to yield triazinone moieties and their conjugates.
       The requirements for radiovalidation of  the current or any proposed
       enforcement analytical method using samples from soybean and wheat
       metabolism studies have been waived.  The waiver was  granted  after
       comparing the methodologies employed in these  metabolism studies with
       the current enforcement method, and because samples from these studies
       have been depleted.

       Soybean Metabolism Study:  The total radioactive  residues (TRR,
       expressed as metribuzin equivalents) found following a preemergence soil
       application of [14C]metribuzin at 0.3 Ib ai/A (active ingredient/acre) were
       12.1 ppm in soybean plants  and 0.48 ppm in mature soybean seeds. The
       major organosoluble residue identified in soybean plant tissue was 6-(l,l-
                             20

-------
dimethylethyl)-3,5-(diketo)-1,2,4-triazin-5-(2H,4H)-dione (DADK), which
is  19.2% of the TRR.  The minor  organosoluble residues include
metribuzin,  4-ammo-6-(l,l-dimethylethyl)-3,5-(diketo)-l,2,4-triazin-5-
(2H,4H)-dione (DK), hydroxy-t-buryl DADK, hydroxy-t-butyl metribuzin,
and 3-amino-DA which collectively accounted for  ~3.6% of the TRR.  In
soybean seeds, the major organosoluble residue identified was free or
conjugated DADK which is 44.5% of the TRR. There was a supplemental
study designed to determine the nature of the residue in the aqueous
fraction. The glucose conjugates of DADK (17% of the TRR) were found
in soybean plant tissues.  The glucose conjugates of DK (10.7% of the
TRR) were found in seeds.

Wheat Metabolism Study:  Wheat grown to the 3-tiller stage was treated
postemergence with [5-14C]metribuzin at 0.15  Ib ai/A; the resulting TRRs
at the following pre-harvest intervals (PHI) are listed below:

Table 3:  Total Radioactive Residues in Wheat
Commodity
Forage
Forage
Straw
Grain
PHI (days)
0
7
33
33
TRR (ppm, expressed as metribuzin equivalents)
5.4
1.2
5.5
0.2
       The organosoluble residues  identified  in  wheat forage were
metribuzin (42.8% of TRR), DADK (6.8% of TRR), and DK (7.5% of
TRR).  The  organosoluble  residues identified in wheat straw were
metribuzin (3.9% of TRR), DADK (11.2% of TRR), DK (3.5% of TRR),
6-(l,l-dimethylethyl)-3-(methylthio)-l,2,4-triazin-5-(4H)-one(DA)(0.7%
of TRR), 3-amino DA (4.3% of TRR), and hydroxy-*-butyl-DADK (0.6%
of TRR).  A large percentage of the metribuzin  residues in wheat straw
were bound and shown to be associated with  lignin (~25% of TRR) or
other biopolymers (10-15% of TRR) such as starch or protein. In grain,
residues were found to consist of metribuzin, DADK, DK, DA, hydroxy-?-
butyl-DADK, and hydroxy-f-butyl-DA which  collectively accounted for
9.3% of the TRR. In a separate study designed to elucidate the nature of
the residue in the aqueous fraction, the only residue identified was tert-
leucine (10.7% TRR).

       GLN 171-4 CbV.  Animal Metabolism

       The qualitative  nature of the  residue  in animals  is adequately
                      21

-------
understood based on acceptable poultry and ruminant metabolism studies
reflecting oral exposure.  The residues of concern in animal commodities
are metribuzin and its triazinone metabolites.  The requirements  for
radiovalidation of the enforcement method using samples from the animal
metabolism studies have been waived.

Ruminant Metabolism  Study:   Two  goats were  orally  dosed with
[5-14C]metribuzin at approximately  410 ppm (approximately 59x  the
calculated dietary burden of metribuzin for ruminants) in the diet for three
consecutive days. The TRR were 12.66 ppm in liver, 4.27 ppm in kidney,
0.97 ppm in fat, 0.44 ppm in muscle, and 0.25-2.09 ppm in milk.  The
major residues identified in muscle, fat, kidney, and liver tissue of goats
were metribuzin, its major metabolites (butylthion, DA, the sulfamate
conjugate of metribuzin, and the glucuronide conjugate of 2-methyl-DK),
and its minor metabolites (DADK, DK, and 2-methyl-DADK).

       The OPP/HED Metabolism Committee met on October 21, 1993,
and concluded that the three metabolites (butylthion, 2-methyl-DADK and
the glucuronide conjugate of 2-methyl-DK) which  are found only in
ruminant  tissues need not  be  specifically included in the tolerance
expression (Le., methodology for the separate determination of these three
compounds is not needed).

Poultry Metabolism  Study:   Laying hens were  orally  dosed with
[5-14C]metribuzin at approximately 400 ppm (approximately 500x the
calculated dietary burden of metribuzin for poultry) in the diet for three
consecutive days. The TRR were 33.6 ppm in liver, 36.3 ppm in kidney,
1.6 ppm in muscle, 5.3 ppm in gizzard, 4.0 ppm in fat, 4.5 ppm in skin, 5.3
ppm in heart, and 0.2-1.0 ppm in eggs.  The study adequately characterized
and identified the majority of the total radioactivity including 64.4% of the
TRR in liver, 55.9% in kidney, 84.2% in muscle, 92.8% in fat, 75.9% in
skin, and 63.2% in eggs.  The terminal residues in poultry liver, muscle,
and  fat tissues; and in eggs  were metribuzin and its metabolites DA,
DADK, and DK; and their conjugates.

       GLN 171-4 (c) and (d): Residue Analytical Methods - Plants and
       Animals

       Adequate methods are available for tolerance enforcement and data
collection for residues of metribuzin and three of its triazinone metabolites
(DK, DA, and DADK) in/on plant and animal commodities. The chemical
structures of these four chemicals are presented in Figure A.
                      22

-------
Figure A.  The Chemical Structures of Metribuzin and Three of its Triazinone
                                     Metabolites.
                 CH,  O
H,C^  ^y ^N
      N
                     -tf ^S
  metribuzin: 4-amino-6-(l,l-
  dimethylethyl)-3-(methylthio)-l,2,4-triazin-
  5-(4H)-one
                                                           CH,
                                                        H3C
                                                        H,C
                                                                  NH
                                                                     ,CH3
                              DA: 6-(l, 1 -dimethylethyl)-3-(methylthio)-
                              1,2,4-triazin-5-(4H)-one
                           ,NH2
  DK:  4-amino-6-(l,l-dimethylethyl)-3,5-
  (diketo)-1,2,4-triazin-5-(2H,4H)-dione
                              DADK:  6-(l, l-dimethylethyl)-3,5-(diketo>
                              1,2,4-triazin-5-(2H,4H)-dione	
                    Tolerance enforcement methods (plant commodities):  The Pesticide
                    Analytical  Manual  (PAM, Vol.  II,  Section  180.332) lists two gas
                    chromatography (GC) methods, designated as Methods I and II, with
                    electron capture detection (BCD) and a detection limit of 0.01 ppm for
                    determination   of  metribuzin,  DK,  DA,  and  DADK  in/on  plant
                    commodities.   Method I is suitable  for determination of residues of
                    metribuzin and DADK only.   Method II, the  preferred  enforcement
                    method, is suitable for determination of residues of metribuzin, DK, DA,
                    and DADK.  Method II can detect all four compounds even if they are
                    present as water-soluble conjugates.

                    Tolerance enforcement methods ranitnal commodities'): Although there are
                    no  methods  listed  in  PAM Vol. II for  the enforcement of animal
                    commodity tolerances, an adequate method is available.  A GC/ECD
                    method, designated as Mobay Method Report No. 42257, is suitable for
                    determination of residues of metribuzin, DK, DA, and DADK in animal
                    tissues, milk, and eggs.  In this method, metribuzin per se is converted to
                    DK, and DA is converted to DADK.  Mobay Method Report No. 42257
                                          23

-------
had been subjected to successful Agency method tryouts and should be
forwarded to FDA for inclusion in PAM Vol. II.

Data  collection methods:  Field and  processing  data  submitted for
tolerance reassessment were  collected  using  the current enforcement
methods or modifications thereof.  The  registrant provided adequate
method validation data to verify the suitability  of these methods for data
collection.

Multiresidue methods: The FDA PESTDATA database dated 1/94 (PAM
Vol. I, Appendix I) indicates that metribuzin, DK, DA, and DADK are not
recovered using multiresidue method PAM  Vol. I Sections 303 (Mills,
Onley, Gaither method) and 304 (Mills fatty food method). The database
also indicates that when Section 302 (Luke  method) is used, DA  is
completely  (>80%) recovered, and metribuzin is variably recovered;
however, DK and DADK are not recovered.

       GLN 171-4 (el:  Storage Stability

       Residues of metribuzin per se are stable under frozen storage
conditions (—20 ฐC) for up to 24 months in/on field corn grain, forage, and
fodder; sweet corn; soybeans and soybean hay;  tomatoes; and in corn oil.
Residues of metribuzin are stable for up to 17 months in tomato catsup and
tomato juice; and wheat bran, flour, and shorts. Residues of metribuzin are
stable for up to 12 months in/on asparagus, declining approximately 30%
after  18 months  and approximately 50% after 24  months of storage.
Metribuzin residues are stable in/on soybean forage for up to 18 months,
declining approximately 50% after 24 months. Residues of metribuzin are
stable for up to 18  months in corn meal declining approximately 35% after
24  months.   In tomato  pomace residues   of metribuzin degrade
immediately, declining approximately 35% after  1 month of frozen storage
and approximately 40% after 3 months of storage. The level then remains
constant through 17 months of storage. Since residues of metribuzin per
se were  not consistently stable,   all future  residue studies must be
supported by concurrent storage stability data.

       Residues of DADK and DA (metribuzin's metabolites) are  stable
under frozen storage conditions for up to 24 months in/on asparagus; field
corn grain,  forage, and fodder; sweet corn; soybeans, forage, and hay;
tomatoes; and in corn oil and meal. Residues are also stable for up to 17
months in tomato catsup, juice, and pomace; and wheat bran, flour, and
shorts.  Residues of DK are relatively stable under frozen storage
conditions for up to 24 months in/on sweet corn, soybeans, tomatoes, and
                      24

-------
 corn meal; and for up to 17 months in wheat flour.   However,  for
 asparagus; field corn grain, forage, and fodder; soybean forage and hay;
 corn oil; tomato catsup, juice, and pomace; and wheat bran and shorts,
 recoveries of DK from storage stability samples were consistently less than
 concurrent method recoveries, indicating declines during storage of up to
 -60%.

       There are additional storage stability data indicating that residues
 of metribuzin per se are stable during frozen storage in/on alfalfa forage
 and potatoes for up to  1 year, green peas for 2 years, soybeans for  1.5
 months, and tomatoes for 3  years, but that residues of metribuzin and
 DADK are not stable in/on carrots during frozen storage.

       Information concerning the storage conditions and intervals of
 animal commodity samples from the previously evaluated poultry (MRID
 00045284, 00045286) and ruminant (MRID 00045283,00036772) feeding
 studies are required to confirm that animal  commodity samples from these
 studies were stored at the storage intervals for which residues of
 metribuzin and its metabolites of concern had been found to be stable in
 muscle (3 months), milk (17 months), and eggs (3 months).  If animal
 commodity samples  were stored, for longer intervals, then new animal
 feeding studies may be required.

       GLN 171-4 (k):  Magnitude oftheResidue in Plants

       The reregistration requirements for magnitude of the residue in
 plants are fulfilled for the following commodities: asparagus; barley grain,
 forage, hay, and straw; carrots; corn (field)  forage and fodder; grass forage
 and hay; lentils; lentil forage; peas (succulent and dry); pea vines and hay;
 sainfoin forage and hay; soybeans, forage and hay; sugarcane; tomatoes;
 and wheat grain, forage, hay, and straw. Adequate residue data, from field
 trials  conducted according to maximum registered use  patterns  are
 available for these commodities (or representative commodities).

       The registrant has indicated that additional trials on field corn and
 potatoes have been initiated in lieu of providing storage stability data for
 the length of time these commodities were stored. Once completed, the
 results must be submitted to EPA for evaluation.

. Aspirated Grain Fractions:. The Agency has recently revised its policy on
 aspirated  grain fractions  (previously referred to as "grain dust"), and
 determined that it should be considered a raw agricultural commodity. The
 Agency has also determined that aspirated grain fraction tolerances should
                       25

-------
be established based on the use of the pesticide on corn, wheat, sorghum,
and soybeans.  Presently, there are registered uses of metribuzin on com,
wheat, and soybeans. The available field corn aspirated grain fraction data
indicate that residues of metribuzin and its metabolites DA and DADK
were nondetectable ( < the level of detection (LOD)  of 0.01 ppm) and
residues of DK were nondetectable ( < LOD of 0.03 ppm) following
treatment at 5x. The tolerance for metribuzin residues of concern in/on
aspirated grain fractions will be evaluated after the outstanding data for
wheat aspirated grain fractions are submitted.

Carrots:  The  labels  for Miles' 75% DF (EPA Reg. Nos. 3125-325 and
3125-402)  were amended 9/14/94 to include metribuzin uses on carrots.
The presently registered uses of metribuzin on carrots are supported by
adequate residue data.  The  available field residue  data, reviewed in
conjunction with the establishment  of the tolerance petition PP#4E3112,
indicate that the combined residues of metribuzin and  its  triazinone
metabolites were below the established tolerance of 0.3 ppm following
multiple postemergence applications of the 75% DF at up to  4x the
maximum rate in trials conducted in CA, DE, IL, MI, NJ, TX, and WA.

Grass Forage and Hay:   There are no registered FIFRA  Section  3
metribuzin  uses on grassier se. The established tolerances of 2 ppm and
7 ppm for grass forage and hay, respectively, were established to cover
metribuzin  residues on grasses which may be treated incidentally in mixed
alfalfa pastures.  Adequate data are available to support the established
tolerances  for these commodities. These data are also  sufficient to cover
any residues that may arise from metribuzin uses under several recent
Section 24(c)  registrations on grasses grown for seed (SLNs OR900025,
OR900028 and WA930003, MT950007, WY950003).

       GLN 171-4 (Ti: Magnitude of the Residue in Processed Food/Feed

       Adequate processing studies have been conducted, to determine the
potential for concentration or reduction of the residues of metribuzin and
its triazinone  metabolites, in processed products of  the following raw
agricultural commodities:  field corn, potatoes and soybeans. Additional
processing studies on sugarcane, tomatoes, and wheat have been initiated
and the results, once completed, must be submitted to EPA for evaluation.
The wheat processing data will be translated to fulfill the reregistration
requirements for a barley processing study.
                       26

-------
             GLN 171-4 (T): Magnitude of the Residue in Meat. Milk. Poultry.
             and Eggs

             The reregistration requirements for magnitude of the residue in
       animals are tentatively fulfilled pending  submission of  acceptable
       confirmatory data on storage stability of animal commodity samples.
       There are no registered direct animal treatments for metribuzin on cattle,
       goats, hogs, horses, sheep, or poultry.

             The  maximum dietary burdens for beef and dairy cattle were
       previously calculated in the Metribuzin Registration Standard to be 7 ppm.
       (See Table 4)

Table 4:  Ruminant Dietary Burden
Commodity
Barley or wheat grain
Alfalfa or sainfoin forage
Soybean forage
Dehydrated tomato pomace
Tolerance
(ppm)
0.75
2 '
4
2
%Dry
Matter
	
21
24
	
Total
Beef Cattle
% of Diet
40
35
20
5
100
Burden
(ppm)
0.3
3.3
3.3
0.1
7.0
Dairy Cattle
%of
Diet
40
35
20
5
100
Burden
(ppm)
0.3
3.3
3.3
0.1
7.0
             It will be necessary to recalculate the dietary burden for ruminants
       after the outstanding field and  processing  data  for  ruminant feed
       commodities have been submitted and evaluated.
       Beef Cattle Feeding Study:  An  unspecified breed of cattle was fed
       unlabeled metribuzin at 3 or 10 ppm in the diet (approximately 0.4x and
       1.4x the calculated dietary  burden, respectively) for approximately 30
       days. The detected residues are given in Table 5.  As previously stated in
       the discussion  on Residue Analytical Methods,  in animal  tissues,
       metribuzin per se is converted to DK, thus being detected as a single peak,
       (level of detection (LOD) meat = 0.01 ppm). Similarly, DA is converted
       to DADK and is also  detected as a  single peak, (LOD meat = 0.02 ppm).

       Dairy Cattle Feeding Study:  An unspecified breed of dairy cattle was fed
       unlabeled metribuzin at 3 or 10 ppm in the diet (approximately 0.4x and
       1.4x the calculated dietary  burden, respectively) for approximately 30
       days.  The residues  detected in milk are also given in Table 5.  This
       procedure also converts metribuzin per se to DK (LOD milk = 0.002 ppm),
       and DA to DADK (LOD milk = 0.002 ppm).
                             27

-------
Table 5:  Results of Beef and Dairy Cattle Feeding Studies
TISSUE
Total Residues
(Metribuzin, DK, DA, and
(ppm)
DADK)
Diet of 10 ppm Metribuzin
muscle
liver
kidney
fat
milk
Non-Detectable (<0
03)
0.55-1.01
0.08-0.17
0.06-1.13
O.004 - 0.007
Diet of 3 ppm Metribuzin
muscle
liver
kidney
fat
milk
Non-Detectable (< 0.
03)
0.27 - 0.40
O.03-0.10
<0.05 - 0.07
O.004 - 0.006
                    The maximum expected dietary intake of metribuzin residues by
             poultry was previously calculated to be approximately 0.8 ppm from a diet
             consisting of 50% barley or wheat grain, 30% soybeans, 10% wheat milled
             by-products, 7% potato waste, and 3% sugarcane molasses.  It will be
             necessary to recalculate the dietary burden for poultry after the outstanding
             field and processing data  for poultry feed commodities have been
             submitted and evaluated.
             Poultry Feeding Study:  Laying hens were fed unlabeled metribuzin at 5
             ppm, 15 ppm, or 50 ppm in the diet (approximately 6.3x, 19x, and 63x the
             calculated dietary burden, respectively) for 28 consecutive days.  The
             resulting combined residues of metribuzin per se, DK, DA, and DADK,
             expressed as metribuzin equivalents, in eggs and poultry tissues are given
             in Table 6.
                                   28

-------
Table 6:  Combined Residues of Metribuzin (ppm) in Eggs and Poultry Tissues
Tissues
28-Day Eggs
Giblet
Muscle
Fat
Skin
Feeding level
5 ppm
0.011-0.020
0.12-0.17
<0.02-0.02
0.04-0.05
0.04-0.07
15 ppm
0.032-0.053
0.23-0.27
0.06-0.07
0.04-0.08
0.03-0.08
50 ppm
Not reported
1.13-1.80
Not reported
Not reported
Not reported
                    GLNs 165-1 and 165-2: Confined/Field Rotational Crops

                    A confined rotational study (MRID 40838402) had been submitted,
             evaluated, and classified as supplemental, not upgradable since (1) the test
             substance was applied at 0.5x the maximum rate for crops which can be
             rotated and (2) no storage stability data were provided. (A new confined
             rotational study is required.)

                    Although the  above study was classified as supplemental, it
             indicates that metribuzin residues accumulated in confined rotational crops
             (kale, red beets, and wheat) planted in sandy loam soil 32, 122, or 270
             days following treatment of the soil with [14C]metribuzin at 0.19 Ib ai/A.
             The major residue identified in the crops and soil was DADK; minor
             residues that were identified were DA, DK, OH-t-butyl-DADK, and 3-
             amino-DA.

             b.     Drinking Water Exposure

                    Acute (1  dav~) Exposure

                    A metribuzin concentration appropriate for use in an acute drinking
             water assessment is 21 ppb. This concentration was the  highest value
             detected in drinking water wells in the Central Sands area of Wisconsin.

       Exposure was calculated using the equation:
                                                                             ,-3 '
       Exposure (mg/kg/day) = (ppb (ug/L) metribuzin in the water consumed) (10
       ug/mg) (2L/day) divided by 60kg.

       in which 60 kg is the default assumption for female body weight and 2L is the
       default assumption for the amount of water consumed by an adult in a day.
                                   29

-------
Exposure = 0.0007 mg/kg/day
             Chronic Drinking Water Exposure

             Water consumption is  defined as all water obtained from the
      household tap that is consumed either directly as a beverage or is used to
      prepare foods (mixing water with a can of soup) and beverages (diluting
      frozen juice concentrate). Two generally accepted default values for water
      consumption are 2 liters (28.6 g/kg-body wt/day) or 1.5 liters (21.4 g/kg-
      body wt/day).  The 22.6 g/kg-body wt/day used in this calculation was
      derived using water consumption values and self reported body weights
      obtained from USDA's 1977-1978 Nationwide Food Consumption Survey.

             The other assumption used is assuming that water from the same
      source containing the same contaminant level is consumed throughout a
      70 year lifetime.  Most of the US population moves at some time during
      their life and does not live in the same area, drinking from the same water
      source for a 70 year lifetime.  It could be 'considered as either an over-
      estimation or an under-estimation of risk depending on the contaminant
      levels in the other sources of drinking water.

             The chronic drinking water exposure assessment is based on a small
      scale retrospective  study conducted in Portage County, Wisconsin, in
      which metribuzin and its DK, and DADK metabolites were detected in
      groundwater (six wells). All analyses of the DA metabolites were reported
      as BQL (Below Quantitation Limit). The information supplied indicated
      that sampling occurred from June 1988 through September  1989 with no
      samples taken January through April 1989, (i.e. 12 samples for each well).
      Analysis was by GC/MS (gas chromatography with a mass-selective
      detector) with  a  specified  LOQ (Limit of Quantitation) of  1 ppb.  A
      monthly concentration  for each well was calculated by adding the
      detections of metribuzin, DK, and DADK. Concentrations reported as
      BQL were averaged in as 0.5 ppb, which is one-half of the LOQ. Then,
      the concentrations from the 12 samples for each well were averaged to
      obtain a yearly  concentration.

The yearly average values calculated for the six wells are:
      AW1
      AW2
      AW3
      AW4
4.275 ppb
5.3667 ppb
3.7 ppb
5.25 ppb
                            30

-------
      AW5  3.925 ppb
      AW6  5.2 ppb

Exposure was calculated using the equation:

Exposure (mg/kg/day) = (ppb metribuzin + DA + DK + DADK)(10'6)(22.6)

For the general population, the exposure values in mg/kg/day calculated for the
6 wells are:
       AW1
       AW2
       AW3
       AW4
       AW5
       AW6
0.0000966
0.0001212
0.0000836
0.0001186
0.0000887
0.0001175
For children (1-6), the exposure values in mg/kg/day calculated for the 6 wells are:
       AW1
       AW2
       AW3
       AW4
       AW5
       AW6
0.0004275
0.0005366
0.00037
0.000525
0.0003925
0.00052
             Metribuzin and its degradates are persistent and mobile. Thus, it
       is expected that metribuzin and its degradates would be available for
       runoff.  Metribuzin has been detected in surface  water samples with
       concentrations ranging from below the detection limit of 0.05 ppb to 7.6
       ppb. No information on detections of metribuzin degradates in surface
       water are available. A USGS stream reconnaissance survey of numerous
       midwestern streams in 1989,  1994, and 1995 collected samples during the
       first major runoff event after application. Thus, these samples could be
       considered to represent peak concentrations, not time-weighted averages.
       The 90th percentile concentrations for 1989, 1994, and 1995 respectively
       were 1.4, 1.2, and 0.5 ppb.

             These concentrations are less than the estimated yearly averages for
       groundwater,  although of the same order  of magnitude.   Thus, the
       exposures would be comparable. Annual means in surface water, unlike
       sometimes for groundwater, are typically substantially  less than peak
       concentrations.
                             31

-------
c.      Occupational Exposure

       An occupational and/or residential exposure assessment is required
for an active ingredient if (1) certain toxicological criteria are triggered and
(2) there is potential exposure  to handlers (such as mixers, loaders,
applicators) during use or to persons entering treated sites after application
is complete.

       All  products containing  metribuzin are intended primarily for
occupational  use;   no products containing metribuzin are  intended
primarily for homeowner use.  Therefore,  a handler assessment for a
residential scenario will not be conducted.

Handler (Mixer/Loader/Applicator) Exposure Scenarios

       The Agency has determined that there is a potential for exposures
to mixers, loaders, applicators, or other handlers during usual use-patterns
associated  with  metribuzin.    There are  potential  exposures to:
mixer/loaders supporting ground, aerial, and chemigation applications of
liquid, wettable powder, and dry-fiowable formulations; mixers/loaders
impregnating  fertilizer with metribuzin and  supporting impregnated
fertilizer applications; applicators using ground and aerial equipment to
apply  as a spray; applicators using granular equipment to apply the
impregnated  dry-bulk fertilizer; applicators using high-volume hand
equipment to apply liquid formulations (commercial turfgrass); fiaggers
participating in aerial application of sprays; and persons mixing, loading,
and applying using low-pressure handwand equipment.

       Based on the use patterns and potential exposures described above,
ten exposure scenarios for handlers  were identified for metribuzin: (1)
mixing/loading the liquid formulation,  (2) mixing/loading the dry-flowable
formulation, (3) mixing/loading the wettable  powder formulation, (4)
mixing/loading the impregnated dry-bulk fertilizer (5) applying as a spray
with aerial equipment, (6) applying as a spray with groundboom sprayer,
(7) applying the impregnated dry-bulk fertilizer, (8) applying  liquid
formulation with high-volume hand equipment, (9) flagging during aerial
spray application, and (10) mixing/loading/applying liquid formulations
with low-pressure handwand equipment. The mixing/loading to support
ground-boom applications scenario is considered worse-case (i.e. highest
exposure) for mixers/loaders supporting ground applications (other than
chemigation)  using other  types of  equipment.  Therefore, a separate
assessment for mixer/loaders supporting high  volume turfgrass sprayer
applications is not necessary.   The assumptions  used  in  defining the
                       32

-------
exposure scenarios are described in Table 7.

       As previously explained, a NOEL for calculating a MOE for dermal
exposure was not identified. Therefore, a dermal exposure occupational
assessment will not be performed.  Only a NOEL for calculating  an
inhalation exposure was identified. Therefore, only inhalation exposures
for agricultural workers have been assessed. Baseline inhalation exposure
values for uses of metribuzin are presented  in Table 8.  Note  that the
description of the calculations is in the footnotes.
                       33

-------
 01

^O
•4-*
 Q,


I


Q

_o

 C3


 O
CO

 2


 1
 Q.
.0



1


S










la
Commen

1
'i.
3



•g

g
3
CO
|
1/3
1





1
ฃ
I
.2
e
c
u;
S
ti
















1
1
X

l_

T3
0
c^
8
s





























line: Inhalation acceptable grades.
ation = 85 replicates;
confidence for inhalation data.
III
g
Io
OO
.*
"a

o ฃ

<3 .B
u *o
o "*
en ob
*-:
Q
U3
ฃ











g All Liquids (Ia,b)
^C
x;
is











line: Inhalation acceptable grades.
a tion =23 replicates;
confidence for inhalation data.
|ll
1
o
00
^T
.S




-------














13
g

O
o







.2
a.
^
•g
CO
*D
C
CO
55

8
o
I


Exposure Scenario (Number)


















ป*
3

tซJ5
•Q
ra .2
•ง —
S S S
III
Baseline: Inhalat
Inhalation = 18 re
High confidence 1




s
0
en
^
ffi
&*


ig (Liquids) (9)
'5)
E



























0
a
"S
c
~^
1
1
i
























ซ
S3 "e
•o o
M tn —
m o eo
li'l
Baseline: Inhalal
Inhalation = 96 re
Low confidence f





0
—
^
ง
s


•essure Hand Wand (10)
cu
J

U >" UU ^H
*C • .0 .S 3
C8 <4-H ^i3 S
C g  „
g -o n 05
S 0) _,
t- •*-> MTl ^3
o ^ 5P S
'f-1 a> "^ ซs
^ s o <;
"ฐ o ^ ง3

"bb a>
.S u -o w
s 3J*
.S o ซ 1
1 111
O co co "^
_^2 KJ q^ cd
di "^ "2 S
2r ID G3
c^ ^r ^
^2 Sfl en
2 '> >
ง 2 5a J
-5 tl^
^_j *Q ^ ^
O "5  J2
>^ ^J flj f"
WVJ

_
cci

G
JS

Q
ซAJ

'S
p*
cS
'g
ง
f
**i
S
*i
S



T-H
<4H
O
S
.1
'S
'a
Kj
•o
ง
03
IS
•a
>U

ซ
j|
a
ง J ซS ง
?
_o

"o
s-l
o
-*-ป
c
o
*en
en
o-
en
5

CO •^*s*
ซ Q
1 w

f3-i trl/
2 0
en .^ en
•ฃ "^ cs
> i— i JD
^ C ^
"o S *
eS ^ Q
en co u
TO -i-> en i*
1 8-11
brj >^ "3 &
.S. -o > X
115 I"'
O f •) _. S3
.^ '•" e ซ>
>^ "2 "ง ง S
s * 1 Q ง
8> <ง•ฃฃ•งซซ u"-2
ซ*< _&ป Coj ป.S*O J "O
1
|
1
| ilgg^gggll
idiiirsiiiti
MIllHllliU
f 8 s-ง3^ a-S'g |-a-S
QcSE5oฃtS2ffi!33.S


U3 -O





O

-------











.ฃ
3
_D
'ฃ
O


0
s
CO
D
u,
8
CS
0
i*
3
CO
0
O
X
W
M
o

JS
o
.E
"eu
CC

oo
.ฃ
-K




Ik-
1 1^
"ฃ,,ง•]=
*5
Q

(3 III
t- "^
•g-Jj
if c o
Mi
I II
o.
S
O




c
i*~
js o "5
03









S"
e
re Scenario (Scci
s
1
ซ



















g
c
W
•o
to
Mixer/Lo
























O Tf CS ~-
^^ OO Tf ซ""
CS 0 0 0

I
o
en

:

o
gar Cane/Noncrop 	
Asparagus
Other Crops
Carrots
3
CO

j


CS






ซ
S"
~
u
•5.
0.
i
1
i
1
ฃ'

en
s
g-
=
bO
.s
'i


OO C\ O (S
TT —• I-H O
O O O O
5
:
o
CO



m CS ซ cs
o
gar Cane/Noncrop
Asparagus
Other Crops
Carrots
3
CO













S"
\^s
c
.2

to
o
"5.
n,
o
5
•o
1
O


33
.ง•
^

^c
is


g
~"


o
en




a
1
5
S,
ซ




f;
O




CN

C
"i
CJ
"c
C
<
c
erial/Chemieatio
<
1
a

|
c
E
a
&
• c
'?
'i


S
0







a




r-
o







Other Crops






























S
o






s
0
IS
g
u






























en
o


0
oo




igar Cane/Noncrop
en












i
g
• c
"K
C

"c
C
c
c
T
\
a
2

_c
C
a
_ฃ
!E


CS
o







1
I
























^
)




o
0







Other Crops






























S
o





m
0
S
n
O






























2
0\


o
tn
en



vo
1
g
1
1
ฃ




en


en

c
.2
"oa
"c
c

c
.ฃ
™
• AeriaRChemiga
1
1
O
cu
1

I
DJ
C
!E


•*
o








1
CO


i






















J


i

S.
~







Other Crops






























8
m"





in
o
CJ






























en
oo
CS


g



VO
igar Cane/Noncrop
_>
CO











en
c
.2
"ea
..s
g
^r1
)r Groundboom i
C5
•o
0
eu

1


'>
ii


?
VO






M
Asparagus 	
























3



VO

-------
c
o
11?
Ill
= C5-ง
ea
D
.ฃ> x 3 Is"
slit

ill
SMS
ซ 'ci^'
S <"

o.
S
O




*J3 %
•5 =,-.
5 S1?
"I" I,
•™ 'ti "

gs
aa




s-
1


_0
CO
1
S
I
ta






•^ oo
en O





in
o



Other Crops
Carrots






























en



r-

„



Soybeans'
Alfalfa





.
ซj












^^ ^
2-
1
'•S
&
~s
P3
ฃ>
Q
M
C
1
ฃ

S














g

ffl
2
CS
"S
a
**























2 3 S |
o o o o-



o
CO

o


r
tt „ S3
1 111
fe < 0
S.

ซi


=ป
c>




-



S
J.
o
o
a
1

H
1
&
•o
'3
CT"
S

1


^J. ^4 \O *-ซ
en — o o
0 O O O



o
00

0


r
ง ง gc
fw 2 3
g O 2
ซ u. ฃ
03 pr ID ™
u f' 5 o
eo O
(jn.
3
tn



r-
o
















Q
U
I
O
*o
c
3
S
o


o
o



o
cx>

.



tl
OT






-'






g
"^
_0
1



0

j^



Soybeans?
Alfalfa





u
CS




^
_o
"o.
Q.
1
0>


O)
"ซ
1
S
!s

1
1
i























vo ซ> m 5S
— 0 0 g
o o o 0-



_,

ซn
>n c^ ^- ^
o


r
u
C3 w ซ
<ง I- 1 3
s "^ o
OJ>
S
m



CO


-












&
'O
I
CO
a
I

5
r-
cn

-------
 CO co
•o c
 03 O
 o '••=
•S's.
.s a,

ง|
t2 *
3 •ซ
as
c o
s g
G, i>
O t.
•— .0
 z n
 GJ <*••*
H3 ง
•5 ฐ.
 5ฃ O
 C/5 *O
 o g

.ซ /3"
o ซ

to 2
c o
"*^ C

S S
ฃ 03
CO ^
A) Cst
 n
 u- U
,o o
H-< O
 ^ ^
 S &
1 s
 ป•.ง
       3   x

       &   5
       •a   f
   ง   -a
        bo

       '53
        rt

        C
        co
        3

        CO
       JO
       ^
        o
       IS


       ~o
 ^i    •ง
 (O rt    CO
  ซM
   o

   I

  "o
     o .5
ซ1
   i
ซ S
™ฃ
"ฐ t!
C iuj
       'S
            ^
        ex
        a.
             g
        3
       O
       O
       o
       r—t

       "Sb
 . *
^ ~ ' -*
0>  Gj
0 X)

s "S
0  o
o  &
'3  OT
           CO
          ซ!"
          CO W
          a  H
     tN

 II
 s -
 3 U

.12
*^^

is
"o T3
 co o
 ra co
•O o
     co cs

     CN S
     —• s
     co E

     •^'S
     /^. KJ
     c^ S
     lA ซ>
     CN -5

     a*
      • CO
     O co
     >2* co

     g5!
     K co
        co
        bo
      o '—
      rt (O
      ป S
      O w
     *s ง•
     •s S-
      CO
       .2
       •*-ป
       o
       CO
       CO


       ง

       co
       CO
       CO
                  co
                 "C
                  c
        G    &
        2    o
       "e   =5
        CO

        o
        o
       .2
       '53
        CO

        O
        CO

       5

       Q
       pa
       rt


       1
       •o
       o

       co
       rt
        co
        S


        03
       -a

                                                                              CO
                                                                              CO
      S3
        &
        3
        co
   —  " J2  &:=
S  ง5

*'ซ g

-1 งB
O **5 ^^x C

ซ-s-s  s
     4!^  CO
      03
                  W>

-------
      Post-Application Exposures

      The Agency has determined that there is potential inhalation exposure to persons entering
treated sites after application is complete. These post-application .exposures may occur (1) to
agricultural workers following applications to vegetables and agronomic crops and to turfgrass
being grown for sod, and (2) to employees and the public following applications to turfgrass in
recreational areas.

      No active-ingredient-specific data are available for post-application inhalation exposures
to metribuzin. Although these exposures cannot be estimated, the Agency is not requiring this
data at this time.

             3.     Risk Assessment

                    a.      Dietary Risk

                           Acute (1 day) Dietary Risk

                           As  previously  stated, the  endpoint  for acute  dietary  risk
                    characterization is the NOEL from the rabbit developmental toxicity study,
                    15 mg/kg/day  (MRID 00087796).  Since this endpoint is  from a
                    developmental toxicity study, the population subgroup females (13+ years)
                    was used to represent women of child-bearing age. It was assumed that
                    one hundred percent of each commodity was treated with metribuzin
                    (100% CT), that all residues were at the current or reassessed tolerance
                    level as specified in Table 46, and that metribuzin is uniformly distributed
                    in the commodity supply.

                           The Margin of Exposure (MOE) is a measure of how closely the
                    estimated high end exposure comes to the NOEL. The  MOE for acute
                    dietary exposure for metribuzin was calculated using the  following
                    formula:

                                 MOE = 15 mg/kg/day
                                        Exposure

                    The calculated exposure of those individuals most highly exposed is 0.012
                    mg/kg/day. Thus:

                               MOE=15jng/kg/day_  =1,250
                                     0.012 mg/kg/day

                    The MOE is not less than  100; therefore, the Agency considers the MOE
                                          39

-------
to be sufficiently protective.

       Chronic Dietary Risk

       The RfD (0.013  mg/kg bwt/day) is used for assessing chronic
dietary risk. It was assumed that one hundred percent of each commodity
was treated with metribuzin (100% CT), that all residues were at the
current or reassessed tolerance level as specified in Table 11, and that
metribuzin is  uniformly distributed hi the commodity supply.

       The Theoretical Maximum Residue Contribution (TMRC) was
calculated for the U.S. population and 22 subgroups. The TMRC for the
U.S. population is 0.0046 which is 36% of the RfD. The commodity with
the largest contribution to the %RfD is wheat flour which is 7% of the
RfD. The two subgroups with the highest %RfDs are non-nursing infants
(less than 1 year) with the TMRC equal to 0.0081 and %RfD equal to 62%,
and children (1 - 6 years) with the TMRC equal to 0.0097 and %RfD equal
to 75%.  For children  (1-6 years)  the  commodity with the largest
contribution to the %RfD is wheat flour which is 16% of the RfD. The
second largest is boneless beef (lean without removable fat) which is 11%
of the RfD.

       These calculations represent a  "worst case" estimate of dietary
exposure for metribuzin since tolerance level residues and 100 %CT were
assumed. The RfD was not exceeded; therefore, the Agency's chronic
dietary risk concerns are not exceeded.

b.     Drinking Water Risk

       •Acute Drinking Water Risk

       The acute MOE for drinking water is calculated in the same manner
as the acute dietary (food source).

       MOE=15fmg/kg/dav)
          exposure (mg/kg/day)

       Chronic Drinking Water Risk

       Metribuzin chronic dietary risk from drinking water is calculated
using  the RfD, which is 0.013 mg/kg/day, and  exposure is based on a
groundwater  study. Thus, risk can be estimated using the equation
                      40

-------
% RfD = [exposure/RfD](100)

      The % RfD for the general population from drinking water are as
follows:

AW1  0.7%
AW2  0.9%
AW3  0.6%
AW4  0.9%
AW5  0.7%
AW6  0.9%

      The % RfD for children (1-6) are:

AW1  3%
AW2  4%
AW3  3%
AW4  4%
AW5  3%
AW6  4%

      All values are less than 1% of the RfD for the general population
and no more than 4% for the children (1-6).  Metribuzin has been detected
in surface water at concentrations less than the estimated yearly averages
for groundwater, although of the same order of magnitude.  Thus, the %
RfDs  would be comparable. The RfD was not exceeded; therefore, the
Agency's chronic dietary consumption of metribuzin in drinking water
(groundwater and surface water) is not exceeded.

c.    Occupational Risk

      A NOEL of 58.5 mg/kg/day, based on a 21-day inhaltion toxicity
study, is used for calculating MOEs for the short-term and intermediate
term inhalation scenarios.

        MOE =NOEL (58.5 mg/kg/dav)
                   inhalation exposure

      The inhalation MOEs are in Table 9.
                     41

-------
Table 9.  Baseline Short-Term and Intermediate-Term Inhalation Risk
Exposure Scenario (Seen. #)
Crop
Baseline Daily
Inhalation Dosef
(mg/kg/day)
Baseline Inhalation
MOEb
Mixer/Loader Risk
Mixing AH Liquids For Aerial\Chemigation Application (la)
Mixing All Liquids for Groundboom Application (Ib)
Mixing Dry Flowables for Aerial\Chemigation Application
(2a)
Mixing Dry Flowables for Groundboom Application (2b)
Mixing Wettable Powder for AerialXChemigation Application
(3a)
Mixing Wettable Powder for Groundboom Application (3b)
Sugar Cane/Noncrop
Asparagus
Other Crops
Carrots
Sugar Cane/Noncrop
Asparagus
Other Crops
Carrots
__ Sugar CaneWoncrop_
Asparagus
Other Crops
Carrots
Sugar Cane/Noncrop^
Asparagus
Other Crops
Carrots
__ Sugar Cane/Noncrop___
Asparagus
Other Crops
Carrots
Sugar Cane/Noncrop _
__ ...Asparagus 	
Other Crops
Carrots
0.03
0.01
0.006
0.002
0.007
0.003
0.001
0.0003
0.02 	
0.008
0.004
0.001
0,005
0.002
0.0009
* 0.0003
1,30 	
0.43
0.22 	
0.05
0,30
0,10 	
0,05
0.01
1,950
5,850
9,750
29,250
8,357
19,500
58,500
195,000
2,925 	
7,313
14,625
58,500
11,700
29,250
65,000
195,000
45 	
136
266
1170
195
	 585 	
5.850
                                   42

-------
Exposure Scenario (Seen. #)
Mixing/Loading Dry Bulk Fertilizer (4)
Crop
Soybeans
Alfalfa
Baseline Daily
Inhalation Dose*
(mg/kg/day)
0.45ฐ
Baseline Inhalation
MOE*
130'
Applicator Risk
Aerial (Liquid Application)-Enclosed Cockpit (5)
Groundboom Tractor (6)
Granular Drop-Type Spreader (Fertilizer Application) (7)
Spreader Truck (Metribuzin Impregnated Fertilizer
Application) (7)
High Volume Hand Sprayer— Turf Grass Applications (8)

Flagging (liquid applications) (9)
Sugar Cane/Noncrop
Asparagus
Other Crops
Carrots
Sugar Cane/Noncrop
Asparagus
Other Crops
Carrots
Soybeans
Alfalfa
Soybeans'
Alfalfa
Turf
Flagger Risk
Su|ar Cane/Noncrqp
Asparagus
Other Crops
Carrots
0.002
0.0007 .
0.0003
0.00009
0.005
0.002
0.0009
0.0001
0.001
0.021=
0.00009

0.008
0.003
0.001
0.0003
29,250
83,571
195,000
650,000
11,700
29,250
65,000
585,000
58,500
2,786'
650,000

7,313
19,500
58,500
195,000
Mixer/Loader/Applicator Risk
Low Pressure Hand Wand (10)
	 Sugar Cfme/Noncrop^
	 Asparagus 	
Other Crops
Carrots
0.002
	 M9.0.?. 	
0.0004
0.0001
.29,250
	 65,000 	
146,250
585,000
The baseline inhalation unit exposure assumes no respirator.  Daily Inhalation Dose
(mg/kg/day;) = Daily Inhalation Exposure (mg/day; see Table 8)/70 kg. Note that 70kg
is the Agency's default male body weight

MOE = NOEL (mg/kg/day)/Daily Inhalation Dose (mg/kg/day). The inhalation NOEL
(rat) = 58.5 mg/kg/day.

Registrant supplied data was used because no data was in PHED. Discussion to follow.
                                  43

-------
             All of the MOEs were calculated using the 70 kg default male body
      weight. If these MOEs were to be re-calculated using the 60 kg default
      female body weight, the MOEs would be slightly smaller. The calculated
      MOEs were  greater than 100 except for scenario 3a, mixing loading
      wettable powders for aerial and chemigation applications, although only
      at the highest label rate of 6 Ibs ai/acre.  A dust/mist filtering respirator
      (MSHA/NIOSH approval number prefix TC-21C) would provide an 80%
      protection factor. Thus, exposure would be considered to be 20% of the
      baseline inhalation exposure.  (See Tables 8 and 9 for an explanation of the
      calculations.)

      Daily Inhalation Exposure = (43.4)(.2)(0.001) (6) (350) = 18.228
             Where:  43.4 is the unit inhalation exposure value for open
                    mixing/loading of wettable powders (mg/lb/ai) protection
                    factor.
                    .2 is the 20% from the protection factor of 80%.
                    0.001 is the conversion factor from ug to mg.
                    6 is the application rate (Ibs ai/acre).
                    350 is the area treated (acres).

      Daily Inhalation Dose = 18.228/70 = 0.26

      MOE = 58.5/0.26 = 225

             A possible alternative to the use of a respirator would be the use of
      water  soluble packets.  Another  possible alternative  to the use of a
      respirator would be to lower the label rate of 6 Ibs ai/acre since label rates
      of 2, 1, and 0.25 Ibs ai/acre had MOEs greater than 100.

             The Agency  has  determined that no additional risk mitigation
      measures are required at this time for mixers/loaders impregnating dry bulk
      fertilizer,   or for applicators  applying  fertilizer impregnated with
      metribuzin. This determination is based on information provided to the
      Agency by Bayer Corporation in a letter dated August 21, 1996, in which
      the processes involved in treating fertilizer with metribuzin and applying
      the treated fertilizer were described. The Agency has used surrogate data
      from the Pesticide Handlers Exposure Database (PHED, Version 1.1) to
      estimate risks to these workers. A more detailed explanation follows.

      Mixers/Loaders Impregnating Dry Bulk Fertilizer

      At the Agency's request information was provided by Bayer describing the
process for impregnating dry bulk fertilizer with  metribuzin and for applying
                             44

-------
      metribuzin impregnated fertilizer. Bayer stated in their letter, dated August 21,
      1996, that the inhalation exposure to the mixer at the dealer site (where the
      impregnation takes place) is very similar to that of a worker who performs open
      system mixing under typical field use conditions. Therefore, open mixing/loading
      of wettable powders was used as the most appropriate scenario for surrogate data.
      The unit inhalation exposure value for open mixing/loading wettable powders is
      43.4 //g/lb ai (PHED Vl.l, inhalation grades A, B, and C, 44 replicates; medium
      confidence).

             The amount of fertilizer and metribuzin handled (at the dealer location)
      depends on the number of acres to be treated. According to metribuzin labels,
      impregnated fertilizer is applied to alfalfa and soybeans at a maximum rate of 1
      Ib active ingredient metribuzin per acre. From 200 to 450 Ibs of treated fertilizer
      may be applied per acre.

             Bayer stated that mixers/loaders can treat 2-3 tons of fertilizer per batch,
      and that it takes 15 to 20 minutes to treat one batch.  At 1 Ib active ingredient per
      200 Ibs fertilizer, each ton of fertilizer would require 10 Ibs of metribuzin active
      ingredient.

              If mixers/loaders prepare 3 batches per hour (an average of 20 minutes
      per batch), 24 batches could be prepared during an 8-hour work period.  At 3 tons
      per batch and 10 Ibs ai per ton, mixers/loaders would prepare 72 tons in a day and
      would handle 720 Ibs of metribuzin.  This  would equal 144,000 Ibs treated
      fertilizer (72 x 2,000 = 144,000) which would be sufficient to treat 720 acres at the
      rate of 200 Ibs  fertilizer per acre (144,000/200 = 720).  This appears to  be a
      reasonable estimate since Bayer estimates that dealers apply  fertilizer to an
      average of 700 to 800 acres per day.  Bayer indicates that in most cases dealers
      make the application because in February and March, when most applications are
      made, growers often do not have the appropriate equipment up and running.
      Additionally, dealers use spreader trucks which, according to Bayer, provides a
      more uniform application. Bayer indicates that dealers can treat from 400 - 1,200
      acres per day using spreader trucks, with 700  - 800 being the average.

             Risk for mixers/loaders impregnating dry bulk fertilizer was estimated as
      follows:

Daily inhalation exposure (mg/day) is calculated using the following equation:

unit exposure (uฃ/lb ai) x Ibs ai handled per day x 1/1,000 (ug to mg conversion)

Given, inhalation unit exposure value = 43.4 ng/lb ai, and
720 Ib ai handled per day.
                                   45

-------
      Therefore,

      43.4 ng x 720 Ibs handled/day x 1/1,000 (conversion to mg) = 31.3 mg/day.

      Daily inhalation dose (mg/kg/day) is calculated by dividing the daily exposure (mg/day)
      by the body weight (bw) of the worker:

      Given,

      Daily exposure = 31.3 mg/day, and
      bw = 70 kg.

      Therefore,

      31.3 mg/day - 70 kg = 0.45 mg/kg/day.

      Risk, in terms of margins of exposure, is calculated by using the following equation:

      NOEL (mg/kg/day) / daily dose (mg/kg/day) = MOE.

      Given,

      NOEL = 58.5 mg/kg/day, and
      Daily inhalation dose = 0.45 mg/kg/day.

      Therefore, the MOE for handlers mixing/loading to impregnate fertilizer with metribuzin
      is

      58.5 mg/kg/day / 0.45 mg/kg/day = 130.

             Because the MOE for mixers/loaders impregnating fertilizer exceeds 100, the
      Agency does not recommend that any additional measures to mitigate risk to these
      workers be required.

Applicators Applying Dry Bulk Fertilizer Impregnated with Metribuzin

             Bayer also stated, in the August 21,1996 letter, that a grower using conventional
      fertilizer-spreading equipment can treat from 100 to 300 acres per day; however, a dealer
      using a spreader truck can treat 400 to 1,200 acres per day. It was noted that spreader
      trucks are equipped with an activated charcoal filtering system.

             Because the Agency has no data for spreader trucks applying  treated fertilizer,
      "applying using a granular drop-type spreader" was determined to be the  most appropriate
                                         46

-------
surrogate data scenario from PHED for use estimating impregnated dry bulk fertilizer
applicator exposure to metribuzin.  The unit exposure value for granular drop-type
spreader applicator is 1.24 ng/lb ai  (PHED Vl.l, inhalation acceptable grades,  5
replicates; low confidence). Since spreader trucks may have functioning air filtering
devices, this should be considered a worst case scenario for fertilizer application.

Daily inhalation exposure (mg/day) is calculated using the following equation:

unit exposure (ug/lb ai) x application rate (Ibs ai/acre) x number of acres treated x 1/1,000
(ug to mg conversion)

Given,

inhalation unit exposure value = 1.24 ug/lb ai,
maximum application rate is 1 Ib ai per acre, and
maximum number of acres treated is 1,200

Therefore,

1.24 ug x 1 Ibs ai/acre x 1,200 acres x  1/1,000 (conversion to mg)  = 1.49 mg/day.

Daily inhalation dose (mg/kg/day) is calculated by dividing the daily exposure (mg/day)
by the body weight (bw) of the worker:

Given,

Daily exposure = 1.49 mg/day, and
bw = 70 kg.

Therefore,

1.49 mg/day •*• 70 kg = 0.021 mg/kg/day.

Risk is calculated by using the following equation:

NOEL (mg/kg/day) / daily dose (mg/kg/day) = MOE.

Given,

NOEL = 58.5 mg/kg/day, and
Daily inhalation dose  = 0.021 mg/kg/day.

Therefore, the MOE for applicators applying fertilizer impregnated with metribuzin is
                                   47

-------
58.5 mg/kg/day / 0.021 mg/kg/day = 2,786.

       Because the MOB for applicators applying fertilizer impregnated with metribuzin
exceeds 100, the Agency does not recommend that any additional measures to mitigate
risk to these workers be required.

                    Risk From Post-Application Exposures

                    There are no data available to address post-application exposure for
             persons reentering areas treated with metribuzin.  However, because no
             dermal endpoints of concern have been identified for metribuzin, the
             Agency has no special occupational post-application dermal exposure
             concerns.  Also, because metribuzin has a low vapor pressure and because
             the potential level of inhalation exposure following applications is low, the
             Agency has no special inhalation exposure concerns for workers or others
             reentering areas following metribuzin applications as long as the entry is
             delayed at least until sprays and dusts have settled out of the ah".

                    Additional Occupational Exposure Studies

                    No additional occupational exposure  studies are required for
             reregistration at this time.

             d.    Food Quality Protection Act (FQPA) Considerations

                           The FQPA of 1996 amended the FFDCA by setting a new
                    safety standard for the establishment of tolerances. In determining
                    whether a tolerance meets the  new  safety standard,  section
                    408(b)(2)(C) directs EPA to consider information concerning the
                    susceptibility of infants and children to pesticide residues in food,
                    and available information concerning aggregate exposure to infants
                    and children of such residues,  as well as the  potential for
                    cumulative effects from pesticide residues and other substances that
                    have a common mechanism of toxicity.

                           The FQPA amendments to section 408(b)(2)(C) require
                    EPA to apply an additional 10-fold uncertainty (safety) unless
                    reliable data demonstrate that the additional factor is unnecessary
                    to protect infants and children.

                           Section 408(b)(2)(D) establishes factors that the Agency
                     must consider in determining whether the safety standard is met in
                     deciding to issue or reassess tolerances. These factors include the
                                    48

-------
consideration of available information on the aggregate exposures
to the pesticide from dietary sources including drinking water as
well as non-occupational exposures such as those derived from
pesticides used in and around the home. The Agency must also
consider the potential cumulative effects of the pesticide for which
a tolerance is being sought as well as other substances that have a
common mechanism of toxicity.

       Because metribuzin has food uses, specific consideration of
the risks to infants and children, as well as aggregate exposures and
potential cumulative effects is warranted.
1)
Potential Risks to Infants and Children
       In determining whether a safety factor different than the
additional 10-fold factor is or is not appropriate for assessing risks
to infants and children, EPA considers all reliable data and makes
a decision using a weight of evidence approach taking into account
the completeness and adequacy of the toxicity database, the nature
and severity of the effects observed in pre- and post-natal studies,
and other information such as epidemiological data.

       For the purpose of assessing pre-and post-natal toxicity of
metribuzin, the Agency has evaluated three developmental studies
and  one  reproductive  study.   Based  on  the  current  data
requirements, these studies, when considered with other required
guideline  toxicity studies, constitute a complete database for
evaluating  pre- and post-natal effects for food-use chemicals.
However,  as  the Agency  fully implements the requirements of
FQPA, additional data related to the special sensitivity of infants
and children may be required.

Developmental and Reproductive Effects

       The effects observed in the metribuzin developmental and
reproductive  studies can be summarized as follows:

       In  a   developmental  toxicity  study,   metribuzin  was
administered by gavage on gestation days 6-18 to pregnant Charles
River Crl:CD BR rats. Maternal toxicity was shown at all dose
levels as reduced body weight gain, reduced mean gravid uterine
weights, and  decreased food consumption. The maternal toxicity
NOEL is less than 25 mg/kg/day and the maternal toxicity LOEL
                49

-------
is equal to or less than 25 mg/kg/day. For developmental toxicity,
the NOEL is 70 mg/kg/day and the LOEL is 200 mg/kg/day based
on  decreased  fetal body  weight and  reduced  ossification or
unossified skull bones, ribs, vertebrae, steraebrae, pelvic bones,
and appendages.

       In a developmental toxicity study, American Dutch rabbits
were given metribuzin by gavage on gestation days 6-18. Maternal
toxicity was noted at 30 mg/kg/day and above based on decreased
maternal body weight gains on gestation days 18-28 at the mid
dose  level and decreased body  weight gains, decreased food
consumption and decreased food efficiency on gestation days 7-19
at the high dose level.  Developmental toxicity was noted at the
high dose in the form of an increased incidence of irregular spinous
processes. The maternal toxicity NOEL is 10 mg/kg/day and the
maternal toxicity LOEL  is 30 mg/kg/day, based on decreased
weight gain on days 18-28. For developmental toxicity, the NOEL
is 30 mg/kg/day and the LOEL is 85  mg/kg/day based on an
increase incidence of irregular spinous processes.

       In a repeat developmental toxicity study, New Zealand
white rabbits were given metribuzin by gavage on gestation days
6-18.  Maternal systemic toxicity was noted at 45 mg/kg/day, as
reduced body weight gain, and reduced food and water intake.
Additionally, at the highest dose tested (135 mg/kg/day) there was
an increased incidence of abortions and decreased body weights.
The maternal toxicity NOEL is 15 mg/kg/day and the maternal
toxicity LOEL is 45 mg/kg/day based  on reduced body weight
gains  and  reduced  food  and water  consumption.    For
developmental toxicity, the NOEL is 15 mg/kg/day and the LOEL
is 45 mg/kg/day based on decreased fetal body weights, increased
number of runts and increased incidence of extra and partial ribs.

       In a two-generation reproduction study, Crl:CD BR  rats
received feed containing metribuzin. Systemic toxicity in both the
parental animals and the pups was noted at the mid dose as slightly
decreased body weights in the FH high and the F2 mid and high dose
pups. The Fj females had decreased body weight gains during the
gestation period for mid and high doses;  F0 and Fj  females  had
increased body weight  during  lactation and  hypertrophy of
hepatocytes in high dose males and mid and high dose females.
The parental/offspring systemic toxicity NOEL is 1.5 mg/kg/day
and the parental/offspring systemic toxicity LOEL is 7.5 mg/kg/day
                50

-------
based on  decreased body weights and body weight gains and
hypertrophy of the hepatocytes.

Uncertainty Factor

      In  the three metribuzin developmental studies discussed
above, the NOELs for developmental effects are equal to or greater
than the NOELs for maternal effects. Generally, the Agency would
be concerned when developmental effects are seen at doses lower
than those  which would  cause  maternal  effects.  Thus,  for
metribuzin there is no unique sensitivity from pre-natal exposure
based on the current toxicological data requirements.  The Agency
concludes that an additional uncertainty factor to account for any
special sensitivity to infants and children is not warranted for the
metribuzin risk assessment.

2)    Aggregate (Multipathway) Exposure and Resultant
      Risk

      In  examining aggregate exposure, FQPA directs EPA to
take into account available information concerning exposures from
pesticide residues in food and all other non-occupational exposures.
The primary non-food sources of exposure the Agency  looks at
include drinking water (whether from groundwater or surface
water), and exposure through pesticide use in gardens, lawns, or
buildings (residential and other indoor uses).  Risk assessments for
aggregate  exposure  consider both  short-term and  long-term
(chronic) exposure scenarios, considering the toxic  effects which
would likely be seen for each exposure duration.

       Short-term aggregate exposure considers high-end spikes in
exposure that could occur during a short time period  (typically 1 -
7  days) for a variety of reasons; ex. a lawn/indoor pesticide
application is made on a particular day on which a  person would
also consume residues of this same pesticide in the diet (food and
water).   To estimate  risk, this  short-term  exposure spike is
compared to pesticide levels at which toxic effects were seen in
short-term toxicity studies.

       Similarly, long-term aggregate exposure considers average
exposure to a population over a lifetime. This average exposure is
then compared to pesticide levels at which toxic effects were seen
in long-term (usually chronic) toxicity studies to estimate risk.
                51

-------
Acute Risk:

Acute (1 day) Dietary ffood source):  The endpoint for acute
dietary risk characterization is the NOEL from the previously
described rabbit developmental toxicity  study, 15 mg/kg/day.
Since this endpoint is from a developmental toxicity study, the
population subgroup females (13+ years) was used to represent
women of child-bearing age. It was assumed that one hundred
percent of each commodity was treated with metribuzin (100%
CT), that all residues were at the current or reassessed tolerance
level and that metribuzin is uniformly distributed in the commodity
supply.

      The Margin of Exposure  (MOE) is a measure of how
closely the  estimated high end acute dietary  exposure (0.012
mg/kg/day) comes to the NOEL (15 mg/kg/day).  Thus, the MOE
for acute dietary exposure for the population subgroup females
(13+  years) for  metribuzin is   1,250  (15  mg/kg/day/  0.012
mg/kg/day).  The MOE is not less than 100; therefore, the Agency
considers the MOE to be sufficiently protective for acute dietary
(food source) risk.

Acute Drinking Water: For the population sub-group females 13+,
the estimated exposure for acute drinking  water  is  0.0007
mg/kg/day.  The MOE is a measure of how closely the estimated
high end  acute drinking water exposure (0.0007 mg/kg/day) comes
to the NOEL (15 mg/kg/day). Thus, the MOE for acute .drinking
water exposure for the population subgroup females (13+ years) for
metribuzin is 21,000 (rounded  to two significant  figures) (15
mg/kg/day/0.0007  mg/kg/day).  The MOE is not less than 100;
therefore, the Agency considers  the MOE to be sufficiently
protective for acute dietary (drinking water source) risk.

       For the population sub-group females 13+, the estimated
exposure for acute dietary (food source) is 0.012 mg/kg/day.  The
estimated exposure for acute drinking water is 0.0007 mg/kg/day.
Thus, the total acute  dietary exposure (food source + drinking
water) is 0.0127  mg/kg/day.   Using this total exposure, the
aggregate MOE for acute exposure for the population sub-group
females 13+ is 1200 (rounded to two significant digits).  The MOE
is not less than 100; therefore, the Agency considers the MOE to be
sufficiently protective for total acute dietary exposure.
                52

-------
Chronic Risk:

Chronic Dietary (food source): The RfD (0.013 mg/kg bwt/day) is
used for assessing chronic dietary risk.  The Reference Dose for
metribuzin was established at 0.013 mg/kg/day based upon a two-
year feeding study in rats with a NOEL of 1.3 mg/kg/day and an
uncertainty factor of 100. The effect observed at the LOEL (13.8
mg/kg/day) was  decreased body weight gains, increased thyroid
and liver weights.  The reproductive study with a NOEL of 1.5
mg/kg/day was considered to be a co-critical study.

       It  was assumed that  one  hundred  percent  of  each
commodity was treated with metribuzin (100% CT), that  all
residues were at the current or reassessed tolerance level, and that
metribuzin is uniformly distributed in the commodity supply.

       The Theoretical Maximum Residue Contribution (TMRC)
was  calculated for the U.S. population and 22 subgroups.  The
TMRC is 36% of the RfD for the U.S. population; 62% of the RfD
for non-nursing infants (less than 1 year); and 75% of the RfD for
children  (1-6  years).  These later groups represent the two
subgroups with the highest %RfDs. These calculations represent
an over-estimate of chronic dietary exposure for metribuzin since
tolerance level residues and 100 %CT were assumed.  Actual risks
will  be much lower.  The RfD was not exceeded; therefore, the
Agency's chronic dietary (food source) risk is not exceeded.

Chronic Drinking Water: As stated previously, the drinking water
exposure assessment is based on a small scale retrospective study
conducted in Portage County, Wisconsin, in which metribuzin and
its DK, and DADK metabolites were detected in groundwater (six
wells). (For more details see the drinking water exposure and risk
assessments sections.)

       For  the   general  population   the   yearly  average
concentrations in well water ranged from 3.7 ppb to 5.3667 ppb,
calculated  exposures  based  on  consumption  ranged   from
0.0000887 mg/kg/day to 0.0001212 mg/kg/day. All values were
less than 1 % of the RfD.

       For the chronic dietary risk (food source), the highest %
RfD for a population sub-group was  75% for children (1-6). For
this population sub-group the yearly average concentrations in well
               53

-------
water ranged from 3.7 ppb to 5.3667 ppb, calculated exposures
based  on  consumption  ranged  from 0.00037 mg/kg/day to
0.0005366 mg/kg/day. All values were less than 4% of the RfD.

       Metribuzin  has  been   detected  in  surface  water at
approximate peak concentrations less than the estimated yearly
averages  for  groundwater, although  of the  same  order of
magnitude. Peaks in surface water generally are much greater than
means. Thus, the %RfDs would be comparable. Therefore, the
Agency has no concerns for  chronic dietary  consumption of
metribuzin in groundwater or surface water, but  believes that
reserving 1% of the RfD for the general population and 4% of the
RfD for children (1-6)  for drinking water to  be appropriate
assumptions.

       When  total chronic dietary risk is  assessed  for  the
population sub-group with the highest %RfDs (children 1-6), the
Agency has concluded that 4 % of the RfD will be reserved for
exposure to residues of metribuzin in drinking water and 75 % of
the RfD will be utilized by exposure to residues of metribuzin in
food commodities.  The total chronic dietary risk is 79 % of the
RfD, thus, not exceeding  the Agency's risk concern  level.

Non-occupational risk

       Metribuzin  is not labeled for use by  homeowners or
certified applicators in the  residential setting. However, metribuzin
can be used on turf in public areas such as parks, athletic fields, or
golf courses.   Therefore, non-occupational exposure  would be
limited to postapplication exposure to persons such as employees
and the public following applications  to turfgrass in  treated
recreational areas. No  active-ingredient-specific data are available
to estimate post-application exposures for persons exposed to
metribuzin-treated turf in recreational areas.  However, because no
dermal endpoints of concern have been identified for metribuzin,
the Agency has no  special  post-application dermal  exposure
concerns.  The Agency  has no inhalation concerns for persons
exposed to metribuzin-treated turf as long as entry is delayed at
least until sprays and dusts have settled out of the air.

       Additionally, given the nature of activities  and therefore the
exposure  in an outdoor public setting, the Agency believes that
such  a short-time  exposure is very unlikely to contribute any
                54

-------
significant amount to an aggregate risk.
3)
Cumulative Effects
       Section 408(b)(2)(D)(v) requires that, when considering
whether to establish, modify, or revoke a tolerance, the Agency
consider "available information" concerning the cumulative effects
of a particular pesticide's residues and "other substances that have
a common mechanism of toxicity."  The Agency believes that
"available  information" in this context might include not only
toxicity, chemistry, and exposure data, but also scientific policies
and methodologies  for understanding common mechanisms of
toxicity and conducting cumulative risk assessments.  For most
pesticides, although the Agency has some information in its files
that may turn out to be helpful in eventually determining whether
a pesticide shares a common mechanism of toxicity with any other
substances, EPA does not at this time have the methodologies to
resolve the  complex  scientific issues concerning  common
mechanism of toxicity in a meaningful way. EPA has begun a pilot
process to study this issue further  through the examination of
particular classes of pesticides.  The Agency hopes that the results
of this  pilot process  will  increase  the  Agency's  scientific
understanding of this question such that EPA  will be able to
develop and apply scientific principles for better determining which
chemicals have a common mechanism of toxicity and evaluating
the cumulative effects of such chemicals. The Agency anticipates,
however, that even as its understanding of the science of common
mechanisms increases, decisions on  specific classes of chemicals
will  be heavily  dependent on chemical specific data, much of
which may not be presently available.

       Although at  present the Agency does not know how to
apply the information in its files concerning common mechanism
issues to most risk assessments, there are pesticides as to which the
common  mechanism issues  can be resolved.   For example,
pesticides that are toxicologically dissimilar to existing chemical
substances (in which case the Agency can  conclude that it is
unlikely that a pesticide shares a common mechanism of activity
with other substances) and pesticides that produce a common toxic
metabolite (in which case common mechanism of activity will be
assumed).

       In the case of metribuzin, EPA does not have at this time,
               55

-------
                         available data to determine whether metribuzin has a common
                         mechanism of toxicity with other substances or how to include this
                         pesticide in a cumulative risk assessment. Unlike other pesticides
                         for which EPA has followed a cumulative risk approach based on
                         a common mechanism of toxicity, metribuzin does not appear to
                         produce atoxic metabolite produced by other substances. For the
                         purposes of this tolerance action, therefore, EPA has not assumed
                         that metribuzin has a common mechanism of toxicity with other
                         substances.
     C.    Environmental Assessment
            1.     Ecological Toxicity Data
                   a.     Toxicity to Terrestrial Animals

                          (1)    Birds, Acute and Subacute

                                An acute oral toxicity study using the technical grade of the
                          active ingredient is required to establish the toxicity of a pesticide
                          to birds. The preferred test species is either mallard duck  (a
                          waterfowl) or bobwhite quail (an upland gamebird). Results of this
                          test are tabulated below.
Table 10. Avian Acute Oral Toxicity
Species
Northern bobwhite quail 97
(Colima virginlamu)
LD50 (mg/kg)
169.2

Toxicity Category
moderately toxic

MRIDNo.
Author/Year
255025
Lamb/1992
Study
Classification
core

                                These results indicate that metribuzin is moderately toxic to
                          avian species on an acute oral basis.  The guideline requirement
                          (71-1) is fulfilled (ACC # 255025).

                                Two subacute dietary studies using the technical grade of
                          the active ingredient are required to establish the toxicity of a
                          pesticide to birds. The preferred test species are mallard duck and
                          bobwhite quail. Results of these tests are tabulated below.
                                         56

-------
Table 11. Avian Subacute Dietary Toxicity
Species
Northern bobwhite quail
(Colinus virginianus)
Mallard duck
(Anas platyrhynchos)
% ai LC50 (ppm)
92.6 >4000
99 >5000
Toxicity Category
practically non-toxic
practically non-toxic
MRIDNo.
Author/Year
262228
1986
065507
Burke & Lamb/1977
Study
Classification
core
core
                                 These results indicate that metribuzin is practically non-
                          toxic to avian species on a subacute dietary basis.  The guideline
                          requirement (71-2) is fulfilled (ACC # 262228, and 065507).

                          (2)    Birds, Chronic

                                 Avian reproduction studies using the technical grade of the
                          active ingredient are required for metribuzin because the following
                          conditions are met:  (1)  birds may be subject to  repeated  or
                          continuous  exposure to the pesticide,  especially preceding  or
                          during the  breeding season, (2) the pesticide  is stable in the
                          environment to the  extent that potentially toxic  amounts  may
                          persist in animal feed, (3) the pesticide is stored or accumulated in
                          plant or animal tissues,  and/or, (4) information derived from
                          mammalian  reproduction  studies  indicates  reproduction  in
                          terrestrial vertebrates may be adversely affected by the anticipated
                          use of the product. The preferred test species are mallard duck and
                          bobwhite quail. Results of these tests are tabulated below.
Table 12. Avian Reproduction
Species % ai
Northern bobwhite quail 93.5
(Colinus virginiamts)
Mallard duck 93.5
(Anas platyrhynchos)
NOEC/LOEC
(ppm)
growth: < 62/62
other: 385/>385
368/>368
Endpoints Affected
14-day hatchling body
weight
No other effects reported
None
MRIDNo.
Author/Year
43926601
Hancock/1996
43860501
Hancock/1996
• Study Classification
Core
Core
                                 There was  a statistically  significant reduction in body
                          weight at 14-days post-hatch at all levels tested in the bobwhite
                          quail study. No other effects were observed in this study.  No
                          effects were observed at any level tested in the mallard study.
                          Since there was some doubt as to whether the 14-day body weight
                          effect was treatment-related in the bobwhite study, and since no
                          reproductive parameters were affected in either study, the mallard
                          NOEC of 368 ppm will be used in the risk quotients. The guideline
                          requirement (71-4) is fulfilled (MRTD # 43926601, and 43860501).
                                          57

-------
                           (3)    Mammals

                                  Wild mammal testing is required on a case-by-case basis,
                           depending on the results of lower tier laboratory mammalian
                           studies,  intended use pattern and  pertinent environmental fate
                           characteristics. In most cases, rat or mouse toxicity values obtained
                           from the Agency's Health Effects Division substitute for wild
                           mammal testing.  These toxicity values are reported in the table
                           below.
Table 13. Mammalian Toxicity

Species                   % ai
         Test Type
               Toxicity Values
                                               MRIDNo.
laboratory rat
(Rattus norvegicus)
Laboratory mouse (Mas
miaculiu)
acute oral
acute oral
2200 mg/kg (female)
2300 mg/kg (male)
711 mg/kg (female)
698 mg/kg (male)
00106158
00106158
                                  The results  indicate that metribuzin  is  slightly  toxic
                           (Category III) to small mammals on an acute oral basis.

                           (4)    Insects

                                  A honey bee acute contact study using the technical grade
                           of the active ingredient is required for metribuzin because its use
                           (foliar,  postemergent, and on established plants  for  several
                           terrestrial food crops) may result in honey bee exposure. Results of
                           this test are tabulated below.
Table 14. Nontarget Insect Acute Contact Toxicity
Species
LD50
(us/bee)
Toxicity Category
                                                          MRIDNo.
                                                          Author/Year
                                      Study
                                      Classification
Honeybee
(Apis mcllifera)
                  tech
                            60.4
           practically non-toxic
                   028772
                   1973
                                  The results indicate that metribuzin is practically non-toxic
                           to bees on an acute contact basis.  The guideline requirement (141-
                           1) is fulfilled (MRID 028772).

                    b.     Toxicity to Aquatic Animals

                           (1)    Freshwater Fish

                                  a. Freshwater Fish, Acute

                                         Two  freshwater  fish toxicity studies using the
                                           58

-------
technical grade  of the active ingredient are required to
establish the toxicity of a pesticide to fish.  The preferred
test species are rainbow trout (a coldwater fish) and bluegill
sunfish (a  warmwater fish).  Results  of these  tests are
tabulated below.
Table 15. Freshwater Fish Acute Toxicity
Species %ai LCSO(ppm) Toxicity Category
Rainbow trout
(Oncorhynchus mykiss)






Bluegill sunfish
(Lepomis macrochirus)




90

70

97

50

90

97

50

42

99

76.77

147

92

75.96

131.1

slightly toxic

slightly toxic

slightly toxic

practically non-toxic

slightly toxic

slightly toxic

practically non-toxic

MRIDNo.
Author/Year
40098001
F.L. Mayer/1986
090427
McCann/1984
255025
Lamb/1972
255025
Lamb/1972
40098001
F.L. Mayer/1986
255025
Lamb/1972
255025
Lamb/1972
Study
Classification
core

core

core

core

core

core

core

       These results indicate that metribuzin is slightly
toxic to practically non-toxic to freshwater fish on an acute
basis.  The guideline requirement (72-1) is fulfilled (ACC
# 255025, 40098001, and 090427).

b.     Freshwater Fish, Chronic

       A  freshwater fish early life-stage test  using the
technical  grade of the active ingredient is required for
metribuzin because the end-use product may be applied
directly to water or is expected to be transported to water
from the intended use site, and the following conditions are
met: (1) the pesticide is intended  for use  such that  its
presence in water is likely to be continuous or recurrent
regardless of toxicity, (2) any aquatic acute LC50 or EC50
is less than 1 mg/1, (3) the EEC in water is equal to or
greater than 0.01 of any acute LC50  or EC50 value, or, (4)
the  actual or estimated environmental concentration in
water resulting from use is less than 0.01 of any acute LC50
or EC50 value and any one of the following conditions
exist: studies of other organisms indicate the reproductive
physiology  of fish may be affected,  physicochemical
properties indicate cumulative effects, or the pesticide is
persistent in water (e.g., half-life greater than 4 days). The
         59

-------
                                 preferred test species is rainbow trout.  Results of this test
                                 are tabulated below.
Table 16. Freshwater Fish Early Life-Stage Toxicity
Species
Rainbow trout
(Oncorhynchus
myklss)
NOEC/LOEC
% ai (ppm)
94 noNOEC
LOEC=3.0
MATC
(ppm)
not
determined
Endpoints
Affected
growth
MRIDNo.
Author/Year
42447801
Gagliano &
Roney/1992
Study
Classification
core
                                 No NOEC was achieved in this study due to effects  on
                          growth at all levels tested.  However, since the LOEC was above
                          exposure estimates calculated at the time of the study, it was
                          classified as core. The guideline requirement (72-4a) is fulfilled
                          (MRID 42447801).

                                 A freshwater fish life-cycle test using the technical grade of
                          the active ingredient is not required for metribuzin.

                          (2)    Freshwater Invertebrates

                                 a.     Freshwater Invertebrates, Acute

                                        A freshwater aquatic invertebrate toxicity test using
                                 the technical grade of the active ingredient is required to
                                 establish the toxicity of a pesticide to invertebrates. The
                                 preferred test species is Daphnia magna. Results of this
                                 test are tabulated below.
Table 17. Freshwater Invertebrate Toxicity
Species
Waterflea
(Daplwia magna)
%ai
93
84
LC50/
ECSO (ppm)
4.2
98.5
Toxicity Category
moderately toxic
slightly toxic
MRIDNo.
Author/Year
72083
Roney/1979
34016
1978
Study
Classification
core
supplemental
                                        The results indicate that metribuzin is moderately to
                                 slightly toxic to  aquatic invertebrates on an acute basis.
                                 The guideline requirement (72-2) is fulfilled (ACC #
                                 72083).

                                 b.     Freshwater Invertebrate, Chronic

                                        A freshwater aquatic  invertebrate life-cycle test

                                          60

-------
                                using the technical grade of the active ingredient is required
                                for metribuzin since the end-use product may be applied
                                directly to water or expected to be transported to water from
                                the intended use site, and the following conditions are met:
                                (1) the pesticide is intended for use such that its presence in
                                water is likely to be continuous or recurrent regardless of
                                toxicity, (2) any aquatic acute LC50 or EC50 is less than 1
                                mg/1, or,  (3) the EEC in water is equal to or greater than
                                0.01 of any acute EC50 or LC50 value, or, (4) the actual or
                                estimated environmental concentration in water resulting
                                from use is less than 0.01 of any  aquatic acute EC50 or
                                LC50  value  and any of the following conditions exist:
                                studies of other organisms  indicate the  reproductive
                                physiology    of   invertebrates   may   be  affected,
                                physicochemical properties indicate cumulative effects, or
                                the pesticide is persistent in water (e.g., half-life greater
                                than 4 days).  The preferred test species is Daphnia magna.
                                Results of this test are tabulated below.
Table 18. Freshwater Aquatic Invertebrate Life-Cycle Toxicity
Species " % ai
Waterflea 93
(Daphnia magna)
NOEC/LOEC
(ppin)
NOEC=1.29
LOEC = 2.62
MATC
(ppm)
1.84
Endpoints
Affected
# offspring
length
MRIDNo.
Author/Year
42447802
Gagliano &
Bowers/1992
Study
Classification
core
                                       A NOEC was achieved for number of offspring and
                                length; however, there were effects on weight at all levels
                                tested, so a NOEC for weight was  not achieved.  The
                                guideline  requirement  (72-4)  is  fulfilled  (MRID   #
                                42447802).

                          (3)    Toxicity to Estuarine and Marine Animals

                                a.     Estuarine and Marine Fish, Acute

                                       Acute toxicity testing with estuarine/marine fish
                                using the technical grade of the active ingredient is required
                                for metribuzin because the end-use product is intended for
                                direct application to the marine/estuarine environment or
                                the active ingredient is expected to reach this environment
                                because of its use in coastal counties. The preferred test
                                species is sheepshead minnow.  Results of these tests are
                                tabulated below.
                                         61

-------
Table 19. Estuarine/Marine Fish Acute Toxicity

Species	%ai	LCSO (ppm)
Toxicity Category
                MRIDNo.
                Author/Year
                 Study
                 Classification
Sheepshead minnow
(Cyprinodon variegatus)
                     92.6
                               85
slightly toxic
42094502
Nicholson &
Suprenanat/1986
                                         The results indicate that metribuzin is slightly toxic
                                  to estuarine/marine fish on an acute basis.  The guideline
                                  requirement (72-3a) is fulfilled (MRID # 42094502).

                                  b.     Estuarine and Marine Fish, Chronic

                                         An estuarine/marine fish early life-stage toxicity test
                                  using the  technical grade of the active ingredient is not
                                  required for metribuzin.

                                  c.     Estuarine and Marine Invertebrates, Acute

                                         Acute  toxicity   testing  with   estuarine/marine
                                  invertebrates using  the technical grade  of the  active
                                  ingredient is required for metribuzin because the end-use
                                  product  is  intended  for   direct   application  to  the
                                  marine/estuarine environment or the active ingredient is
                                  expected to reach this environment because of its  use  in
                                  coastal counties.   The  preferred test species are  mysid
                                  shrimp and eastern  oyster.   Results of these  tests are
                                  tabulated below.
Table 20. Estuarine/Marine Invertebrate Acute Toxicity
Species %ai. LC50/EC50 (ppm)
Eastern oyster
(shell deposition or embryo-
larvae)
(Crasiostrea virginica)





Pink shrimp
(Penaeia duorarum)
92

92

92.6

92.6


92

42

40.7

49.8

52 (shell dep.)


48.3

Toxicity Category
slightly toxic

slightly toxic

slightly toxic

slightly toxic


slightly toxic

MRIDNo.
Author/Year
43851
1975
106197
Heitmuller/1975
42094501
1986
47023411
Dionne &
Suprenant/1986
106197
Heitmuller/1975
Study
Classification
supplemental

core

core

supplemental


core

                                         The results indicate that metribuzin is slightly toxic
                                  to estuarine/marine invertebrates on an acute basis.  The
                                  guideline  requirements (72-3b  and 72-3c)  are  fulfilled
                                            62

-------
              (MRID # 106197 and 42094501).

c.     Toxicity to Plants

       (1)     Terrestrial

              Terrestrial plant testing (seedling emergence and vegetative
       vigor) is required for herbicides that have terrestrial non-residential
       outdoor use patterns and that may move off the application site
       through volatilization (vapor pressure >1.0 x 10"5mm Hg at 25ฐC)
       or drift (aerial,  ground, or chemigation) and/or that may have
       endangered or  threatened plant species   associated  with the
       application site.

              Currently,  terrestrial plant  testing  is  not  required for
       pesticides other  than herbicides  except  on a case-by-case basis
       (e.g., labeling bears phytotoxicity warnings,  incident data, or
       literature that demonstrate phytotoxicity).

              For seedling emergence and vegetative vigor testing the
       following plant species and groups should be tested: (1) six species
       of at least four dicotyledonous families,  one species of which is
       soybean (Glycine max), and the second of which is a root  crop, and
       (2) four species of at least two monocotyledonous families, one of
       which is corn (Zea mays).

              Terrestrial Tier II studies are required for  all  low dose
       herbicides (those with the maximum use rate of 0.5  Ibs ai/A or
       less). Terrestrial plant testing is required for metribuzin because it
       is an herbicide with the majority  of use rates at 0.5 Ibs ai/A or less.

              Tier II tests measure the response of plants, relative to a
       control, at five or more test concentrations.  Results of Tier II
       toxicity testing on the technical material are  tabulated below.
                       63

-------
Table 21. Nontarget Terrestrial Plant Seedling Emergence Toxicity (Tier II)
Species
Monocot- corn
Monocot- onion
Monocot- wheat
Monocot- pea
Dicot- turnip
Dicot- soybean
Dicot- cotton
Dicot- cucumber
Dicot- tomato
Dicot- sorghum
%ai
91.3
91.3
91.3
91.3
91.3
91.3
94.1
91.3
91.3
91.3
EC25
(Ibsai/A)
Endpoint
Affected
0.059 weight
0.020 survival
0.024 % emer. &
weight
not determined
0.008 % emer.
not determined
0.0423 weight
0.029 height
not determined
0.043 weight
NOECorEC05
(Ibs ai/A)
Endpoint
Affected
0.056 weight
0.014 survival
0.014 weight
0.113 weight
0.007 %emer.
0.225 all
0.0281 weight
0.014 height
0.1 13 survival
0.028 weight
MRIDNo.
Author/Year
42447803
Burge/1992
42447803
Burge/1992
42447803
Burge/1992
42447803
Burge/1992
42447803
Burge/1992
42447803
Burge/1992
43208301
Johns/1994
42447803
Burge/1992
42447803
Burge/1992
42447803
Burge/1992
Study Classification
core
core
core
core
core
core
core
core
core
core
                                 For Tier II seedling emergence, turnip is the most sensitive
                          dicot, and onion and wheat are the most sensitive monocots. The
                          guideline requirement (123-1) is fulfilled (MRID#43208301 and
                          42447803).
                                           64

-------
 Table 22. Nontarget Terrestrial Plant Vegetative Vigor Toxicity (Tier II)
Species
Monocot- corn
Monocot- onion
Monocot- wheat
Monocot- pea
Dicot- turnip
Dicot- soybean
Dicot- cotton
Dicot- cucumber
Dicot- tomato
Dicot- sorghum
%ai
91.3
91.3
91.3
91.3
91.3
91.3
91.3
91.3
91.3
91.3
EC251
(Ibsai/A)
Endpoint
Affected
not determined
0,017 weight
0.041 weight
not determined
0.005 weight
not determined
0.016 weight
0.024 weight
not determined
not determined
NOECorECOS
(Ibs ai/A)
Endpoint
Affected
0.090 none
0.0112
height/weight
0.0225 weight
0.0900 none
0.0028 weight
0.0450 weight
0.0028 weight
0.01 12 weight
0.0900 none
0.0450 weight
MRIDNo.
Author/Year
42447803
Burge/1992
42447803
Burge/1992
42447803
Burge/1992
42447803
Burge/1992
42447803
Burge/1992
42447803
Burge/1992
42447803
Burge/1992
42447803
Burge/1992
424478703
Burge/1992
42447803
Burge/1992
Study Classification
core
core
core
core
core
core
core
core
core
core
1 EC is the effective concentration. EC25 is 25% detrimental effect on plant growth (mass or
rate).

                                  For Tier II vegetative vigor, turnip is the most sensitive
                           dicot and onion is the  most sensitive monocot. The guideline
                           requirement (123-1) is fulfilled (MRID#42447803).

                           (2)    Aquatic

                                  Aquatic plant testing is required for any herbicide that has
                           outdoor non-residential terrestrial uses that may move off-site by
                           runoff (solubility >10 ppm in water), by drift (aerial, ground, or
                           chemigation), or that is applied directly to aquatic use sites (except
                           residential).  Terrestrial Tier II studies are required for all low dose
                           herbicides (those with  the maximum use rate of 0.5 Ibs ai/A or
                           less). The following species should be tested at Tier I:  Kirchneria
                           subcapitata and Lemna gibba.  The following species should be
                           tested at  Tier II:   Kirchneria  subcapitata,  Lemna gibba,
                           Skeletonema costatum,  Anabaena flos-aquae, and a freshwater
                           diatom.  Aquatic plant  testing is required for metribuzin because
                           it is an herbicide which is relatively mobile (Koc=41), and many of
                                           65

-------
                          the uses are 0.5 Ib ai/A or less.

                          Results of Tier n toxicity testing on the technical/TEP material are
                          tabulated below.
Table 23. Nontarget Aquatic Plant Toxicity (Tier II)
Species
Vascular Plants
Duckweed
Lemnagibba
Nonvascular Plants
Green algae
Kirchncria svbcapilata
Marine diatom
Skeletonema costanan
Freshwater diatom
Naviculapelliculosa
Blue-green algae
Anctbaennflos-aquae
% ai EC50 (ppm)

94.2 0.13

94.1 0.021
93.5 0.0087
99.0 0.0119
94.2 0.017
NOECorECOS
(ppm)

0.018

0.004
0.0058
0.0089
0.0097
MRIDNo.
Author/Year

43893501
Boerietal./1995

43133601
Gagliano &
Orr/1994
43867701
Bowers/1995
43826101
Bowers/1995
43893502
Boerietal/1995
Study
Classification

supplemental

core
core
core
supplemental
             2.
             The Tier n results indicate that Skeletonema costatum is the
       most  sensitive  non-vascular  aquatic  plant.    The  guideline
       requirement (123-2) is fulfilled for green algae, marine diatom and
       freshwater diatom (MRID43867701, 43133601, and 43826101).
       The guideline requirement (123-2) is not fulfilled for vascular
       plants and blue-green algae; however, enough information on
       aquatic plants is available to conduct a risk assessment.

Environmental Fate
                   a.
                          Environmental Fate Assessment
                          Based on available data, the primary routes of degradation of
                   metribuzin and  its  main  degradates diketo  metribuzin  (DK)  and
                   deaminated diketo metribuzin (DADK) are microbial metabolism  and
                   photolytic degradation on soil.  These compounds will be available for
                   leaching  to  ground water and  runoff to  surface water in many  use
                   conditions. This is because metribuzin and its degradates are not volatile.
                   In  addition,  while the rate of photodegradation is rapid for exposed
                   chemicals, only approximately the top 1mm of soil is actually exposed to
                   sunlight.  Once in ground water, metribuzin is expected to persist due to
                   its  stability to hydrolysis and the lack of light penetration.  Conversely,
                   residues of metribuzin in surface water are not likely to persist in clear,
                                          66

-------
well-mixed, shallow surface water with good light penetration since parent
metribuzin degrades rapidly by aqueous photolysis with a calculated half-
life of 4.3 hours. However, if the surface water that receives metribuzin
runoff contains significant sediments, metribuzin is expected to persist
since it is stable to hydrolysis and since light penetration would be limited.

       Parent metribuzin is very stable to abiotic hydrolysis and relatively
stable to both aerobic and anaerobic soil metabolism (T1/2's of 106 and 112
days, respectively). Even though direct photolysis in water and on soil
appear to degrade metribuzin rapidly in the laboratory (T1/2's of 4.3 hours
and 2.5 days), only metribuzin that is on the surface of the soil is affected
by photolysis. For that reason, persistence in field soil appears to be more
affected by soil metabolism (aerobic and anaerobic) than by photolysis,
with field half-lives of 40-128 days. Because of the potential for runoff,
photolysis in H2O results are critical. The major photolytic products were
deaminated metribuzin in H2O and pentylidene and hexylidene metribuzin
on soil.

       Metribuzin and its  degradates diketo metribuzin (DK) and
deaminated diketo metribuzin (DADK) are persistent and mobile in soil.
They have also been found in ground water in 12 states as a result of
normal  agricultural  applications  done under  a  wide  range   of
hydrogeological and climatic conditions. According to state monitoring
data from Wisconsin,  documented concentrations in ground water are as
high  as  54  ppb compared to the Health Advisory  of 100 ppb.  In a
retrospective ground water monitoring study submitted to  the Agency,
metribuzin was detected in ground water at levels ranging up to 2.3 ppb
metribuzin parent and  up to 7.6 ppb total metribuzin residues.  In surface
waters, metribuzin and its degradates have been found in the Midwestern
U.S. at several ppb.

b.     Environmental Fate and Transport

       (1)    Degradation

             Hvdrolvsis (161-1)

       Metribuzin was stable in sterile aqueous buffer solutions (pH 5, 7,
and 9) that were incubated in darkness at 25ฐ C. The guideline requirement
was fulfilled (TRID 47017-008).
                      67

-------
             Aqueous Photolysis (161-2)

       Metribuzin had a half-life of 4.3 hours in pH 6.6 water irradiated
with natural sunlight in Kansas  City, MO at 25  ฐC.  The identified
degradate was deaminated metribuzin (DA; major degradate),  and 3
unknown degradates each comprised <5.2%. Metribuzin was stable in the
dark controls. The guideline requirement was fulfilled (TRID 470173-
007).

             Soil Photolysis (161-3)

       Metribuzin had a half-life of 2.5 days on sandy loam soil irradiated
outdoors in Kansas City, Missouri at temperatures up to 31 ฐC. The major
degradates  were  deaminated  metribuzin  (DA),  and  the  distinct
photoproducts  pentylidene  metribuzin  and  hexylidene  metribuzin.
Metribuzin was stable in the dark controls.  The guideline requirement was
fulfilled (MRID 470173-009).

             Aerobic Soil Metabolism (162-1)

       Metribuzin degraded with a half-life of 106 days in sandy loam soil.
The identified major degradates were deaminated, diketo metribuzin
(DADK) and diketo metribuzin (DK). The identified minor degradates
were deaminated metribuzin (DA), 2-methyl-DADK, 4-methyl-DADK,
and 3-amino-DA.  The guideline requirement  was fulfilled (MRID
40367602).

             Anaerobic Soil Metabolism (162-2)

       Metribuzin had a  half-life of 112 days following 30 days of
anaerobic incubation.  During the anaerobic portion of the study, the
degradates  identified were DADK, DA, DK, and  2-methyl-DADK.
Seventy-eight to 88 % of all radioactivity was in the organic phase from
the methanol extractions of soil and <5 % was in the aqueous phase. The
guideline requirement is fulfilled (MRID 40367603).

       (2)   Mobility

             Leaching-adsorption-desorption (163-1)

Unaged leaching-adsorption-desorption.  Parent metribuzin was  very
mobile in sandy (0.58 % OC), sandy loam (0.64 % OC), silt loam (1.68 %
OC), and clay loam (1.28 % OC) soils with Freundlich Kads values of 0.25,
                      68

-------
0.02,0.22, and 0.20, respectively.  Freundlich Kdes values were 0.56, 0.14,
0.51, and 0.41, respectively. K^^ were 47, 3, 15, and 17 and Kocdes values
were  106, 24, 33, and 36, respectively. The N values were 0.92, 0.66,
0.86, and 0.94 for adsorption and 0.76, 0.60, 0.77, and 0.84 for desorption,
respectively. The guideline requirement is fulfilled (MRID 42283001).

Agedleaching-adsorption-desorption. DADK was very mobile in Astatula
sand (0.35 % OC), Arkport sandy loam (1.57 % OC), Drummer silt loam
(1.92 % OC), and Trix clay (0.52 % OC) soils with Freundlich Kads values
of 0.13, 0.47, 0.51, and 0.19, respectively. Kdes values were 0.21, 1.1, 1.2,
and 0.61, respectively,  Kocads values were 37, 30, 27, and 36 and ^.des
values were 60, 70, 63, and 117, respectively. N values were 0.86, 0.94,
0.93, and 0.96 for adsorption and 0.80, 0.99,0.95, and 1.09 for desorption,
respectively. The guideline requirement is fulfilled (MRID 43058501).

       DK was very mobile in Astatula sand (0.35 % OC), Arkport sandy
loam (1.57 % OCM), Drummer silt loam (1.92 % OC), and Trix clay (0.52
% OC) soils with Freundlich Kads values of 0.15, 0.70, 0.95, and 0.29,
respectively.  Kdes values were 0.82, 3.3, 1.13, and 0.56, respectively.
Kocads values were 43, 45, 50, and 56 and Kocdes values were 236, 211, 59,
and  107, respectively.   N values were 0.94,  1.0, 0.91,  and 0.96 for
adsorption and 0.94, 0.1.07, 0.85, and 0.87 for desorption, respectively.

Aged soil column leaching. Metribuzin and its oxidative degradates were
very mobile in an aged soil column leaching study. Kansas sandy loam
soil spiked with 7.4 ppm of metribuzin was added to sandy loam, silt loam,
and silty clay soils packed in 30-cm columns and leached with 50.8 cm of
water. The amount of applied radioactivity in the leachate was 23, 42, 28,
and 55 % in the silt loam, silty clay, Kansas sandy loam, and California
sandy loam.  Most of the  radioactivity  in  the  leachate was parent
metribuzin, and the degradates DA, DADK, and DK ranged from 1-3.1 %
of the applied  radioactivity.  The  guideline  requirement  is fulfilled
(Accession # 263702).

       (3)     Field Dissipation

              Terrestrial (164-1)

              The calculated half-lives of metribuzin (Sencor 75 DF) in
       sandy loam soils in California were 128 and 40 days at Watsonville
       and  Fresno,  respectively.   No leaching of metribuzin or  its
       oxidative degradate DADK were observed below 12 inches of
       depth at either site except for some detections that were probable
                       69

-------
c.
      contamination or sampling error in the Fresno site.  The other
      degradates of interest, DA and DK, were not found below 6 inches
      of depth (MRID 42236101).

            The calculated half-lives of metribuzin (Sencor 75 DF) in
      silty clay loam, muck sandy loam, muck clay loam, and sandy loam
      soils in Maine, Michigan, and  California  were 58 to  107 days
      (MRID 40380901).

            The guideline requirement for the terrestrial field dissipation
      study (164-1) is fulfilled.

            Retrospective Ground-Water Monitoring (166-2)

            Metribuzin and two of its degradates (DK and DADK) were
      detected in ground water in a small scale  retrospective study
      conducted in  Portage County,  Wisconsin on a minor use crop
      (potatoes).  Concentrations ranged up to 2.3 ppb parent metribuzin
      and 7.6 ppb total residues.  Results indicated that metribuzin and its
      metabolites were extremely persistent  under the  conditions
      illustrated by this study, and residues were still detected in ground
      water over two years after an application (DP Barcode S261873).
      New monitoring information in Wisconsin indicates that metribuzin
      can leach to ground water at concentration up to 54 ppb or 54
      percent of the lifetime Health Advisory.  Residues up to 21 ppb
      have been detected in Wisconsin drinking water wells. For this
      reason, the registrant is required to determine those areas that are
      vulnerable to  ground-water contamination  by  metribuzin  and
      recommend  restrictions  for   its  use  to  prevent  continued
      contamination at these levels

      (4)    Spray  Drift

             The registrant is  required to  submit data to support the
      Spray  Drift data requirements because  aerial  application  of
      metribuzin may cause damage to nontarget plants due to spray
      drift. Bayer Corporation is a member of the Spray Drift Task Force
      (SDTF), and therefore, may elect to satisfy these data requirements
      through the SDTF.  If the registrant  wishes to satisfy these data
      requirements in this manner, the procedures outlined in PR Notice
      90-3 should be followed.

      Water Resources
                      70

-------
(1)    Ground Water

       Background

       The requirement for a large-scale ground-water monitoring
study for metribuzin was issued in the June  1985 Registration
Standard.  In an amendment to the Standard, the Agency requested
two studies: one to be conducted on a minor use crop and the other
to be conducted on a major use crop.  In 1987, Bayer (then Mobay)
had not yet initiated the studies, and the requirement was changed
to a small-scale retrospective study. This monitoring study was
designed to evaluate the  impact of continued  metribuzin use on
ground water in a vulnerable area. One small-scale retrospective
study was conducted from  1988 to 1989  in Portage  County,
Wisconsin on potatoes. Results indicated that metribuzin and its
metabolites  were  extremely  persistent  under the  conditions
illustrated by this study.  Over one year after the final metribuzin
application, up to 2.3 ppb metribuzin parent and  up to 7.6 ppb total
metribuzin residues were detected in ground water on the site. Up
to 1.4 ppb metribuzin and 6.7 ppb total residues were still present
over two years after the metribuzin application.

       Although the small-scale retrospective  study on a major use
crop  has not been conducted, the Agency  believes  that the
determination of those areas that are vulnerable to ground-water
contamination by metribuzin will provide more useful information.

       Occurrence of Metribuzin in Ground  Water

       The Pesticides and Ground Water Database  (PGWDB)
indicates that metribuzin has been detected in ground water in 12
states  including  Connecticut,  Iowa,  Illinois, Kansas,  Maine,
Minnesota, Missouri, New Jersey, Ohio, South Dakota, Virginia,
and Wisconsin  because of  probable  nonpoint  source  use.
Concentrations in ground water range up to 25.1 ppb (EPA, 1992).
Monitoring for metribuzin in  11 other states  did not yield any
detections (EPA, 1992).

       Recent evidence suggests that metribuzin is likely  to be
detected in ground waters that are vulnerable to contamination in
areas where it is used. According to some of the  initial results from
the National Water Quality Assessment (NAWQA) Program of the
               71

-------
U.S. Geological  Survey (Kolpin  and others,  in  preparation),
metribuzin was detected in shallow ground water in both urban and
agricultural areas, but the concentrations were low. The herbicide
was detected at or above 0.004 ppb in five of the nine agricultural
settings examined. The maximum concentration measured in these
studies was 0.30 ppb.

 •      In the Central Sands area of Wisconsin, metribuzin is used
primarily on potatoes. In this area, metribuzin has been detected in
21 out of 27 monitoring wells and in 91 private drinking water
wells.  Metribuzin concentrations in ground water are also higher
here; up to 54 ppb has been found in the monitoring wells and up
to 21  ppb found  in the drinking water wells.  However, most
detections range from about 1 to 5 ppb and the chemical appears to
dissipate quickly in the Central Sands area.

       Ground-Water Exposure Assessment

       Risk Concerns:

       Quality of Ground-water resources:

       Metribuzin has been detected in a variety of environments
in 12 states because of nonpoint source use,  although generally
below toxicity thresholds for humans and animals. Considering the
widespread use of metribuzin and its detection in many states, the
Agency is concerned about the degradation of water  quality that
occurs in metribuzin use areas.

       Non-target terrestrial plants:

       Concentrations of metribuzin  in ground water  have not
exceeded the LOG for terrestrial plants. However, levels detected
in ground water have approached approximately 40 percent of the
concentration that could present a risk. Therefore, although there
is not a concern at the present time, in areas where irrigation water
is contaminated with metribuzin, residues could pose a threat to
plants.

       Recommendations

       1.   Metribuzin meets the triggers for classification as a
       Restricted Use compound for ground-water concerns, as it
                72

-------
(2)
is stated in the proposed Restricted Use rule. When the rule
becomes final, metribuzin may be considered a candidate
for restricted use for ground-water concerns.

2.   Metribuzin is clearly a compound that will leach to
ground water in vulnerable areas. At the present time, most
of the  concentrations found  in ground water are low
compared to the levels of concern for human and ecosystem
health. However, in some areas, metribuzin residues have
been found in ground water at relatively high levels and the
Agency  is concerned that these concentrations are 54
percent of the HAL. In addition, concentrations up to 21
percent of the HAL have been found in drinking water
wells.  For these reasons, the registrant must examine the
metribuzin  use area, determine those areas  that  are
vulnerable to ground-water contamination by metribuzin
and recommend restrictions for its use to prevent continued
contamination at these levels.

3.   The Agency is requiring that the  registrant develop
educational  materials to  inform applicators about  the
potential problems that metribuzin poses to ground-water
quality.

Surface Water
       Metribuzin can contaminate surface water at application via
spray drift. Substantial fractions of applied metribuzin could be
available for runoff to surface waters for several weeks to months
post-application (aerobic soil metabolism half-life of 40 and 106
days, terrestrial field dissipation half-lives of 15 to 149  days).
Although metribuzin is susceptible to photodegradation on soil
(half-life = 2.5 days), its much longer half-lives in terrestrial field
dissipation studies reflect that only the metribuzin in approximately
the top 1 mm of soil is probably exposed to  sunlight. The low
soil/water partitioning of metribuzin (SCS/ARS  database Koc = 60,
Freundlich binding constants < 1) indicates that most of metribuzin
runoff will occur via dissolution in runoff water (as opposed to
adsorption to eroding soil particulates).

       Metribuzin is susceptible to direct aqueous photolysis (half-
life 4.3 hours) which should limit its persistence in the water
column of well mixed, shallow surface  water with low light
                73

-------
attenuation. However,  its resistance to  abiotic hydrolysis, low
volatilization  potential  (Henry's  Law  constant  = 3.5 X  10"11
atm*m3/mol), only moderate susceptibility to aerobic and anaerobic
metabolism and only slightly greater susceptibility to anaerobic
metabolism (anaerobic soil metabolism half-life of 25-59 days)
should make it more persistent in other types of surface water,
particularly those with rather long hydrological residence times.
Freundlich  soil/water  binding constants  <  1  and  Freundlich
exponents close to one indicate that dissolved concentrations of
metribuzin  in  sediment pore   water  will  be  greater  than
concentrations adsorbed to  suspended and bottom  sediment.
Although dissolved metribuzin concentrations in the water column
will be lower than dissolved concentrations in the sediment pore
water  they may be  at  least somewhat comparable  to  the
concentrations adsorbed to suspended and bottom sediment.

       The major degradates of metribuzin in soil include diketo
metribuzin (DK) and deaminated diketo metribuzin (DADK). Both
are reported to exhibit similar mobility and persistence to that of
the parent. Consequently, like metribuzin, both DK and DADK are
expected to:

(1)    be available for runoff for extended periods due to their
       persistence in soil,
(2)    run off primarily via dissolution in runoff water as opposed
       to adsorption to eroding soil,
(3)    have dissolved  concentrations  in  the water  column
       comparable to concentrations adsorbed to suspended and
       bottom sediment.

       The USGS  (Goolsby/Thurman  1991;  Goolsby  1995;
Goolsby 1996) conducted reconnaissance  surveys of numerous
midwestern streams in 1989, 1990, 1994, and 1995 to determine
pre-application, post-application, and Fall concentrations of various
herbicides  including  metribuzin.  Pre-application  and  Fall
metribuzin concentrations  were  much  less  than 1 ug/L and
 generally below the detection limit of 0.05 ug/L.  Since post-
 application samples were generally collected during the first major
 runoff event after application, the concentrations in those samples
 may often approximately represent peak concentrations. The 90th
 percentile (upper 10th  percentile)  post-application  metribuzin
 concentrations for  1989, 1994, and 1995 were 1.4,  1.2  and 0.5
 ug/L, respectively. The 90th percentile concentrations for 1989 and
                74

-------
             1994 were comparable, but the 1989 data for 129 streams included
             nine concentrations (from 2.2 to 7.6 ug/L) greater than the 1994
             and 1995 maximums (1.9 and 1.4, respectively) for 50 of those
             streams.

                   Based upon  data on other major use herbicides, peak
             metribuzin concentrations in streams may generally be higher than
             in rivers and reservoirs but elevated levels of metribuzin may be
             present longer in rivers and reservoirs. Concentrations in edge of
             the field farm ponds may be substantially greater than in streams.

                   The USGS (Coupe et al 1995) sampled 8 locations on rivers
             within the Mississippi Basin from April 1991 through September
             1992 and analyzed the samples for numerous  insecticides and
             herbicides including metribuzin. Samples were collected twice per
             week from May 6 to July 15  1991, once per every two weeks from
             November 1991 to February 1992, and once per week at other
             times. Filtered (0.7 u) (dissolved) metribuzin was detected above
             a detection limit of 0.05 ug/L at all of the locations, but in less than
             3% to 28%  of the samples at each  location. The maximum
             concentration detected was 0.38 ug/L. Only 5 additional samples
             had metribuzin concentrations > 0.2 ug/L.

                   The  USGS (Goolsby et al  1993) sampled  each  of 76
             midwestem reservoirs at least eight times from April 1992 through
             September 93  and analyzed them for various herbicide degradates
             and herbicides including metribuzin.  Metribuzin was detected
             above a detection limit of 0.05 ug/L in 36/732 = 4.9% of the 732
             samples collected from 15/76 = 20% of the 77 reservoirs samples.
          •  The only concentrations > 0.5 ug/L were  0.67 ug/L (Huntington
             Lake IN), 0.67 ug/L (Mississinewa Lake IN), and 0.91  ug/L, and
             1.3 ug/L (Salamonie Lake IN).

                   The  State of Illinois (Taylor  1994) recently summarized
             pesticide data for surface water samples collected from 34 stations
             from 10/1/85 through 2/15/94. A total of 1278 samples were
             analyzed for metribuzin at a  detection limit of 0.05  ug/L.
             Apparently assuming non-detects were equal to the detection limit,
             Illinois reported maximum,  95th percentile and mean  unfiltered
             sample (total) metribuzin concentrations of 3.7 ug/L, 0.11 ug/L,
             and 0.065 ug/L, respectively.

3.    Exposure and Risk Characterization
                            75

-------
a.     Ecological Exposure and Risk Characterization

       Risk characterization integrates the results of the exposure and
ecotoxicity data to evaluate the likelihood of adverse ecological effects.
The means of integrating the results of exposure and ecotoxicity data is
called the quotient method.  For this method, risk quotients (RQs) are
calculated by dividing exposure estimates by ecotoxicity values, both acute
and chronic.

       RQ =  EXPOSURE^TOXICITY

       RQs are then compared to OPP's levels of concern (LOCs). These
LOCs are criteria used by OPP to indicate potential risk to nontarget
organisms and the need to consider regulatory action. The criteria indicate
that a pesticide used as directed has the potential to cause adverse effects
on nontarget  organisms.  LOCs currently address  the following risk
presumption categories: (1) acute high - potential for acute risk is high and
regulatory action may be warranted in  addition  to  restricted  use
classification (2) acute restricted use - the potential for acute risk is high,
but this may be mitigated through restricted use classification (3) acute
endangered species- the potential for  acute risk to endangered species is
high, and regulatory action may be warranted, and (4) chronic risk- the
potential for chronic risk is  high, and regulatory action may be warranted.
Currently, the Agency has no  procedures  for assessing chronic risk to
plants, acute or chronic risks to nontarget insects, or chronic risk from
granular/bait formulations to mammalian or avian species.

       The ecotoxicity test values  (i.e., measurement endpoints) used in
the acute and chronic risk quotients are derived from the results of required
studies. Examples of ecotoxicity values derived from the results of short-
term  laboratory studies that assess acute effects  are:  (1) LC50 (fish and
birds) (2) LD50 (birds and mammals (3) EC50 (aquatic plants and aquatic
invertebrates) (4) EC25  (terrestrial  plants) and (5) EC05  or  NOEC
(endangered plants).  Examples'of toxicity test effect levels derived from
the results of long-term laboratory  studies that assess chronic effects are:
(1) LOEC (birds, fish, and aquatic invertebrates) (2) NOEC (birds, fish and
aquatic invertebrates) and (3) MATC (fish and aquatic invertebrates).  For
birds and mammals, the NOEC value is generally used as the ecotoxicity
test value in assessing chronic  effects. Other values may be used when
justified.  Generally, the MATC (defined as the geometric mean of the
NOEC and LOEC) is used as the ecotoxicity test value in assessing chronic
effects to fish and aquatic invertebrates. However, the NOEC is used if the
                       76

-------
                         measurement end point is production of offspring or survival.
                                 Risk presumptions, along with the corresponding RQs and LOCs
                         are tabulated below.
 Table 24. Risk Presumptions for Terrestrial Animals
 Risk Presumption	RQ
                                                                   LOG
 Birds
 Acute High Risk
 Acute Restricted Use
 Acute Endangered Species
 Chronic Risk
 Wild Mammals
 Acute High Risk
 Acute Restricted Use
 Acute Endangered Species
 Chronic Risk
                   EECVLC50 or LDSO/sqft or LOSO/day1                   0.5
                   EEC/LC50 or LD50/sqft or LD50/day (or LD50 < 50 mg/kg)   0.2
                   EEC/LC50orLD50/sqftorLD50/day                    0.1
                   EEC/NOEC                                       1

                   EEC/LC50orLD50/sqftorLD50/day                    0.5
                   EEC/LC50 or LDSO/sqft or LD50/day (or LD50 < 50 mg/kg)   0.2
                   EEC/LC50 or LDSO/sqft or LD50/day                    0.1
                   EEC/NOEC                                       1
 1 abbreviation for Estimated Environmental Concentration (ppm) on avian/mammalian food items
 1  me/ff      3 mg of toxicant consumed/day
 LD50 * wt. of bird      LD50 * wt. of bird
 Table 25. Risk Presumptions for Aquatic Animals
Risk Presumption
Acute High Risk
Acute Restricted Use
Acute Endangered Species
Chronic Risk
RQ
EECYLCSOorECSO
EEC/LC50orEC50
EEC/LC50orEC50
EEC/MATCorNOEC
LOG
0.5
0.1
0.05
1
 1 EEC = (ppm or ppb) in water

 Table 26. Risk Presumptions for Plants
 Risk Presumption
                     RQ
LOG
 Acute High Risk
 Acute Endangered Species

 Acute High Risk
 Acute Endangered Species
 Terrestrial and Semi-Aquatic Plants
                     EECVEC25
                     EEC/ECOSorNOEC
                     Aquatic Plants
                     EEC2/EC50
	      EEC/EC05 or NOEC
1 EEC = lbsai/A
2 EEC = (ppb/ppm) in water
                                                    77

-------
                              (1)     Exposure and Risk to Nontarget Terrestrial Animals

                                      For pesticides applied as a nongranular product (e.g., liquid, dust), the
                              estimated environmental concentrations (EECs) on food items following product
                              application are compared to LC50 values to assess risk.  The predicted 0-day
                              maximum and mean residues of a pesticide that may be expected to occur on
                              selected avian or mammalian food items immediately following  a direct single
                              application at 1 Ib  ai/A are tabulated below.
 Table 27. Estimated Environmental Concentrations on  Avian and Mammalian Food Items (ppm) Following a Single
 Application at 1 Ib ai/A)
                                                EEC (ppm)
EEC (ppm)
Food Items Predicted Maximum Residue1 Predicted Mean Residue!
Short grass
Tall grass
Broadleaf/forage plants, and small insects

240
110
135
15
85
36
45
7
1 Predicted maximum and mean residues are for a 1 Ibs ai/a application rate and are based on Hoerger and Kenaga (1972) as modified by Fletcher


                                      Predicted  residues  (EECs)  resulting   from  multiple
                               applications are calculated in various ways.  For the purpose of
                               metribuzin the following procedure was used:

                                      (a)     Birds

                                      The  acute  risk quotients  for broadcast  applications  of
                                                 78

-------
                                   nongranular products are tabulated below.
Table 28. Avian Acute Risk Quotients for a Single Application of Nongranular Products (Broadcast) Based on a quail LC50 of 4000.
Site/Application
Method
Application
Rate
(Ibs ai/A)
Food Items
Maximum EEC
(ppm)
                                          LC50 (ppm)
Acute RQ
(EEC/LCSO)
sugarcane 6.0
aerial



Short
grass
Tall
grass
Broadleaf
1,440
660

810
4000
4000

4000
0.36
0.17

0.20
potato
ground
                     0.9975
sugarcane
ground
                     4.025
                  plants/Insects
                  Seeds                   90
                  short grass               239
                  Tall grass                110
                  Broadleaf plants/Insects    135
                  Seeds                   15
                  Short                   966
                  grass
                  Tall                     443
                  grass
                  Broadleaf                543
                  plants/Insects
                  Seeds                   60
                                          4000
                                          4000
                                          4000
                                          4000
                                          4000
                                          4000

                                          4000

                                          4000

                                          4000
                                    0.02
                                    0.06
                                    0.03
                                    0.03
                                    0.00
                                    0.24

                                    0.11

                                    0.14

                                    0.02
                                                        79

-------
Table 29. Avian Acute Risk Quotients for Multiple Applications o f Nongranular Products (Broadcast) Based on a quail LC50 of 4000 ppm.
EECs were calculated with the FATE program using the soil metabolic half-life of 106 days.
Site/Application
Method
turf
ground




sugarcane
ground




Application
Rate in Ibs ai/A
(No. of
Applications)
0.5(2)




4(2)




Food Items •
Short
grass
Tall
grass
Broadleaf
plants/Insects
Seeds
Short
grass
Tall
grass
Broadleaf
plants/Insects
Seeds
Maximum EEC
(ppm)
235
108

132
15
1836
842

1033
115
LC50 (ppm)
4000
4000

4000
4000
4000
4000

4000
4000
Acute RQ
(EEC/LC50)
0.06
0.03

0.03
0.00
0.46
0.21

0.26
0.03
                                    The results indicate that  for broadcast applications  of
                             nongranular products, avian acute restricted use and endangered
                             species levels of concern are exceeded at  registered maximum
                             application rates equal to or above 4.0 Ibs ai/A.

                                    The chronic risk  quotients for broadcast applications  of
                             nongranular products are tabulated below.
                                              80

-------
Table 30. Avian Chronic Risk Quotients for Nongranular Products (Broadcast) Based on a mallard reproduction NOEC of
368 ppm.
Site/Application
Method
Sugarcane
aerial




Turf
ground




Application
Rate in Ibs ai/A
(No. of
Applications)
4(2)




0.5(2)




Food Items
Short
grass
'Tall
grass
Broadleaf
plants/Insects
Seeds
Short
grass
Tall
grass
Broadleaf
plants/Insects
Seeds
Maximum EEC
(ppm)
1836
842

1033
115
235
107

132
15
NOEC (ppm)
368
368

368
368
368
368

. 368
368
Chronic RQ
(EEC/NOEC)
4.99
2.29

2.81
0.31
0.64
0.29

0.36
0.04
                                The above results indicate that for broadcast applications of
                          nongranular products,  the  avian chronic level  of concern is
                          exceeded at registered  maximum application rates equal to or
                          above 4.0 Ibs ai/A.  If the bobwhite growth NOEC of 62 ppm is
                          used, all rates equal to or greater than 0.5 would exceed the chronic
                          level of concern; however, since there was some doubt whether the
                          effects seen on hatchling growth in the bobwhite study were truly
                          treatment-related, and no effects of this nature were observed in the
                          mallard study, the mallard reproductive NOEC of 368 ppm  was
                          used.
                                (b)
Mammals
                                Birds and mammals have similar responses to xenobiotics,
                          their differences being more quantitative rather than qualitative.
                          Since metribuzin  does not present an acute risk to endangered
                          birds, mammals are also presumed to be protected.

                                Estimating the  potential for adverse  effects  to  wild
                          mammals is based upon EEB's draft 1995 SOP of mammalian risk
                          assessments and methods used by Hoerger and Kenaga (1972) as
                          modified by  Fletcher  et  dl.  (1994).   The concentration of
                          metribuzin in the diet that is expected to be acutely lethal to 50%
                          of the test population (LC50) is determined by dividing the LD50
                                         81

-------
                           value (usually rat LD50) by the percent of body weight consumed.
                           A risk quotient is then determined by dividing the EEC by the
                           derived LC50  value.   Risk  quotients  are calculated for three
                           separate weight classes of mammals (15, 35, and 1000 g), each
                           presumed to consume four different kinds of food (grass,  forage,
                           insects, and  seeds).   The  acute risk quotients  for broadcast
                           applications of nongranular products are tabulated below.
Table 31. Mammalian (Herbivore/Insectivore) Acute Risk Quotients for Single Application of Nongranular Products
(Broadcast) Based on a rat LD50 of 2200 mg/kg.
Site/
Application
Method/
Rate
in Ibs ai/A
Sugarcane
aerial
6
6
6
Potato
aerial
1
1
1
1 RQ =
Body
Weight
(g)

15
35
1000
15
35
1000
EEC (me/kg)
%Body
Weight
Consumed

95
66
15
95
66
15

Rat
LD50
mg/kg

2200
2200
2200
2200
2200
2200

EEC
Short
Grass

1440
1440
1440
240
240
240

EEC
Forage &
Small
Insects

810
810
810
135
135
135

EEC
Large
Insects

90
90
90
15
IS
15

Acute
RQ
Short
Grass

0.62
0.43
0.10
0.10
0.07
0.02

Acute RQ
Forage
& Small
Insects

0.35
0.24
0.06
0.06
0.04
0.00

Acute RQ
Large
Insects

0.04
0.03
0.01
0.01
0.00
0.00

    LD50 (mg/kg)/ % Body Weight Consumed

Table 32. Mammalian (Granivore) Acute Risk Quotients for Single Application of Nongranular Products (Broadcast)
Based on a rat LD50 of 2200 mg/kg.
Site/
Application
Method/Rate in
Ibs ai/A 	
Sugarcane
aerial
6
6
6
Potato
aerial
1
1
1

Body
Weight
fe)


15
35
1000


15
35
1000

%Body
Weight


21
15
3


21
15
3

Rat
LD50
(mg/kg)


2200
2200
2200


2200
2200
2200

EEC
Seeds


90
90
90


15
15
15

Acute RQ
Seeds


0.01
0.01
0.00


0.00
0.00
0.00
1 RO = EEC (me/feel
     LD50 (mg/kgy % Body Weight Consumed
                                             82

-------
Table 33.  Mammalian (Herbivore/Insectivore) Acute Risk Quotients Multiple Applications of Nongranular Products
(Broadcast) Based on a rat LD50 of 2200 rag/kg.
Site/
App. Method/
Rate in Ibs ai/A
(No. of Apps.)
Sugarcane
aerial
4(2)
4(2)
4(2)
Turf
ground
0.5(2)
0.5(2)
0.5(2)
Body
Weight
(g)

15
35
1000
15
35
1000
% Body
Weight
Consumed

95
66
15
95
66
15
Rat
LD50
mg/kg

2200
2200
2200
2200
2200
2200
EEC
Short
Grass

1836
1836
1836
235
235
235
EEC
Forage &
Small
Insects

1033
1033
1033
132
132
132
EEC
Large
Insects

115
115
115
15
15
15
Acute
RQ
Short
Grass

0.79
0.55
0.13
0.10
0.07
0.02
Acute RQ
Forage
& Small
Insects

0.45
0,31
0.07
0.06
0.04
0.01
Acute RQ
Large
Insects

0.05
0.03
0.01
0.01
0.00
0.00
1 RO = EEC (me/kg)
   LD50 (mg/kg)/ % Body Weight Consumed
Table 34. Mammalian (Granivore) Acute Risk Quotients for Multiple Applications Nongranular Products (Broadcast)
Based on a rat LD50 of 2200 mg/kg.
Site/
App. Method/ Rate
in Ibs ai/A
(No. of Apps.)
sugarcane
aerial
4(2)'
4(2)
4(2)
turf
ground
0.5(2)
0.5(2)
0.5(2)

Body
Weight
(g)

15
35
1000

15
35
1000

% Body
Weight
Consumed

21
15
3

21
15
3

Rat
LD50
(mg/kg)

2200
2200
2200

2200
2200
2200

EEC
Seeds

115
115
115

15
15
15

Acute RQ
Seeds

0.01
0.01
0.00

0.00
0.00
0.00
1 RO= EEC(mefke)
   LD50 (mg/kg)/ % Body Weight Consumed
                                    The  results  indicate that for  broadcast applications  of
                             nongranular products, acute high risk LOCs are exceeded for small
                             herbivorous/insectivorous  mammals at application rates greater
                             than or equal to 4.0 Ibs ai/A. Restricted use levels of concern are
                                              83

-------
                             also exceeded for small herbivorous/insectivorous mammals at
                             application rates greater than or equal to 4.0 Ibs ai/A.  Endangered
                             species     levels    of    concern     are     exceeded     for
                             herbivorous/insectivorous  small  mammals at application rates
                             greater  than  single applications  of  1.0  Ib  ai/A  or multiple
                             applications of 0.5 Ibs ai/A or greater.
                                    The chronic risk quotients  for  broadcast applications of
                             nongranular products are tabulated below.
Table 35. Mammalian Chronic Risk Quotients for Nongranular Products (Broadcast) Based on a rat NOEC of 30 ppm in a 2-generation
reproduction study. EECs were generated using the FATE program, using the aerobic soil metabolism half-life of 106 days.
Site/Application
Method
Application
Rate in Ibs ai/A
(No. of Apps.)
Food Items
Maximum EEC
(ppm)	
                                   NOEC (ppm)
Chronic RQ
(EEC/NOEC)
Sugarcane
aerial
4(2)
Potato
ground
Short                1836
grass
Tall                 842
grass
Broadleaf             1033
plants/Insects
Seeds                115
Short grass            240
Tall grass             110
Broadleaf plants/Insects    135
Seeds                15
               30

               30

               30

               30
               30
               30
               30
               30
61.20

28.07

34.43

3.83
8.00
3.67
4.50
0.50
Turf
ground






0.5 (2) Short 235
grass
Tall 107
grass
Broadleaf 132
plants/Insects
15
Seeds
30 7.83

30 3.57

30 4.4

30 0.5

                                     The above results indicate that for broadcast applications of
                             nongranular products, the  chronic level  of concern  for small
                             mammals is exceeded at registered application rates equal'to or
                             above 0.5 Ibs ai/A.
                                     (c)     Insects
                                     Currently, the Agency has no procedure for assessing risk
                             to  nontarget insects.  Results of acceptable studies are used for
                                               84

-------
recommending appropriate label precautions.

(1)    Exposure and Risk to Nontarget Freshwater Aquatic
       Animals

       The Agency calculates EECs using the GENeric Expected
Environmental Concentration Program (GENEEC).  The resultant
EECs, termed GEECs, are used for assessing acute and chronic
risks to aquatic organisms.  Acute risk assessments are performed
using either 0-day GEEC values for single applications or peak
(GEEC) values for multiple applications. Chronic risk assessments
are performed using the 21-day GEECs for invertebrates and 56-
day GEECs for fish.

       The GENEEC program uses a few basic environmental fate
chemical parameters and pesticide label application information to
provide  a  rough   estimate  of  the  expected environmental
concentrations following treatment of 10 hectares.  The model
calculates the concentration of pesticide in a one hectare, two meter
deep pond, taking into account the following: (1) adsorption to soil
or sediment (2) soil incorporation (3) degradation  in soil before
washoff to a water body and (4) degradation within the water body.
The model also accounts for direct deposition of spray drift into the
water body (assumed to be 1% and 5% of the application rate for
ground and aerial applications, respectively).  (When multiple
applications are  permitted:  The interval  between applications is
included in the calculations.  The  environmental fate parameters
used in the model for this pesticide are: soil Koc = 41, solubility =
1200 ppm, aerobic soil metabolism half-life =106 days, hydrolysis
(n/a~"stable"),  water  photolysis  =  4.3  hours,  and  aquatic
metabolism (n/a). GEECs are tabulated below.
                85

-------
Tabl&36. Estimated Environmental Concentrations (EECs) For Aquatic Exposure
Site
GENEEC
Sugarcane
Sugarcane
Turf
Peas
Application
Method

aerial application of
liquid formulation
ground unincorporated
ground unincorporated
ground incorporated
Application
Rate
(Ibs ai/A)

6.00
4.00
0.50
0.50
# of Apps./
Interval
Between Apps.

1
2 (14 days)
2 (7 days)
1
Initial
(PEAK)
EEC
(ppm)

0.39
0.07
0.024
0.024
21-day
EEC
(ppm)

0.24
0.13
0.043
0.015
56-
day
EEC
(ppm)

0.12
0.10
0.034
0.008
                                 (a)    Freshwater Fish

                                       Acute and chronic risk  quotients  are  tabulated
                                 below.
Table 37. Risk Quotients for Freshwater Fish Based On a Rainbow Trout LC50 of 42 ppm and a Rainbow Trout LOEC
of 3.0 ppm.
Site/
Application
Method/Rate in Ibs
ai/A (No. of Apps.)
sugarcanp/aeriai
6(1)
sugarcane/ground
unincorp,
4(2)
turf/ground unincorp.
0.5(2)
peas/ground incorp,
0.5(1)
LCSO
(ppm)
42
42
42
42
LOEC
(ppm)
3
3
3
3
EEC
Initial/Peak
(ppm)
0.39
0.07
0.024
0.024
EEC
56-Day
(ppm)
0.12
0.10
0.034
0.008
Acute RQ
(EEC/LC50)
0.01
0.00
0.00
0.00
Chronic RQ
(EEC/NOEC or
MATC)
0.04
0.03
0.01
0.00
                                       The results indicate that no acute or chronic levels of
                                 concern for freshwater fish are exceeded at any registered
                                 application rate.

                                 (b)   Freshwater Invertebrates

                                       The acute and chronic risk quotients are tabulated
                                 below.
                                          86

-------
Table 38. Risk Quotients for Freshwater Invertebrates Based On a Daphnid EC50 of 4.2 ppm and a Daphnid NOEC of
1.29 ppm.
Site/
Application Method/
Rate in Ibs ai/A
(No. of Apps.)
sugarcane/aerial
6(1)
sugarcane/ground
unincorp.
4(2)
turf/ground unincoip.
0.5 (2)
peas/ground incorp.
0.5(1)
LC50
(ppm)
4.2
4.2
4.2
4.2
NOEC
(ppm)
1.29
1.29
1.29
1.29
EEC
Initial/Peak
(ppm)
0.39
0.07
0.024
0.024
EEC
21-Day
Average
0.12
0.10
0.043
0.008
Acute RQ
(EEC/LC50)
0.09
0.02
0.00
0.01
Chronic RQ
(EEC/NOEC or
MATC)
0.09
0.08
0.01
0.01
                                         The results indicate that no acute or chronic level of
                                  concern  is exceeded for freshwater invertebrates at  any
                                  registered application rate.

                                  (c)     Estuarine and Marine Animals

                                         The acute risk quotients are tabulated below.

Table 39. Risk Quotients for Estuarine/Marine Fish Based on a Sheepshead Minnow LC50 of 85 ppm.
Site/
Application Method
Sugarcane/
aerial
Sugarcane/
ground unincorp.
Turf?
ground
unincorp.
Peas/
ground incorp.
Rate in Ibs ai/A (No. of
Apps.)
6(1)
4(2)
0.5 (2)
0.5 (1)
LC50
(ppm)
85
85
85
85
EEC
Initial/
Peak
(ppm)
0.39
0.07
0.024
0.024
Acute RQ
EEC/LC50
0.00
0.00
0.00
0.00
                                         The results indicate that no acute level of concern is
                                  exceeded for  estuarine/marine fish  at any registered
                                  application rate.

                                         The   acute  risk  quotients  for  estuarine/marine
                                           87

-------
                                 invertebrates are calculated below.

Table 40. Risk Quotients for Estuarine/Marine Aquatic Invertebrates Based on a Oyster EC50 of 40.7 ppm.
Site/
Application Method
Sugarcane/
aerial
Sugarcane/
ground unincorp.
Turf/
ground
unincorp.
Peas/
Rate in Ibs as/A (No. of
Apps.)
6(1)
4(2)
0.5 (2)
0.5 (1)
LC50
(ppm)
40.7
40.7
40.7
40.7
EEC
Initial/
Peak
(ppm)
0.39
0.07
0.024
0.024
Acute RQ
(EEC/LC50)
0.01
0.00
0.00
0.00
                                        The results indicate that no acute level of concern is
                                 exceeded  for  estuarine  invertebrates   any registered
                                 application rate.

                          (2)    Exposure and Risk to Nontarget Plants

                                 (a)    Terrestrial and Semi-aquatic

                                        Terrestrial and semi-aquatic plants may be exposed
                                 to pesticides from runoff, spray drift or volatilization.
                                 Semi-aquatic plants are  those that inhabit low-lying wet
                                 areas that may be dry at certain times of the year.  The
                                 Agency's runoff scenario  is: (1)  based  on a pesticide's
                                 water solubility and the amount of pesticide present on the
                                 soil surface and its top one inch (2)  characterized as "sheet
                                 runoff' (one treated acre  to an adjacent acre) for terrestrial
                                 plants (3) characterized as "channelized runoff (10 treated
                                 acres to  a distant low-lying acre) for semi-aquatic plants
                                 and (4) based on % runoff values of 0.01, 0.02, and 0.05 for
                                 water solubility of <10 ppm, 10-100 ppm, and >100 ppm,
                                 respectively.

                                        Spray drift exposure from ground application is
                                 assumed to be 1% of the application rate.  Spray drift from
                                 aerial, airblast, forced-air, and chemigation applications is
                                 assumed to be 5% of the application rate.

                                        EECs are calculated for the following application
                                          88

-------
                                    methods:   (1) unincorporated ground  applications, (2)
                                    incorporated ground application, and (3)  aerial, airblast,
                                    forced-air, andchemigationapplications.  Estimated
                                    environmental concentrations for  terrestrial and  semi-
                                    aquatic plants are tabulated below.

Table 41.  Estimated Environmental Concentrations (Ibs ai/A) For Terrestrial and Semi-Aquatic Plants for a Single
Application
Site/ Application
Method/No, of
Apps./Rateof
Application in Ibs
ai/A
Minimum                         Channelized
Incorporation   Runoff   Sheet Run-off   Run-off         Drift
Depth (in)     Value    (Ibs ai/A)      (Ibs ai/A)	(Ibs ai/A)
           Total
Total        Loading to
Loading to    Semi-aquatic
Adjacent     Area
Area        (Channel
(Sheet Run-   Run-off+
off+Drift)    Drift)
Sugarcane
Unincorporated
aerial
6.0

Peas
Incorporated
Ground

0.5

Tomato,
Chemigation
                            0.05     0.30
            0.05     0.03
                            0.05     0.05
                                                3.00
                                0.30
                                                0.50
                                                              0.06
                                                              0.05
                                                                         0.36
                                                         0.03
                                                                          0.10
                                                                                     3.06
                                                                     0.30
                                                                                     0.55
                                            The EC25 value of the most sensitive species in the
                                    seedling emergence study  is compared to runoff and drift
                                    exposure to determine the risk quotient for those exposure
                                    scenarios. The EC25 value of the most sensitive species in
                                    the vegetative vigor study is compared to the drift exposure
                                    to determine the risk quotient for that exposure scenario.

                                            EECs and acute high risk quotients for terrestrial and
                                    semi-aquatic  plants  based  on  a single application are
                                    tabulated below.
                                               89

-------
Table 42. Acute High Risk Quotients from a Single Application for Terrestrial and Semi-Aquatic Plants Based On a
Turnip Emergence EC25 of 0.008 Ibs ai/A and a Turnip Vegetative Vigor EC25 of 0.005 Ibs ai/A.
Site, Method
and Rate of
Application
(Ibs ai/A)
Sugarcane
Unincorp,
Ground
6,0
Peas
Incorp.
Ground
0.5
Tomato,
Chemiga-
tion
1
Seedling
Emergence Vegetative
EC25 Vigor EC25
(Ibs ai/A) (Ibs ai/A)

0,008 0.005


0.008 0.005

0.008 0.005
Total
Loading to
Adjacent
Area
Drift (Ibs (Sheet
ai/A) Runoff+
Drift)

0.3 0.36


0.03

0.05 0.1
Total
Loading to
Semi-aquatic
Area
(Channelized
Run-off+
Drift)

3.06


0.30

0.55
Emer-
gence
RQ
Terres-
trial
Plants

45.00


3.75

12.50
Emer-
gence
RQ
Semi-
Aquatic
Plants

382.50


37.50

68.75
Vegeta-
tive Vigor
, RQ
Terrestrial
and Semi-
Aquatic
Plants

60.00


0.00

10.00
                                        The NOEC or EC05 (if a NOEC is unavailable)
                                 value  of  the  most  sensitive  species in the  seedling
                                 emergence study is compared to runoff and drift exposure
                                 to determine the endangered species risk quotient for those
                                 exposure scenarios. The NOEC or EC05 value of the most
                                 sensitive species in the vegetative vigor study is compared
                                 to the drift exposure to determine the endangered species
                                 risk quotient for that exposure scenario.

                                        EECs and acute (endangered species) risk quotients
                                 for terrestrial and semi-aquatic plants based on a single
                                 application are tabulated below.
                                          90

-------
Table 43. Acute Endangered Species Risk Quotients from a Single Application for Terrestrial and Semi-Aquatic
Plants Based On a Turnip Emergence NOEC of 0.007 Ibs ai/A and a Turnip Vegetative Vigor NOEC of 0.0028 Ibs
ai/A.

Site, Method
and Rate of
Application
(Ibs ai/A)



Sugarcane
Unincorp.
Ground
6
Peas
Incorp.
Ground
0.5
Tomato,
Chemiga-
tion
1



Seedling
Emergence
NOEC or
EC05
(Ifas ai/A)



0.007



0.007



0.007



Vegetative
Vigor
NOEC or Drift
EC05(lbs (Ibs
ai/A) ai/A)



0.0028 0.30



0.0028



0.0028 0.05

Total
Loading to
Adjacent
Area
(Sheet
Runoff+
Drift)



0.36



0.03



0.1

Total
Loading to
Semi-aquatic
Area
(Channelized
Run-off+
Drift)



3.06



0.3



0.55


Emer-
gence
RQ
Terres-
trial
Plants



51.43



4.29



14.29


Emer-
gence
RQ
Semi-
Aquatic
Plants



437.14



42.86



78.57
Vegeta-
tive
Vigor
RQ
Terres-
trial and
Semi-
Aquatic
Plats



107.14



0.00



17.86
                                      The results indicate that for a single  application,
                               acute high risk and endangered species levels of concern
                               are exceeded for terrestrial plants at a registered maximum
                               single application rate equal to or above 0.5 Ibs ai/A. For
                               semi-aquatic plants, acute high risk and endangered species
                               levels of concern are exceeded at a registered maximum
                               single application rate equal to or above 0.5 Ibs ai/A.  Since
                               all registered rates for multiple applications are greater than
                               or equal to 0.5 Ibs ai/A, all registered multiple application
                               rates will  also exceed acute high risk, restricted use and
                               endangered species levels  of concern.    Currently, the
                               Agency does not have a procedure for assessing chronic
                               risk to terrestrial and semi-aquatic plants.

                               (b)    Aquatic

                                      Exposure to nontarget aquatic plants may  occur
                               through runoff or spray drift from adjacent treated sites or
                               directly from such uses as aquatic weed or mosquito larvae
                               control. An aquatic plant risk assessment for acute high
                               risk is usually made for aquatic vascular plants  from the
                               surrogate duckweed Lemnagibba. Non-vascular high acute
                                         91

-------
                                  aquatic plant risk assessments are performed using either
                                  algae or a diatom, whichever is the most sensitive species.
                                  An aquatic plant risk assessment for acute- endangered
                                  species is usually made for aquatic vascular plants from the
                                  surrogate duckweed Lemna  gibba.   Runoff and  drift
                                  exposure is computed from GENEEC. The risk quotient is
                                  determined  by  dividing the  pesticide's  initial or  peak
                                  concentration in water by the plant EC50 value.

                                         Acute risk quotients for vascular and non-vascular
                                  plants are tabulated below.
Table44, Acute Risk Quotients for Aquatic Plants based upon a Duckweed &mna gibba) EC50 of0.13 ppm and a Marine Diatom
(Skeletonema costotum) EC50 of 0.0087 ppm.
Site/ Application Method/ Rate of
Application in Ibs ai/A (No. of Apps.)
Sugarcane
Aerial
6(1)
Peas
Incorp. Ground
0.5(1)
Turf
Uninc. ground
0,5(2)
Test Species
duckweed
diatom
duckweed
algae or diatom
duckweed
algae or diatom
EC50
(ppm)
0.13
0.0087
0.13
0.0087
0.13
0.0087
EEC
(ppm)
0.39
0.39
0.024
0.024
0.024
0.024
RQ
(EEC/
EC50)
3.00
44.83
0.18
2.76
0.18
2.76
                                         Endangered species risk  quotients  for vascular
                                  aquatic  plants  are tabulated  below.    (Non-vascular
                                  endangered species are not known to exist at this time.)
Table 45. Endangered Species Risk Quotients (RQs) for Aquatic Plants based upon a duckweed I^emna gibba) NOEC of 0.018 ppm.
Site/ Application Method/
Rate of Application in Ibs ai/A
(No. of Apps)
Sugarcane
Aerial
6(1)
Peas
Incorp. Ground
0.5(1)

Turf
0.5 (2)
Test Species
duckweed


duckweed


duckweed


NOECorEQa
(ppm)
0.018


0.018


0.018


EEC
(ppm)
0.39


0.024


0.024


RQ
(EEC/
EC50)
21.67


1.33


1.33


                                         The results indicate that acute high risk levels of
                                            92

-------
             concern are exceeded for vascular plants at application rates
             equal to  and above 6.0 Ibs ai/A, and endangered species
             levels  of concern are exceeded  for  vascular plants at
             registered maximum rates equal to or above 0.5 Ibs ai/A.
             The results indicate that  acute high risk and endangered
             species levels of concern  are exceeded for nonvascular
             aquatic plants at registered maximum rates equal to or
             above 0.5 Ibs ai/A. Currently, the Agency does not have a
             procedure for assessing chronic risk to aquatic plants.

       (3)    Endangered Species

             Endangered species LOCs for birds, mammals, terrestrial
       plants, and aquatic plants are exceeded for metribuzin.

             The Endangered Species Protection Program is expected to
       become final in the future. Limitations in the use of metribuzin
       may be required to protect endangered and threatened species, but
       these limitations have not been defined and may be formulation
       specific. EPA anticipates that a consultation with the Fish and
       Wildlife Service may be conducted in accordance with the species-
       based  priority  approach described  in  the  Program.    After
       completion of consultation, registrants will be informed if any
       required label modifications are necessary.  Such modifications
       would most likely consist of the generic label statement referring
       pesticide users to use limitations  contained in county Bulletins.

b.     Water Resources Risk Implication for Human Health
       (1)
Ground Water
             Metribuzin is clearly a compound that leaches to ground
       water, but at the present time, the concentrations found in ground
       water are low compared to the levels of concern for human health.
       However, in some studies, metribuzin residues have been found in
       ground water at relatively high levels (14 and 54 ppb).

             The  lifetime Health Advisory for metribuzin has been
       established at  100  ppb.  Metribuzin has been placed in Cancer
       Group D (not classifiable as to human carcinogenicity).   All
       metribuzin formulations carry a ground-water advisory on their
       labels.
                      93

-------
(2)    Surface Water

       Metribuzin is not currently regulated  under the  Safe
Drinking  Water  Act (SDWA); therefore, no  MCL has been
established for it and water supply systems are not  required to
sample and analyze for it.- Metribuzin has lifetime and 1- and 10-
day drinking water health advisories of 100 ug/L and 5000 ug/L,
respectively. The low soil/water partitioning of metribuzin and its
major degradates probably makes their removal by the primary
treatment processes employed by  most  surface water  supply
systems ineffective. However, the available data on metribuzin in
surface water indicates that it is unlikely that annual  average
concentrations of metribuzin will exceed  the lifetime health
advisory or that peak or short term average concentrations will
exceed the 1- to  10-day health advisory in surface water source
drinking water. Also, no drinking water Health Advisories are
available for the major degradates.

(5)    Summary Environmental Risk Characterization

       A.     Avian Species

              Acute Risks

              Although acute RQs approach, or exceed, the acute
high risk LOG (0.5) and acute endangered species LOG (0.1) for
certain crop/rate  scenarios, the Agency concludes that minimal
acute risks exist for these avian species. Our conclusion is based
on the observation that metribuzin's dietary LG50s for bobwhite
quail  and mallard  duck are > 4000 ppm and  >  5000 ppm,
respectively,  classifying metribuzin as  practically non-toxic.
Typically, herbicides that exhibit such toxicity are expected to have
minimal acute effects on birds. Further, the typical use rate for
metribuzin is 1 Ib ai/acre, a rate that does not result in RQs that
exceed the LOCs.

              The certainty of the above assessment is moderate to
high. However, one factor that affects the certainty (and prevents
it from being high) is that the acute oral LD50 for bobwhite quail
exposed to metribuzin is 169.2 mg/kg. This value classifies this
pesticide as moderately  toxic to quail and indicates that dietary
 ingestion  may underestimate  potential  acute effects to  avian
 species.
                94

-------
             Chronic Risks

             The Agency concludes that chronic risks are likely
for avian species, including endangered species, for rates of 4 Ib
ai/acre or higher. However, for the typical use rate of 1 Ib ai/acre,
RQs do not exceed the LOG of 1.0, and therefore, chronic risks  are
not likely to occur under these use situations.

             The certainty of the above assessment is moderate.
The  following factors affect the utility  of the data  in a risk
assessment:

1.     The avian reproduction studies, using bobwhite quail and
      mallard  duck, did not result in effects on reproductive
      parameters. Instead, there were reductions in body weights
      of hatchlings of treated birds.

2.     There was some question as to whether the body weight
      reductions in the bobwhite quail study were treatment-
      related.

3.     Since there were no reproductive parameters affected in  the
      duck study, the highest test concentration, 368 ppm, was
      considered to be the No Observed Effect Concentration
      (NOEC) and the Lowest Observable Effect Concentration
      (LOEC) was not established (i.e., LOEC was > 368 ppm).
      Since  the LOEC was not determined in this study, it is
      possible that the NOEC would be at a higher concentration.

             These factors lead to a conclusion that while  the
possibility of chronic risk exists, the probability that it will occur
may be relatively low.

      B.     Mammalian Species

             Acute

             Use applications of 0.5 Ib ai/acre and higher resulted
in RQs that either exceed the acute endangered species LOG (0.1)
or the acute high risk LOG (0.5). However, considering the factors
discussed below, the Agency concludes that minimal acute risks
exist for these species.
               95

-------
             The certainty of the assessment is moderate. This is
based on the following:

1.     The rat acute oral LD50 is  > 2000  mg/kg, classifying
       metribuzin as practically non-toxic. Typically, herbicides
       that exhibit such toxicity are expected to have minimal
       acute effects on mammals.

2.     However,  the  laboratory mouse acute oral  LD50  is
       approximately 700 mg/kg, a value less than half the 2000
       mg/kg value for rats. This lower value raises some question
       as to differences in sensitivity between species. It is not
       known how sensitive wild mammals may be to metribuzin.
       If they are substantially more sensitive, they may be at
       greater risk than indicated by the RQs.

             Therefore, it is only with moderate certainty that the
Agency concludes  that mammals  are not  at acute  risk from
metribuzin applications.

              Chronic

              The Agency concludes that chronic risks are likely
for mammalian species, including endangered species, for rates of
1 Ib ai/acre or higher.
              The  certainty  of the above  assessment is  high
 because:

 1.
      The  available chronic mammalian data appear  to  be
      scientifically sound and provide values (NOEC and LOEC)
      related to effects on reproductive parameters.

2.    Metribuzin and/or its degradates persist in the environment,
      allowing chronic exposure of mammalian species.

      C.    Aquatic Species

             Acute

      The Agency concludes that minimal acute risks exist for
nontarget aquatic species, including endangered species. Although
one RQ (0.09) for sugarcane, at an application rate of 6 Ib ai/acre,
                96

-------
exceeds the acute endangered species LOG  (0.05) for aquatic
invertebrates, the Agency concludes that minimal acute risks exist
for these species. This conclusion is based on metribuzin's overall
lack  of  acute toxicity  to  a  variety   of freshwater  and
estuarine/marine  species,  both  vertebrate  and  invertebrate.
Metribuzin ranged from practically non-toxic to slightly toxic for
all species except Daphnia, which ranged from slightly toxic to
moderately toxic. Further, for the typical use rate of 1 Ib ai/acre,
acute RQs do not exceed the LOCs of 0.5 (non-endangered) or 0.05
(endangered),  and therefore, acute risks are not likely to occur
under these use situations.

       The certainty of the above assessment is moderate to high.
However, one factor that affects the certainty (and prevents it from
being high) is the sensitivity of Daphnia to metribuzin relative to
other aquatic organisms. The EG50 value of 4.2 ppm is significantly
lower than other aquatic LC50/EC50 values. This lower value raises
some question as to  differences in sensitivity between species. It
is not known how sensitive wild aquatic organisms may be to
metribuzin. If they are substantially more sensitive, they may be
at greater risk than indicated by the RQs.

             Chronic

             The Agency concludes that minimal chronic risks
exist for nontarget aquatic  species, including endangered species.
All RQs are well below the chronic LOC of 1.0.

             The certainty of the above assessment is moderate to
high because:

1.     The  available  chronic  aquatic data  appear to  be
       scientifically sound and provide values (NOEC and LOEC)
       related to effects on reproductive parameters. Although a
       NOEC was not determined in the rainbow trout early life-
       stage study, use of the  LOEC in developing  RQs still
       resulted in values well below the LOC of 1.0.

2.     However, metribuzin  and  its  degradates  persist in  the
       aquatic  environment,  allowing  for chronic exposure of
       aquatic  species.  Because of this persistence and lack of
       available chronic aquatic data on degradates, the Agency
       cannot   determine  the  chronic risks  for metribuzin
               97

-------
                                 degradates. This factor affects the certainty and prevents it
                                 from  being high.    However,   one  chronic aquatic
                                 invertebrate study using Daphnia and DADK, a degradate
                                 of metribuzin, is available. The results from this study are
                                 comparable to those using parent compound.

                                 D.     Plants

                                        The  Agency concludes that risks are likely for
                                 nontarget terrestrial and aquatic plant species,  including
                                 endangered species, for rates of 0.5 Ib ai/acre or higher.
                                 Routes of  exposure  include  drift  and  runoff (both
                                 channelized and sheet runoff) for such organisms.

                                        The  certainty  of the above assessment is high
                                 because metribuzin is a herbicide and as such is intended to
                                 adversely affect plants.

IV.    RISK MANAGEMENT AND REREGISTRATION DECISION

       A.    Determination of Eligibility

             Section 4(g)(2)(A) of FIFRA calls for the Agency to determine, after submission
       of relevant data concerning an active ingredient, whether products containing the active
       ingredients are eligible for reregistration. The Agency has previously identified and
       required the submission of the generic (i.e. active ingredient specific) data required to
       support reregistration of products containing metribuzin as an  active ingredient.  The
       Agency has completed its review of these generic data, and has determined that the data
       "are sufficient to support reregistration of all products containing metribuzin under the
       conditions specified in the RED. Appendix B identifies the generic data requirements that
       the Agency reviewed as part of its determination of reregistration eligibility of metribuzin,
       and lists the submitted studies that the Agency found acceptable.

             The data identified in Appendix B were sufficient to allow the Agency to assess
       the registered uses of metribuzin and to determine that metribuzin can be used without
       resulting in unreasonable  adverse effects to  humans and the environment if  used
       according to the labels as amended by this RED.  The Agency therefore finds that all
       products containing metribuzin as  the active ingredients are eligible for reregistration
       under the conditions specified in this RED.  The reregistration of particular products is
       addressed in Section V of this document.

             The Agency made its reregistration eligibility determination based upon the target
       data base required for reregistration, the current guidelines for conducting acceptable
                                           98

-------
studies to generate such data, published scientific literature, etc. and the data identified
in Appendix B. Although the Agency has found that all uses of metribuzin are eligible
for reregistration under the conditions specified in this RED, it should be understood that
the Agency may take additional appropriate  regulatory action,  and/or  require the
submission  of additional  data  to  support the registration of products containing
metribuzin, if new information comes to the Agency's attention or if the data requirements
for registration (or the guidelines for generating such data) change.

B.     D etermination of Eligibility D ecision

       1.     Eligibility Decision

              Based on the reviews of the generic data for the active ingredient
       metribuzin,  the  Agency  has sufficient  information on the health effects of
       metribuzin and on its potential for causing adverse effects in fish and wildlife and
       the environment. The Agency has determined that metribuzin products, labeled
       and used as specified in  this Reregistration Eligibility Decision, will not pose
       unreasonable risks or adverse effects to humans or the environment. Under the
       Food Quality Protection Act of 1996, the Agency has determined that there is a
       reasonable certainty that no harm will result to infants, children or to the general
       population from aggregate exposure to metribuzin. Significant non-occupational
       exposures are unlikely, therefore, the only risks considered in the aggregate
       exposure assessment were those from dietary and drinking water sources.  EPA
       has concluded that consideration of a common mode of toxicity is not appropriate
       at this  time since EPA does not have information to indicate that toxic effects
       produced by metribuzin would be cumulative with those of any other chemical
       compounds. Therefore, the Agency concludes that products containing jtnetribuzin
       for all uses are eligible for reregistration under the conditions  specified in the
       RED.

       2.     Eligible and Ineligible Uses

              The Agency has determined that all uses of metribuzin are eligible for
       reregistration under the conditions specified in the RED.

C.     Regulatory Position

       The  following is a summary of the regulatory  positions and rationales for
metribuzin.  Where labeling revisions are imposed, specific language is  set forth in
Section V of this document.
                                    99

-------
1.     Food Quality Protection Act Consideration

       Determination of Safety for Metribuzin

       EPA has determined that the established tolerances for metribuzin meet the
safety standards under the FQPA amendments to section 40S(b)(2)(D) for the
general population. In reaching this determination, EPA has considered available
information on the aggregate exposures (both  acute and chronic) from non-
occupational sources, food  and drinking water, as well as the possibility of
cumulative effects from metribuzin and other chemicals with a similar mechanism
of toxicity.

       Determination of safety includes consideration of special sensitivity to
children, potential cumulative effects with pesticides that have a common mode
of toxicity  and aggregate risks resulting from exposure to dietary residues,
residues in drinking water, and residential sources.

       The available toxicological database for metribuzin does not indicate any
special sensitivity for infants and children to metribuzin.  Therefore, the Agency
concludes that an additional uncertainty factor is not warranted, that the RfD
established  at 0.013 mg/kg/day is appropriate for assessing aggregate chronic
dietary risk to infants and children, and that the NOEL of 15 mg/kg/day used in
calculating acute dietary exposure is also appropriate.

       EPA does not have,  at this time, available data to determine whether
metribuzin has a common mechanism of toxicity with other substances or how to
include this pesticide in a cumulative risk assessment.  Unlike other pesticides for
which EPA has followed a cumulative risk approach based on a common
mechanism  of toxicty, metribuzin does not appear to produce a toxic metabolite
produced by other substances. For the purposes of this tolerance action, therfore,
EPA has not assumed that metribuzin has a common mechanism of toxicity with
other substances.

       The Agency has determined that significant non-occupational exposures
are unlikely. The only risks which must be considered are those from dietary and
drinking water sources. There  are no chronic homeowner exposure scenarios;
therefore, the aggregate acute or chronic risk would be the total dietary risk (food
source + drinking water).

       The  total acute dietary (food and drinking water source) risk assessment
was performed for the sub-population females (13+ years). The MOE was 1200
(rounded to two significant digits). Metribuzin's  acute dietary MOE  greatly
exceeds  100; therefore, the Agency considers the MOE to be sufficiently
                             100

-------
protective for the acute total dietary (food source and drinking water) risk.

       Using the previously described exposure  assumptions, the Agency has
concluded that for the general population  1% of the RfD will be reserved for
exposure to residues of metribuzin in drinking water and 36% of the RfD will be
utilized by exposure to residues of metribuzin in food  commodities. Thus, the
total chronic dietary risk is 37% of the RfD.

       When total chronic dietary risk is assessed for the population sub-group
with the highest %RfDs (children 1 - 6), the Agency has concluded that 4% of the
RfD will be reserved for exposure to residues of metribuzin in drinking water and
75% of the RfD will be utilized by exposure to residues of metribuzin in  food
commodities. The total chronic dietary risk is 79% of the  RfD, thus not exceeding
the Agency's risk concern level.

2.     Tolerance Reassessment

       Tolerances Listed Under 40 CFR ง180.332

       The tolerances listed under 40 CFR ง180.332 are expressed in terms of the
combined residues of metribuzin and its triazinone metabolites. A summary of
metribuzin tolerance reassessments is  presented  in  Table  46.  Tolerance
reassessments were prepared for metribuzin and its metabolites DADK, DK, and
DA. It should be noted that the registrant has requested that the current tolerance
expression be amended to consider only metribuzin and its DADK metabolite.
However, the Agency has not received a formal proposal containing additional
data and/or discussion concerning this request.

       Sufficient data are available to ascertain the adequacy of the tolerances
established in 40 CFR ง180.332  for the following commodities:  barley, grain;
barley, straw; carrots; corn, stover (fodder); com, forage; grass; grass, hay; lentils
(dried); lentils,  forage; peas; peas (dried); peas, forage; sainfoin; sainfoin, hay;
soybeans; soybeans, forage; soybeans, hay; sugarcane; tomatoes; wheat, forage;
wheat, grain; and wheat straw.  Additional confirmatory data/information are
needed before the  established  tolerances for animal  commodities  can  be
reassessed. When tolerances for animal commodities are reassessed, a separate
dietary exposure assessment should be made to determine the necessity of
including any of these animal metabolites in the tolerance expression.

       Tolerances for residues in alfalfa chaff, alfalfa seed, and cannery waste of
fresh corn (previously proposed in PP#8F3683/FAP#8H6663) are not needed.

       There are presently no registered uses of metribuzin on popcorn. When
                            101

-------
acceptable field corn grain data have been  submitted and  evaluated, the
established  tolerance  for  "corn,  grain  (inc. popcorn)" should be  revoked
concomitant with the establishment of a tolerance for "corn, field, grain." There
are also no registered uses of metribuzin on sweet corn; therefore, the established
tolerance for this commodity will be revoked.

       The livestock feeds table for Subdivision O (9/95) no longer considers
lentil hay, lentil forage, or barley forage to be significant livestock feed stuffs.
The established tolerances for lentil vine hay, lentil forage, and barley forage will
therefore be revoked.

       Tolerances That Need To Be Proposed Under 40 CFR SI 80.332

       The Agency has recently determined that tolerances for aspirated grain
fractions should be established based on the use of a pesticide on corn, wheat,
sorghum, and soybeans; there are presently registered uses of metribuzin on corn,
wheat, and  soybeans.  The available field corn grain dust data indicate that
residues of metribuzin and its metabolites DA and DADK were nondetectable
(<0.01 ppm each) and residues of DK were nondetectable (<0.03 ppm) following
treatment at 5x.  An adequate  level for a tolerance for metribuzin residues of
concern in/on aspirated grain fractions will be determined when the outstanding
data for wheat aspirated grain fractions are submitted.

       Food/Feed Additive Issues Under 40 CFR ง185.250 and 40 CFR S186.250

       Adequate processing studies have been submitted for field corn, potatoes,
and  soybeans.  The field corn and soybean processing studies suggest that no
food/feed additive tolerances are needed on the processed commodities of these
crops; nondetectable residues in the raw agricultural and processed commodities
of these crops-were obtained following applications  of metribuzin at exaggerated
rates. The potato processing study suggests that the established food/feed additive
tolerances on processed potato  commodities are appropriate.

       The  livestock feeds table for Subdivision O (9/95) no longer considers
sugarcane forage to be a  major raw  agricultural commodity of sugarcane.
Therefore, no tolerance or feeding restrictions are required for this commodity.

       The  registrant has  indicated  that  additional processing  studies on
sugarcane,  tomatoes,  and wheat have been initiated and  the  results,  once
completed, will be submitted to EPA for evaluation.  The wheat processing study,
once completed and evaluated, will be translated to  fulfill the reregistration
requirements for a barley processing study.
                             102

-------
      The listing in 40 CFR ง186.250 of 0.3 ppm for sugarcane molasses is in
error. The Metribuzin Residue Chemistry Science Chapter, dated 12/84, noted
that an increase in the feed additive tolerance for sugarcane molasses from 0.3 to
2 ppm was accepted as proposed in FAP#5H5151. This higher tolerance had been
established (43 FR 157:35915, 8/24/78).
                            103

-------
              Alfalfa meal is no longer regulated as a processed feed item of alfalfa (per
       livestock feeds table for  Subdivision O - 9/95).  Therefore, a tolerance and
       supporting residue data are not required for this commodity. Alfalfa meal should,
       however, be considered in the calculation of livestock diet using the alfalfa hay
       tolerance level.

Table 46: Tolerance Reassessment Summary

Current
Tolerance
Tolerance
Reassessment
Comment/fCorrecf Commodity Definition ]
Tolerances Listed Under 40 CFR ง180.332
Alfalfa, green
Alfalfa, hay
Asparagus

Barley, straw
Carrots
Cattle, fat
Cattle, mbyp
Cattle, meat
Com, fodder
Corn, forage
Corn, fresh (inc. sweet
K + CWHR)
Corn, grain (inc.
popcorn)
Eggs 	
Goats, fat
Goats, mbyp
Goats, meat
Grass

2
7
0.05
0.75
1
0.3
0.7
0.7
0.7
0.1
0.1
0.05
0.05
0.01
0.7
0.7
0.7
2
7
TBDa
TBDa
0.1
0.75
1
0.3
TBDa
TBDa
TBDa
0.1
0.1
Revoke
TBDa
TBDa
TBDa
TBDa
TBDa
2
7
[Alfalfa, forage ]

Previously proposed at a different tolerance
level in PP#8F3683.






[Corn, field, fodder]
[Corn, field, forage ]
There are no registered uses of metribuzin on
sweet corn; therefore, the established tolerance
should be revoked.
There are presently no registered uses of
metribuzin on popcorn. When acceptable field
corn grain data have been submitted and
evaluated, the established tolerance for "corn,
grain (inc. popcorn)" should be revoked
concomitant with the establishment of tolerance
for "Corn, field, grain".




[Grass, forage ]

                                     104

-------
Commodity
Hogs, fat
Hogs, mbyp
Hogs, meat
Horses, fat
Horses, mbyp
Horses, meat
Lentils (dried)
Lentils, forage
Lentils, vine hay
Milk
Peas
Peas (dried)
Peas, forage
Peas, vine hay
Potatoes
Poultry, fat
Poultry, mbyp
Poultry, meat
Sainfoin
Sainfoin, hay
Sheep, fat
Sheep, mbyp
Sheep, meat
Soybeans
Soybeans, forage
Soybeans, hay
Sugarcane
Tomatoes
Wheat, forage
Current
Tolerance
(ppm)
0.7
0.7
0.7
0.7-
0.7
0.7
0.05
0.5
0.05
0.05
0.1
0.05
0.5
0.05
0.6
0.7
0.7
0.7
2
7
0.7
0.7
0.7
0.1
4
4
0.1
0.1
2
Tolerance
Reassessment
(ppm)
TBDa
TBDa
TBDa
TBDa
TBDa
TBDa
0.05
Revoke
Revoke
TBDa
0.1
0.05
0.5
4.0
TBDa
TBDa
TBDa
TBDa
2
7
TBDa
TBDa
TBDa
0.3
4
. 4
0.1
0.1
2
Comment/[ Correct Commodity Definition ]






{Lentils']
Lentil forage is no longer considered to be a
significant livestock feed stuff per Table II
(9/95).
Lentil hay is no longer considered to be a
significant livestock feed stuff per Table II
(9/95).

[Peas, succulent]
[Peas, seed]
[Peas, field, forage ]
Previously proposed at a different tolerance
level in PP#8F3683.
[Peas, field, hay]




[Sainfoin, forage ]




Previously proposed at a different tolerance
level in PP#2F2677.





105

-------
Com in od ity
Wheat, grain
Wheat, straw
Current
Tolerance
(ppm)
0.75
1
Tolerance
Reassessment
(ppm)
0.75
1
Comment/[ Correct Commodity Definition ]


Tolerances That Need To Be Established Under 40 CFR ง180.332
Aspirated grain
fractions
Barley, hay
Wheat, hay
None
established
None
established
None
established
TBDa
7
7
A tolerance level for aspirated grain fractions
may need to be established when the
outstanding data for wheat aspirated grain
fractions are submitted and evaluated.
Previously proposed in PP#8F3683.
TOLERANCESLlSTED UNDER 40 CFR ง185.250
Barley, milled fractions
(except flour)
Potatoes, processed

Wheat, milled fractions
(except flour)
3
3
2
3
TBD"
3
TBD"
TBDa
The wheat processing study, once completed
and evaluated, will be translated to fulfill the
reregistration requirements for a barley
processing study.
[Barley, milled fractions (exc. flour) ]

[Sugarcane, molasses ]
[Wheat, milled fractions (exc. flour) ]
Tolerances Listed Under 40 CFR ง186.250
Barley, milled fractions
(except flour)
Potato waste, processed
(dried)
Sugarcane bagasse
Sugarcane molasses
3
3
0.5
0.3 (in
error);
2.0 (correct
TBDa
3
Revoke
TBDa
The wheat processing study, once completed
and evaluated, will be translated to fulfill the
reregistration requirements for a barley
processing study. [Barley, milled fractions (exc.
flour)}
[Potatoes, waste from processing ]
Sugarcane, bagasse is no longer considered to
be a significant livestock feed stuff per Table II
(9/95).
[Sugarcane, molasses ]
106

-------
Commodity
Tomato pomace, dried
Wheat, milled fractions
(except flour)
Current
Tolerance
(ppm)
2
3
Tolerance
Reassessment
(ppm)
Revoke
TBDa
Comment/[ Correct Commodity Definition ]
Dried tomato pomace is no longer considered to
be a significant livestock feed stuff per Table II
(9/95).
[Wheat, milled fractions (exc flour) ]
TBD = These tolerance(s) will be evaluated once confirmatory data is submitted and reviewed.
The currently established tolerance of 0.3 ppm as published in 40 CFR 186.250 for sugarcane molasses is
in error. The appropriate tolerance should be 2 ppm (See 43 FR 157:35915, 8/24/78).

       CODEX HARMONIZATION

              There  are no Codex MRLs established  or proposed  for  residues  of
       metribuzin and its triazinone metabolites.  Therefore, there are no questions with
       respect to compatibility of U.S. tolerances with Codex MRLs.

              There  is a  Canadian tolerance  of 0.05  ppm for metribuzin  and its
       metabolites for potatoes.  Canada also  has a negligible residue limit  for
       metribuzin, per se, on alfalfa, asparagus, barley, corn, fava beans, lentils, lupine,
       peas, rapeseed (canola oil), soybeans, sunflowers, tomatoes, wheat, fruit tree
       orchards (fruit), meat, milk, and eggs.

       3.     Tolerance Revocations and Import Tolerances

              As part of EPA's reregistration eligibility decision for metribuzin, food
       additive tolerances are no longer needed. Under the new law (FQPA,  H.R. 1627),
       the residues on processed food/feed items will be regulated Section 408.  Once a
       pesticide use  is no longer registered in the United States, the related pesticide
       residue tolerance and/or  food/feed additive regulation generally is no longer
       needed. It is EPA's policy to propose revocation of a tolerance, and/or food/feed
       additive regulation, following the deletion of a related food use from a  registration,
       or following the cancellation of a related food-use registration.  EPA  has the
       responsibility under the  Federal Food, Drug, and Cosmetic Act (FFDCA) to
       revoke a tolerance/regulation on the grounds that the Agency cannot conclude that
       the tolerance/regulation is protective of the public health.

              The Agency recognizes, however, that interested parties may want to retain
       a tolerance and/or food/feed additive regulation in  the absence of a U.S.
       registration, to allow legal importation of food into the U.S. To assure that all
       food marketed in the U.S. is safe, under FFDCA, EPA requires the same technical
       chemistry and toxicology data for such  import tolerances (tolerances  without
                                    107

-------
related U.S. registrations) as are required to support U.S. food use registrations
and any resulting tolerances. See 40 CFR Part 158 for EPA's data requirements
to support domestic use of a pesticide and establishment and maintenance of a
tolerance and/or food/feed regulation. In addition, EPA requires residue chemistry
data (crop field trials) that are representative of growing conditions in exporting
countries in the same manner that EPA requires representative residue chemistry
data from different U.S. regions to support domestic use of the pesticide and the
tolerance and/or regulation. Additional guidance on the Agency's import tolerance
policy will be published in an upcoming Federal Register Notice.

       Parties interested in supporting an existing metribuzin tolerance as an
import tolerance should ensure that all of the data noted above are available to
EPA during its further assessments of existing tolerances and regulations, so that
the Agency may determine whether maintenance of the tolerance and/or regulation
would be protective of the public health."

4.     Summary of Risk Management Decisions

       The Agency has determined that the current uses of metribuzin exceed
levels of concern for, 1) acute and chronic avian and mammalian effects; 2)
nontarget terrestrial and aquatic plant species; 3)  endangered species; 4) ground
water contamination, which could  potentially  impact drinking  water  and
ecological endpoints; and 5) occupational inhalation exposure.

       Several risk mitigation measures to address these concerns have been
proposed by the technical registrant, Bayer Corporation. They were considered
by the Agency,  and  are being required.  It must be noted that risk mitigation
measures are required for all metribuzin registrants.

       Below is  a brief summary of the Agency's concerns arid associated  risk
mitigation measures.

o     There is  potential  acute and  chronic risk concern  for  avian  species,
including endangered species, for rates of 4 Ib ai/acre or higher. Also, acute and
chronic risks are likely for mammalian species, including endangered species, for
rates of 1 Ib ai/acre  or higher.  In addition,  metribuzin and its  degradates are
mobile and persist in the environment. Risks are likely for nontarget terrestrial
and aquatic plant species, including endangered species, for rates of 0.5 Ib ai/acre
or higher.  Routes of exposure include drift and runoff for such organisms.

       Mitigation measures which specifically  reduce the exposure of metribuzin
to nontarget organisms are: 1) prohibiting aerial application on asparagus and
tomatoes; 2) reducing the application  rate  of metribuzin being applied to
                             108

-------
sugarcane via aerial and chemigation methods from 6.0 Ib ai/acre to 2.0 Ib ai/acre;
and 3) spray drift labeling requirements, specified in Section V of this document,
Actions Required of Registrants.

o      Although presently there are ground water advisories on metribuzin
product labels,  the Agency  is  still concerned  with potential  ground water
contamination with metribuzin use.  Data currently available to the Agency
indicate that metribuzin and its degradates are very mobile and highly persistent
and thus have the potential to contaminate ground water  and surface water;
however, the persistence of parent metribuzin in surface water may be lessened by
its susceptibility to photolytic degradation.  Metribuzin use could adversely affect
ground-water quality,  especially in vulnerable areas.  Detections have been
reported in the "Pesticides in Ground Water Database" (Hoheisel et al., 1992) and
other studies. These ground water contamination concerns are enhanced by the
widespread use patterns.

       Mitigation measures that will reduce the likelihood of metribuzin and its
primary degradates contaminating ground and surface water are:  1) specifying
Best Management Practices; and 2) determining areas that are vulnerable to
ground-water contamination by metribuzin and recommending risk mitigation
measures.  This  information,  once submitted and reviewed, will  determine the
need for additional labeling.  Other actions proposed by the registrant include: 1)
providing additional information on how levels of detects and nondetects were
handled in the small-scale retrospective study which was conducted in Portage
County,  Wisconsin on potatoes; and 2) providing available historic data on
accumulations of metribuzin in surface water over time.

o      There is  an inhalation toxicity concern for mixer  and loaders of the
wettable powder formulation for chemigation and aerial application  at 6 Ibs.
ai/acre.

       Mitigation measures which specifically reduce potential human health risk
of metribuzin use are: 1) reducing the application rate of metribuzin being applied
to sugarcane by chemigation and aerial application methods from 6.0 Ib ai/acre to
2.0 Ib  ai/acre; and 2) prohibiting the use of low-pressure or high volume hand
wand equipment.  As noted previously, although the 70 kg default male body
weight was used in calculating the MOEs, if the MOEs were to be re-calculated
using the 60 kg  default female body weight, the  MOEs would only be slightly
smaller. Therefore, the acceptable MOEs with mitigation measures all sufficiently
exceed 100 so that all MOEs estimated  using the default female body weight
would also be acceptable.

       Based on  the Agency's overall risk assessment and risk characterization of
                             109

-------
metribuzin, and the mitigation measures required in this document, the Agency
believes that human risks associated with metribuzin use will be minimal and that
the risks to the environment from metribuzin and its degradates are relatively low.
The required rate reductions will adequately reduce the exposure of metribuzin to
occupational workers.   Although the  risk mitigation measures may  not
quantitatively bring the risks below the level of concern for birds, mammals, and
plants; the Agency believes that these measures will substantially reduce the risks.
Minimizing spray drift will greatly reduce the risk to nontarget plants. Also, the
restrictions placed on the high use rate crop (sugarcane), will greatly reduce the
level of concern for birds, mammals and plants.

5.     Endangered Species Statement

       Currently, the Agency is developing a program ("The Endangered Species
Protection  Program") to  identify all pesticides whose use may cause adverse
impacts on endangered  and threatened species  and  to  implement mitigation
measures that will eliminate the adverse impacts.  The program would require use
restrictions to protect endangered  and threatened species at the county level.
Consultations with the Fish and Wildlife Service may be necessary to assess risks
to newly listed species or from proposed new uses. In the future, the Agency
plans to publish a description of the Endangered Species Program in the Federal
Register and have  available voluntary county-specific bulletins. Because the
Agency is taking this approach for protecting endangered and threatened species,
it is not imposing label modifications at this time through the RED. Rather, any
requirements for product use modifications will occur  in the future under the
Endangered Species Protection Program.

6.     Occupational Labeling Rationale

       The Worker Protection Standard (WPS)

       Scope of the WPS

       On August  21, 1992 the Agency issued  worker protection regulations
affecting all pesticide products  whose labeling reasonably permits use in the
production of agricultural  plants on any farm forest, nursery or greenhouse. These
regulations established certain worker protection requirements (personal protective
equipment, restricted entry intervals, etc.). In general, products within the scope
of the Worker  Protection Standard(WPS) had to bear complying labeling when
sold or distributed by the registrant after April 21, 1994.

       At this time some of the registered uses of metribuzin are within the scope
of the Worker  Protection Standard for Agricultural Pesticides (WPS) and some
                             110

-------
uses are outside the scope of the WPS, Those that are outside the scope of the
WPS include use:
             on pastures or rangelands,
             on plants grown for other than commercial or research purposes,
             which may include plants in habitations, home fruit and vegetable
             gardens, and home greenhouses,
             on plants that are in ornamental gardens, parks, golf courses, and
             public or private lawns and grounds and that are intended only for
             decorative or environmental benefit,
             in a manner not directly related to the production of agricultural
             plants, including,  for example, control of  vegetation  along
             rights-of-way and in other noncrop areas.

             Personal Protective Equipment/Engineering Controls for
             Handlers
             At this time there are no engineering control requirements, such as
       closed  systems, currently required on  labeling for end-use products
       containing metribuzin, though some metribuzin products are formulated
       in water-soluble packaging, which is an engineering control for mixing and
       loading.

       B.    Occupational-Use Products

             EPA has determined that occupational handler exposures and risks
       generally are the same for WPS  and nonWPS uses of metribuzin.
       Therefore, occupational handler exposures and risks are evaluated jointly.
       As a result of the reregistration evaluation of the acute and other adverse
       effects of metribuzin, the Agency has determined that risks to handlers do
       not warrant the establishment of active-ingredient-based  minimum
       personal protective equipment or engineering-control requirements that
       would  apply to  all  metribuzin  end-use products.   Handler  PPE
       requirements for metribuzin are to be based solely on the acute toxicity of
       individual end-use products.

       C.    Post-Application/Entry Restrictions

       1)    Occupational-Use Products (WPS Uses)

             Restricted-Entry Interval:

             Under the Worker Protection Standard (WPS), interim restricted
                            111

-------
entry intervals (REIs) for all uses within the scope of the WPS are based
on the acute toxicity of the active ingredient. The toxicity categories of the
active ingredient for acute dermal toxicity, eye irritation potential, and skin
irritation potential are used to determine the interim WPS REI. If one or
more of the three acute toxicity effects are  in toxicity category I, the
interim WPS REI is established at 48 hours. If none of the acute toxicity
effects are in category I,  but  one or more of the three is classified as
category n, the interim WPS REI is established at 24 hours.  If none of the
three acute toxicity effects are in category I or II, the interim WPS REI is
established at 12 hours. In addition, the WPS specifically retains two types
of REI's established by the Agency prior to the promulgation of the WPS:
(1) product-specific REI's established on the basis of adequate data, and (2)
interim REI's that are longer than those that would be established under the
WPS.

       Since at this tune there are no dermal toxicological endpoints of
concern  and metribuzin is classified as toxicity category IV for acute
dermal toxicity, eye irritation potential, and skin irritation potential, EPA
is establishing a 12-hour restricted-entry interval for all uses within the
scope of the WPS.  The Agency believes that the 12 hour REI provides
adequate protection for workers reentering treated sites, and that a longer
REI is not needed.  Although there are no active ingredient specific data
on which to base a quantitative estimate of post-application exposure, in
the Agency's judgement such workers are not likely to have substantially
greater exposure than pesticide handlers (those who mix, load or apply
pesticides). The Agency is not calling in post application exposure data at
this time, because EPA  concludes that there  is unlikely to  be any
significant benefit to users from a shorter REI. In addition, EPA believes
that workers reentering a treated site much sooner than 12 hours after
application could experience significantly higher dermal exposure through
contact with wet surfaces on which the sprays have not completely dried.
The Agency doubts that post application exposure studies would support
much  reduction in the REI for metribuzin products,  however, if the
registrant would like to reduce the 12 hours REI, post application exposure
data would need to be provided to the Agency for review.

       The WPS interim REI in effect is. 12 hours.  EPA notes that the 12-
hour interim WPS REI was established because EPA data indicates that
metribuzin is classified as toxicity category IV for acute dermal toxicity,
eye irritation potential, and skin irritation potential.

       EPA notes that the WPS places very specific requirements for
persons  entering areas during restricted-entry intervals when that entry
                       112

-------
involves contact with treated surfaces. EPA believes that existing WPS
protections are sufficient to mitigate post-application exposures of workers
who contact surfaces treated with metribuzin.

       EPA also notes that if metribuzin has been correctly incorporated
in soil, the WPS permits workers to enter the treated area during the
restricted-entry interval without personal protective equipment or any other
restriction if they are performing tasks that do not involve contact with the
soil surface.

       Early-Entry PPE:

       The WPS establishes very specific restrictions on entry by workers
to areas that remain under a restricted-entry interval if the entry involves
contact with treated surfaces. Among those restrictions are a prohibition
on routine entry to perform hand labor tasks  and a requirement that
personal protective equipment be worn.  Personal protective equipment
requirements  for persons  who  must enter areas  that remain under  a
restricted-entry interval are based on the toxicity concerns for the active
ingredient.

       During the  reregistration process, EPA considers all relevant
product-specific information to decide whether there is reason to set
personal protective equipment requirements that  differ from those set
through  the  WPS. The  RED  requirements  for  early-entry  personal
protective equipment are set in one of two ways:

1.     If EPA determines that no regulatory action must be taken as the
       result of the acute  effects or other adverse effects of an active
       ingredient, it establishes the early-entry PPE requirements on the
       basis of the acute dermal toxicity category, skin irritation potential
       category,  and  eye irritation potential  category of  the active
       ingredient.

2.     If EPA determines that regulatory action on an active ingredient
       must be taken as the result of very high acute toxicity or to certain
       other adverse effects, such as allergic  effects or delayed effects
       (cancer,  developmental  toxicity, reproductive effects), it  may
       establish early-entry PPE requirements that are more stringent than
       would be established otherwise.

       Since metribuzin is classified as category  IV for skin  irritation
potential and IV for acute dermal toxicity, and EPA has determined that no
                      113

-------
      regulatory action must be taken due to the acute effects or other adverse
      effects of metribuzin active ingredient, the PPE for dermal protection
      required for early entry is the minimum early-entry PPE permitted under
      the WPS.  Since metribuzin is classified as toxicity category IV for eye
      rritation potential, no protective eyewear is required.

             WPS Notification Statement

             Under the WPS, the labels of some pesticide products must require
      employers to notify workers about pesticide-treated areas orally as well as
      by posting of the treated areas. Also, during the reregistration process,
      EPA may decide that a product requires this type of "double notification."
      EPA has determined that double notification is not required for metribuzin
      end-use products.

      2)     Occupational-Use Products (NonWPS Uses)

             Since EPA has concerns about post-application exposures to
      persons immediately following nonWPS  occupational applications of
      metribuzin, it is establishing entry restrictions for all nonWPS occupational
      uses  of metribuzin end-use products. For specific language refer to
      Section V of this document.

      D.    Additional Labeling Requirements

             The Agency is requiring additional labeling statements to be located
      on all end-use products containing metribuzin. There are also- several
      clarifications that need to be made to the labels. For the specific labeling
      statements, refer to Section V of this document.

7.    Spray Drift Advisory

      The Agency has been working with the Spray Drift Task  Force, EPA
Regional Offices and State Lead Agencies for pesticide regulation to develop the
best spray drift management practices.  The Agency is now requiring interim
measures that must be placed on product labels/labeling as specified in Section V.
Once the Agency completes its evaluation of the new data base submitted by the
Spray Drift Task Force, a membership of U.S. pesticide registrants, the Agency
may impose further refinements in spray drift management practices to further
reduce off-target drift and risks associated with this drift.
                             114

-------
V.     ACTIONS REQUIRED OF REGISTRANTS

       This section specifies the data requirements and responses necessary for the reregistration
of both manufacturing-use and end-use products.

       A.    Manufacturing-Use Products

             1.     Additional Generic Data Requirements

                    The generic data base supporting the reregistration of metribuzin for the
             above eligible uses has  been reviewed and determined to be  substantially
             complete.  All uses of metribuzin are eligible for reregistration, however, the
             Agency is requiring that the following confirmatory data be submitted to fulfill the
             generic data requirements for reregistration of metribuzin.

                    1)     Magnitude of residue studies (alfalfa and field corn trials, and field
                    rotational crop studies, additional field trials for field corn and potatoes,
                    and  outstanding  data  for  wheat  aspirated grain  fractions must be
                    submitted).

                    2)     Processing studies for sugarcane and wheat are in progress.  These
                    data must be submitted. A processing study for tomatoes was submitted
                    and is currently under review.

                    3)     Certified limits  (GLN 62-2)  and analytical methods to  verify
                    certified limits (GLN 62-3) are required for three impurities related to the
                    active ingredient in the 90% T.

                    4)     Storage stability data for animal commodity samples from the
                    previously evaluated poultry and ruminant feeding studies are required.
                    If the storage intervals and conditions for livestock commodities are not
                    supported by adequate data, additional feeding study data may be required.

                    5)     Confined rotational  crop and field  rotational crop studies are
                    required.

                    6)     Ground water information. (GLN 166-17)

             2.     Labeling Requirements for Manufacturing-Use Products

                    To remain in compliance with FIFRA, manufacturing use product (MP)
             labeling must be revised to comply with all current EPA regulations, PR Notices
             and applicable policies. The MP labeling must bear the following statement under
                                          115

-------
      Directions for Use:

             "Only for formulation into an Herbicide for those uses that are being
             supported by MP registrant."

      An MP registrant may, at his/her discretion, add one of the following statements
      to an MP label under

             "Directions for Use" to permit the reformulation of the product for
             a specific use or all additional uses supported by a forrnulator or
             user group:

      (a)    "This product may be used to formulate products for specific use(s)
             not listed on the MP label if the forrnulator, user group, or grower
             has complied with U.S. EPA submission requirements regarding
             support of such use(s)."

      (b)    "This product may be used to formulate products for any additional
             use(s) not listed on the MP label if the forrnulator, user group, or
             grower has complied with U.S.  EPA submission requirements
             regarding support of such use(s)."

B.    End-Use Products

      1.     Additional Product-Specific Data Requirements

             Section 4(g)(2)(B) of FIFRA calls for the Agency to obtain any needed
      product-specific data regarding the pesticide  after a determination of eligibility
      has been made.   Registrants must review previous data submissions to ensure that
      they meet current EPA acceptance criteria and if not, commit to conduct new
      studies. If a registrant believes that previously submitted data meet current testing
      standards, then study MRID numbers should be cited according to the instructions
      in the Requirement  Status and Registrants Response Form provided for each
      product.

      2.    Labeling Requirements for End-Use Products
             a.     Worker Protection Standard

             Any product whose labeling reasonably permits use in the production of
       an agricultural plant on any farm, forest, nursery, or greenhouse must comply with
       the labeling requirements of PR Notice 93-7, "Labeling Revisions Required by the
                                   116

-------
Worker Protection  Standard  (WPS),  and PR Notice 93-11, "Supplemental
Guidance for PR Notice 93-7, which reflect the requirements of EPA' s labeling
regulations for worker protection statements (40 CFR part 156, subpart K). These
labeling revisions are necessary to implement the Worker Protection Standard for
Agricultural Pesticides (40 CFR part 170) and must be completed in accordance
with, and within the deadlines specified in, PR Notices 93-7 and 93-11. Unless
otherwise specifically directed in mis RED, all statements required by PR Notices
93-7 and 93-11 are to be on the product label exactly as instructed in those notices.

       After April 21,1994, except as otherwise provided in PR Notices 93-7 and
93-11, all products within the scope of those notices must bear WPS PR Notice
complying labeling when they are distributed or sold by the primary registrant or
any supplementally registered distributor.

       After October 23, 1995, except as otherwise provided in PR Notices 93-7
and  93-11, all products within the scope of those notices must bear WPS PR
Notice complying labeling when they are distributed or sold by any person.

       The labels and labeling of all products must comply with EPA's current
regulations and requirements as specified in 40 CFR ง 156.10 and other applicable
notices.

       b.     Occupational/Residential Labeling

PPE Requirements for Pesticide Handlers

       Sole-active-ingredient end-use products that contain metribuzin must
be revised to adopt the handler personal protective equipment requirements set
forth in this section. Any conflicting PPE requirements on their current labeling
must be removed.

       Multiple-active-ingredient end-use products that contain metribuzin
must compare the handler personal protective equipment requirements set forth
in this section to the PPE requirements on their current labeling and retain the
more protective. For guidance on which PPE is considered more protective, see
PR Notice 93-7.

1.     WPS and nonWPS uses

       a)  Minimum (baseline) PPE requirements —

       For all formulations:  EPA is not establishing active-ingredient-based
       minimum  (baseline) PPE  or  engineering control requirements  for
                            117

-------
2.
metribuzin end-use products.

b)  Actual end-use  product PPE requirements —Minimum PPE
requirements must be'compared with the PPE that would be designated on
the basis of the acute toxicity of the end-use product. The most protective
PPE must be placed on the product labeling. For guidance on which PPE
is considered more protective, see PR Notice 93-7.

c) Placement in labeling —The personal protective equipment must be
placed on the end-use product labeling in the location specified in PR
Notice 93-7 and the format and language of the PPE requirements must be
the same as is specified in PR Notice 93-7.

d) Entry Restrictions

       Sole-active-ingredientend-use products that contain metribuzin
must be revised to adopt the entry restrictions set forth in this section. Any
conflicting entry restrictions on their current labeling must be removed.

       Multiple-active-ingredient  end-use  products   that  contain
metribuzin must compare the entry restrictions set forth in this section to
the entry restrictions on  their current  labeling  and retain the more
protective. A specific time-period in hours or days is considered more
protective than "sprays have dried" or "dusts  have settled."

WPS uses
Restricted-entryinterval - A 12-hour restricted entry interval (REI) is required
for uses within the scope of the WPS (see PR Notice 93-7) on all end-use products
with WPS uses (see tests in PR Notices 93-7 and 93-11).

Early-Entry Personal Protective Equipment (PPE)- The PPE required for
early entry is:
—coveralls,
—chemical-resistant gloves,
—shoes plus socks.

Placement on the Labeling- The REI must be inserted into the standardized REI
statement required by Supplement Three of PR Notice 93-7. The PPE required for
early entry  must be  inserted into the standardized early entry PPE statement
required by Supplement Three of PR Notice 93-7.

3. NonWPS uses
                            118

-------
      Entry restrictions --

      Spray Applications: The entry restriction for all nonWPS uses applied as a spray
      is:

      "Do not enter or allow others to enter the treated area until sprays have dried. If
      soil incorporation is required following the application, do not enter or allow
      others to enter the treated area (except those persons involved in the incorporation)
      until the  incorporation is complete.  If the incorporation  is accomplished by
      watering-in, do not enter or allow others to enter the treated area until the surface
      is dry following the watering-in."

      Dry (Fertilizer) Applications: The entry restriction for all nonWPS uses applied
      dry is:

      "Do not enter or allow others to enter the treated area until dusts have settled.  If
      soil incorporation is required following the application, do not enter or allow
      others to enter the treated area (except those persons involved in the incorporation)
      until the  incorporation is complete.  If the incorporation  is accomplished by
      watering-in, do not enter or allow others to enter the treated area until the surface
      is dry following the watering-in."

      Placement in labeling ~

              If WPS uses are also on label:    Follow the instructions in PR
      Notice 93-7 for establishing a Non-Agricultural Use Requirements box and
      place the appropriate nonWPS entry restriction in that box.

              If no  WPS  uses are on  label:  Add the appropriate nonWPS  entry
      restriction to the labels of all end-use products, except products primarily intended
      for homeowner use, in a section in the Directions For Use with the heading: "Entry
      Restrictions:"

              The Agency is requiring the following labeling statements to
      be located on all end-use products containing metribuzin that are
      intended primarily for occupational use.

Application restrictions
       "Do not apply this product in a way that will contact workers or
      other persons, either  directly or through drift.   Only protected
      handlers may be in the area during application."

Engineering controls
                                   119

-------
       "When handlers use closed systems, enclosed cabs, or aircraft in a manner that
       meets the requirements listed in the  Worker Protection Standard (WPS) for
       agricultural pesticides (40 CFR 170.240(d)(4-6), the handler PPE requirements
       may be reduced or modified as specified in the WPS."

User safety requirements

       "Follow manufacturer's instructions for  cleaning and maintaining PPE. If
       no such instructions are available for  washables, use detergent and hot
       water. Keep and wash PPE separately  from other laundry."

User safety recommendations

       • '   "Users should wash hands before eating, drinking, chewing
             gum, using tobacco, or using the toilet."

       "     "Users should remove clothing immediately if pesticide gets
             inside. Then wash thoroughly and put on clean clothing."

       •     "Users should remove PPE immediately after handling this
             product. Wash the outside of gloves before removing. As
             soon as possible, wash thoroughly and change into clean
             clothing."

Optional Soil incorporation statement

       "Exception:  if the product  is soil-incorporated  or watered-in, the  Worker
       Protection Standard, under certain circumstances, allows workers to enter the
       treated area if there will be no contact with anything that has been treated."
             c.
                    Environmental Hazard Statements
       "Do not apply directly to water, or to areas where surface water is present or to
       intertidal areas below the mean high-water mark.  Do not contaminate water when
       disposing of equipment wash water or rinsate."

             d.     Application Restrictions

       The  labels of all metribuzin end-use products must be revised to  bear the
       following application restrictions under the Directions for Use Section:

             For asparagus and tomato uses:
             "Aerial application is prohibited"
                                   120

-------
             For aerial application on sugarcane:
             "To assure that spray will not adversely affect adjacent sensitive nontarget
             plant, apply this product by aircraft at a minimum upwind distance of 400
             ft from sensitive plants."

             For all uses:
             "low-pressure and high volume hand wand equipment is prohibited"
             e.     Application Rates

             The labels of metribuzin end-use products must be revised to bear the
             following application rates under the Crop Uses Section for the respective
             crops:

             For the aerial and chemigation application methods of metribuzin on
             sugarcane:
             " A maximum application rate of 2.0 Ib ai/acre.

C.     Spray Drift Labeling

       The following language must be placed on each product label that can be applied
aerially:

       Avoiding spray drift at the application site is the responsibility of the applicator.
       The interaction of many equipment-and-weather-related factors determine the
       potential for spray drift.   The applicator and the grower are responsible for
       considering all these factors when making decisions.

       The following drift management requirements must be followed to avoid off-target
       drift movement from  aerial applications to agricultural field crops.  These
       requirements do not apply to forestry applications, public health uses or to
       applications using dry formulations.

       1.     The distance of the outer  most nozzles on the boom must not exceed 3/4
       the length of the wingspan or rotor.

       2.     Nozzles must always point backward parallel with the air stream and never
       be pointed downwards more than 45 degrees.

       Where states have more stringent regulations, they should be observed.

       The applicator should be familiar with and take into account the information
                                   121

-------
covered in the Aerial Drift Reduction Advisory Information.

The following aerial drift reduction advisory information must be contained in the
product labeling:

[This section is advisory in nature and does not supersede the mandatory label
requirements.]

INFORMATION ON DROPLET SIZE

The most effective way to reduce drift potential is to apply large droplets.  The
best drift management strategy is to apply the  largest droplets that provide
sufficient coverage and control. Applying larger droplets reduces drift potential,
but will not prevent  drift if  applications  are  made improperly,  or under
unfavorable environmental conditions (see Wind, Temperature and Humidity, and
Temperature Inversions).

CONTROLLING DROPLET SIZE

•     Volume - Use high flow rate nozzles to apply the highest practical spray
volume. Nozzles with higher rated flows produce larger droplets.

•     Pressure  - Do  not exceed  the nozzle  manufacturer's recommended
pressures. For many nozzle types lower pressure produces larger droplets. When
higher flow rates are needed, use higher flow rate nozzles instead of increasing
pressure.

•     Number of nozzles - Use the minimum number of nozzles that provide
uniform coverage.

•     Nozzle Orientation - Orienting nozzles so that the spray is released parallel
to the  airstream produces larger droplets than  other orientations and is the
recommended practice.  Significant deflection from horizontal will reduce droplet
size and increase drift potential.

•     Nozzle Type - Use a nozzle type that  is designed for the intended
application.  With  most nozzle types, narrower spray angles produce larger
droplets. Consider using low-drift nozzles.  Solid stream nozzles oriented straight
back produce the largest droplets and the lowest drift.

BOOM LENGTH

For some use patterns, reducing the effective boom length to less than 3/4 of the
                             122

-------
wingspan or rotor length may further reduce drift without reducing swath width.

APPLICATION HEIGHT

Applications should not be made at a height greater than 10 feet above the top of
the largest plants unless a greater height is required for aircraft safety. Making
applications at the lowest height that is safe reduces exposure of droplets to
evaporation and wind.

SWATH ADJUSTMENT

When applications are made with a crosswind, the swath will be displaced
downward. Therefore, on the up and downwind edges of the field, the applicator
must  compensate for this displacement by adjusting the path  of the aircraft
upwind. Swath adjustment distance should increase, with increasing drift potential
(higher wind, smaller drops, etc.)

WIND

Drift  potential is lowest between wind speeds of 2-10 mph.  However, many
factors, including droplet size and equipment type determine drift potential at any
given speed.  Application should be avoided below 2 mph due to variable wind
direction and high inversion potential. NOTE: Local terrain can influence wind
patterns. Every applicator should be familiar with local wind patterns and how
they affect spray drift.

TEMPERATURE AND HUMIDITY

When making applications in low relative humidity, set up equipment to produce
larger droplets to compensate for evaporation.  Droplet evaporation is most severe
when conditions are both hot and dry.

TEMPERATURE INVERSIONS

Applications should not occur during a temperature inversion because  drift
potential is high. Temperature inversions restrict vertical air mixing, which causes
small suspended droplets to remain in a concentrated cloud. This cloud can move
in  unpredictable directions due to the light variable winds common during
inversions. Temperature inversions are characterized by increasing temperatures
with altitude and are  common on nights with limited cloud cover and light to no
wind. They begin to form as the sun sets and often continue into the morning.
Their presence can be indicated by ground fog; however, if fog is not present,
inversions can also be identified by the movement of smoke from a ground source
                            123

-------
       or  an aircraft smoke generator.  Smoke that layers and moves laterally in a
       concentrated cloud (under low wind conditions) indicates an inversion, while
       smoke that moves upward and rapidly dissipates indicates good vertical air
       mixing.

       SENSITIVE AREAS

       The pesticide should only be applied when the potential for drift to adjacent
       sensitive areas (e.g. residential areas,  bodies of water, known habitat for
       threatened or endangered species, non-target crops) is minimal (e.g. when wind
       is blowing away from the sensitive areas).

D.     OTHER LABELING REQUIREMENTS

       Clarifications that need to be made to the label are:

              1) On several labels the maximum Ib per acre application rate when applied
       once a year is different from the application rate per year.

              2) Labels should include registration number/site/rate/appl. method, etc
        for items such as aerial application.

              3) Labels should clearly state approved methods of application.

              Label revisions are required for alfalfa and winter wheat.  For alfalfa, the
       registrant must amend all pertinent labels to specify a maximum seasonal rate
       which must be consistent with the available  (and required) residue data.  A
       previous recommendation to establish a 180-day PHI  (pre-harvest interval) for
       alfalfa grown for seed based on available data is no longer applicable since
       presently there are no registered uses of metribuzin on alfalfa grown for seed. For
       whiter wheat,  the  registrant must amend  all pertinent labels  to specify an
       appropriate PHI consistent with that reflected in the residue data used to support
       the tolerance.

              Because finite residues were observed at all plantback intervals tested in
       the confined rotational study,  field rotational crop  studies (GLN  165-2) are
       required.  The available field rotational crop  studies  must be replaced. In the
       absence of adequate field rotational crop studies a label restriction stating  "Do not
       rotate to any crop not on the metribuzin label" must be added to all pertinent
       labels.

              When end-use product DCIs are developed (e.g., at issuance of the RED),
       the Agency should require that all end-use product labels (e.g., MAI labels, SLNs,
                                    124

-------
       and products subject to the generic data exemption) be amended such that the uses
       on these labels are consistent with the uses on the basic producer labels.

D.     Existing Stocks

       Registrants may generally distribute and sell products bearing old labels/labeling
for 26 months from the date of the issuance of this Reregistration Eligibility Decision
(RED). Persons other than the registrant may generally distribute or sell such products for
50 months from the date of the issuance of this RED. However, existing stocks time
frames will be established case-by-case, depending on the number of products involved,
the number of label changes, and  other factors. Refer to "Existing Stocks of Pesticide
Products; Statement of Policy"; Federal Register. Volume 56, No. 123, June 26,1991.

       The Agency has determined that registrants may distribute and sell metribuzin
products bearing old labels/labeling for 26 months from the date of issuance of this RED.
Persons other than the registrant may distribute or sell such products for 50 months from
the date of the issuance of this RED.  Registrants and persons other than registrants
remain obligated to meet pre-existing Agency imposed label changes and existing stocks
requirements applicable to products they sell or distribute.
                                   125

-------

-------
                              VI. APPENDICES
                          APPENDIX A. Table of Use Patterns Subject to Reregistration




Appendix A is 126 pages long and is not being included. Copies of Appendix A are available upon request per the instructions in Appendix D
                                            127

-------

-------
                                        GUIDE TO APPENDIX B
Appendix B contains listings of data requirements which support the reregistration for active ingredients within the case
Metribuzin covered by this Reregistration Eligibility Decision Document. It contains generic data requirements that
apply to Metribuzin in all products, including data requirements for which a "typical formulation" is the test substance.

       The data table is organized in the following format:

       1. Data Requirement (Column 1). The data requirements are listed in the order in which they appear in 40 CFR
Part 158. the reference numbers accompanying each  test refer to the test protocols set in the Pesticide Assessment
Guidelines, which are available from the National Technical Information Service, 5285 Port Royal Road, Springfield,
VA 22161 (703)487-4650.

       2. Use Pattern (Column 2). This column indicates the use patterns for which the data requirements apply. The
following letter designations are used for the given use patterns:

                           A     Terrestrial food
                           B     Terrestrial feed
                           C     Terrestrial non-food
                           D     Aquatic food
                           E     Aquatic non-food outdoor
                           F     Aquatic non-food industrial
                           G     Aquatic non-food residential
                           H     Greenhouse food
                           I     Greenhouse non-food
                           J     Forestry
                           K     Residential
                           L     Indoor food
                           M     Indoor non-food
                           N     Indoor medical
                           O     Indoor residential

       3. Bibliographic citation (Column 3).  If the  Agency has acceptable data in its files, this column lists the
identifying number of each study. This normally is the Master Record Identification (MRED) number, but may be a
"GS" number if no MRID number has been assigned.  Refer to the Bibliography appendix for a complete citation of
the study.
                                                   128

-------











M
a
gr
r"i
(•"M
PM
PH
•^






















^
'3
Jjjr
'2
Q)
J>-
0
ff
^o
•*->
"3t
I
.S3
-*->
S-<
ซo
43
a
s
ฃ
"5
a
.ฃ
"a
2

O

tป
.5
S"
o
a
c
V.
3
CS
O





S
g
O
H
&~*
U









z
e:
H
f.*
1

D












EMENT
d

C
Pj-
P
o
00
3
o\ cn
O O
in cS
T-t 00
vo Os
o cs
o •*
rrT ' rrT t
O 0 O 0
^ ^ c> ^~
C""* vo f^*> ^i"
•Sj* Os ^" OO
j-* vo *•"< cs
O >— i O T— i
O "3- 0 •*





_ - - -
< < < <





03
CO
u
O M
(• s

• 'la •"
^ O. i^"
F**H >H< ^H tf 2
fn "2 ซ i—t 5
| | 2 | g-
Si 5 1 1
W ฃ 1 1 2
HO 03 fa P*
U
|2
ft
O"^C CQ
^ rSl r5 ^
QJ, i^ ii *, ^A
p^ so vo ^o vo
3
-*^
Q
cs"
cs
cn
vo
in
o
o
T_l
cn
in
0
0





t
<









as
•*-•
3
^^
o
Certification


r<
_\
vo
Cu
es
•2
Q
T-H
o
oo
cs
**
cn
o
0

0
o





t
<











"8
O
JS
•s
Analytical M


m
_.ซ
VO
cn cn
O 0
0 0
t-- C"ป

o c>
0 0
r^- T^- •^f •^
cs cs cs cs
cn cn cn cn
vo vo vo vo
in in in in
0 0 O O
0000
cn cn cs cs
o o _ _
o o o o
r- f~ m in
•^j- ^ vo vo
o o o o
O 0 O O





, , 	 . 	 .
< < < <













0> -M
•s .s
*• o
cc fc
"ซ W)
w fl
"0*2^
O Pk O S


r^ to, •* ซn
fO fO fO CO
vo vo vo vo
cn cn
o o
0 O
•<* **
0 0
0 0
^jT ^.jT
cn cn
vo vo

0 0
0_ 0_
cs" -— < cn cs
~H O O ^H
O VO O O
in in t^ in
\O CS Tt- VO
o cs o o
o ^ o o





01 =3 =3 53 =3
5? 
a
0 0
a U
a S? ซ
"o ซ .2
W> ฃป 53 fc, '3
.S 'S * o ฐ


o
vo t- op os TH
ro co co co co
vo vo vo vo vo
cn
o
o
f-
2]
o
0
'*
cn
vo
in
O
o
•>
cs
o
VO
o
0





J- 1
^







0
_o

^-



-------


a

"5
s
•j*
s->
M
^?
F^H
^•4
o
a
.2
Is
h
"Si
ซs
42

ฃ
'3
cr
S3
p"ซ3
Qi
!ฐ
Data Supporting Gu






|
H
H
H^
U













s
H
W
S5
P






^
i^
S
c

N"
rt


c^
o
o
^:
1-H
O
o
(vf '—i
*-< O
O CN
ปo oo
vo vo
1-H i-H
o m
o •*




3 3








e
Stability
Oxidizing/Reducing Actio


1— 1 l-H

-f^ ^f^
vo vo








m •*
o cs
o m
c- vo
•^f 
T-H 1— 1
0 O
0 0




g4 S IS gฃ
^ < < a









Flammability .
Explodability
Storage stability
Viscosity


m vo r- oo
i— ( TH 1-H 1— 1
1 1 1 1

vo vo vo vo



















1









Miscibility


i— i
i
fO
vo








m
o
o
c-.
rf
i-H
O
O




g









Corrosion characteristics


0

fO
vo



















1 1








.>
Dielectric breakdown vol
Submittal of Samples
ICAL EFFECTS
<3
O
3 ^ O

CO T r i.
^O ^? N""






fQ
o
 0>
"3 "eS
!~ h
O O
e e
os os
• IM *^-
S ^
O fli
•4^ S-ป
0 3
U W
•< ^


•< PQ

T1^ ^^
l> (-
oo
cs


^
ซ
-4—
•PM
Q
M
.2
^



^
u
s
O
^
es
^^
- e
.S
^


^
|3
'S
o
H
"es
S
s
es
g
^—4
2
i
*"ซ
s
a
i
c
.2
•*•ป
u
s
•a
o
e<
ป
-o
•4^
02
2
"ซ
ta
"3
3
0
<
<

1-H
t-
                      P5

-------




.s
S3
•*•*
*H
•C*
g
t*-<
O
A
.2
hซ
co
"So
0)
s
0)
il
Mrf
S3

PH
.S
upporting Guide!
cs
•*-•
cs
ft




K
O
H
*^M
fcj
u













z
1
S
W
9






H
SB
P
a

H*j
ซ


T— *
O
O
OO
ON
0
O

**
cs
0
cs
*ft
2







03
<







icity Bluegill
x
o
H
en
S
3

— o
t-







cs
0
cs
*tfc
o







pa
<







icity Bluegill -TEP
ง
H
A
.2
M
1

^


0
0
00
ON
O
O
^~
ซ
CS
o
s
=8=
O
O







03
•<







icity Rainbow Trout
x
o
H
tn
u
1

*-



c--
S
ON
O
ป•
CS
o
m
CS
=tfc
0







m
•<





PL,
H
•4-*
1
H
o
'S
;s
"x
o
H
en
E
O
T-H

ซo
r-









ป— i CS
0 0
oo v>

•* ON
•* O
CS CS
"^J" ^







CO Cc<







E
rate Toxicity
rate Toxicity - TEP
e/Marine Toxicity -]
A A- a
ซ ซ '2
•**•!•ป•;
h> i. es
ซ o> a
> > ts
•M ซM Gป
5 >5 w
 -fc* •i—> ^
•3 '3 '3 '3
• PM >PM P*
X X X X
o o o o
H H H H
o> m ซ a>
a a a e
•r" •;• *c T
hi IN hi ^ pH
cs cs cs cs 1^
S S ^ |j H

-------


g
"5
s
o
S
.2
"ซ

.a
we
.s
eg
"c
i
_*ซ
"3
o
JB
"3
S
o
upporting
OJ
5
A
A




0
H
H
U









i
H
PM
CO
p





1
H
ฃ
&
ฃ
03














1




i
"S
05
OJD
O
"es
1
i
2
T3
Is
s

ป'
'
•>








,





1






OJD
e
12
•3
V
mination/Se
ce
Seed Ger
Emergen

3
S
^
          o
          CO
          c-~
          o
          CO
          OO
          o
          cs
          CO
             o o
             VO ^
             CO VO
             CO CN
             •^ OO
             CO CO
        CO   i—i  ซ—i
        o   o  o
        OO   ซO  t~~
        c~-   co  r-
                                                                oo   ON
                                                                                   oo   oo
•*
CM
             OO OO
             CO CO
                  cs
                  r--
00

o
                                                                o
                                                                O
                                                           o
                                                           O
              
                                                     cs
                                                     O
                   o
                   O
          o
          O
                                                                                                   cs
          CQ
        ซ   fQ
        <   <

      1
*.
 ox
=
1
1
 o
1
                                                
-------
      M

      o
      {•3

      U
."2
*S
o
s
o
                                  o
                                  p-
                                  o
                                  p-

                                  co
VO
O
p-
                                            o
                                            o
                                                           es
                                                           vo
                                                           o   p-
ซs   P-
p-   oo
VO   O
o   o o
                                                                                                         t~-   o o
                                                                                                         tr>   o cr>
                                                                                                         O
                                                                                                         O
                                                                                                              v   ir
                                                                                                              vo  vo
                                                                                                    oo
                                                                                                    CO
                                                                                                    oo
                                                                                                    o
                                        p-   oo co   
                                                                                                                               CO

                                                                                                                               CO
fc,
o

42
e
a>
S


                                                                                                    "*•*   r.
                                                                                          r>   K>   Si
                                                                                          ."S   .M    S    B5
                                                                                          3    3   T3    9>
                                                                                          "R  ' 'R    ฐ    S
                                                                                          o    o    tL  <1
                                                                                          H   H    ป   o

                                                                                          "es   "ซ         *
                                                                                          **   •**    ฃ9
                                                                                          a    c    S
                                                                                          u    4>   .s

                                                                                          S    |  1

                                                                                                *   S
                                                              o
                                                              ••a
                                                              03
                                                                                          &.
                                                                                          o


                                                                                          Q   Q
Ge
                                                                                                         O
                                                                                                               es

                                                                                                               S
                                                                                                               o
                                                                                                               BQ
                                                                                                               O
                                                                                                               S
                                                                                                               o
                                              ^a
                                               2-2

                                              5  2
                                               2  ^
                                               S  4>
                                               *•"  >O
                                              **  •*;
                                              co  
-------


N
a
-o
"S
o>
J5!
F~ (
^M
0
a
.2
•*•ป
"DID
oi
ents for the ]
i
•|
O1
04
o
•M
"•ซ
Data Supporting Guid


0
H
U












PATTERN
w






EMENT
ซ
M
a
w
ซ






cซl
O
V}
V}
>n
o



a
ml







General Metabolism

•n
oo















13
>
3
^






Dermal Penetration

V)
oo















.







Domestic Animal Safety

oo















g
ง
05
O
PM
^
w
J
^
'ATIONAL/RESIDENTL
Foliar Residue Dissipation
ป•**
P <
^^J ^H
!J ^
O 2















gj fti
J2: ฃ







Soil Residue Dissipation
Dermal Passive Dosimetry
Exposure

ปH fi
i i
TH 1— 1















s






b
Inhalation Passive Dosimeti
Exposure

•<*
fO















1




"S
w
03
Estimation of Dermal Expo
Outdoor Sites

a















1




2
3
O
a
Estimation of Inhalation Ex
at Outdoor Sites

3















1 1




OS *ซ
V 3
s I
so S"
Estimation of Dermal Expo
Indoor Sites
Estimation of Inhalation Ex
at Indoor Sites
ONMENTAL FATE
&
I-H
>
ฃ 2 ฃS
8 S W


t--
o
o
CO
s ง
o c- Y
m •* m
t- ^ r-
12 W S
o p^ t^.
o H •*


rv^ r*n /*n
*;;; IT> 'T, 
-------



d
*S
p
.D
-*-"
i
CM
O
d
to
•4-j
JM
"5c
<^j
JU
c2
**•"<
42
S
i
i.
ซซ•
c
O)
.ฃ
"S
O
fel
•*•
c
c
9
C


S?
O
ง
S
O







2
t&
a

D-
W
tn
P





IEMENT
pw
C

0
<
T*~4
o
in
OO
O
CO
c o o
VO VO O CS
c~ซ r— co ^
vo vo oo c~-
CO CO CS CO
O O CS VO
\J* ^^* ^J" C"N






f^t PQ i p^ O^ CQ
& < < x z <




e
g -2
is •*••
a g &
g 2 -2 o
a ja S3 tn
a •— es o ซ
A 1 i | -i 9
< 1 3 s -s |
a 3 g "-S ^ "S*
*3 M _ a 35 o
1 -3 ซ f | I
bn CO ปpj -5 "^S Hfi
/vป ^n J2 * \ ซ•ซ
13 '2 2 2 'S *2
5 •ง&ซ?•ง •ง
o *? 2 2 &; ซ
j-  ซ
35 .2"
•MM GO
S 1
•3 g
S w
u S
•-S -t-
2 S
9 ^
? >ง
r^ 
-------





__
ฃฃ
s
JZ
*^
>s
5^
Mq
S
Q

|
"So
g
42
a
i
i*
'3
O
f^
flป
.g
"S
ns
"3
O
we
Si
Data Support!





Q
I

•<*
H
HH
^}










H
tป
S










MENT
EB
H-
c

S









ซ 0
V< I*
O O
Tjr. ฃ&
^^ ป"4
<ป 00
H H

eซi pa PQ
ง J
h o- "ซ ซ
ซ ซ 02 > H
ซ .&; g W 02
*1 S 1 g
•a eu -j- •ซ ^
a g JJ ft W
!! s l 3
oซ ซ.ซ ซ
P
Q
ซ7 "71 'Y cc
V^ ^^ f>| Cj3
vo 0 O -/
^H (S (S ft




T-H t~- ON
O CO i— i
VO P** CS
O CS CO
Ov O O
CS O O
•* o o
, 	 1 , 	 1 (\J
o o — <
ON ON ป— i
O O- VO
vo vo co
ON ON O
CS CS O
^3" *^i" ^^

pa









42
1
i
Nature of Residue

^
i
^•H
T— 1
00
VO
O
O
o
p~ o oo o
ซn vo t~ oo
CS CS CS CS
O O 0 0
o o o o
o o o o
O oo ซr> ON
CS  p- t-~
CS CN CS CS
CO ^i" ^f ""^
0000
o o o o
o o o o
























C^ *^f" VO CS
O VD O O
r-H r-l ^H CS
vo vo VO OO
CO O CO ON
o i— i o vi
O 0 O CS
0 0 O Tf
VI CO ^H CS
O VO 0 \O
i— i fS CS CS
vo v> oo m
CO ^- ON Tf
o o 
-------
 a

*N
I
 o


.3


I
.52
 
 CS

ft
      M
      co
       p
       a
                                                   f-
                                                   o
                                                   o
                                                            vo
                                                            o
             ocsenmvoesvor-oooso^H       ,-<
                                                            oo


                                                            CN
             cscnmmv>ooooooori-|
             O r^  o o  O O  *— < i— '  ' — " ^~* *— ' ^
             C5OOC3OOOOOOO,"
             csoooooooooog
             O^OO^O<—'<—'i—IT-
             00000000000 r>-
             oooooooooooO

      Tl-  Tt CS  t^ CS O
                                             cs o
             OOOOOOr-l.—<<—lr-4T-HT—lO


             OOOOOOOOOOOO1*
                                                            o
                                                            CS
                                                            00
                                                            CS
                                                            oo
                                                            CS
                                                            •n
                                                            o
                                                            o
                                                            vo
                                                            m
                                                            o
                                                            o
                                                            o
                                                                     i/^ vo  ฎฎ o  ^

                                                                     en en  '—' cS  C5
                                                                     •^f ^  cs oo

                                                                     o o  •* cs  ti
                                                                     o o  ^~ en  5


                                                                     00" O" iฃ -rf ^H"
                                                                     C^ VO  ^ O  O
                                                                     c— en  cs cs  **o
                                                                     \o ^  o oo  cs
                                                                     en >/n  >—' T—<  
                                                                     o o  •* cs  cs
                                                                     O O    r en  en
                                                                  >n   '  o  o
                                                                  en  ฃQ cS  cs
                                                                  —  ~ 00  00
                                                                     en ir>  -,
                                                                     o o  S
                                                                     o o  ?2
                                                                     o o  O
                                                                                cs cs
                                                                                en en
                                                                  
                                                                                                                     •* •*
                                                                                                                     o o
                                                                                                                     o o
                                                                                                                     o o

                                                                                                                     en" o-T
                                                                                                                     oo ON
                                                                                                                     CS r-H
                                                                                                                     

                                                                                              s
                                                                                              •4^

                                                                                              'S
                                                                                                   "O
                                                                                                   -2


                                                                                                   f
                                                                                                   I— I
                                                                                                    ,
                                                                                                    en
                                                                                                    
                                                                                                             3
                                                                                                               4J  BJD

                                                                                                               S  W
                                                                                                                         O
                                                                                                   -8
                                                                                                             s  M   s
                                                                                                             SB   s
                                                                                                            "S  ••"   ."S
                                                                                                    C  a.  'S  S   'S
                                                                                                    60 S*   Me   W)
                                                             rr
                                                                       r
                                                                     TH
                                                                     t-
                                                                                        O   K       -


                                                                                        t^   IT-       f-
                                                                                                                     1-9


                                                                                                                     lH
                                                                                                                     c-

-------





"S
=1
in of Met
o
•ฃ3
S3
**
"f"*
•S
1*1
o
h(
1
^
g
ซl-t
"a

cu
"3
a
a>
CM
V
a
O
M
a
•a
*ซw
o
&
D
a
02
C3
•+J
ft



*~>
fc
o
hH
H
^3
e
U












iz
H
1
P*
W
CO













H
Z
ซ
ง
6=:
g
C





OS
O
CM
VO
O
0
00144087,












PQ





iป
_4j
es
>


.2 pQ
h a
HH
2 -o
— < **
o o j5
0 O M
rt' r-T f-T
en Os os
Os vo vo
en O O
0 ป-H ^
0 O O
o o o
ซrT c-f  vo
en O O
O ^H ^-C
O O O
0 O 0
i— i oo en
~H en o
••* -* cs
VO OO VO
es t-~ o
0 O ^H
o o o
0 O O
















... ซB
GC ^
"o 2

B" es "g
0 U PH
0 ' '



             en


             O
                OS
Os
VO
O
O
o
      en
      o
      ON
      C~-
      f-
      cs
      o
      •Tj-
        r\
      Os
vo
o
o
o
             os
             t-~
             5
             vo
             o
      S s
      o w
      o O
             C- -H
O i—
o o
o o
                             OS
                vo
                O
o
o
                             en
                             o
                             Os
                             t-
                                    OS
                                    t-
      VO
      O
o
o
                                      oo  ^*
                                      vo  eM
                                      vo  VO
                                      OO  O
                                      o  ^
                                      o  o
                                      o  o

                                      en" en"
                                      en  oo
                                      Tj-  -H
                                      r-  vo
                                      vo  O
                                      O  .-i
                                      o  o
                                      o  o

                                      OS  l> O
                                      •*  en O
                                      os  /">
                                      o  o cs
                                      O  O "3-

                                      en" 
                                                •e
                                                 a

                                                 ซ
                                                 be
                                                 2
                                                ฃ
                                                 a
                                                 es
                                                     >>
                                                     O
                                                           &

                                                           O

                                                           O

                                                           s
                                                                  0>
                                                                  UD
                                     DC -S
                                     a  ซ
                                    •-S  S
                                    "3  o
                                     S H
                                                                     o
                                        es

                                       O

                                       "es
                                        
-------






ja
*l
.Q
{•4
•s
ฃ
O
ซwt
o
•fj
CS
fc<
CA
• MM
W
2
P>
CO
tl
<2
42
S3
0)
.S
'3
0
Qt
 CO CS OO
vo vo c*- vo
cs co oo o
t-ซ 0 O "-•
o o o o
O 0 0 O
co vo in ^~ ^t*
^)- cS CS OO O
oo vo r- vo r-
pซ- co vo o vo
O O O T-t CO
o o o o o
o o o o •*


















ti
'a
DA
~ซ
 r*-
   O CO
   o o
   o TI-
                             co
      vo
      o
      o
      o
                oo
      o
      vo
      r-
   o co
   o o
   o •<*
   vo t-
   co t->
   O (N
   O O
   o •*
VO
CO
o
o
                    00
                    1—(
                    vo
      vo
      •*  CS
      CO  OO
      •*  *-*
      vo  vo
      CO  O
      O  1-H
      o  o
      o  o
   ON co
   C-4 C-
   •* ~
   vo vo
   CO O
   O 1-1
   o o
   o o
VO
cs
         CS
         oo
   vo vo vo
   CO CO O
   o o *-*
   o o o
   o o o
                      o
                      oo
                      t-ป
                      VO
                      CO
                      o
                      o
                      o
   vo
   CO
   o
   o
   o

   oo
   CO
   •*
   VO
   CO
   o
   o
   o
                                                           vo
                                                           o
                                 O
                                 o
                                 vo
                                 CO
                                 o
                                 o
                                 o

                                 oC cs"
                                 VO  O
                                 r-  ON
                                 VO  P-
                                 CO  C^-
                                 O  CS
                                 o  o
                                 CO  00
                                 •*  i-<
                                 vo  vo
                                 CO  O
                                 O  —i
                                 o  o
                                 o  o
00
r-
vo
CO
o
o
o
  n
VO
CO
•*
vo
CO
o
o
o
                                                                                   ON
                                                                                   CO
       1
       2
    2
•a  B

 DD
 A


I

•O
 8
•O
•a
.o
              a
              o
             O
I
                       'O
                        a
           a
           be
           ซ

          .2
          B
          "O

           C3
                                     0)
                                     •e
                                     •o
                                     cs
       o

       O
       01
       •B
 CS

•a
 s
 cs

 ec
 cs

.o
                              ซ
                              o
                                     •8
                                      B
                                      ft
                                      4)
                                      M)
                                      *  SO B5
                                      fcซ  3 4>

                                     •s  งs  s

                                     I  S o  8?
                        8  -.
                        05  ft
                        eg  S
                                                   "
        -
                                                  Z  7
                                                         U  '

-------




.s
N
O
,fi
"jj
•4^
4}
^^
iCj
F— t
O
e
.2
ts
•4-1
•p^
WD

^

ซ
•*ซ>
s*
*2

•*••
Of
i
h
'3
o
s
fl>
SS
3
V
Data Supporting Guid


^_ <
fc
O

H
H
G

















;s
tf
td
H
CM
cc
P







REMENT
C
0!













n-
es
O
-2
"ซ
P
o
CN
CO
o\

CO















- Aspirated grain fractions









cs
cs

1
0
o

o"
\o
o
o
0
cv
oo
vo
^o
^^
f— (

0













fi
- Sugarcane
Magnitude of the Residues i
^
ฃ
















&
03
[J

OS
"*"J

P



pa
<3









Processed Food/Feed




































"2
ง
^
L.
s
A
A
tn
"3
A
?
"S
cs
ซ


„
oo
ป—H
0
0
o
vjrT
o)
o\
oo
o

o

"^" f^
5 ง)
CO *
O *S
งp
oo" irT

O o

0 ^









^
•* 'o *•
"53 K *o 'JJ'
&. *o S ••" -Sซ
** JJ M^ ^J J5
O ฃ1 Q c, ,_„.
i^ *- fli ^
^ oT S ซ a
•s 23 ซN CS 03
% ^ 4> fl ซN
^ 2 ^ 5 ซ
.^4 pia 5ซ o +*
•g -- a-r aซ
-> ง ซซ es ป a
Ss^ go e"1 ^ ซr
jai "S S '3 ^ S ^ ซ
M!2 g, g * S-S S S
|1ซ S g |S 5ป
111 f! 11 If
p^g-a cป -a aj-o HS
. W) = i 8 i 8 , 0
s.' C8 C3 C9 &M


a<

6J3
_g
"ซ
P
of
o
s
o
1— ^
o
o
m
^5
2
0
o
o
*\
^5
00
T— (
vo
^D
I""1

0






















































- Wheat, milled fractions



-------


a
1
ฃ
•*•ป
cu
CM
O
a
0
•43
OS
*ฃ•)
.us
'3
if
S
PH
0)
1
co
•*•*
0
ง
.ซ
'3
CJ
o
.s
WMI
•a
• M
O
cue
ag
•*•ป
Jซ
o
B
a
9
<ฃ>
a
•*-ป
03
P



ง
EJ
EH
0















i
1
&
en
D











H
2
1
a
PS)












CO
co
CN

0
o
o







"ef -a
s !
.S  h
S M 0
^O Qj) pC3
S [^ ฐ^
P5 ^3 O
^ ซM ^^
-4-* CO
*^< ^ "e5
O iS &0
•9 S -,
S 0 ซ
.-s PW s
n ^ Ta a
es ns ^ ซ
53 S ' •=ป
ft ฃ5 en
— >
iH
vo
oo
       as
Th     O
O     1—1
o     o
o     o

•**    cs"
oo     r--

S     ฃ
TJ-     m
O     O
O     O
o     o
              vo
              oo
              o
              o
              o
              oo
              o
              o
              o
                     1
                            ฃj   ^   a!

                            Z   &   &
                                      -2
                                       cs
                                      •a
                                       c
                                       S3
    —     BJ)
                  3
                  -a
                  O


                  _o

                  *!




                  I
                         aj
                         ซ
                         0
                         a,

                         2
                                  w
                                  e
                                  03
      V
      o
      a
      &
 <^j    ^


ฃ   ^
H    u


 o   ^
ซw   "ซ
•w   _U

 O   ^*
 D.  -a

 g"  |

O5   •<

-------
                                  GUIDE TO APPENDIX C

CONTENTS OF BIBLIOGRAPHY. This bibliography contains citations of all studies considered relevant by
EPA in arriving at the positions and conclusions stated elsewhere in the Reregistration Eligibility Document.
Primary sources for studies in this bibliography have been the body of data submitted to EPA and its
predecessor agencies in support of past regulatory decisions. Selections from other sources including the
published literature, in those instances where they have been considered, are included.

UNITS OF ENTRY.  The unit of entry in this bibliography is called a "study".  In the case of published
materials, this corresponds closely to an article.  In the case of unpublished materials submitted to the Agency,
the Agency has sought to identify documents at a level parallel to the published article from within the typically
larger volumes in which they were submitted. The resulting "studies" generally have a distinct title (or at least
a single subject), can stand alone for purposes of review and can be described with a conventional bibliographic
citation.  The Agency has also attempted to unite basic documents and commentaries upon them, treating them
as a single study.

IDENTIFICATION OF ENTRIES. The entries in this bibliography are sorted numerically by Master Record
Identifier, or "MRID number".  This number is unique to the citation, and should be used whenever a specific
reference is required. It is not related to the six-digit "Accession Number" which has been used to identify
volumes of submitted studies (see paragraph 4(d)(4) below for further explanation).  In a few cases,  entries
added to the bibliography late in the review may be preceded by a nine character temporary identifier. These
entries are listed after all MRID entries. This temporary identifying number is  also to be used whenever
specific reference is needed.

FORM OF ENTRY.  In addition to the Master Record Identifier (MRID), each entry consists of a citation
containing standard elements followed, in the case of material submitted to EPA, by a description of the earliest
known submission. Bibliographic conventions used reflect the standard of the American National Standards
Institute (ANSI), expanded to provide for certain special needs.

a.     Author. Whenever the author could confidently be identified, the Agency has chosen to show a
       personal author.  When no individual was identified, the Agency has shown an identifiable laboratory or
       testing facility as the author.  When no author or laboratory could be identified, the Agency has shown
       the first submitter as the author.

b.     Document date. The date of the study is taken directly from the document.  When the date is followed
       by a question mark, the bibliographer has deduced the date from the evidence contained in the
       document. When the date appears as (19??), the Agency was unable to determine or estimate the date of
       the document.

c.     Title. In some cases, it has been necessary for the Agency bibliographers to create or enhance a
       document title. Any such editorial insertions are contained between square brackets.

d.     Trailing parentheses.  For studies submitted to the Agency in the past, the trailing parentheses include
       (in addition to any self-explanatory text) the following elements describing the earliest known
       submission:

       (1)     Submission date. The date of the earliest known submission appears immediately following the
              word "received."
                                              143

-------
(2)    Administrative number. The next element immediately following the word "under" is the
      registration number, experimental use permit number, petition number, or other administrative
      number associated with the earliest known submission.

(3)    Submitter.  The third element is the submitter. When authorship is defaulted to the submitter,
      this element is omitted.

(4)    Volume Identification (Accession Numbers). The final element hi the trailing parentheses
      identifies the EPA accession number of the volume hi which the original submission of the study
      appears. The six-digit accession number follows the symbol "CDL," which stands for "Company
      Data Library." This accession number is hi turn followed by an alphabetic suffix which shows
      the relative position of the study within the volume.
                                      144

-------
                                        BIBLIOGRAPHY
         MRID
CITATION
00015412    Analytical Biochemistry Laboratories (1976) Recovery of Sencor and Metabolites from Soybeans:
            Report No. 51072. (Unpublished study received Jan 19, 1977 under 100-583; prepared for Mobay
            Chemical Corp., submitted by Ciba-Geigy Corp., Greensboro, N.C.; CDL: 095747-W)

00015414    Thornton, J.S. (1974) A Modified Gas Chromatographic Method for the Determination of Sencor and
            Its Deaminated Diketo Metabolite in Soybeans: Report No. 42232. Method dated Dec 4, 1974.
            (Unpublished study received Jan 19, 1977 under 100-583; prepared by Mobay Chemical Corp.,
            submitted by Ciba-Geigy Corp., Greensboro, N.C.; CDL:095748-V)

00015773    Searcy, S.; Herman, D.; Slagowski, J.L. (1978) Metolachlor (Dual-'(R)a5 8E); Metribuzin (Sencor
            SOW); Paraquat (2C1): AG-A No. 48941,11. (Unpublished study including letter dated May 23,1978
            from J.D. Riggleman to Robert A. Kahrs, received Mar 16, 1979 under 100-583; prepared in
            cooperation with E.I. du Pont de Nemours & Co., Inc. and Chevron Chemical Co., submitted by
            Ciba-Geigy Corp., Greensboro, N.C.; CDL:237821-O)

00015949    Analytical Biochemistry Laboratories (1977) Chemagro Agricultural Division—Mobay Chemical
            Corporation Residue Experiment: MW-HR409-75: Report No. 51071. (Unpublished study including
            report nos. 51065, 51069 and 51070, received Jan 19, 1977 under 100583; submitted by Ciba-Geigy
            Corp., Greensboro, N.C.; CDL: 095747-AH)

00024503    Monsanto Company (1974) Summary of Residue Data. (Unpublished study received Jan 16, 1978
            under 524-285; CDL:232680-B)

00024737    Hilton, H.W.; Nomura, N.S.; Kameda, S.S.; et al. (1976) Some patterns of herbicide and growth
            regulator intake, persistence, and distribution in sugarcane. Archives of Environmental
            Contamination and Toxicology 4(4):385-394. (Also~In~unpublished submission received Jul 19,
           ' 1978 under 201-403; submitted by Shell Chemical Co., Washington, D.C.; CDL:234470-AP)

00026411    Mobay Chemical Corporation (1977) ^Residue Data for Sencor, Alachlor in Potatoes |. (Unpublished
            study received Jan 2, 1980 under WA 79/88; prepared in cooperation with Analytical Biochemistry
            Laboratories, Inc., submitted by State of Washington for Monsanto Co., Washington, D.C.;
            CDL:241541-A)

00029800    Thornton, J.S.; Schumann, S.A.; Boughton, P.J.; et al. (1974) A Gas Chromatographic Method for
            the Determination of Sencor and Its Deaminated Diketo Metabolite in Soybeans.  Rev. Method no.
            30387 dated Apr 11, 1972.  (Unpublished study received Dec 21, 1974 under 5G1580; prepared by
            Baychem Corp., submitted by American Cyanamid Co., Princeton, N.J.; CDL:094331-J)

00032428    Stanley, C.W.; Thornton, J.S. (1972) A Gas Chromatographic Method for the Determination of
            Sencor and Metabolites in Sugarcane and Products: Report No. 35115. Method dated Dec 7, 1972.
            (Unpublished study received Jul 2, 1975 under 239-2186; submitted by Chevron Chemical Co.,
            Richmond, Calif.; CDL:119807-E)
                                                145

-------
         MRID
                                       BIBLIOGRAPHY
                                       CITATION
00032429    Baychem Corporation (1973) Recovery of Sencor from Dry Soybeans: Report No. 35413.
            (Unpublished study received Jul 2, 1975 under 239-2186; submitted by Chevron Chemical Co.,
            Richmond, Calif.; CDL:119807-F)

00036105    Murphy, J.J.; Jacobs, K.; Lamb, D.W. (1974) The Metabolism of Sencor in a Dairy Cow: Report No.
            40708. (Unpublished study received Oct 10, 1974 under 5F1559; submitted by Mobay Chemical
            Corp., Kansas City, Mo.; CDL:095130-B)
            Bell, R.L.; Murphy, J.J. (1974) The Metabolism of Sencor in Chickens: Report No. 40712. Rev.
            (Unpublished study received Oct 10,1974 under 5F1559; submitted by Mobay Chemical Corp.,
            Kansas City, Mo.; CDL:095130-C)
00036106
00036107    Shaw, H.R., II; Murphy, J.J. (1974) The Metabolic Fate of 05-14C | Sencor in Pigs: Report No.
            40768. (Unpublished study received Oct 10, 1974 under 5F1559; submitted by Mobay Chemical
            Corp., Kansas City, Mo.; CDL:095130-D)

00036110    Thornton, J.S. (1974) Effect of Commercial Processing on Residues of Sencor in Potatoes: Report
            No. 42341. (Unpublished study received on unknown date under 5F1559; submitted by Mobay
            Chemical Corp., Kansas City, Mo.; CDL:095987-B)

00036112    Simmons, C.E.; Gronberg, R.R.  (1974) The Fate of Carbon-14-Labeled Sencor in Potatoes Processed
            by Pan or French Frying: Report No. 42452. (Unpublished study received on unknown date under
            5F1559; submitted by Mobay Chemical Corp., Kansas City, Mo.; CDL:095987-D)

00036216    Stanley, C.W. (1974) Comparison of Hydrolysis Methods for Sencor from Alfalfa: Report No.
            40977. (Unpublished study received on unknown date under 4F1432; submitted by Chemagro Corp.,
            Kansas City, Mo.; CDL:095519-A)

00036219    Morgan, J.G. (1972) Preliminary Studies on the Metabolism of Sencor in Tomatoes: Report No.
            35013. (Unpublished study received Sep 27, 1973 under 4F1432; submitted by Chemagro Corp.,
            Kansas City, Mo.; CDL:095519-F)

00036220    Morgan, J.G. (1973) Metabolism of Sencor in Tomatoes: Report No. 35969. (Unpublished study
            received Sep 27, 1973 under 4F1432; submitted by Chemagro Corp., Kansas City, Mo.; CDL:
            095519-G)

00036426    Chemagro Corporation (1974) Chemagro Division of Baychem Corporation Residue Experiment
            661-4828-73H: Report No. 41349. (Unpublished study including report nos. 41350 and 41351,
            received May 14, 1975 under 5F1628; prepared in cooperation with Cannon Laboratories,
            CDL:094425-A)
                                                146

-------
         MRID
                                       BIBLIOGRAPHY
                           CITATION
00036427    Cannon Laboratories (1974) Recovery of Sencor and Dadk from Barley and Wheat Grain: Report
            No. 41352.  (Unpublished study received May 14, 1975 under 5F1628; submitted by Mobay
            Chemical Corp., Kansas City, Mo.; CDL:094425-B)

00036428    Chemagro Corporation (1974) Chemagro Division of Baychem Corporation Residue Experiment
            661-Extra-73D: Report No. 41353. (Unpublished study including report nos. 41354, 41355,
            41356..., received May 14, 1975 under 5F1628; prepared in cooperation with Cannon Laboratories;
            CDL:094425-C)

00036429    Morse Laboratories (1974) Chemagro Agricultural Division—Mobay Chemical Corporation Residue
            Experiment 361-4701-73H: Report No. 41820.  (Unpublished study including report nos. 41822,
            41823, 41824..., received May 14, 1975 under 5F1628; submitted by Mobay Chemical Corp., Kansas
            City, Mo.; CDL:094425-D)

00036431    Sandie, F.E.; Gronberg, R.R. (1975) A Gas Chromatographic Method for Determining Residues of
            Sencor and Metabolites in Animal Tissues, Milk and Eggs: Report No. 42257.  Method dated May 5,
            1975. (Unpublished study received May 14,1975 under 5F1628; submitted by Mobay Chemical
            Corp., Kansas City, Mo.; CDL: 094425-F)

00036432    Cannon Laboratories (1974) Recovery of Sencor from Barley and Wheat Straw: Report No. 42292.
            (Unpublished study received May 14, 1975 under 5F1628; submitted by Mobay Chemical Corp.,
            Kansas City, Mo.; CDL:094425-G)

00036433    Mobay Chemical Corporation (1974) Recovery of Sencor and Metabolites from Barley and Wheat
            Straw:  Report No. 42293. (Unpublished study received May 14, 1975 under 5F1628;
            CDL:094425-H)


00036435    Mobay Chemical Corporation (1974) Raw Data and Chromatograms for Analysis of Sencor and
            Dadk on Wheat Straw: Report No. 42295. (Unpublished study received May 14, 1975 under 5F1628;
            CDL: 094425-J)
00036436
00036437
00036438
Mobay Chemical Corporation (1974) Chemagro Agricultural Division-Mobay Chemical Corporation
Residue Experiment 661-47795-72H: Report No. 42326.  (Unpublished study including report no.
42328, received May 14, 1975 under 5F1628; CDL:094425-K)

Mobay Chemical Corporation (1974) Chemagro Agricultural Division-Mobay Chemical Corporation
Residue Experiment 661-4779A-72H: Report No. 42327. (Unpublished study including report nos.
42329, 42330 and 42332, received May 14, 1975 under 5F1628; CDL: 094425-L)

Mobay Chemical Corporation (1974) Chemagro Agricultural Division-Mobay Chemical Corporation
Residue Experiment 661-4714 Extra-72H: Report No. 42331.  (Unpublished study including report

                                   147

-------
                                       BIBLIOGRAPHY
         MRID
CITATION
            no. 42333, received May 14, 1975 under 5F1628; CDL:094425-M)

00036439    Mobay Chemical Corporation (1974) Chemagro Agricultural Division-Mobay Chemical Corporation
            Residue Experiment 661-4832-73H: Report No. 42350.  (Unpublished study including report nos.
            42351,42352, 42353..., received May 14, 1975 under 5F1628; prepared hi cooperation with Cannon
            Laboratories; CDL:094425-N)

00036440    Mobay Chemical Corporation (1974) Chemagro Agricultural Division-Mobay Chemical Corporation
            Residue Experiment 661-4822-73H: Report No. 42363.  (Unpublished study including report nos.
            42364, 42365, 42366..., received May 14, 1975 under 5F1628; prepared in cooperation with Cannon
            Laboratories; CDL:094425-O)

00036441    Mobay Chemical Corporation (1974) The Effect of Frozen Storage at 0 to -lO-oasF on Sencor and
            Metabolite Residue in Milk: Report No. 42372. (Unpublished study received May 14, 1975 under
            5F1628; CDL:094425-P)

00036443    Chemagro Corporation (1974) Chemagro Division of Baychem Corporation Residue Experiment
            661-4710-73D: Report No. 40910. (Unpublished study including report nos. 40911, 40912, 40913...,
            received May 14, 1975 under 5F1628; prepared in cooperation with Morse Laboratories, submitted
            by Mobay Chemical Corp., Kansas City, Mo.; CDL:094424-C)

00036444    Mobay Chemical Corporation (1974) Raw Data and Chromatograms for the Analysis of Sencor and
            DADK in Barley Grain: Report No. 41237. Rev. (Unpublished study received May 14, 1975 under
            5F1628; CDL:094424-D)

00036445    Cannon Laboratories (1974) Chemagro Division of Baychem Corporation Residue Experiment:
            263-4839-73H: Report No. 41339. (Unpublished study including report nos. 41341,41342, 41343...,
            received May 14, 1975 under 5F1628; submitted by Mobay Chemical Corp., Kansas City, Mo.;
            CDL:094424-E)

00036769    Mobay Chemical Corporation (1974) Chemagro Agricultural Division-Mobay Chemical Corporation
            Residue Experiment 861-4708A-72D: Report No. 42374. (Unpublished study including report nos.
            42466,42467, 42468..., received May 14, 1975 under 5F1628; CDL: 094426-B)

00036770    Mobay Chemical Corporation (1974) Chemagro Agricultural Division-Mobay Chemical Corporation
            Residue Experiment: 861-4708 G-72H: Report No. 42375.  (Unpublished study received May 14,
            1975 under 5F1628; CDL-.094426-C)

00036772    Mobay Chemical Corporation (1974) Chemagro Agricultural Division-Mobay Chemical Corporation
            Residue Experiment AH-71A-851: Report No. 42449. (Unpublished study received May 14, 1975
            under 5F1628; CDL:094426-E)

00036776    Mobay Chemical Corporation (1974) Recovery of Sencor from Sainfoin: Report No. 42470.

                                                148

-------
         MRID
                                       BIBLIOGRAPHY
CITATION
            (Unpublished study received May 14, 1975 under 5F1628; CDL:094426-I)

00036777    Mobay Chemical Corporation (1974) The Effect of Frozen Storage at 0 to -lO^oasF on Sencor
            Residues in Green Alfalfa: Report No. 42471. (Unpublished study received May 14, 1975 under
            5F1628; CDL:094426-J)

00036778    Mobay Chemical Corporation (1974) The Effect of Frozen Storage at 0 to -IQ-'OffiF on Sencor
            Residues in Poultry Tissues and Eggs: Report No. 42451. (Unpublished study received May 14,
            1975 under 5F1628; CDL:094426-K)

00036779    Mobay Chemical Corporation (1975) Chemagro Agricultural Division-Mobay Chemical Corporation
            Residue Experiment 263-4701-72H: Report No. 42484.  (Unpublished study including report nos.
            42485, 42486, 42487..., received May 14, 1975 under 5F1628; CDL: 094427-A)

00036780    Mobay Chemical Corporation (1974) Chemagro Agricultural Division-Mobay Chemical Corporation
            Residue Experiment 661-4704 Extra72H: Report No. 42492. (Unpublished study received May 14,
            1975 under 5F1628; CDL:094427-B)

00036782    Morris, R.A. (1975) Interference Study for the Residue Method for Sencor and Its Metabolites in
            Various Crops: Report No. 42735. (Unpublished study received May 14, 1975 under 5F1628;
            submitted by Mobay Chemical Corp., Kansas City, Mo.; CDL:094427-D)


00039525    American Cyanamid Company (1975) General Summary: Prowl Herbicide and Its-Metabolite and
            Sencor Residues in or on Potatoes. Summary of studies 095485-Q through 095485-S. (Unpublished
            study received Feb 9,  1976 under 6G1739; CDL:095485-K)

00039530    Devine, J.M.; Thornton, J.S.; Stanley, C.W. (1975) Sencor (Bay 94337): The Gas Chromatographic
            Determination of Sencor 0Amino-6-t-buryl-3-(methylthio)-l,2,4-triazin-5(4H)-one | from Fortified
            Potatoes: Report No. C-767. Includes method, report no. 33005, dated Apr 14, 1972. (Unpublished
            study received Feb 9,  1976 under 6G1739; prepared in cooperation with Chemagro Corp., submitted
            by American Cyanamid Co., Princeton, N.J.; CDL: 095485-P)

00039531    Devine, J.M.; Nzewi, G.I.; Boughton, P.J.; et al. (1975) Prowl-(R)as (CL 92,553): Determination of
            CL 92,553 0N-(l-Emylpropyl)-3,4dimethyl-2,6-dinitrobenzenamide|, CL 202,347
            (24-(01-Ethylpropyl j amino)-2-methyl-3,5-dinitro benzyl alcohol) and Sencor
            04-Amino6-t-butyl-3-(methylthio)-l,2,4-triazin-5(4H)-one | Residues in Potatoes: Report No. C-787.
            (Unpublished study received Feb 9, 1976 under 6G1739; submitted by American Cyanamid Co.,
            Princeton, N.J.; CDL:095485-Q)

00045255    Chemagro Corporation (1975) Supplement to Synopsis of the Effects of Sencor on the Environment.
             Summary of studies 094871-C through 094871-F, 094871-1 through 094871-O, 094871-Q through
            094871-S.  (Supplement no. 1; unpublished study received Mar 7, 1975 under 5F1559; submitted by
                                                149

-------
         MRID
                                       BIBLIOGRAPHY
                           CITATION
            Mobay Chemical Corp., Kansas City, Mo.; CDL:094871-A)


00045256    Stanley, C.W.; Schumann, S.A. (1969) A Gas Chromatographic Method for the Determination of
            Bay 94337 Residues in Potatoes, Soybeans, and Corn: Report No. 25,838. Method dated Oct 16,
            1969. (Unpublished study received Mar 7,1975 under 5F1559; submitted by Mobay Chemical Corp.,
            Kansas City, Mo.; CDL:094871-B)

00045257    Robinson, R.A.; Gronberg,' R.R.; Shaw, H.R., II (1970) Bay 94337 Metabolism in Plants: Report No.
            26,175. Rev. (Unpublished study received Mar 7, 1975 under 5F1559; submitted by Mobay
            Chemical Corp., Kansas City, Mo.; CDL:094871-C)

00045258    Gronberg, R.R.; Flint, D.R.; Shaw, H.R.; et al. (1971) The Metabolism of Sencor (Bay 94337) in
            Soybean Plants: Report No. 29800. (Unpublished study received Mar 7, 1975 under 5F1559;
            submitted by Mobay Chemical Corp., Kansas City, Mo.; CDL:094871-D)
00045260
00045262
00045263
00045275
 00045278
 00045279
 00045280
Church, D.D.; Flint, D.R. (1973) The Metabolism of Sencor in Potatoes: Report No. 32047.  Rev.
(Unpublished study received Mar 7, 1975 under 5F1559; submitted by Mobay Chemical Corp.,
Kansas City, Mo.; CDL:094871-F)

Morgan, J.G.; Flint, D.R. (1972) Sencor Residues in Chicken Eggs and Tissue: Report No. 33226.
(Unpublished study received Mar 7, 1975 under 5F1559; submitted by Mobay Chemical Corp.,
Kansas City, Mo.; CDL:094871-H)

Flint, D.R.; Shaw, H.R., H (1972) Residues in Tissue and Milk from Goats Treated Daily with
Sencor-14C in the Diet: Report No. 33255. (Unpublished study received Mar 7, 1975 under 5F1559;
submitted by Mobay Chemical Corp., Kansas City, Mo.; CDL:094871-I)

Morgan, J.G. (1974) The Metabolism of Sencor in Seedling Potatoes: Report No. 40564.
(Unpublished study received Mar 7, 1975 under 5F1559; submitted by Mobay Chemical Corp.,
Kansas City, Mo., CDI/.094870-C)

Stanley, C.W.; Flint, D.R. (1974) The Metabolism of Sencor in Alfalfa: Report No. 40853.
(Unpublished study received Mar 7,1975 under 5F1559; submitted by Mobay Chemical Corp.,
Kansas City, Mo.; CDL:094870-I)
Hargroder, T.G.; Rogers, R.L. (1974) Behavior and fate of Metribuzin in soybean and hemp
sesbania. Weed Science 22(3):238-245. (Also~In~unpublished submission received Mar 7,
under 5F1559; submitted by Mobay Chemical Corp., Kansas City, Mo.; CDL:094870-J)
                                                                                          1975
 Schumacher, R.W. (1974) Metabolism of Metribuzin in Soybeans and Soil: Report No. 40865..
 Doctoral dissertation, Univ. of Kentucky. (Unpublished study received Mar 7,1975 under 5F1559;

                                   150

-------
         MRID
                                       BIBLIOGRAPHY
                                       CITATION
            submitted by Mobay Chemical Corp., Kansas City, Mo.; CDL: 094870-K)

00045282    Sandie, F.E.; Gronberg, R.R. (1974) A Gas Chromatographic Method for Determining Residues of
            Sencor and Metabolites in Animal Tissues, Milk and Eggs: Report No. 42257. Method dated Dec 5,
            1974. (Unpublished study received Mar 7, 1975 under 5F1559; submitted by Mobay Chemical
            Corp., Kansas City, Mo.; CDL: 094870-M)

00045283    Mobay Chemical Corporation (1974) ^Sencor Residues in Cattle |: Report No. 42373. (Unpublished
            study received Mar 7, 1975 under 5F1559; CDL:094870-N)

00045284    Mobay Chemical Corporation (1974) jiSencor Residues in Poultry |: Report No. 42448.
            (Unpublished study received Mar 7, 1975 under 5F1559; CDL:094870-O)

00045286    Mobay Chemical Corporation (1974) jiSencor Residues in Eggs |: Report No. 42450.  (Unpublished
            study received Mar 7, 1975 under 5F1559; CDL:094870-Q)
00054354
00054355
00054356
00054358
00054360
00054363
            Thornton, J.S.; Stanley, C.W. (1972) A Gas Chromatographic Method for the Determination of
            Residues of Sencor and Its Metabolites in Potatoes: Report No. 33005. Method dated Apr 14, 1972.
            (Unpublished study received Aug 14, 1980 under 3125-314; submitted by Mobay Chemical Corp.,
            Kansas City, Mo.; CDL:243067-B)

            Thornton, J.S. (1972) Effect of Room Temperature Storage on Residues of Sencor and Metabolites in
            Mature Potatoes: Report No. 33058. (Unpublished study received Aug 14, 1980 under 3 1253 14;
            submitted by Mobay Chemical Corp., Kansas City, Mo.; CDL: 243067-C)
            Mobay Chemical Corporation (1 972) Effect of Frozen Storage at O-offiF on Sencor and DADK
            Residues in Soybeans: Report No. 33289.  (Unpublished study received Aug 14, 1980 under
            3125-314; CDL: 243067-D)

            Mobay Chemical Corporation (1973) The Effect of Frozen Storage at 0 to -lO-oasF on Sencor
            Residues in Potatoes: Report No. 35845. (Unpublished study received Aug 14, 1980 under 3125-314;
            CDL: 243067-F)

            Mobay Chemical Corporation (1974) The Effect of Frozen Storage at 0 to -IQ-'oasF on Sencor
            Residues in Green Alfalfa: Report No. 42471. (Unpublished study received Aug 14, 1980 under
            3125314; CDL:243067-M)

            Mobay Chemical Corporation (1975) The Effect of Frozen Storage at 0 to -lO-osF on
            Sencor-{TM)ffi! and Metabolite Residues in Green Peas: Report No. 44621 . (Unpublished study
            received Aug 14, 1980 under 3125-314; CDL:243067-P)
 00054366    Mobay Chemical Corporation (1 974) The Effect of Frozen Storage at 0 to - 1 0-o
-------
         MRID
                                        BIBLIOGRAPHY
CITATION
            Residues in Tomatoes: Report No. 47371. (Unpublished study received Aug 14, 1980 under
            3125314;CDL:243067-S)

00054369    Thornton, J.S.; Stanley, O.W. (1977) Gas chromatographic determination of Sencor and metabolites
            in crops and soil. Journal of Agricultural and Food Chemistry 25(2):380-386. (Submitter report no.
            52909; also~In~unpublished submission received Aug 14, 1980 under 3125-314; submitted by
            Mobay Chemical Corp., Kansas City, Mo.; CDL:243067-W)

00061260    Loser, E.; Mirea, D. (1974) Bay 94 337: Chronic Toxicity Studies on Dogs (Two-Year Feeding
            Experiment): Report No. 4887; ReportNo. 41814.  (Unpublished study received on unknown date
            under 5F1559; prepared by Bayer, AG, submitted by Mobay Chemical Corp., Kansas City, Mo.;
            CDL:094258-J)

00061261    Loser, E.; Mohr, U. (1974) Bay 94337: Chronic Toxicity Studies on Rats (Two-Year Feeding
            Experiment): Report No. 4888; Report No. 41816.  (Unpublished study received on unknown date
            under 5F1559; prepared by Bayer, AG and Medizinische Hoschule Hannover, submitted by Mobay
            Chemical Corp., Kansas City, Mo.; CDL:094259-A)

00064797    Wilson, G.R.; Baszis, S.R.; Steinmetz, J.R.; et al. (1980) Residues of Acetochlor in Soybean and
            Corn Grain following Preemergent Treatment with Acetochlor Alone or in Tank-mix Combinations
            with Atrazine, Linuron and Metribuzin: Report No. MSL-1242. Final rept. (Unpublished study
            received Dec 12,1980 under 524-EX-56; submitted by Monsanto Co., Washington, D.C.; CDL:
            099813-A)

00065507    Lamb, D.W.; Burke, M.A. (1977) Dietary Toxicity of ~(R)aeSencor Technical to Bobwhite Quail and
            Mallard Ducks: ReportNo. 51593. (Unpublished study received Apr 13, 1977 under 3125-270;
            submitted by Mobay Chemical Corp., Kansas City, Mo.; CDL:229312-A)

00067425    Monsanto Company (1980) Residues of Glyphosate and Other Herbicides in Wheat following
            Chemical Fallow Applications of Roundup--(R)ae Tank Mix Combinations.  Includes method dated
            Jul 1,1979 and undated methods entitled: 2,4-D in wheat forage, straw and grain; Dicamba in wheat
            forage, straw and grain;  Residues of alachlor in wheat grain, forage and straw; Atrazine in wheat
            forage, straw and grain;  Cyanazine in wheat forage, straw and grain; Metribuzin and metabolites in
            wheat forage, straw and grain.  (Unpublished study, including published data, received Dec 29,  1980
            under 524-308; CDL:243990-A; 243991)

00067433    Harrison, S.L.; Boros, E.J. (1980) Chloramben, Trifluralin & Metribuzin (+ DADK) Analyses of
            Soybeans Treated with Amiben + Treflan + Sencor or Lexone Tank Mix PPI: Project Report
            10123/1280A. (Unpublished study received Dec 19, 1980 under 264-138; prepared in cooperation
            with Southern Illinois Univ., Plant & Soil Science Dept. and others, submitted by Union Carbide
            Agricultural Products Co., Inc., Ambler, Pa.; CDL:243984-F)

00069067    Thornton, J.S. (1974) A Gas Chromatographic Method for the Determination of Sencor and
                                                 152

-------
                                       BIBLIOGRAPHY
         MRID
CITATION
            Metabolites in Various Crops: Report No. 40901. Method dated Dec 11,1974. (Unpublished study
            received Sep 13, 1976 under 3125-277; submitted by Mobay Chemical Corp., Kansas City, Mo.;
            CDL:226759-H)

00078436    Wilson, G.R.; Dubelman, S. (1981) Residues of Alachlor in Potatoes following Preemergent and
            Lay-by Treatment with Lasso~'(R)ae Alone or in Tank-mix Combinations with Metribuzin: Report
            No. MSL1559. Final rept.  (Unpublished study received Aug 7, 1981 under 1F2551; submitted by
            Monsanto Co., Washington, D.C.; CDL: 070279-A)

00078438    Stauffer Chemical Company (1980) Eptam 7-E + Metribuzin Tank Mix on Potatoes: Summary of
            Crop Residue Data. (Compilation; unpublished study received Jul 27, 1981 under 476-2154;
            CDL:245620-B)

00078943    Mobay Chemical Corporation (1981) Addition to Synopsis of Sencor Residue Chemistry on Various
            Crops: Addition No. 5.  (Compilation; unpublished study received Jul 13, 1981 under 3125-314;
            CDL:245573-A)

00086681    Mobay Chemical Corporation (1981) Addition to Synopsis of Sencor: Residue Chemistry on
            Soybeans. Summary of studies 246225-B and 246225-C.  (Compilation; unpublished study received
            Oct29, 1981 under 3125-277; CDL:246225-A)

00086765    Machemer, L.; Lorke, D. (1974) Evaluation of the Mutagenic Potential of ~'(R)aeSencor in an~in
            vivo~Cytogenetic Study on Spermatogonia of Chinese Hamster: Report No. 4961; 43067.
            (Unpublished study received Nov 3, 1981 under 3125-270; prepared by Bayer AG, West Germany,
            submitted by Mobay Chemical Corp., Kansas City, Mo.; CDL:246226-A)

00086766    Machemer, L.; Lorke, D. (1974) Evaluation of ~'(R)aeSencor for Mutagenic Effects on the Mouse:
            Report No. 4942; 43068. (Unpublished study received Nov 3, 1981 under 3125-270; prepared by
            Bayer AG, West Germany, submitted by Mobay Chemical Corp., Kansas City, Mo.; CDL:246226-B)

00086767    Machemer, L.; Lorke, D. (1975) ~-(R)ffiSencor: Dominant Lethal Study on Male Mice To Test for
            Mutagenic Effects: Report No. 5523; 45023. (Unpublished study received Nov 3, 1981 under
            3125-270; prepared by Bayer AG, West Germany, submitted by Mobay Chemical Corp., Kansas
            City, Mo.; CDL:246226-C)

00086770    Inukai, H.; lyatomi, A. (1977) Bay 94337: Mutagenicity Test on Bacterial Systems: Report No. 67;
            54127. (Unpublished study received Nov 3, 1981 under 3125-270; prepared by Nitokuno
            Agricultural Chemicals Institute, Japan, submitted by Mobay Chemical Corp., Kansas City, Mo.;
            CDL:246226-F)

00087795    Hayes, R.H.; Lamb, D.W.; Mallicoat, D.R.; et al. (1981) Metribuzin (-{R)as Sencor) Oncogenicity
            Study in Mice: 80050. (Unpublished study received Nov 23, 1981 under 3125-270; submitted by
            Mobay Chemical Corp., Kansas City, Mo.; CDL:246397-A)
                                                153

-------
         MRID
                                       BIBLIOGRAPHY
CITATION
00087796    Unger, T.M.; Shellenberger, T.E. (1981) A Teratological Evaluation of Sencoi-'(R)as in Mated
            Female Rabbits: 80051.  Final rept. (Unpublished study received Nov 23, 1981 under 3125-270;
            submitted by Mobay Chemical Corp., Kansas City, Mo.; CDL:246397-B)

00087925    Mobay Chemical Corporation (1978) -(R)a;Sencor Residue Chemistry on Soybeans: Supplement
            No. 5. (Compilation; unpublished study received Dec 16, 1981 under 3125-277; CDL:246510-A)

00087926    Mobay Chemical Corporation (1981) -
-------
         MRID
                                       BIBLIOGRAPHY
CITATION
            093822-A; 093820)

00106169    Mobay Chemical Corp. (1972) Sencor (BAY 94337): Metabolic, Analytical, and Residue
            Information on Tomatoes. (Compilation; unpublished study received Apr 25, 1972 under 4F1432;
            CDL: 093821-A)

00106173    Mobay Chemical Corp. (1975) Sencor: Analytical, Metabolic, and Residue Information for Various
            Crops.  (Compilation; unpublished study received May 14, 1975 under 5F1628; CDL:094423-A)

00106179    Mobay Chemical Corp. (1975) Sencor ... Residue Chemistry on Lentils and Peas: Document No.
            AS76-788.  (Compilation; unpublished study received Jun 29, 1976 under 3125-277;
            CDL:095551-A)

00106180    Mobay Chemical Corp. (1976) Addition No. 1 to Brochure Entitled: Sencor: Residue Chemistry on
            Tomatoes: Document No. AS76-549. (Compilation; unpublished study received May 6, 1976 under
            6F1783; CDL:095907-A)

00106182    Mobay Chemical Corp. (1977) Sencor Residue Chemistry on Various Crops: Addition No. 1 to
            Brochure Entitled: Sencor Analytical, Metabolic, and Residue Information for Various Crops:
            Document No. AS 77-1557. (Compilation; unpublished study received Sep 21, 1977 under
            3125-277; CDL:096367-A)

00106183    Mobay Chemical Corp. (1977) Sencor Residue Chemistry on Soybeans: Supplement No. 4 to
            Brochure Entitled: Sencor (Formerly Bay 94337) Metabolic, Analytical and Residue Information on
            Soybeans: Document No. AS 78-153. (Compilation; unpublished study received Feb 13, 1978 under
            3125-277; CDL:096820-A)

00106184    Kadoum, A.; Gronberg, R. (1978) Effect of Dry Milling and Gluten Processing on Sencor and
            DADK Residues in Wheat Grain: Document No. AS78-1271; Report No. 66113. (Unpublished
            study received Jun 16, 1978 under 3125-277; prepared by Kansas State Univ., Dept. of Entomology,
            submitted by Mobay Chemical Corp., Kansas City, MO; CDL:097164-A)

00106185    Mobay Chemical Corp. (1978) Sencor Residue Chemistry on Various Crops: Addition No. 3 to
            Brochure Entitled: Sencor Analytical, Metabolic and Residue Information for Various Crops:
            Document No. AS78-1274. (Compilation; unpublished study received Jun 16, 1978 under 3125-277;
            CDL:097165-A)

00106190    Chemagro Corp. (1975) ^Residues of Sencor in Sugarcane |. (Compilation; unpublished study
            received Oct 8, 1975 under 4F1432; CDL:098168-F)

00106191    Houseworth, L. (1979) Residues of Metolachlor and Metribuzin in Potato Tubers Resulting from the
            Use of Metolachlor and Metolachlor/Metribuzin Tank Mixes for Weed Control in Potato Culture:
            Report No.: ABR-79040. (Unpublished study received Apr 25, 1979 under 100-583; submitted by
                                                155

-------
         MRID
                                       BIBLIOGRAPHY
                            CITATION
00106193
00106197
00106199
00106202
00106203



00106205


00106211
00106212
00106215
Ciba-Geigy Corp., Greensboro, NC; CDL:098227-A)

Thornton, J.; Schumann, S. (1971) A Gas Chromatographic Method for the Determination of Sencor
and Its Deaminated Diketo Metabolite in Potatoes and Soybeans: Report No. 30387. (Unpublished
study received on unknown date under OG0940; submitted by Chemagro Corp., Kansas City, MO;
CDL:098576-A)

Heitmuller, T. (1975) Acute Toxicity of Sencor to Eastern Oysters (Crassostrea virginica), Pink
Shrimp (Penaeus duorarum), and Fiddler Crabs (Uca pugilator): jzisubmitter | 43851. (Unpublished
study received Aug 19, 1975 under 3125-294; prepared by Bionomics-EG & G, Inc., submitted by
Mobay Chemical Corp., Kansas City, MO; CDL:165011-A)

Mobay Chemical Corp. (1973) Sencor (Formerly BAY 94337): Metabolic, Analytical, Residue, and
Flavor Evaluation for Potatoes.  (Compilation; unpublished study received Mar 8, 1973 under
3125-EX120; CDL:127000-A; 127001)

Mobay Chemical Corp. (1976) Sencor: Residue Chemistry on Sugarcane: Addition No. 2 to
Brochure Entitled: Sencor: Metabolic, Analytical and Residue Information for Sugarcane (Hawaii):
Document No. AS76-1245. (Compilation; unpublished study received Sep 10, 1976 under
3125-277; CDL:226131-A)

Mobay Chemical Corp. (1973) Addition No. 1 to Brochure Entitled: Sencor: Residue Chemistry on
Potatoes: Document No. AS77-47. (Compilation; unpublished study received Jan 24, 1977 under
3125-277; CDI/.228041-A)

Mobay Chemical Corp. (1973) Addition No. 2 to Brochure Entitled: Sencor: Residue Chemistry on
Potatoes. (Compilation; unpublished study received Nov 30, 1977 under 3125-314; CDL:232357-A)

Mobay Chemical Corp. (1978) Sencor Residue Chemistry on Various Crops: Addition No. 2, Feb 3,
1978, to Brochure Entitled: Sencor Analytical, Metabolic and Residue Information for Various Crops
(Dated January 23, 1975): Document No. AS78-1882. (Compilation; unpublished study received
Sep 11, 1978 under 3125-314; CDL: 235087-A)

Mobay Chemical Corp. (1978) Sencor Residue Chemistry on Tomatoes: Addition No. 2, May 3,
1978, to Brochure Entitled: Sencor (Bay 94337) Metabolic, Analytical and Residue Information on
Tomatoes (Dated Apr 25, 1972): Document No. AS78-2011. (Compilation; unpublished study
received Oct 3, 1978 under 3125-314; CDL: 235319-A)

BASF Wyandotte Chemical Corp. (1978) Basalin Herbicide Amended Registration: Basalin Tank
Mixture and Sequential Application with Metribuzin: Residue Chemistry-Part 03. (Compilation;
unpublished study received Nov 8, 1978 under 7969-46; CDL: 235698-B)
 00106797    American Cyanamid Co. (1978) Amounts of Residues of Prowl, Its Metabolite (CL 202,347)
                                                156

-------
                                       BIBLIOGRAPHY
         MRID
CITATION
            Metribuzin (Sencor or Lexone) and Eptam in or on Potatoes. (Compilation; unpublished study
            received Oct 5, 1978 under 241-243; CDL:097433-A; 097434)

00144087    Interregional Research Project No. 4 (1983) The Results of Tests on the Amount of Metribuzin
            Residues Remaining in or on Carrots. Unpublished compilation. 51 p.

00147003    Mobay Chemical Corp. (1985) Product Chemistry of Sencor Technical. Unpublished study.  104 p.

00153706    Thyssen, J. (1981) DIG 1468: (Sencor Active Ingredient): Subacute Inhalation Studies with Rats:
            Report No. 9679. Unpublished study prepared by Bayer AG, Institute of Toxicology. 126 p.

00156321    Talbott, T. (1980) The Composition of Sencor: Report No. 68761. Unpublished study prepared by
            Mobay Chemical Corp.  lip.

00156322    Johnson, M. (1985) Maximum and Minimum Certified Limits for Sencor 50% Wettable Powder
            (Repacking): GLC Determination of Sencor and Bay 98719 (N-Methyl Isomer): Report No. 90369:
            C-28.1.  Unpublished study.  13 p.

00156324    Mobay Chemical Corp. (1985) Product Chemistry of Sencor Technical: Brochure 1433: Supplement
            1 [to Brochure 1388.  Unpublished compilation.  81 p.

00157524    Shiotsuka, R. (1986) Acute Inhalation Toxicity Study with Metribuzin (Sencor) in Rats: Study No.
            85-041-18: Mobay Report No. 91754. Unpublished study prepared by Mobay Chemical Corp. 20 p.

00157527    Yang, L. (1986) CHO/HGPRT Mutation Assay in the Presence and Absense of Exogenous Metabolic
            Activation: Test Article: Sencor Technical (Metribuzin): Final Report: MA Study No. T4485.332.
            Unpublished Mobay Report No. 91760 prepared by Microbiological Associates, Inc. 17 p.

00157530    Morgan, J. (1986) The Hydrolysis of Sencor-5- fcarbon 14: Mobay Report No. 91764. Unpublished
            study prepared by Mobay Chemical Corp. lip.


00157531    Morgan, J. (1986) The Photodecomposition of Sencor-5- [Carbon 14 on Soil: Mobay Report No.
            91765. Unpublished study prepared by Mobay Chemical Corp. 26 p.

00161503    Nicholson, R.; Surprenant, D. (1986) Acute Toxicity of Sencor to Sheephead Minnow (Cyprinodon
            variegatus): Study No. 274-1285-6105-500: Report No. BW-86-2-1942. Unpublished study prepared
            by Springborn Bionomics, Inc. 20 p.

00161509    Talbott, T. (1983) Maximum and Minimum Certified Limits for Sencor: Report No.  86268.
            Unpublished study prepared by Mobay Corporation.  4 p.

00162025    Maitlen, J. (1985) Report of Residue Analysis: Metribuzin [Carrots: Rept. No. PCY  85-12.
                                                157

-------
                                        BIBLIOGRAPHY
         MRID
CITATION
            Unpublished study prepared by Yakima Agricultural Research Laboratory, U.S. Dept. of Agriculture.
            20 p.

00163802   Kowalski, R.; Clemens, G.; Bare, J.; et al. (1986) A Teratology Study with Sencor Technical
            (Metribuzin) in the Rat: 91330. Unpublished study prepared by Miles Laboratories, Inc. 212 p.

00165012   Betker, W. (1986) The Solubility, Melting Point and Density of Technical Sencor: Report No. 90935.
            Unpublished study prepared by Mobay Corp.  5 p.

40255503   Cain, K.; Hanlon, C.; Lane, J. (1987) The Excretion and Metabolism of Sencor by Rats: Lab Project
            ID: Mobay No. 94605.  Unpublished study prepared by Mobay Corp. 62 p.

40277901   Loeffler, W. (1987) Sencor-Magnitude of Residue on Cora: Laboratory Project ID: SE-3086-86:
            Sencor Objective No. 3086. Unpublished Mobay report 94739 prepared by Morse Laboratories, Inc.
            93 p.

40277902   Loeffler, W. (1987) Sencor-Magnitude of Residue on Seed Alfalfa: Laboratory Project ID:
            SE-3222-86: Sencor Objective No. 3222. Unpublished Mobay report 94745 prepared by Morse
            Laboratories, Inc. 57 p.

40277903   Loeffler, W. (1987) Sencor-Magnitude of Residue on Dry Peas: Laboratory Project ID: SE-1523-86:
            Sencor Objective No. 1523. Unpublished Mobay report 94735 prepared by Morse Laboratories, Inc.
            46 p.

40277904   Loeffler, W. (1987) Sencor-Magnitude of Residue on Soybeans: Laboratory Project ID:
            SE-3745-86: Sencor Objective No. 3745. Unpublished Mobay report 94737 prepared by Morse
            Laboratories, Inc. 77 p.

40277905   Loeffler, W. (1987) Sencor-Magnitude of Residue on Wheat: Laboratory Project ID:
            SE-3052-85/86: Sencor Objective No. 3052. Unpublished Mobay report 94742 prepared by Morse
            Laboratories, Inc. 84 p.

40367601   Delk, J. (1987) Sencor Magnitude of Residues on Wheat and Wheat Processing Products: Lab. Proj.
            ID. SE-3052-85/86. Unpublished Mobay Study 94743 prepared by Morse Laboratories, Inc. 25 p.

40367602   Detra, R.; Lane, J.; Thyssen, M. (1987) Degradation of Sencor in Aerobic Sandy Loam: Rept. No.
             94880. Unpublished study prepared by Mobay Corp. 44 p.

40367603   Detra, R.; Thyssen, M. (1987) Degradation of Sencor in Anaerobic Sandy Loam: Rept. No. 94881.
            Unpublished study prepared by Mobay Corp. 43 p.

40367604    Calovich, C. (1987) Summary of Residue Data on Wheat Potential for Secondary Residues in Animal
             Tissues and Products. Unpublished Mobay study 94744 prepared by Mobay Corp. and Morse

                                                 158

-------
                                        BIBLIOGRAPHY
         MRID
CITATION
            Laboratories, Inc. 13 p.

40367605    Delk, J. (1987) Sencor Magnitude of Residues on Corn and Cora Processing Products. Unpublished
            Mobay compilation 94740 prepared by Harris Laboratories, Inc. and Texas A & M Univ. System.
            123 p.

40371701    Calovich, C. (1987) Summary of Residue Data on Corn Potential for Secondary Residues in Animal
            Tissues and Products: Sencor: Laboratory Project ID: SE-3086-86. Unpublished study prepared by
            Morse Laboratories, Inc. 12 p.

40380901    Delk, J. (1987) Dissipation of Sencor and its Oxidative Metabolites in Field Soil: Laboratory Project
            ID: SR-8300-87. Unpublished Mobay report no. 95000 prepared by Morse Laboratories Inc. 198 p.

40577701    Naidu, M. (1988) Metribuzin Confined Accumulation Study on Peanuts: Laboratory Project ID
            AMR-563-86. Unpublished study prepared by Research and Development Division, E. I. du Pont de
            Nemours and Company, Inc. 47 p.

40802701    Anderson, L. (1988) SENCOR Magnitude of Residue on Asparagus: Project ID. SE-1855-85.
            Unpublished study prepared by Morse Laboratories.  100 p.

40838401    Porter, M.; Jasty, V.; Hartnagel, R. (1988) A Two-Generation Reproduction Study in Rats with
            Sencor Technical (Metribuzin): Report No. 98295: MTD0080.  Unpublished study prepared by
            Miles, Inc. 1025 p.

40838402    Christopher, R.; Lane, J.; Parker, G. (1988) Residues of Metribuzin (Sencor) in Rotational Crops and
            Soils: Report No. 98324: Project No. SE-052301. Unpublished study prepared by Mobay Corp. 45
            P-

41020601    Burge, C.; Parker, G. (1988) Stability of Metribuzin and Ethiozin Metabolite Residues in Biological
            Matrices During Frozen Storage: Report NO. 98504. Unpublished study prepared by Mobay
            Corporation. 62 p.

41021001    Ver Hey, M. (1988) Sencor, Sencor DA, Sencor DK and Sencor DADK: Multiresidue Method Trial:
            Final Report: Mobay 1093: SE161601. Unpublished study prepared by Colorado Analytical Research
            & Development Corp. 496 p.

41249201    Clemens, G.; Hartnagel, R. (1989) Teratology Study in the Rabbit with Sencor Technical
            (Metribuzin): Project ID 99654. Unpublished study prepared by Miles, Inc.  131 p.

41284401    Talbott, T. (1989) Product Chemistry of Sencor Technical: Lab Project Number:  86268 : 91780 :
            93048. Unpublished study prepared by Mobay Corp.  168 p.

41422001    Mulford, D.; Clay, V.; Lane, J.; et al. (1990) Small-scale Retrospective Ground Water Monitoring for
                                                 159

-------
         MRID
                                        BIBLIOGRAPHY
CITATION
             Metribuzin and Its Metabolites: Lab Project Number: 98510: SE-7000-87-R-1. Unpublished study
             prepared by Mobay Corp. 2381 p.

41555102    Murli, H. (1990) Mutagenicity Test on Sencor Technical in an In Vitro Cytogenetic Assay Measuring
             Chromosonal Aberration Frequen cies in Chinese Hamster Ovary (CHO) Cells: Lab Project Number:
             10857-0-437.  Unpublished study prepared by Hazleton Labs America, Inc. 55 p.

41696401    Talbott, T. (1989) Sencor: Product Chemistry: Lab Project Number: ANR-01189: ANR-01289: BR
             1662.  Unpublished study prepared by Mobay Corp. 29 p.

42094501    Gagliano, G. (1991) Raw Data Supplement for Acute Toxicity of Sencor Technical to Eastern
             Oysters (Crassostrea virginica): Lab Project Number: 274-1285-6105-504: 91755-1. Unpublished
             study prepared by Springborn Bionomics, Inc.  lip.

42094502    Gagliano, G. (1991) Raw Data Supplement for Acute Toxicity of Sencor Technical to Sheepshead
             Minnow (Cyprindon variegatus): Lab Project Number: 274-1285-6105-500: 91756-1. Unpublished
             study prepared by Springborn Bionomics, Inc.  13 p.

42236101    Grace, T.; Cain, K. (1990) Dissipation of Metribuzin in California Soils: Lab Project Number:
             SE830089R01; 100170; ML022101.  Unpublished study prepared by Plant Sciences, Inc.; Siemer
             and Assoc's., Inc. and NET Atlantic, Inc. 3154 p.

42283001    Daly, D. (1988) Soil Adsorption/Desorption with jiCarbon 14 |-Sencor: Lab Project Number: #36997.
             Unpublished study prepared by Analytical Bio-Chemistry Laboratories, Inc. 54 p.

42425601    Fontaine, L. (1992) Supplemental Product Chemistry of Sencor Technical: Lab Project Number:
             90935: BR 1802. Unpublished study prepared by Miles, Inc. lip.

42447801    Gagliano, G.; Roney, D. (1992) Early Life Stage Toxicity of Sencor Technical to the Rainbow Trout
             (Oncorhynchus mykiss) under Flow-through Conditions: Lab Project Number: 103249: SE842201.
             Unpublished study prepared by Miles, Inc. 87 p.

42447802    Gagliano, G.; Bowers, L. (1992) Chronic Toxicity of Sencor Technical to the Waterflea (Daphnia
             magna) under Flow-through Conditions: Lab Project Number: 103248: SE840701. Unpublished
             study prepared by Miles, Inc.  75 p.

42447803    Burge, C. (1992) Tier 2 Seed Germination, Seed Emergence, and Seedling Vigor Nontarget
             Phytotoxicity Study Using Metribuzin: Lab Project Number: 103800: SE201601. Unpublished study
             prepared by Miles, Inc.  90 p.

42598200    Miles Inc. (1992) Supplemental submission of residue and product chemistry data in support of the
             registration standard for Metribuzin (Sencor Metribuzin Herbicide). Transmittal of 3 studies.
                                                 160

-------
         MRID
                                        BIBLIOGRAPHY
CITATION
42598202    Christopher, R.; Muller, S. (1986) Distribution and Metabolism of Sencor in Laying Hens: Lab
            Project Number: SE-4-P: 94234. Unpublished study prepared by Mobay Corp.  62 p.

42598203    Fontaine, L. (1992) Product Chemistry of Sencor Technical: A Supplement: Lab Project Number:
            ANR-00892: BR 1815. Unpublished study prepared by Miles, Inc.  lip.

42672501    Christenson, W.; Wahle, B. (1993) Technical Grade Metribuzin (Sencor): A Combined Chronic
            Toxicity/Oncogenicity Feeding Toxicity Study in the Rat: Lab Project Number: 88-271-BM: 1039.70.
            Unpublished study prepared by Miles Inc. 4593 p.

42903601    Morgan, J. (1993) Addendum 2: Characterization of Metribuzin Metabolites in Wheat Grain
            Aqueous Phase Reply to EPA Review. Lab Project Number: SE041601. Unpublished study prepared
            by Miles Inc. Research & Development Dept. 7 p.

42967901    Lenz, M.; Marlow, V.; Fig, P.; et al. (1993) Characterization for Two Metabolites of (carbon
             14)-Metribuzin in Soybeans: Lab Project Number: 94593-1: SE041602. Unpublished study prepared
            by Miles Inc. 23 p.

43058501    Blumhorst, M.; Halarnkar, P. (1993) Soil Adsorption/Desorption of Metribuzin-DK: Lab Project
            Number: 122S17: SE182101: 106233. Unpublished study prepared by Bio-Analytical Services, Inc.
             58 p.

4313 3 601     Gagliano, G.; Orr, W. (1994) Acute Toxicity of SENCOR Technical to the Green Alga (Selenastrum
             capricornutum): Lab Project Number: SE881402. Unpublished study prepared by-Miles,  Inc.
             Sponsor report number: 106417. 33 p.

43168201     Fontaine,  L. (1994) Product Chemistry of SENCOR Technical: Lab Project Number: 106482:  BR
             1871. Unpublished study prepared by Miles, Inc. 16 p.

43208301     Johns, C.  (1994) Tier 2  Seed Germination and Seed Emergence Nontarget Phytotoxicity Study Using
             Metribuzin: Lab Project Number: SE201602: 106568. Unpublished study prepared by Miles Inc. 44
             P-

43218201     Murphy, J.; Jacobs, K. (1974) Stability of SENCOR and Its Metabolites Under Frozen Storage: Lab
             Project Number: 40707R. Unpublished study prepared by Miles Inc. lip.

43218202    Gronberg, R. (1994) A Gas Chromatographic Method for the Determination of SENCOR and
             Metabolites in Various Crops: Reformat: Lab Project Number: 40901R. Unpublished study prepared
             by Miles Inc.  21 p.


43218203    Gronberg, R. (1994) A Gas Chromatographic Method for the Determination of SENCOR and
             Metabolites in Various Crops: Response to an EPA Inquiry Regarding Analysis of Aged Radioactive
                                                 161

-------
         MRID
                                       BIBLIOGRAPHY
CITATION
            Tissues with the Enforcement Method: Lab Project Number: 40901R-1.  Unpublished study prepared
            by Miles Inc. 10 p.

43218204   Gronberg, R. (1994) A Gas Chromatographic Method for the Determination of SENCOR and
            Metabolites in Various Crops: Method Update: Lab Project Number: 40901R-2.  Unpublished study
            prepared by Morse Laboratories, Inc. and Chemonics Industries. 10 p.

43218205   Gronberg, R. (1994) A Gas Chromatographic Method for the Determining Residues of SENCOR and
            Metabolites in Animal Tissues, Milk and Eggs: Reformat: Lab Project Number: 42257R.
            Unpublished study prepared by Miles Inc. 39 p.

43218206   Gronberg, R. (1994) A Gas Chromatographic Method for the Determining Residues of SENCOR and
            Metabolites in Animal Tissues, Milk and Eggs: Response to an EPA Inquiry Regarding Analysis of
            Aged Radioactive Tissues with the Enforcement Method: Lab Project Number: 42257R-1.
            Unpublished study prepared by Miles Inc. 12 p..

43218207   Minor, R. (1994) Review of the Storage Stability Data on Metribuzin and Its Metabolites in Crops
            and Processed Products: Lab Project Number: 102615: SE161601: SE131602. Unpublished study
            prepared by Ricerca, Inc. 1587 p.

43253601   Minor, R. (1994) Replies to Comments and Questions from EPA's Review of Data Submitted in
            Response to  the Data Call-in (DCI) for Metribuzin: (Data submitted as alternate to Craven
            Laboratories generated data): Lab Project Number: 106566. Unpublished study prepared by Miles
            Inc.  103 p.

43826101   Bowers, L. (1995) Acute Toxicity of (carbon 14)-Sencor to the Freshwater Diatom (Navicula
            pelliculosa): Lab Project Number: 106975: SE881601. Unpublished study prepared by Bayer Corp.
            33 p.

43860501   Hancock, G. (1995) Effect of Technical SENCOR on Mallard Reproduction: Lab Project Number:
            SE740801: 106983. Unpublished study prepared by Bayer Corp. 107 p.

43867701   Bowers, L. (1995) Toxicity of (carbon 14)-Sencor to the Marine Diatom, Skeletonema costatum: Lab
            Project Number:  SE881602: 106992. Unpublished study prepared by Bayer Corp. 34 p.

43893501   Boeri, R.; Magazu, J.; Ward, T. (1995) Toxicity of Sencor to the Duckweed, Lemna gibba G3:
            (Amended Report): Lab Project Number: 667-MI: 106982. Unpublished study prepared by T. R.
            Wilbury Labs, Inc.  32 p.

43926601   Hancock, G. (1996) Effect of Technical SENCOR on Northern Bobwhite Reproduction: Lab Project
            Number: SE741701: 106984. Unpublished study prepared by Bayer Corp. 110 p.

43970701   Flucke, W.; Hartmann, E. (1989) DIG 1468 Technical Grade: (Common Name: Metribuzin):
                                                162

-------
         MRID
                                       BIBLIOGRAPHY
CITATION
            Subacute Dermal Toxicity Study In Rabbits: Lab Project Number: 99683: 18195: T 3029453.
            Unpublished study prepared by Bayer Ag. 220 p.

44009900    Bayer Corp. (1996) Submission of Pesticide Use and Exposure/Risk to Non-Target Organisms Data
            in Support of RED for Metribuzin. Transmittal of 1 Study.

44009901    Ellisor, G.; Van Goethem, D.; Dannenberg, I. et al. (1996) Metribuzin Use Patterns, Exposure
            Assessment, Toxicological Endpoints, and Margins of Safety Estimates: Lab Project Number:
            107305.  Unpublished study prepared by Bayer Corp. 44 p.
                                                163

-------

-------
                 UNITED STATES ENVIRONMENTAL PROTECTION AGENCY
                                     WASHINGTON, D.C. 20460
                                        FEB  1  3 1998
                                                                         OFFICE OF
                                                                   PREVENTION, PESTICIDES
                                                                   AND TOXIC SUBSTANCES
                        GENERIC AND PRODUCT SPECIFIC
                              DATA CALL-IN NOTICE
CERTIFIED MAIL
Dear Sir or Madam:

      This Notice requires you and other registrants of pesticide products containing the active
ingredient identified in Attachment A of this Notice, the Data Call-in Chemical Status Sheet, to
submit certain data as noted herein to the U.S. Environmental Protection Agency (EPA, the
Agency). These data are necessary to maintain the continued registration of your produces)
containing this active ingredient. Within 90 days after you receive this Notice you must respond
as set forth in Section HI below. Your response must state:

       1.     How you will comply with the requirements set forth in this Notice and its
             Attachments 1 through 7; or

      2.     Why you believe you are exempt from the requirements listed in this Notice and
             hi Attachment 3 (for both generic and product specific data), the Requirements
             Status and Registrant's Response Form, (see section ffi-B); or

      3.     Why you believe EPA should not require your submission of data in the manner
             specified by this Notice (see section m-D).

      If you do not respond to this Notice, or if you do not satisfy EPA that you will comply
with its requirements or should be exempt or excused from doing so, then the registration of
your product(s) subject to this Notice will be subject to suspension. We have provided a list of
all of your products subject to this Notice in Attachment 2. All products are listed on both the
generic and product specific Data Call-In Response Forms.  Also included is a list of all
registrants who were sent this Notice (Attachment 5).

       The authority for this Notice is section 3(c)(2)(B) of the Federal Insecticide, Fungicide
and Rodenticide Act as amended (FIFRA), 7 U.S.C. section 136a(c)(2)(B). Collection of this
                                         165

-------
information is authorized under the Paperwork Reduction Act by OMB Approval No. 2070-0107
and 2070-0057 (expiration date 3-31-99).

       This Notice is divided into six sections and seven Attachments. The Notice itself contains
information and instructions applicable to all Data Call-In Notices. The Attachments contain
specific chemical information and instructions. The six sections of the Notice are:
Section I
Section II
Section IE
Section IV
Section V
Section VI
Why You are Receiving this Notice
Data Required by this Notice
Compliance with Requirements of this Notice
Consequences of Failure to Comply with this Notice
Registrants' Obligation to Report Possible Unreasonable Adverse Effects
Inquiries and Responses to this Notice
       The Attachments to this Notice are:

       1 -    Data Call-In Chemical Status Sheet
       2 -    Generic Data Call-in and Product Specific Data Call-In Response Forms with
             Instructions (Form A)
       3-    Generic Data Call-In and Product Specific Data Call-In Requirements Status and
             Registrant's Response Forms with Instructions (Form B)
       4-    EPA Batching of End-Use Products for Meeting Acute Toxicology Data
             Requirements for Reregistration
       5-    List of Registrants Receiving This Notice
       6-    Cost Share and Data Compensation Forms
SECTION I. WHY YOU ARE RECEIVING THIS NOTICE

       The Agency has reviewed existing data for this active ingredient(s) and reevaluated the
data needed to support continued registration of the subject active ingredient(s). This
reevaluation identified additional data necessary to assess the health and safety of the continued
use of products containing this active ingredient(s). You have been sent this Notice because you
have product(s) containing the subject active ingredients.
SECTION n. DATA REQUIRED BY THIS NOTICE

n-A. DATA REQUIRED

       The data required by this Notice are specified in the Requirements Status and Registrant's
Response Forms: Attachment 3 (for both generic and product specific data requirements).
Depending on the results of the studies required in this Notice, additional studies/testing may be
required.

E-B. SCHEDULE FOR SUBMISSION OF DATA

                                          166

-------
      You are required to submit the data or otherwise satisfy the data requirements specified
in the Requirements Status and Registrant's Response Forms (Attachment 3) within the
timeframes provided.

II-C. TESTING PROTOCOL

      All studies required under this Notice must be conducted in accordance with test
standards outlined in the Pesticide Assessment Guidelines for those studies for which guidelines
have been established.

      These EPA Guidelines are available from the National Technical Information Service
(NTIS), Attn: Order Desk, 5285 Port Royal Road, Springfield, Va 22161 (Telephone number:
703-487-4650).

      Protocols approved by the Organization for Economic  Cooperation and Development
(OECD) are also acceptable if the OECD recommended test standards conform to those
specified in the Pesticide Data Requirements regulation (40 CFR ง 158.70). When using the
OECD protocols, they should be modified as appropriate so that the data generated by the study
will satisfy the requirements of 40 CFR ง 158. Normally, the Agency will not extend deadlines
for complying with data requirements when  the studies were not conducted in accordance with
acceptable standards. The OECD protocols are available from OECD, 2001 L Street, N.W.,
Washington, D.C. 20036 (Telephone number 202-785-6323; Fax telephone number 202-785-
0350).

       All new studies and proposed protocols submitted in response to this Data Call-in Notice
must be hi accordance with Good Laboratory Practices [40 CFR Part 160].

E-D.  REGISTRANTS RECEIVING PREVIOUS SECTION 3rcฅ2)fB1 NOTICES ISSUED
       BY THE AGENCY

       Unless otherwise noted herein, this Data Call-in does not in any way supersede or change
the requirements of any previous Data Call-In(s). or any other agreements entered into with the
Agency pertaining to such prior Notice. Registrants must comply with the requirements of all
Notices to avoid issuance of a Notice of Intent to Suspend their affected products.


SECTION m.       COMPLIANCE WITH REQUIREMENTS OF THIS NOTICE

       You must use the correct forms and instructions when completing your response to this
Notice. The type of Data Call-In you must comply with (Generic or Product Specific) is
specified in item number 3 on the four Data Call-In forms (Attachments 2 and 3).

m-A.  SCHEDULE FOR RESPONDING TO THE AGENCY

       The appropriate responses initially required by this Notice for generic and product
specific data must be submitted to the Agency within 90 days after your receipt of this Notice.

                                         167

-------
Failure to adequately respond to this Notice within 90 days of your receipt will be a basis for
issuing a Notice of Intent to Suspend (NOIS) affecting your products. This and other bases for
issuance of NOIS due to failure to comply with this Notice are presented in Section IV-A and
IV-B.

m-B. OPTIONS FOR RESPONDING TO THE AGENCY

       1. Generic Data Requirements

      The options for responding to this Notice for generic data requirements are: (a) voluntary
cancellation, (b) delete use(s), (c) claim generic data exemption, (d) agree to satisfy the generic
data requirements imposed by this Notice or (e) request a data waiver(s).

      A discussion of how to respond if you choose the Voluntary Cancellation option, the
Delete Use(s) option or the Generic Data Exemption option is presented below.  A discussion of
the various options available for satisfying the generic data requirements of this Notice is
contained in Section ffl-C. A discussion of options relating to requests for data waivers is
contained in Section m-D.

      Two forms apply to generic data requirements, one or both of which must be used in
responding to the Agency, depending upon your response.  These two forms are the Data-Call-in
Response Form, and the Requirements Status and Registrant's Response Form, (contained in
Attachments 2 and 3, respectively).

      The Data Call-In Response Forms must be submitted as part of every response to this
Notice. The Requirements Status and Registrant's Response Forms also must be submitted if you
do not qualify for a Generic Data Exemption or are not requesting voluntary cancellation of your
registration(s).  Please note that the company's authorized representative is required to sign the
first page of both Data Call-in Response Forms and the Requirements Status and Registrant's
Response Forms (if this form is required) and initial any subsequent pages. The forms contain
separate detailed instructions on the response options. Do not alter the printed material. If you
have questions or need assistance in preparing your response, call or write the contact person(s)
identified in Attachment 1.

       a.      Voluntary Cancellation -

       You may avoid the requirements of this Notice by requesting voluntary cancellation of
your product(s) containing the active ingredient that is the subject of this Notice. If you wish to
voluntarily cancel your product, you must submit completed Generic and Product Specific Data
Call-in Response Forms (Attachment 2), indicating your election of this option. Voluntary
cancellation is item number 5 on both Data Call-in Response Form(s). If you choose this option,
these are the only forms that you are required to complete.

       If you chose to voluntarily cancel your product, further sale and distribution of your
product after the effective date of cancellation must be in accordance with the Existing Stocks
provisions of this Notice, which are contained in Section IV-C.

                                          168

-------
      b.     Use Deletion -

      You may avoid the requirements of this Notice by eliminating the uses of your product to
which the requirements apply. If you wish to amend your registration to delete uses, you must
submit the Requirements Status and Registrant's Response Form (Attachment 3), a completed
application for amendment, a copy of your proposed amended labeling, and all other information
required for processing the application. Use deletion is option number 7 under item 9 in the
instructions for the Requirements Status and Registrant's Response Forms. You must also
complete a Data Call-In Response Form by signing the certification, item number 8.
Application forms for amending registrations may be obtained from the Registration Support
Branch, Registration Division, Office of Pesticide Programs, EPA, by calling (703) 308-8358.

       If you choose to delete the use(s) subject to this Notice or uses subject to specific data
requirements, further sale, distribution, or use of your product after one year from the due date
of your 90 day response, is allowed only if the product bears an amended label.

       c.      Generic Data Exemption -

       Under section 3(c)(2)(D) of FIFRA, an applicant for registration of a product is exempt
from the requirement to submit or cite generic data concerning an active ingredient if the active
ingredient hi the product is derived exclusively from purchased, registered pesticide products
containing the active ingredient. EPA has concluded, as an exercise of its discretion, that it
normally will not suspend the registration of a product which would qualify and continue to
qualify for the generic data exemption in section 3(c)(2)(D) of FIFRA. To qualify, all of the
following requirements must be met:

       (i). The active ingredient in your registered product must be present solely because of
       incorporation of another registered product which contains the subject active ingredient
       and is purchased from a source not connected with you;


       (ii).  Every registrant who is the ultimate source of the active ingredient in your product
       subject to this DCI must be in compliance with the requirements of this Notice and must
       remain in compliance; and

       (iii). You must have provided to EPA an accurate and current "Confidential Statement of
       Formula" for each of your products to which this Notice applies.

       To apply for the Generic Data Exemption you must submit a completed Data Call-in
Response Form, Attachment 2 and all supporting documentation. The Generic Data Exemption
is item number 6a on the Data Call-In Response Form. If you claim a generic data exemption
you are not required to complete the Requirements Status and Registrant's Response Form.
Generic Data Exemption cannot be selected as an option for responding to product specific data
requirements.

       If you are granted a Generic Data Exemption, you rely on the efforts of other persons to

                                          169

-------
provide the Agency with the requked data. If the registrant(s) who have committed to generate
and submit the required data fail to take appropriate steps to meet requirements or are no longer
in compliance with this Data Call-in Notice, the Agency will consider that both they and you are
not compliance and will normally initiate proceedings to suspend the registrations of both your
and their product(s), unless you commit to submit and do submit the requked data within the
specified time. In such cases the Agency generally will not grant a time extension for submitting
the data.
       d.
Satisfvine the Generic Data Requirements of this Notice
       There are various options available to satisfy the generic data requkements of this
Notice. These options are discussed in Section IEE-C.1. of this Notice and comprise options 1
through 6 of item 9 in the instructions for the Requkements Status and Registrant's Response
Form and item 6b on the Data Call-In Response Form. If you choose item 6b (agree to satisfy
the generic data requkements), you must submit the Data Call-In Response Form and the
Requirements Status and Registrant's Response Form as well as any other information/data
pertaining to the option chosen to address the data requkement. Your response must be on the
forms marked "GENERIC" hi item number 3.
       e.
             Request for Generic Data Waivers.
       Waivers for generic data are discussed in Section m-D.l. of this Notice and are covered
by options 8 and 9 of item 9 in the instructions for the Requirements Status and Registrant's
Response Form. If you choose one of these options, you must submit both forms as well as any
other information/data pertaining to the option chosen to address the data requirement.

       2. Product Specific Data Requkements

       The options for responding to this Notice for product specific data are: (a) voluntary
cancellation, (b) agree to satisfy the product specific data requirements imposed by this Notice
or (c) request a data waiver(s).

       A discussion of how to respond if you choose the Voluntary Cancellation option is
presented below. A discussion of the various options available for satisfying the product specific
data requkements of this Notice is contained in Section IH-C.2. A discussion of options relating
to requests for data waivers is contained hi Section IE-D.2.

       Two forms apply to the product specific data requkements one or both of which must be
used in responding to the Agency, depending upon your response. These forms are the
Data-Call-in Response Form, and the Requirements Status and Registrant's Response Form, for
product specific data (contained in Attachments 2 and 3, respectively). The Data Call-In
Response Form must be submitted as part of every response to this Notice. In addition, one
copy of the Requirements Status and Registrant's Response Form also must be submitted for
each product listed on the Data Call-in Response Form unless the voluntary cancellation option
is selected. Please note that the company's authorized representative is requked to sign the first
page of the Data Call-In Response Form and Requirements Status and Registrant's Response

                                          170

-------
Form (if this form is required) and initial any subsequent pages. The forms contain separate
detailed instructions on the response options. Do not alter the printed material. If you have
questions or need assistance in preparing your response, call or write the contact person(s)
identified in Attachment 1.

       a.     Voluntary Cancellation

       You may avoid the requirements of this Notice by requesting voluntary cancellation of
your product(s) containing the active ingredient that is the subject of this Notice. If you wish to
voluntarily cancel your product, you must submit a completed Data Call-In Response Form.
indicating your election of this option. Voluntary cancellation is item number 5 on both the
Generic and Product Specific Data Call-in Response Forms. If you choose this
option, you must complete both Data Call-In response forms.  These are the only forms that you
are required to complete.

       If you choose to voluntarily cancel your product, further sale and distribution of your
product after the effective date of cancellation must be in accordance with the Existing Stocks
provisions of this Notice which are contained in Section IV-C.

       b.      Satisfying the Product Specific Data Requirements of this Notice.

       There are various options available to satisfy the product specific data requirements of
this Notice. These options are discussed in Section DI-C.2. of this Notice and comprise options 1
through 6 of item 9 in the instructions for the product specific Requirements Status and
Registrant's Response Form and item numbers 7a and 7b (agree to satisfy the product specific
data requirements for an MUP or EUP as applicable) on the product specific Data Call-in
Response Form. Note that the options available for addressing product specific data
requirements differ slightly from those options for fulfilling generic data requirements. Deletion
of a use(s) and the low volume/minor use option are not valid options for fulfilling product
specific data requirements. It is important to ensure that you are using the correct forms and
instructions when completing your response to the Reregistration Eligibility Decision document.

       c.      Request for Product Specific Data Waivers.

       Waivers for product specific data are discussed in Section m-D.2. of this Notice and are
covered by option 7 of item 9 in the instructions for the Requirements Status and Registrant's
Response Form. If you choose this option, you must submit the Data Call-In Response Form
and the Requirements Status and Registrant's Response Form  as well as any other
information/data pertaining to the option chosen to address the data requkement.  Your response
must be on the forms marked "PRODUCT SPECIFIC" in item number 3.

in-C SATISFYING THE DATA REQUIREMENTS OF THIS NOTICE

        1.     Generic Data

        If you acknowledge on the Generic Data Call-In Response Form that you agree to satisfy

                                           171

-------
the generic data requkements (i.e. you select item number 6b), then you must select one of the
six options on the Generic Requirements Status and Registrant's Response Form related to data
production for each data requirement. Your option selection should be entered under item
number 9, "Registrant Response." The six options related to data production are the first six
options discussed under item 9 in the instructions for completing the Requkements Status and
Registrant's Response Form. These six options are listed
immediately below with information in parentheses to guide you to additional instructions
provided in this Section. The options are:

       (1)    I will generate and submit data within the specified timeframe (Developing Data)
       (2)    I have entered into an agreement with one or more registrants to develop data
             jointly (Cost Sharing)
       (3)    I have made offers to cost-share (Offers to Cost Share)
       (4)    I am submitting an existing study that has not been submitted previously to the
             Agency by anyone (Submitting an Existing Study)
       (5)    I am submitting or citing data to upgrade a study classified by EPA as partially
             acceptable and upgradeable (Upgrading a Study)
       (6)    I am citing an existing study that EPA has classified as acceptable or an existing
             study that has been submitted but not reviewed by the Agency (Citing an Existing
             Study)

Option 1. Developing Data

       If you choose to develop the requked data it must be in conformance with Agency
deadlines and with other Agency requirements as referenced herein and in the attachments. All
data generated and submitted must comply with the Good Laboratory Practice (GLP) rule (40
CFR Part 160), be conducted according to the Pesticide Assessment Guidelines (PAG) and be in
conformance with the requkements of PR Notice 86-5. In addition, certain studies require
Agency approval of test protocols in advance of study initiation. Those studies for which a
protocol must be submitted have been identified hi the Requirements Status and Registrant's
Response Form and/or footnotes to the form. If you wish to use a protocol which differs from
the options discussed in Section n-C of this Notice, you must submit a detailed description of
the proposed protocol and your reason for wishing to use it. The Agency may choose to reject a
protocol not specified in Section n-C. If the Agency rejects your protocol you will be notified in
writing, however, you should be aware that rejection of a proposed protocol will not be a basis
for extending the deadline for submission of data.

       A progress report must be submitted for each study within 90 days from the date you are
requked to commit to generate or undertake some other means  to address that study requkement,
such as making an offer to cost share or agreeing to share in the cost  of developing that study.
This 90-day progress report must include the date the study was or will be initiated  and, for
studies to be started within 12 months of commitment, the name and  address of the
laboratories) or individuals who are or will be conducting the study.

       In addition, if the time frame for submission of a final report is more than 1  year, interim
reports must be submitted at 12 month intervals from the date you are required to commit to

                                          172

-------
generate or otherwise address the requirement for the study. In addition to the other information
specified in the preceding paragraph, at a minimum, a brief description of current activity on and
the status of the study must be included as well as a full description of any problems encountered
since the last progress report.


       The time frames in the Requirements Status and Registrant's Response Form are the time
frames that the Agency is allowing for the submission of completed study reports or protocols.
The noted deadlines run from the date of the receipt of this Notice by the registrant. If the data
are not submitted by the deadline, each registrant is subject to receipt of a Notice of Intent to
Suspend the affected registration(s).

       If you cannot submit the data/reports to the Agency in the time required by this Notice
and intend to seek additional time to meet the requirements(s), you must submit a request to the
Agency which includes: (1) a detailed description of the expected difficulty and (2) a proposed
schedule including alternative dates for meeting such requirements on a step-by-step basis. You
must explain any technical or laboratory difficulties and provide documentation from the
laboratory performing the testing. While EPA is considering your request, the original deadline
remains. The Agency will respond to your request in writing. If EPA does not grant your
request, the original deadline remains. Normally, extensions can be requested only in cases of
extraordinary testing problems beyond the expectation or control of the registrant. Extensions
will not be given in submitting the 90-day responses. Extensions will not be considered if the
request for extension is not made in a timely fashion; in no event shall an extension request be
considered if it is submitted at or after the lapse of the subject deadline.

Option 2. Agreement to Share in Cost to Develop Data

       If you choose to enter into an agreement to share in the cost of producing the required
data but will not be submitting the data yourself, you must provide the name of the registrant
who will be submitting the data. You must also provide EPA with documentary evidence that an
agreement has been formed. -Such evidence may be your letter offering to join in an agreement
and the other registrant's acceptance of your offer, or a written statement by the parties that an
agreement exists. The agreement to produce the data need not specify all of the terms of the final
arrangement between the parties or the mechanism to resolve the terms. Section  3(c)(2)(B)
provides that if the parties cannot resolve the terms of the agreement they may resolve their
differences through binding arbitration.

Option 3. Offer to Share in the Cost of Data Development

       If you have made an offer to pay in an attempt to enter into an agreement or amend an
existing agreement to meet the requirements of this Notice and have been unsuccessful, you may
request EPA (by selecting this option) to exercise its discretion not to suspend your
registration(s), although you do not comply with the data submission requirements of this
Notice. EPA has determined that as a general policy, absent other relevant considerations, it will
not suspend the registration of a product of a registrant who has in good faith sought and
continues to seek to enter into a joint data development/cost sharing program, but the other

                                           173

-------
registrants) developing the data has refused to accept the offer. To qualify for this option, you
must submit documentation to the Agency proving that you have made an offer to another
registrant (who has an obligation to submit data) to share in the burden of developing that data.
You must also submit to the Agency a completed EPA Form 8570-32, Certification of Offer to
Cost Share in the Development of Data, Attachment 7. In addition, you must demonstrate that
the other registrant to whom the offer was made has not accepted your offer to enter into a cost-
sharing agreement by including a copy of your offer and proof of the other registrant's receipt of
that offer (such as a certified mail receipt). Your offer must, in addition to anything else, offer to
share in the burden of producing the data upon terms to be agreed to or, failing agreement, to be
bound by binding arbitration as provided by FIFRA section 3(c)(2)(B)(iii) and must not qualify
this offer. The other registrant must also inform EPA of its election of an option to develop and
submit the data required by this Notice by submitting a Data Call-in Response Form and a
Requirements Status and Registrant's Response Form committing to develop and submit the data
required by this Notice.

       In order for you to avoid suspension under this option, you may not withdraw your offer
to share in the burden of developing the data. In addition, the other registrant must fulfill its
commitment to develop and submit the data as required by this Notice. If the other registrant
fails to develop the data or for some other reason is subject to suspension, your registration as
well as that of the other registrant normally will be subject to initiation of suspension
proceedings, unless you commit to submit, and do submit, the required data in the specified time
frame. In such cases, the Agency generally will not grant a time extension for submitting the
data.

Option A Submitting an Existing Study

       If you choose to submit an existing study in response to this Notice, you must determine
that the study satisfies the requirements imposed by this Notice. You may only submit a study
that has not been previously submitted to the Agency or previously cited by anyone. Existing
studies are  studies which predate issuance of this Notice. Do not use this option if you are
submitting  data to upgrade a study. (See Option 5).

       You should be aware that if the Agency determines that the study is not acceptable,  the
Agency will require you to comply with this Notice, normally without an extension of the
required date of submission. The Agency may determine at any time that a study is not valid and
needs to be repeated.

       To meet the requirements of the DCI Notice for submitting an existing study, all of the
following three criteria must be clearly Met:

       a.     You must certify at the time that the existing study is submitted that the raw data
              and specimens from the study are available for audit and review and you must
              identify where they are available. This must be done in accordance with the
              requirements of the Good Laboratory Practice (GLP) regulation, 40 CFR Part
              160. As stated in 40 CFR 160.3 'Raw data' means any laboratory worksheets,
              records, memoranda, notes, or exact copies thereof, that are the result of original

                                           174

-------
             observations and activities of a study and are necessary for the reconstruction and
             evaluation of the report of that study. In the event that exact transcripts of raw
             data have been prepared (e.g., tapes which have been transcribed verbatim, dated,
             and verified accurate by signature), the exact copy or exact transcript may be
             substituted for the original source as raw data. 'Raw data1 may include
             photographs, microfilm or microfiche copies, computer printouts, magnetic
             media, including dictated observations, and recorded data from automated
             instruments." The term "specimens", according to 40 CFR 160.3, means "any
             material derived from a test system for examination or analysis."

      b.     Health and safety studies completed after May 1984 also must also contain all
             GLP-required quality assurance and quality control information, pursuant to the
             requirements of 40 CFR Part 160. Registrants also must certify at the time of
             submitting the existing study that such GLP information is available for post May
             1984 studies by including an appropriate statement on or attached to the study
             signed by an authorized official or representative of the registrant.

      c.     You must certify that each study fulfills the acceptance criteria for the Guideline
             relevant to the study provided in the FEFRA Accelerated Reregistration Phase 3
             Technical Guidance and that the study has been conducted according to the
             Pesticide Assessment Guidelines (PAG) or meets the purpose of the PAG (both
             available from NTIS). A study not conducted according to the PAG may be
             submitted to the Agency for consideration if the registrant believes that the study
             clearly meets the purpose of the PAG. The registrant is referred to 40 CFR 158.70
             which states the Agency's policy regarding acceptable protocols. If you wish to
             submit the study, you must, in addition to certifying that the purposes of the PAG
             are met by the study, clearly articulate the rationale why you believe the study
             meets the purpose of the PAG, including copies of any supporting information or
             data. It has been the Agency's experience that studies completed prior to January
             1970 rarely satisfied the purpose of the PAG and that necessary raw data usually
             are not available for such studies.

      If you submit an existing study, you must certify that the study meets all requirements of
the criteria outlined above.

      If EPA has previously reviewed a protocol for a study you are submitting, you must
identify any action taken by the Agency on the protocol and must indicate, as part of your
certification, the manner in which all Agency comments, concerns, or issues were addressed in
the final protocol and study.

      If you know of a study pertaining to any requirement in this Notice which does not meet
the criteria outlined above but does contain factual information regarding unreasonable adverse
effects,  you must notify the Agency of such a study. If such study is in the Agency's files, you
need only cite it along with the notification. If not in the Agency's files, you must submit a
summary and copies as required by PR Notice 86-5.
                                           175

-------
Option 5. Upgrading a Study

       If a study has been classified as partially acceptable and upgradeable, you may submit
data to upgrade that study. The Agency will review the data submitted and determine if the
requirement is satisfied. If the Agency decides the requirement is not satisfied, you may still be
required to submit new data normally without any time extension. Deficient, but upgradeable
studies will normally be classified as supplemental. However, it is important to note that not all
studies classified as supplemental are upgradeable. If you have questions regarding the
classification of a study or whether a study may be upgraded, call or write the contact person
listed in Attachment 1. If you submit data to upgrade an existing study you must satisfy or
supply information to correct all deficiencies in the study identified by EPA. You must provide a
clearly articulated rationale of how the deficiencies have been remedied or corrected and why
the study should be rated as acceptable to EPA. Your submission must also specify the MRID
number(s) of the study which you are attempting to upgrade and must be in conformance with
PR Notice 86-5.
                                                                                     •
       Do not submit additional data for the purpose of upgrading a study classified as
unacceptable and determined by the Agency as not capable of being upgraded.

       This option also should be used to cite data that has been previously submitted to upgrade
a study, but has not yet been reviewed by the Agency. You must provide the MRID number of
the data submission as well as the MRID number of the study being upgraded.

       The criteria for submitting an existing study, as specified in Option 4 above, apply to all
data submissions intended to upgrade studies. Additionally, your submission of data intended to
upgrade studies must be accompanied by a certification that you comply with each of those
criteria, as well as a certification regarding protocol compliance with Agency
requirements.

Option 6. Citing Existing Studies

       If you choose to cite a study that has been previously submitted to EPA, that study must
have been previously classified by EPA as acceptable, or it must be a study which has not yet
been reviewed by the Agency. Acceptable toxicology studies generally will have been classified
as "core-guideline" or "core-minimum." For ecological effects studies, the classification
generally would be a rating of "core." For all other disciplines the classification would be
"acceptable." With respect to any studies for which you wish to select this option, you must
provide the MRID  number of the study you are citing and, if the study has been reviewed by the
Agency, you must  provide the Agency's classification of the study.

       If you are citing a study of which you are not the original data submitter, you must
submit a completed copy of EPA Form 8570-31, Certification with Respect to Data
Compensation Requirements.

       2. Product Specific Data
                                          176

-------
       If you acknowledge on the product specific Data Call-In Response Form that you agree
to satisfy the product specific data requirements (i.e. you select option 7a or 7b), then you must
select one of the six options on the Requirements Status and Registrant's Response Form related
to data production for each data requirement. Your option selection should be entered under item
number 9, "Registrant Response." The six options related to data production are the first six
options discussed under item 9 in the instructions for completing the Requirements Status and
Registrant's Response Form. These six options are listed immediately below with information in
parentheses to guide registrants to additional instructions provided in this Section. The options
are:

       (1)    I will generate and submit data within the specified time-frame (Developing
              Data)
       (2)    I have entered into an agreement with one or more registrants to develop data
              jointly (Cost Sharing)
       (3)    I have made offers to cost-share (Offers to Cost Share)
       (4)    I am submitting an existing study that has not been submitted previously to the
              Agency by anyone (Submitting an Existing Study)
       (5)    I am submitting or citing data to upgrade a study classified by EPA as partially
              acceptable and upgradeable (Upgrading a Study)
       (6)    I am citing an existing study that EPA has classified as acceptable or an existing
              study that has been
              submitted but not reviewed by  the Agency (Citing an Existing Study)

Option 1. Developing Data — The requirements for developing product specific data are the
same as those described for generic data (see Section ffl.C.l, Option 1) except that normally no
protocols or progress reports are required.

Option 2. Agree to Share in Cost to Develop Data — If you enter into an agreement to cost share,
the same requirements apply to product specific data as to generic data (see Section DI.C.1,
Option 2). However, registrants may only choose this option for acute toxicity data and certain
efficacy data and only if EPA has indicated in the attached data tables that your product and at
least one other product are similar for purposes of depending on the same data. If this is the case,
data may be generated for just one of the products in the group. The registration number of the
product for which data will be submitted must be noted in the agreement to cost share by the
registrant selecting this option.

Option 3. Offer to  Share in the Cost of Data Development -The same requirements for generic
data (Section m.C.I., Option 3) apply to this option. This option only applies to acute toxicity
and certain efficacy data as described in option 2 above.

Option 4. Submitting an Existing Study — The same requirements described for generic data (see
Section m.C.l., Option 4) apply to this option for product specific data.

Option 5. Upgrading a Study — The same requirements described for generic data (see Section
m.C.l., Option 5) apply to this option for product specific data.
                                           177

-------
Option 6. Citing Existing Studies — The same requirements described for generic data (see
Section DI.C.l., Option 6) apply to this option for product specific data.

       Registrants who select one of the above 6 options must meet all of the requirements
described in the instructions for completing the Data Call-In Response Form and the
Requirements Status and Registrant's Response Form, and in the generic data requirements
section (in.C.1.), as appropriate.
m-D REQUESTS FOR DATA WAIVERS

       1.     Generic Data

       There are two types of data waiver responses to this Notice. The first is a request for a
low volume/minor use waiver and the second is a waiver request based on your belief that the
data requirement(s) are not appropriate for your product.

       a.     Low Volume/Minor Use Waiver

             Option 8 under item 9 on the Requirements Status and Registrant's Response
       Form. Section 3(c)(2)(A) of FIFRA requires EPA to consider the appropriateness of
       requiring data for low volume,  minor use pesticides. In implementing this provision,
       EPA considers low volume pesticides to be only those active ingredients whose total
       production volume for all pesticide registrants is small. In determining whether to grant a
       low volume, minor use waiver, the Agency will consider the extent, pattern and volume
       of use, the economic incentive to conduct the testing, the importance of the pesticide, and
       the exposure and risk from use of the pesticide. If an active ingredient is used for both
       high volume and low volume uses, a low volume exemption will not be approved. If all
       uses of an active ingredient are low volume and the combined volumes for all uses are
       also low, then an exemption may be granted, depending on review of other information
       outlined below. An exemption will not be granted if any registrant of the active
       ingredient elects to conduct the testing. Any registrant receiving a low volume minor use
       waiver must remain within the  sales figures in their forecast supporting the waiver
       request in order to remain qualified for such waiver. If granted a waiver, a registrant will
       be required, as a condition of the waiver, to submit annual sales  reports. The Agency will
       respond  to requests for waivers hi writing.

             To apply for a low volume, minor use waiver, you must submit the following
       information, as applicable to your product(s), as part of your 90-day response to this
       Notice:

             (i). Total company sales (pounds and dollars) of all registered produces)
       containing the active ingredient. If applicable to the active ingredient, include foreign
       sales for those products that are not registered in this country but are applied to sugar
       (cane or beet), coffee, bananas, cocoa, and other such crops. Present the above
       information by year for each of the past five years.

                                          178

-------
       (ii) Provide an estimate of the sales (pounds and dollars) of the active ingredient
for each major use site. Present the above information by year for each of the past five
years.

       (iii)  Total direct production cost of produces) containing the active ingredient by
year for the past five years. Include information on raw material cost, direct labor cost,
advertising, sales and marketing, and any other significant costs listed separately.

       (iv)  Total indirect production cost (e.g. plant overhead, amortized plant and
equipment) charged to product(s) containing the active ingredient by year for the past
five years. Exclude all non-recurring costs that were directly related to the active
ingredient, such as costs of initial registration and any data development.

       (v) A list of each data requirement for which you seek a waiver. Indicate the type
of waiver sought and the estimated cost to you (listed separately for each data
requirement and associated test) of conducting the testing needed to fulfill each of these
data requirements.

       (vi)  A list of each data requirement for which you are not seeking any waiver and
the estimated cost to you (listed separately for each data requirement and associated test)
of conducting the testing needed to fulfill each of these data requirements.

       (vii)  For each of the next ten years, a year-by-year forecast of company sales
(pounds and dollars) of the active ingredient, direct production costs of product(s)
containing the active ingredient (following the parameters in item 2 above), indirect
production costs of produces) containing the active ingredient (following the parameters
in item 3 above), and costs of data development pertaining to the active ingredient.

       (viii) A description of the importance and unique benefits of the active ingredient
to users. Discuss the use patterns and the effectiveness of the active ingredient relative to
registered alternative chemicals and non-chemical control strategies. Focus on benefits
unique to the active ingredient, providing information that is as quantitative as possible.
If you do not have quantitative data upon which to base your estimates, then present the
reasoning used to derive your estimates. To assist the Agency in determining the degree
of importance of the active ingredient in terms of its benefits, you should provide
information on any of the following factors, as applicable to your product(s): (a)
documentation of the usefulness of the active ingredient in Integrated Pest Management,
(b) description of the beneficial impacts on the environment of use of the active
ingredient, as opposed to its registered alternatives, (c) information on the breakdown of
the active ingredient after use and on its persistence in the environment, and (d)
description of its usefulness against a pest(s) of public health significance.

       Failure to submit sufficient information for the Agency to make a determination
regarding a request for a low volume/minor use waiver will result in denial of the request
for a waiver.
                                     179

-------
      b.     Request for Waiver of Data

             Option 9, under Item 9, on the Requirements Status and Registrant's Response
      Form. This option may be used if you believe that a particular data requirement should
      not apply because the requirement is inappropriate. You must submit a rationale
      explaining why you believe the data requirements should not apply. You also must
      submit the current label(s) of your product(s) and, if a current copy of your Confidential
      Statement of Formula is not already on file you must submit a current copy.

             You will be informed of the Agency's decision in writing. If the Agency
      determines that the data requirements of this Notice are not appropriate to your
      product(s), you will not be required to supply the data pursuant to section 3(c)(2)(B). If
      EPA determines that the data are required for your produces'), you must choose a method
      of meeting the requirements of this Notice within the time frame provided bv this Notice.
      Within 30 days of your receipt of the Agency's written decision, you must submit a
      revised Requirements Status and Registrant's Response Form indicating the option
      chosen.

      2. Product Specific Data

             If you request a waiver for product specific data because you believe it is
      inappropriate, you must attach a complete justification for the request including technical
      reasons, data and references to relevant EPA regulations, guidelines or policies. (Note:
      any supplemental data must be submitted in the format required by PR Notice 86-5). This
      will be the only opportunity to state the reasons or provide information in support of your
      request. If the Agency approves your waiver request, you will not be required to supply
    •  the data pursuant to section 3(c)(2)(B) of FIFRA. If the Agency denies your waiver
      request, you must choose an option for meeting the data requirements of this Notice
      within 30 days of the receipt of the Agency's decision. You must indicate and submit the
      option chosen on the product specific Requirements Status and Registrant's Response
      Form. Product specific data requirements for product chemistry, acute toxicity and
      efficacy (where appropriate) are required for all products and the Agency would grant a
      waiver only under extraordinary circumstances. You should also be aware that
      submitting a waiver request will not automatically extend the due date for the study in
      question. Waiver requests submitted without adequate supporting rationale will be denied
      and the original due date will remain in force.


SECTION IV.       CONSEQUENCES OF FAILURE TO COMPLY WITH THIS
                    NOTICE

IV-A NOTICE OF INTENT TO SUSPEND

      The Agency may issue a Notice of Intent to Suspend products subject to this Notice due
to failure by a registrant to comply with the requirements of this Data Call-In Notice, pursuant to
FIFRA section 3(c)(2)(B). Events which may be the basis for issuance of a Notice of Intent to

                                          180

-------
Suspend include, but are not limited to, the following:

       1.      Failure to respond as required by this Notice within 90 days of your receipt of this
              Notice.

       2.      Failure to submit on the required schedule an acceptable proposed or final
              protocol when such is required to be submitted to the Agency for review.

       3.      Failure to submit on the required schedule an adequate progress report on a study
              as required by this Notice.

       4.      Failure to submit on the required schedule acceptable data as required by this
              Notice.

       5.      Failure to take a required action or submit adequate information pertaining to any
              option chosen to address the data requirements (e.g., any required action or
              information pertaining to submission or citation of existing studies or offers,
              arrangements, or arbitration on the sharing of costs or the formation of Task
              Forces, failure to comply with the terms of an agreement or arbitration
              concerning joint data development or failure to comply with any terms of a data
              waiver).

       6.      Failure to submit supportable certifications as to the conditions of submitted
              studies, as required by Section ffl-C of this Notice.

       7.      Withdrawal of an offer to share in the cost of developing required data.

       8.      Failure of the registrant to whom you have tendered an offer to share in the cost
              of developing data and provided proof of the registrant's receipt of such offer or
              failure of a registrant on whom you rely for a generic data exemption either to:

              i. Inform EPA of intent to develop and submit the data required by this Notice on
              a Data Call-in Response Form and a Requirements Status and Registrant's
              Response Form.

              ii. Fulfill the commitment to  develop and submit the data as required by this
              Notice; or

              iii.  Otherwise take appropriate steps to meet the requirements stated in this
              Notice,

              unless you commit to submit and do submit the required data in the specified time
              frame.

       9.     Failure to take any required or appropriate steps, not mentioned above, at any
              time following the issuance of this Notice.

                                            181

-------
IV-B.  BASIS FOR DETERMINATION THAT SUBMITTED STUDY IS UNACCEPTABLE

       The Agency may determine that a study (even if submitted within the required time) is
unacceptable and constitutes a basis for issuance of a Notice of Intent to Suspend. The grounds
for suspension include, but are not limited to, failure to meet any of the following:

       1)     EPA requirements specified in the Data Call-In Notice or other documents
       incorporated by reference (including, as applicable, EPA Pesticide Assessment
       Guidelines, Data Reporting Guidelines, and GeneTox Health Effects Test Guidelines)
       regarding the design, conduct, and reporting of required studies. Such requirements
       include, but are not limited to, those relating to test material, test procedures, selection of
       species, number of animals, sex and distribution of animals, dose and effect levels to be
       tested or attained, duration of test, and, as applicable, Good Laboratory Practices.

       2)     EPA requirements regarding the submission of protocols, including the
       incorporation of any changes required by the Agency following review.

       3)     EPA requirements regarding the reporting of data,  including the manner of
       reporting, the completeness of results, and the adequacy of any required supporting (or
       raw) data, including, but not limited to, requirements referenced or included in this
       Notice or contained in PR 86-5. All studies must be submitted in the form of a final
       report; a preliminary report will not be considered to fulfill the submission requirement.

IV-C  EXISTING STOCKS OF SUSPENDED OR CANCELLED PRODUCTS

       EPA has statutory authority to permit continued sale, distribution and use of existing
stocks of a pesticide product which has been suspended or cancelled if doing so would be
consistent with the purposes of the Act.

       The Agency has determined that such disposition by registrants of existing stocks for a
suspended registration when a section 3(c)(2)(B) data request is outstanding generally would not
be consistent with the Act's purposes. Accordingly, the Agency anticipates granting registrants
permission to sell, distribute, or use existing stocks of suspended product(s) only in exceptional
circumstances. If you believe such disposition of existing stocks of your product(s) which may
be suspended for failure to comply with this Notice should be permitted, you have the burden of
clearly demonstrating to EPA that granting such permission would be consistent with the Act.
You also must explain why an "existing stocks" provision is necessary, including a statement of
the quantity of existing stocks and your estimate of the time required for their sale, distribution,
and use. Unless you meet this burden, the Agency will not consider any request pertaining to the
continued sale, distribution, or use of your existing stocks after suspension.

       If you request a voluntary cancellation of your produces)  as a response to this Notice and
your product is in full compliance with all Agency requirements,  you will have,  under most
circumstances, one year from the date your 90 day response to this Notice is due, to sell,
distribute, or use existing stocks. Normally, the Agency will allow persons other than the
registrant  such as independent distributors, retailers and end users to sell, distribute or use such

                                          182

-------
existing stocks until the stocks are exhausted. Any sale, distribution or use of stocks of
voluntarily cancelled products containing an active ingredient for which the Agency has
particular risk concerns will be determined on a case-by-case basis.

       Requests for voluntary cancellation received after the 90 day response period required by
this Notice will not result in the agency granting any additional time to sell, distribute, or use
existing stocks beyond a year from the date the 90 day response was due, unless you demonstrate
to the Agency that you are in full compliance with all Agency requirements, including the
requirements of this Notice. For example, if you decide to voluntarily cancel your registration
six months before a 3-year study is scheduled to be submitted, all progress reports and other
information necessary to establish that you have been conducting the study in an acceptable and
good faith manner must have been submitted to the Agency, before EPA will consider granting
an existing stocks provision.
SECTION V. REGISTRANTS' OBLIGATION TO REPORT POSSIBLE
             UNREASONABLE ADVERSE EFFECTS

       Registrants are reminded that FIFRA section 6(a)(2) states that if at any time after a
pesticide is registered a registrant has additional factual information regarding unreasonable
adverse effects on the environment by the pesticide, the registrant shall submit the information to
the Agency. Registrants must notify the Agency of any factual information they have, from
whatever source, including but not limited to interim or preliminary results of studies, regarding
unreasonable adverse effects on man or the environment. This requirement continues as long as
the products are registered by the Agency.
SECTION VI.
INQUIRIES AND RESPONSES TO THIS NOTICE
      "If you have any questions regarding the requirements and procedures established by this
Notice, call the contact person(s) listed in Attachment 1, the Data Call-In Chemical Status Sheet.

      All responses to this Notice must include completed Data Call-In Response Forms
(Attachment 2)and completed Requirements Status and Registrant's Response Forms
(Attachment 3), for both (generic and product specific data) and any other documents required
                                         183

-------
by this Notice, and should be submitted to the contact person(s) identified in Attachment 1. If
the voluntary cancellation or generic data exemption option is chosen, only the Generic and
Product Specific Data Call-In Response Forms need be submitted.

      The Office of Compliance (OC) of the Office of Enforcement and Compliance Assurance
(OECA), EPA, will be monitoring the data being generated in response to this Notice.
                                 Sincerely yours,
                                            i, Doctor
                                 Special Review and
                                  Reregistration Division
Attachments
       The Attachments to this Notice are:

       1 -    Data Call-in Chemical Status Sheet
       2 -    Generic Data Call-In and Product Specific Data Call-In Response Forms with
             Instructions
       3-    Generic Data Call-In and Product Specific Data Call-in Requirements Status and
             Registrant's Response Forms with Instructions
       4-    EPA Batching of End-Use Products for Meeting Acute Toxicology Data
             Requirements for Reregistration
       5-    List of Registrants Receiving This Notice
       6-    Confidential Statement of Formula. Cost Share and Data Compensation Forms
                                         184

-------
Metribuzin DATA CALL-IN CHEMICAL STATUS SHEET

INTRODUCTION

      You have been sent this Product Specific Data Call-In Notice because you have product(s)
containing Metribuzin.

      This Product Specific Data Call-In Chemical Status Sheet, contains an overview of data
required by this notice, and point of contact for inquiries pertaining to the reregistration of
Metribuzin. This attachment is to be used in conjunction with (1) the Product Specific Data Call-
in Notice, (2) the Product Specific Data Call-In Response Form (Attachment 2), (3)  the
Requirements Status and Registrant's Form (Attachment 3), (4) EPA's Grouping of End-Use
Products for Meeting Acute Toxicology Data Requirement  (Attachment 4), (5) the EPA
Acceptance Criteria (Attachment 5), (6) a list of registrants receiving this DCI (Attachment 6) and
(7) the Cost Share and Data Compensation Forms in replying to this Metribuzin Product Specific
Data Call-in (Attachment 7). Instructions and guidance accompany each form.

DATA REQUIRED BY THIS NOTICE

      The additional data requirements  needed to complete the database for Metribuzin are
contained in the Requirements Status and Registrant's Response. Attachment 3. The Agency has
concluded that additional data on Metribuzin are needed for specific products. These data are
required to be submitted to the Agency within the time frame listed. These data are needed to
fully complete the reregistration of all eligible Metribuzin products.

INQUIRIES AND RESPONSES TO THIS NOTICE
      If you  have any questions regarding this product specific data  requirements and
procedures established by this Notice, please contact Jean Holmes at (703) 308-8008.

      All responses to  this Notice for the  Product Specific data requirements should be
      submitted to:
             Jean Holmes
             Chemical Review Manager Team 81
             Product Reregistration Branch
             Special Review and Reregistration Branch 7508W
             Office of Pesticide Programs
             U.S. Environmental Protection Agency
             Washington, D.C. 20460

             RE: Metribuzin
                                        185

-------
Metribuzin DATA CALL-IN CHEMICAL STATUS SHEET

INTRODUCTION

      You have been sent this Generic  Data Call-In Notice because you have product(s)
containing Metribuzin.

      This Generic Data Call-In Chemical Status Sheet contains an overview of data required
by this notice, and point of contact for inquiries pertaining to the reregistration of Metribuzin.
This attachment is to be used in conjunction with (1) the Generic Data Call-In Notice, (2) the
Generic Data Call-In Response  Form (Attachment 2), (3) the Requirements Status and
Registrant's Form (Attachment 2), (4) a list of registrants receiving this DCI (Attachment 4), (5)
the EPA Acceptance Criteria (Attachment 5), and (6) the Cost Share and Data Compensation
Forms in replying to this Metribuzin Generic Data Call In (Attachment F).  Instructions and
guidance accompany each form.

DATA REQUIRED BY THIS NOTICE
       The additional data requirements needed to complete the generic database for Metribuzin
are contained in the Requirements Status and Registrant's Response. Attachment C. The Agency
has concluded that additional product chemistry data on Metribuzin are needed. These data are
needed to fully complete the reregistration of all eligible Metribuzin products.

INQUIRIES AND RESPONSES TO THIS NOTICE

       If you have any questions regarding the generic data requirements and procedures
established by this Notice, please contact Jean Holmes at (703) 308-8008.

       All responsades to this Notice for the generic data requirements should be submitted to:

             Jean Holmes, Chemical Review Manager
             PRB
             Special Review and Registration Division (H7508W)
             Office of Pesticiafde Programs
             U.S. Environmental Protection Agency
             Washington, D.C. 20460
             RE:  Metribuzin
                                        186

-------
 Instructions For Completing The "Data Call-In Response Forms" For The Generic And
                             Product Specific Data Call-In
INTRODUCTION

These instructions apply to the Generic and Product Specific "Data Call-In Response Forms" and
are to be used by registrants to respond to generic and product specific Data Call-ins as part of
EPA's Reregistration Program under the Federal Insecticide, Fungicide, and Rodenticide Act. If
you are an end-use product registrant only and have been sent this DCI letter as part of a RED
document you have been sent just the product specific "Data Call-in Response Forms." Only
registrants responsible for generic data have been sent the generic data response form. The type
of Data Call-In (generic or product specific) is indicated in item number 3 ("Date and
Type of DCI") on each form.
Although the form is the same for both generic and product specific data, instructions for
completing these forms are different.  Please read these instructions carefully before filling out
the forms.

EPA has developed these forms individually for each registrant, and has preprinted these forms
with a number of items. DQNOT use these forms for any other active ingredient.

Items 1 through 4 have been preprinted on the form.  Items 5 through 7 must be completed by
the registrant as appropriate. Items 8 through 11 must be completed by the registrant before
submitting a response to the Agency.

The public reporting burden for this collection of information is estimated to average 15 minutes
per response, including time for reviewing instructions, searching existing data sources,
gathering and maintaining the data needed, and completing and reviewing the collection of
information. Send comments regarding the burden estimate or any other aspect of this collection
of information, including suggestions for reducing this burden, to Chief, Information Policy
Branch, Mail Code 2136, U.S. Environmental Protection Agency, 401 M St., S.W., Washington,
D.C. 20460; and  to the Office of Management and Budget, Paperwork Reduction Project
2070-0107, Washington, D.C. 20503.
                                         187

-------
INSTRUCTIONS FOR COMPLETING THE DATA CALL-IN RESPONSE FORMS
Generic and Product Specific Data Call-In
Item 1.       ON BOTH FORMS: This item identifies your company name, number and
             address.

Item 2.       ON BOTH FORMS: This item identifies the case number, case name, EPA
             chemical number and chemical name.

ItemS.       ON BOTH FORMS: This item identifies the type of Data Call-in. The date of
             issuance is date stamped.

Item 4.       ON BOTH FORMS: This item identifies the EPA product registrations relevant
             to the data call-in. Please note that you are also responsible for informing the
             Agency of your response regarding any product that you believe may be covered
             by this Data Call-In but that is not listed by the Agency in Item 4. You must bring
             any such apparent omission to the Agency's attention within the period required
             for submission of this response form.

Item 5.       ON BOTH FORMS: Check this item for each product registration you wish to
             cancel voluntarily. If a registration number is listed for a product for which you
             previously requested voluntary cancellation, indicate in Item 5 the date of that
             request. Since this Data Call-in requires both generic and product specific data,
             you must complete item 5 on both Data Call-in response forms. You do not need
             to complete any item on the Requirements Status and Registrant's Response
             Forms.

Item 6a.     ON THE GENERIC DATA FORM: Check this Item if the Data Call-in is for
             generic data as indicated in Item 3 and you are eligible for a Generic Data
             Exemption for the chemical listed in Item 2 and used in the subject product. By
             electing this exemption, you agree to the terms and conditions of a Generic Data
             Exemption as explained in the Data Call-in Notice.

             If you are eligible for or claim a Generic Data Exemption, enter the EPA
             registration Number of each registered source of that active ingredient that you
             use in your product.

             Typically, if you purchase an EPA-registered product from one or more other
             producers (who, with respect to the incorporated product, are in compliance with
             this and any other outstanding Data Call-In Notice), and incorporate that product
             into all your products, you may complete this item for all products listed on this
             form. If, however, you produce the active ingredient yourself, or use any
             unregistered product (regardless of the fact that some of your sources are
             registered), you may not claim a Generic Data Exemption and you may not select
             this item.

                                          188

-------
INSTRUCTIONS FOR COMPLETING'
Generic and Product Specific Data Call-In
Item 6b.      ON THE GENERIC DATA FORM: Check this Item if the Data Call-In is for
             generic data as indicated in Item 3 and if you are agreeing to satisfy the generic
             data requirements of this Data Call-in. Attach the Requirements Status and
             Registrant's Response Form that indicates how you will satisfy those
             requirements.

             NOTE: Item 6a and 6b are not applicable for Product Specific Data.

Item 7a.      ON THE PRODUCT SPECIFIC DATA FORM: ฐFor each manufacturing use
             product (MUP) for which you wish to maintain registration, you must agree to
             satisfy the data requirements by responding "yes."

Item 7b.      For each end use product (EUP) for which you wish to maintain registration, you
             must agree to satisfy the data requirements by responding "yes."

             FOR BOTH MUP and EUP products

             You should also respond "yes" to this item (7a for MUP's and 7b for EUP's) if
             your product is identical to another product and you qualify for a data exemption.
              You must provide the EPA registration numbers of your source(s); do not
             complete the Requirements Status and Registrant's Response form. Examples of
             such products include repackaged products and Special Local Needs (Section
             24c) products which are identical to federally registered products.

             If you are requesting a data waiver, answer "yes" here; in addition, on the
             "Requirements Status and Registrant's Response" form under Item 9, you must
             respond with option 7 (Waiver Request) for each study for which you are
             requesting a waiver.

             NOTE: Item 7a and 7b are not applicable for Generic Data.
                                         189

-------
INSTRUCTIONS FOR COMPLETING THE DATA CALL-IN RESPONSE FORMS
Generic and Product Specific Data Call-In
Item 8.       ON BOTH FORMS: This certification statement must be signed by an
              authorized representative of your company and the person signing must include
              his/her title.  Additional pages used in your response must be initialled and dated
              in the space provided for the certification.

Item 9.       ON BOTH FORMS: Enter the date of signature.

Item 10.      ON BOTH FORMS: Enter the name of the person EPA should contact with
              questions regarding your response.

Item 11.      ON BOTH FORMS: Enter the phone number of your company contact.
 Note:    You may provide additional information that does not fit on this form in a signed letter that accompanies your response. For example, you may
         wish to report that your product has already been transferred to another company or that you have already voluntarily cancelled this product. For
         these cases, please supply all relevant details so that EPA can ensure that its records are correct
                                             190

-------
^


q_l
O

H



)
Cu
O
U

fe
rtj

PH

P




ง
i
ro
PO
o
oin co
ซ— o cu
00 L.
cu pp '5.
O OO UJ
L- CMCM
Q. — '
CL • CO

= ฐ
E i-
[_ CQ Q.
0 E Q.
u- o <
























O
(~j

tn


O
•H
.!-> 0
o u>
0) •* H
4-) 0 CO
O CM !EH
J-l O
P^ • P|
U CQ
•H W
ftS • P4
j_> Q



CU

O


t_

g

4-*
CD
E
L.
O
S-
c
CD


1:
3
CO
1
CO
g
4-*
O
3
4j
cn
c.
T!
CU
-C
u
•2
4-*
CO
 c.
2 O
ฃ .—
Oฃ CO
t—
CO CU
Z CO
I—I *~i






r }

H

_ H
||

Q.

(— t^'
"g j^
CO [^
cu O

S CM
M























-H
N
-H

= 4J
ro (P
1s
CO
% t~"i
CU ฐฐ
cn H
CO -^
o O
f\i












O
O
CQ 0
CQ O
|||ฐ
3 cu sq x
-D S
c ^) ฃ-1
10 u w >.
2; fty] pn
g-CM CQ O

ง-^ o o
cS CQ 13 &
*~



















CO
4-*
CO
Q
O

M-

CU
CL
CO

4-*
U


ฃ_
o.






















ro
4-ป
CO
0
u
1
cu
CS

-o

•a -a
c cu cn
(B Q. JT 4J
O 0 C

jz: co ฃ- 4^
C 4-> — C
CO CU 3 CO
>-JZ D" C-
cn H- 4-ป cu 4-*
•— cn g; co
4-ป 4-* O ~ D)
O CO "DO
3 cn co cu o:
T3 4J — '
O O C 4-> T> =
Q. E 4-J CO 0)
CU CU • C CO
X cu t. cu cn c
O)'5 E 4-> Q.
• co cr c- co co
-Q CU O 4-> CU
t^ — . t- •ป- 
CO Z3 O C
E CO 0)
Q. 4-< E CO
=3 CU 4-> CU ~
E J= CO C- 4J
CO . CU '5 CO
>-J= D" t-
CO M- 4J CU 4->
••- cn Qฃ CO
4-> 4-< O ~ 5)
O CO T3 O
3 CO CO CU Qฃ
T3 4-" — •
0 0 C 4-> -D =
Q. E 4-* CO CU
CU CU C CO
>. cu i- cu cn c
E t- •— 30
• co cr t- co co
CO CU O 4-> CU
N. 1-4 ฃ- H- CO tฃ.
,
o-a
'H ฃ To
O CO — •
g.Sฃ
C3 13 4-> TI
.c c c =
>*— CU CO •
M- a
cn cn E co cn
— CO I- 3 C
4J O 4-> 0
co cn s- co Q.
CO 4J 4-ป W
o ||"ซ
CU U 4-> CO
CU t- CO C ^
0) if— 4-f CU 4-*
D] C7 CO CU CO
CO CU S- i-
~ *" j= '5 ซ
co *-• cr—
• 4-> CU D)
JQ CO C CU CU
M3 Q O = ce.




s 1 . g
ฃ_ ..- 0) ™r
CU H- TJ — CD
C CD O)-Q
CD CU ฃ- CU
0 JO g^-g
CD CD •*- ^ 4J
o a. co
D) CU CD UJ ••-
S -ฐ .> o "
E C 4-J O L.
•- O O ฃ- CD
co •-- co D _a
— ' *-* O E
O Q. CD CO D
E CU 4-* CD
CO X -C C
UJ C -M 0
CD CO E 4J
• 4-> 4-* O CD
tO CO JD ฃ_ L_
ปO O O H- 4-*

t t
4J co 'ro — •
.= ฃ 2 ง
•2 *- 4, C .
3 -• 0 0 X
CU 3 — — •
— 0 TJ 4^ •—
C O CO t-
• CO i- C_ CO
in o Q. 4J 4->




u
•gg
o •—
CL CO
< 4-*
CX CO
UJ ••-
D>
sf a.





























,















,
riJ
0
*









<
&










^
^5
g
^^
i
g
1
^




















cu
CO
a


















cu cu
4-* E


Q. CO
o c!
i*
CO -
cu

4-* H-
2 ^k
o
U CD
•>  >
CO '•—
— ' 4J 4J
—-CO CO
(0 4J
-a? S
c ซ•— to
CD T3 CD
CO t-
E CD Q.
t- — * CD
O CO Qi
*E "D
(ft CD
ซ•- ฃ- N
_C O ••-
4-ป L.
CD O
g^2 ฃ
•g " 5
CO >. CO
* -5 3 cS
C 3 JO D.
EC o
a ^ cu u
CD >s -Q M-
4-> C CO O
CO CO O
CU 4-> ^ —
c 5^ a .t
O 4J CO H-
4J CO CU S- T3
CO JC D) CU C
0 4^-D-D 10
*t- >* — ' 3 CU
— M- 3 c_
4J — 0 .E 3
1- 4-ป C 4-> 4-*
CU t. ^^ O CO
o cu o ja c
O CO D)
CO — .-. 0 CO
















cu


cu
f-
o
Q_















































u
CO
4-1
c
o
u
t

ฃ
o
s-
o
cu
z:
3

-------
OJ


t-t
O
r4

.
(U
tn
rt
ft








































^,

ft
O
u
EH

b

^A
Pi

Q



0
o
1
to
8
OlA CO
*O 1 I ปc—
5 ^!p ^*
2 8S "
& • "o
"* ฃ o
งm B:
ซC












>•ซ M
O CO
0 O
tn ft
CS (2
O
•H CO
4J 0 *
O vo EH
(1) ^* 525
4-) O 9
8 ฐ* EH
ft • CO
ซ• * tj
O H
rH CD
(tJ • M
4-> Q 3
fl

ง n P
O 4J
JH tn CO
-H fl g
^^ *''• t**

W CO EH
ttf co
OQ S
0) CO



CO S
•d 2
mLj
t?
Jj J3)
S M
t> S
























m
s-
ซ

^5

g
2
CO
CU
1
I
4-*
i
o
CU
_5"
&
CO
CO


1—
•M
g
a

1
1
•M
•M
O
O
JC
ฃ.
_*
1
co
o
1
CU
CO


ฃL
_^

.H ^
t-
4-> CO
C CO
•r- CO
*ง
&8
M-

4-* CO

O V
tn oj
SO)
_^ j=
n.
g S
2 4J
iง
Cf. CO
C/l OJ




n
O a
i t H^
ry. |

_ H Q
ฐ W 1
"5 ft S
Q.W ง
^ EH g
"S B a
" Q
ffl PH Q
0 ft H

to

• ' •



I
1
Jg
e
-S 1
N S
ฃj
,Q •
-H O
5^1 is
g Jj
^2 tn
•g a)
CO p^
u co tS,
to tH ft
3 0 H
t
CM












O
0
CO O
co o

o 12 Q
4? ^ 9 b

^^ ^Ji
*o w -
i H >H
CS Prl fv! p^
C3EHH
g-ft CO CJ
trii O O
co s a
c
CO
c_
U Ol
'o?i
ฐ! **
C> Qฃ


OJ
.i cu
CO
• L.
co i*-







0)
o
CO CD
O 4J
t^ CO




c
0) t-
CO 0)
• "

to
to

L. ฃ. ..
O) 0 ""
0 0.
f\ f\*
*"
Lo:oi-ocjo-i















0)
4-*
1
CO
tn






C4^
^ g
S 1 u
'3 ••- o)
ej =J .n
• OJ 3
•!!* % i. A-
O< JOj- ft , ft ft ft ft ft ,^ ," ft
•M JS3 W W tซl W (SI H fjt? H
^1" -i ^Mim s I
OO ^O^-OOOOOO 0
งง 3 งง3333 3
' ^^ *"^ ^^^^^^ ^
CD 0 'CD CD S3 CD t& CD O CD
pr| rfl |yi ** ** pr] J5Jฃ| ptj pgj |ฅj j5ฃJ pjfj
-88 ^8 888888 ป8

^ i- ^ rt- _
^> ' f *
ซ /
%

, , _ ,- r " \-
•••./ ^, ?jp
-."'' *'S ^ ; *''{*
** ^., -\ |--j"
^^ , ~f -. i^.
^5 5 H S^P- ^ ง

*" r "* "• ' $•
, ง w- s ' ^ ซ
•^ >Pป (0 H- O '•>•ป-
OJ CO •ป- O t- J* -M
U 0 L. Q. O 0



g O S JO 4J WE"1 H- S)U ^C
CS >^ปwt_ O — ป tyป o W t. "S T3
^ J-J *J O H- COOJZ •r-^Q)CU

(P' C -H o3 OW O E W CUtpC—
DC CUซ OJ>.ซ>- 4J C. ' ' O
s ^, 4-ioco. ••->ปซ coo— < o<ฃc
c 4-> ft, 3 cu CA *&>• •*" *^* ••" ro ^ซ c. •**" ง^*
Cu O <** "O O Cfl 3 E H".. 4J O +^ O N
53 t. O O 3 O. ป^- 'ซ- >. *r- ปr- >. ^01 -r-
T3 O ฃ- t, O E — j^J— -• - t/5 CO T3&,^O
^ tป ^

j
_
•••'
^_^ t 	 ^ A
<{S '"".Q A'
•— ' •• *-* ^ •• t>5 ro <4*
iH <^J f ^ / ,ri f^t.,^ <*1 C*- r-l rH rH
It I % 1 •• t 1 _t ' 1 i 1 1
H r-i H 05 oj 03 jgi n <") n n
VO •tO" VO ^O \P VO '^^ V^ \0- ^ปO VO

















OJ

ca
a
^





• c
OJ QJ
Q. CO
fr
O Q.
•n •ป—
c
ป. c
d> ••—
CO
u
O Jj*
* CO
3 CO
c_ ••—
•M ฃ
CU Q.
CO CU
CO ^
c |
E
-g c
CD 0)'

CO 4J >
CO •—
— * 4-ป 4-*
—•CO CD
CD 4->
D) C
TJ C 0)
CD TJ O
CO t-
E cu a.
f • fl)
o co a:
**" 'i TJ
CO OJ
••- C- N
f O ••-
4-* C.
c to j=
O — ' 4->
CO 3
eu s- . CO
c '5 co a.
EC O
ro X J2 H-
4-ป C CO O
ca co o
a> 4J 13 _j
ง.C CO Q. 4J
4J JC D. ซt-
••- 4J CO 1—
4-* 4-*
CO CD 01 C. TJ
O J= D) 0) C
HK CU C
•r- >s— < 3 0)
4-ป M- 3 ฃ-
t- •ฃ 5 J= 3
0) 4-> C 4-" 4-<
U (- ^ O CD
CD 0 ja C
• o co O)
*- _ _ o Cfl













C.
i
%
0)
c
o
a.
ro

































o
CO
4-*
g
CJ

c
o
•*-
0
1
z
CM

-------
CM




O

CM
CD
tn
rt
ft
ft

o

O


E-"

Pn


Ct!

P
          ^ 8

          oin co
          oo t-
           i  i  ••—

          l^p*"- x
          OO W
          CM CM

           <>•  1
          =   E
          >V|   Q_

          ง   S-
     &
     a
     0)
     tn
 d      ^
 O
-H      CO
4-> O   ซ.
 O VD   H

-U O   S
 O CM   ซ

ft   •   CO
   O   H
•H      CD
 (d   •   W
j-> P   (*!

 (D   ~  Q


 O JJ
 i-i  tn  co
-H  a   p

 fl'ii   rf
H  CQ   E-l
    cti   CO
 CQ &
 CD
4->
 td
4J
CO

-o
 CD
 fl
P
                  ro

               ol
               Cฃ  CO

               CO  CU
                          o
                               a
                              -H
                               N

                              J!
                              -H

                             ; jj
                           "O

                            co

                           •it T~i
                            oCO
                                     tn
                                     ft
                                     H
^v* n


O Of
                                        ซE
                                        CO 0)
                                        =>
                                            a> o
                                            o a.
                                            ฃ- CU
                                            Q. Qi
                                            CO


                                            in
                                                                                                       ^*
                                                        CQ  K>  CQ tQ HI  CB
                                                           2     S     Q
                                                    CO OO CO OO CO CO CO
                                             CO CQ    CQ  CQ  CQ CQ
                                             O O    O  O  O O



                                            CO 00    CO CO CO CO
                                                                                                    a*
                                                                                    o o    o o o o
                                                        &3
                                                        Q  P jSj P & P
                                                        y  o o o o o

                                                         "     SงSง
                                                                                        tft  N-
                                                                                         J-  f)
                                                                                        'ซ        O  C  4J
                                                                                         I-     *J •—  O  CO

                                                                                         i,     g ง ^  .t
                                             O     SO 4->
                                             **  "S  ^ ffl
                                            -  I  >. o
                                             TO  ซ-  +J= .C
                                             ti  QJ  ^f C

                                                   •**f
                                              co a?v o ft
                                                        •p-f H r-t H i-f CM ifปJ
                                                         1111)11
                                                        cO ro rfป ro c
                                                                                                                            *-• X
                                                                                                                               (1)

-------





H J
H-t
ฐ
H





Ol
ri
n,
***ซ



















































PM


O

|X|
tf
Q













































O
0)
tn



CJ
0
-H
rotect
P4


r-t
(6
JJ
a
m
s Environnu
0)



4J
CO


0)
4J
-H
g






























































20460


*
u
*
p
ashington,
3-























































CQ



PyH
S


H
B


P5

1
a
3UIDEL:
xx


O
ง
CO
DEFINITIOE
W,



pc<

M

rfj
1
g
1
























































rt
•rl

i
•3
4J
g



H
CX>
H
O
ff*
0)
•d
stฃ

ft\
O
m

u















01 4->
4-* C
M- CU
O E

t- I.
O  D-
M- CD
S t. Ol
3 CO —
CO 4J 4J
CO O
4-> TJ CO
0
C >.=


000.
C 4J =
>* 4-ป II
CD 0
.e _cu <ฃ

- 3 <ฃ
01 CO O.
0
t- 4-ป ซ.
3 0 4J
O C C
CO CU
O —
TJ I- TJ
Ol CO 01
t- L.
01 CO 01
4-ป 4J C
CO C •.=
•ซ— CO
Dl ฃ- 01
01 4-* >
t_ CO —
CO D] O
CD CO
g c-
t_ .'5)
M- 4-* t-
31^"
4-ป C- 11
C Q.
01 t-i

C. C! • .
o <-> 4J
cue
01 CD TJ
> ซ_ CD
O CD C
CO JC —
L. O 01
•— e >
01 CO —
.C 4-ป
4-< •*- O
O CO
01
CO CD CD
CO O) J=
O -V
C- o M-
ed formulators pu
100 percent repa
technical grade o
TJ CO
'> CO "
O ••- i-ซ
c-  01
5 .. 3
I QJ i
"SB'S
CD 55 OJ
11 " — <
4J CO
D- O O
* •ง 'a.
•- O >•
4J t- 4-ป
0 D.
SB
•o -o
O O Q.
t. 05 UJ
Q. CD h-
OJ U ••ป
33-7.
t Q. CO TJ
C71 CD 01
C 01 — • — '
— JC J3 01
t- 4-ป CO XI
3 4-> CO
4-1 O — •
O 4J 01 O
co j: —
i 'i — *
CO TJ 4-*
11 4-> 01 C
t. — 0)
Q. 01 ป4- —
E 0_ — TJ
4-> 01
"act-
II *ฃ
•at U tr^ lr^







C.
|

3 — •
O CO

TJ 4J
0 C
O CU
*c ^
O CO
C CD
O C-
— 4-* ฃ-
4-> CO O
CD 01 O
&t- TJ
O C
ซฃ U- •-<



Ul —i O






Q.
2
u

*n
D. 0
o o
0 *C —
O CD
•g cฃ
O 01 TJ
M- CO 01


CO CD O
|-ฃ1

i i i
O —• 2=
g-
" Q. '
TJ 0
O t_
o o
ซ4-
C O 0
>ป_ o
— ' H-
03 CD C
— CO O,
C - Terrestr
I H - Greenhou
H - Indoor n
Q. CO
ฃป 4-ป
0 C
CU
us
01 CO
M- 0)
c_

H- 0
M-
"000
— CO
r- t-
4-> O
CO — C-
01 4J O
!—<:•-ซ
1 i t
CO C3 — I


CO
C_
Q. CO
ฃx? c.
OCO
TJ " TJ
O TJ 4J
003
. • M- O O
>• H-
01 — C —
id CO 0 CO
CO ฃ- 4->
CD 4-ป O C
iซ- CO — 01
1- 01 4J TJ
D) fc 3 'ซ
QJ 01 O" 01
•M I- < OS
U i i •
Cl) < u- V























g
o
s-

UJ
CO


0.
CO
UJ
a:
CO

i—
2:

i—
CO

3
Ul
a:
1

CO
=>
1—
<
s
CO
EQUIREMENT
a:

o
jr
o




O
O
C

•g
o
c
CU
ฃ-
01
H-
Ol
L.
01
CO
CO
o
4->
O
C

en
c

o
M-
0)
-C
H-;
• •
Q)
JJ
B
4J
o











































































_,
Chernica
3
"3
O)
a?
i
5
1
^


O — '
4-ป CO • 01
4J — • 0 TJ > CO
ฃ- C CO TJ — 01 — 4->
OCD4*JCDC4-' 4**C
H-ฃC4->J=4-> O CU
Ol O> 4-* O ••- CD TJ
tn t- o E — Ol E —
tnOฃ-*r-E4-'^5 010
v-ซ+-Ot-j5 3 i- c-
CO N- C Q. CO J= ""
in^OCDX 4->01 4->L-
T— ซ- 01 oi .a CD o
* • C_ XI M- -C
CO O C •-< 4-" 4J T>
in H- co — >co 01
• • ซ— — > 3 S 4J
c*eoc^:TJ J:CD
OT-COC0014-' COD.
— ... N C CO
SfMinO4J — •"- 4->CO
I r- — C CO TJ CO

*O O — CO t- —
C ^TJ TJ U 01 C 4J >.
— CO C 0 L. J2 —• .r-4J
3 W CO ฃ- 01 — —
O01 O_C4^01 •• 	 •


OC-CM — • — 'EE4J 4JCD
H- Q. i CD CD O CO 4->
^CM 0 g c < ^ g

.C C ^^ — 01 ซ*- Ol —
4-ป 'r- — J 4J ซF- O CO
ฃ- CO — ' C TJ t- 4-*
C34-J301O101 OO

OS C Dl CO CO TJ
ฃ- CO — C- — C ฃ- O
CU M 	 . 0) C — O) 0)1-
J= 3 TJ 3 J= D.
4-> C M- C 01 — • 4-<
t-COO3'4->CD ^^
3 E O — O ^ O
"^TJOT^Co'E 5^
TJ C — CO 0 O
— • CO t- CO S- 01 TJ
•f-COO— >COO4-> CDซ
CO — • — CO 3 4-" TJ
4->cos- oaicu 4^01
CD -r- .^ 4-" CO TJ -C — 4->
TJ t- 4J O — CD 4-" E O
01 t- C TJ t- Xt 01
CD 4J CD Ol *ซ- 34^
C-CDOCOCO O C001
co S — — • TJ
I- CO 4J 01
C T- —"&'ฃ—•• O CO
— C.N>— OO>CO CO
TJCOซ— 4JCOCD—3 TJ01
0) 4J . CO 4-> 3 01 4->
t-cocaaico cr — • t-co
OJ in Q. — CD 01 CO — TJ
CH-T— jr 4-ป ซ3ca
— o * O4J4J— ปc eocrt-
JC <^- CO 01 4-ป 01 Ol
H-C 4->ฃ.OE Cl-CD
O 0 •ซ E ซJ — — CD TJ
— ^H-01O4->[- ^> S.TJ"-
H-TJ— 3C04J4JH- — ' "- C
•<—COC04-'CO O3^O>
4-i->. c >-H-TJ i_cro —
1.O — ' — ' CD COO 01 4-*01CDCOซ
CDS-CD— *E CO CDOC
o c — — TJ c o a.— ••>->. o
tncD 3: t- 010 D. COM 	 ' —
TJiS CU4->— 0 JIO-) 	 -4J
C ซ~~ ^* CO O* CD 4^ t— 4-* 'r* Q) (D CD
OJซt- CO X L..r- Q. —t_ OS
CO tn CU (D D) CO 3E4->o*t'*-I-.
ปin Co cuoco o to o) o
COr--*-* O C 4JO.4J TJCU^xOM-
••-EฃปCOCฃO OJ — ป — * C
eoTj-f- Q. .f-o n 4-ป. (0 4-* O34JE
O L. O O^4-Jป-C C dJL.
ป*-o 3 •— ceo— QJ .acaa-t-f-
C-H-TJ^TJCDCD D) LLJOO
o co o o o e ja co • CD o TJ M-
"-inO ฃ- =1 U 0> 4->ฃ- 4-ป (U t- W
4->ซ— N- Q. T3 13 4J 0 C  Q_ idJ n* TJ ^ o — •
E r- ซ- O CO>.t_j:T3CO C 4J ป*m O  3-r-3.r-z
4-ป 1 *r- — ' JT CO O ฃ- — • _. .^- O" W 4-*
•r-  — • • 3: ^ QJ^O CO ซt— TJ I— OJ
4^>ซ>O Q. DO OCOC"~CCUO — ' C CD 0 Q.
C •*"* vx >r- v|_ ^ •. (/) i^ yj ••— -^ — J m r> M
CU^r- t_ J3Q.-^-C ฃ~ N .Q Q. 0) O
TJ i CO O C-CDUJ Ol-CU'r-'r-X — / TJ 4-- QJ 4-ป
>r-ซ-o eo cu — ' cu oo.TJ4-ปcij ^j-f-ojr
sOป*- CU TJ't-ฃ_.QTJ**-CO"-CO C03C4-ปฃ-
4J<>4-' -a ctaoa •— x zi >. "-ir oi
O ••- 3> 4-ป L. TJ TJ O J3 — ' H-'i-TJCH-
3Cฃ- H- CDO-O •<-* ฃC=Jฃ.ojcoco"Oco n j= o;
O ••- Q. ••- TJW CO""-t-taO"-"--^CflO4->
(-•ME I- CO •— C CD 0) D CO 4-ป3D*^-J= —
Q..^-.r- ^1 flj CDOL.CT COCOCtTE C03ซ
tO -L.C Q)COCCQJ"-GJ4-' TJ
COS- .L_4-ป— *OH-4JCUI-ClJ'r-ปr-4J-- O 4-ป 4-ป (U
4-*CLO'^O.CCD'^-OC^ OCDCDO C33O4J
งro "^-. CD 4-ป cu 4-ปC4J4-ปa. ฃ_ 3: CU JD L.L.
caraEcococ*— ct-ccocowooo oococ^-^cu
4-* I-TJC-— — 4-> ป-* CL 33I3^33CO ฃ-
ฃ- >ป O O D) <1) 0) CO EC04-ปTJTJTJT3T3i COCO

4-ปM-
CU— OCO-M— CUCt- UJTJ CJa
E -ป-OCOeQ.a)OH-  CO -^ ฃ S_ 4-*O.OC"-CUCUCUll) eOTJCD4-ซ33333333t."-
D~ O CO CD CO CJ CJ flj 4-* ฃ— CT CT CT" D* CT CT" U" O" O)
CJt-'^-C eO*HJSOt— (D c
— ' CO •
ฃ CO
Ol O 4->
— 4-> O
.e CD
CD M-
t- > H-
O — 01
ca
ca o c
CO C- O
O) C. ••-
O JJ
CO O CD
4J
CO CO "-


CO CO
ฃ- L. CD
4? ฃ E
CO CD QJ
E E TJ
4-> 4J TJ
SCO C
CD CO
S- t- >.
QJ CU CO
o, cu _ro
111
01 CD 4-*
C- t- O
a.
O O M-
•si •=. a
r- CM


-------
CNI


O


oa


 a
fl-H
H .ฃ<
03
m nj
fl) *
8  o o co •
CO — J= •- ~
— •* 4-1 4-* ฃ— ซ—
3 CO CU CU xx
O O E 4-> ^
•- Q. — CO
4-< TJ t. vx
C. C- C U
CO CU CO N.
•*•* 4-> CO JZ -*
— • o — • 4-ป tn
00*-
01 TJ 0 4->
o CO cu o;
ฃ_ CO 4-* CU u_
CU 0 E 0
CO CO L.
I— *"* >* CO
^ O CO ^^
O 4-* 4- E

* ^ ro •—
CO '^4-" C
CU ซ~ c "— ^3
u c cu 4-ป eu
C ••— E CO •ซ—
CO Q. CU M-
4^ CU O 4-* '*•• i
CO CO — • O
-Q CO CU .C CU
3 ฃ- > O Q.
CO CU CU 3 CO
4-* TJ CO
CU CO 3
— • CU i- H- CD
ฃ c ,ฃ ฐ "~

CO — ป CO CU
— • OX VI-
O JZ O — •
> 0 C 3 -•
CU CO CD
•, ฃ_ o> CU •ป-
CO CU CO C- O
CO JZ CU
O) 4-> CU CU Q.
OJ O JZ 4-ป O
H- 4J CO
o -a '5 5 o
"" ฃ- 4J T3 4J
^^ *Fป ซ-j CU CO
CO 33 4J .^
••- D" CO CO 4J
f- CU C O. ••-
0 c- 0 •?- C
*•ป O O •!-
— • CO
CU X 3 CO S-
CO CO — ' "~
— • ~O J2 t-
CO C CO CO CU
JZ CO 4J C 4J
C C 0 •-
— ป CO CO t-
tfi t- CO O
C 0) 4-i CU
CO 4-ป CO f- CU
• CO ••- JZ
-  a> v
C CO CO CU JQ
••-300: t-
-C CO
4-* ซ*- Q. CO
*3 C E 2
CO CO CO CU 4-* v
CU C 0) 4J '— 0
C- O C- CO IN-
— • 4J CO ^ *"^
— • •— c- rj
"- TJ o — • "o in
3 C s- CO CU ซ-
O 3 t-
CU O "D CO •— Cฃ.
CO CU "- 3 u_
3 tj t- > cru
M- T3 3 CU t- O
3 CU 4-ป CO
CO t- — C
C i- 4J •-
o 3 co o a.
• •- U ป- CU E "D
4J 0 s_ (u
.•- O ^N M- t_ -t-
TJ O CO O H-

O O E X Q. O
O C O — ' tU  L.
3 0 T3 0 0
O ^ CO 4J 4J
t- t_ T3 CO
O 3 C O C U
CO CO 4-* O •—
- 0 .. 	 .
O X O CO "- Q.
CU '*— •*— ~O CO
CO C 4J "D
4-> — • O C • CO "D
CO CO t_ CU CO CU
•- E JZ 4-- CU C —
c cu Ja o.^ "~ ^
** 0 CO CO 4-> O t!
*~* T3 CO •— CU
4-* CU ^ "O 4-1 O
• O 4J CU CU S- 3
1) 3C04->4->O — 'X
TT "n cu 3 co •ป- J2
C 0 Q. O t- C "O
77 t- cu co 4J o - CU 4-* JZ 4^
rn H- ~c co 'c ** c
g-3ซg-'S0
, 1 "O T3 CO O 4J
*J CU CU — • J= 4-> D) 0
O i i .2 j= t. .^ T
CJ 33OUOV4->
r\ CT* o" cu ••-••- co co
JJ CU CU Q.JZ c- CU CU
O o: CK cn 3 Q.I— c.
o
fe MsrS P;

-------

-------
  Instructions For Completing The "Requirements Status and Registrant's Response
              Forms" For The Generic and Product Specific Data Call-In
INTRODUCTION

      These instructions apply to the Generic and Product Specific "Requirements Status and
Registrant's Response Forms" and are to be used by registrants to respond to generic and
product specific Data Call-in's as part of EPA's reregistration program under the Federal
Insecticide, Fungicide, and Rodenticide Act.  If you are an end-use product registrant only
and have been sent this DCI letter as part of a RED document you have been sent just the
product specific "Requirements Status and Registrant's Response Forms." Only registrants
responsible for generic data have been sent the generic data response forms. The type of
Data Call-in (generic or product specific) is indicated in item number 3 ("Date and
Type of DCI") on each form.

      Although the form is the same for both product specific and generic data, instructions
for completing the forms differ slightly. Specifically, options for satisfying product specific
data requirements do not include (1) deletion of uses or (2) request for a low volume/minor
use waiver. Please read these instructions carefully before filling out the forms.

      EPA has developed these forms individually for each registrant, and has preprinted
these forms to include  certain information unique to this chemical. DO NOT use these forms
for any other active ingredient.

      Items 1 through 8 have been preprinted on the form. Item 9 must be completed by the
registrant as appropriate. Items 10 through 13 must be completed by the registrant before
submitting a response to the Agency.

      The public reporting burden for this collection of information is estimated to average
30 minutes per response, including time for reviewing instructions, searching existing data
sources, gathering and maintaining the data needed, and completing and reviewing the
collection of information. Send comments regarding the burden estimate or any other aspect
of this collection of information, including suggestions for reducing this burden, to Chief,
Information Policy Branch, Mail Code 2136, U.S. Environmental Protection Agency, 401 M
St., S.W., Washington, D.C. 20460; and to the Office of Management and Budget, Paperwork
Reduction Project 2070-0107, Washington, D.C. 20503.
                                         192

-------
   INSTRUCTIONS FOR COMPLETING THE "REQUIREMENTS STATUS AND
                      REGISTRANT'S RESPONSE FORMS"

Generic and Product Specific Data Call-in
Item 1.       ON BOTH FORMS: This item identifies your company name, number and
             address.

Item 2.       ON THE GENERIC DATA FORM: This item identifies the case number,
             case name, EPA chemical number and chemical name.

             ON THE PRODUCT SPECIFIC DATA FORM:This item identifies the
             case number, case name, and the EPA Registration Number of the product for
             which the Agency is requesting product specific data.

Item 3.       ON THE GENERIC DATA FORM: This item identifies the type of Data
             Call-in. The date of issuance is date stamped.

             ON THE PRODUCT SPECIFIC DATA FORM:This item identifies the
             type of Data Call-in. The date of issuance is also date stamped.  Note the
             unique identifier number (ID#) assigned by the Agency. This ID number must
             be used hi the transmittal document for any data submissions in response to this
             Data Call-In Notice.

Item 4.       ON BOTH FORMS: This item identifies the guideline reference number of
             studies required.  These guidelines, in addition to the requirements specified in
             the Data Call-in Notice, govern the conduct of the required studies. Note that
             series 61 and 62 in product chemistry are now listed under 40 CFR 158.155
             through 158.180, Subpartc.

Item 5.       ON BOTH FORMS: This item identifies the study title associated with the
             guideline reference number and whether protocols and 1, 2, or 3-year progress
             reports are required to be submitted in connection with the study. As noted in
             Section III of the Data Call-In Notice, 90-day progress reports are required, for
             all studies.

             If an asterisk appears in Item 5, EPA has attached information relevant to this
             guideline reference number to the Requirements Status and Registrant's
             Response Form.
   INSTRUCTIONS FOR COMPLETING THE "REQUIREMENTS STATUS AND

                                       193

-------
                      REGISTRANT'S RESPONSE FORMS"
Generic and Product Specific Data Call-in

Item 6.       ON BOTH FORMS: This item identifies the code associated with the use
             pattern of the pesticide.  In the case of efficacy data (product specific
             requirement), the required study only pertains to products which have the use
             sites and/or pests indicated. A brief description of each code follows:

             A     Terrestrial food
             B     Terrestrial feed
             C     Terrestrial non-food
             D     Aquatic food
             E     Aquatic non-food outdoor
             F     Aquatic non-food industrial
             G     Aquatic non-food residential
             H     Greenhouse food
             I     Greenhouse non-food crop
             J     Forestry
             K     Residential
             L     Indoor food
             M    Indoor non-food
             N     Indoor medical
             O     Indoor residential

Item 7.       ON BOTH FORMS: This item identifies the code assigned to the substance
             that must be used for testing. A brief description of each code follows:
             EUP
             MP
             MP/TGAI

             PAL
             PAI/M
             PAI/PAIRA

             PAIRA
             PAIRA/M
             PAIRA/PM

             TEP
             TEP    %
             TEP/MET
             TEP/PAI/M
End-Use Product
Manufacturing-Use Product
Manufacturing-Use Product and Technical Grade Active
Ingredient
Pure Active Ingredient
Pure Active Ingredient and Metabolites
Pure Active Indredient or Pute Active
Ingredient Radiolabelled
Pure Active Ingredient Radiolabelled
Pure Active Ingredient Radiolabelled and Metabolites
Pure Active Ingredient Radiolabelled and Plant
Metabolites
Typical End-Use Product
Typical End-Use Product, Percent Active Ingredient
Specified
Typical End-Use Product and Metabolites
Typical End-Use Product or Pure Active Ingredient and
                                        194

-------
             TGAI
             TGAI/PAI

             TGAI/PAIRA

             TGAI/TEP

             MET
             IMP
             DEGR
Metabolites
Technical Grade Active Ingredient
Technical Grade Active Ingredient or Pure Active
Ingredient
Technical Grade Active Ingredient or Pure Active
Ingredient Radiolabelled
Technical Grade Active Ingredient or Typical End-Use
Product
Metabolites
Impurities
Degradates
See: guideline comment
Item 8.       This item completed by the Agency identifies the time frame allowed for
             submission of the study or protocol identified in item 5.

             ON THE GENERIC DATA FORM: The time frame runs from the date of
             your receipt of the Data Call-In notice.

             ON THE PRODUCT SPECIFIC DATA FORM:The due date for
             submission of product specific studies begins from the date stamped on the
             letter transmitting the Reregistration Eligibility Decision document, and not
             from the date of receipt. However, your response to the Data Call-In itself is
             due 90 days from the date of receipt.

Item 9.       ON BOTH FORMS: Enter the appropriate Response Code or Codes to show
             how you intend to comply with each data requirement. Brief descriptions of
             each code follow. The Data Call-In Notice contains a fuller description of each
             of these options.

       Option 1.     ON BOTH FORMS: (Developing Data^ I will conduct a new study
                    and submit it within the time frames specified in item 8 above. By
                    indicating that I have chosen this option, I certify that I will comply with
                    all the requirements pertaining to the conditions for submittal of this
                    study as outlined in the Data Call-In Notice and that I will provide the
                    protocols and progress reports required in item 5 above.

       Option 2.     ON BOTH FORMS: (Agreement to Cost Share) I have entered into an
                    agreement with one or more registrants to develop data jointly. By
                    indicating that I have chosen this option, I certify that I will comply with
                    all the requirements pertaining to sharing in the cost of developing data
                    as outlined in the Data Call-In Notice.

                          However, for Product Specific Data,! understand that this
                    option is available for acute toxicity or certain efficacy data ONLY if
                                         195

-------
             the Agency indicates in an attachment to this notice that my product is
             similar enough to another product to qualify for this option. I certify that
             another party in the agreement is committing to submit or provide the
             required data; if the required study is not submitted on time, my product
             may be subject to suspension.

Option 3.     ON BOTH FORMS: (Offer to Cost Share) I have made an offer to
             enter into an agreement with one or more registrants to develop data
             jointly. I am  also submitting a completed "Certification of offer to Cost
             Share in the Development of Data" form. I am submitting evidence that
             I have made an offer to another registrant (who has an obligation to
             submit data) to share in the cost of that data. I am including a copy of
             my offer and  proof of the other registrant's receipt of that offer. I am
             identifying the party which is committing to submit or provide the
             required data; if the required study is not submitted on time, my product
             may be subject to suspension. I understand that other terms under
             Option 3 in the Data Call-In Notice apply as well.

                   However, for Product Specific Data, I understand that this
             option is available  only for acute toxicity or certain efficacy data and
             only if the Agency indicates hi an attachment to this Data Call-In Notice
             that my product is similar enough to another product to qualify for this
             option.

Option 4.     ON BOTH FORMS: (Submitting Existing Data) I will submit an
             existing study by the specified due date that has never before been
             submitted to EPA.  By indicating that I have chosen this option, I certify
             that this study meets all the requirements pertaining to the conditions for
             submittal of existing data outlined in the Data Call-In Notice  and I have
             attached the needed supporting information along with this response.

Option 5.     ON BOTH FORMS: (Upgrading a Study) I will submit by the
             specified due date, or will cite data to upgrade a study that EPA has
             classified as partially acceptable and potentially upgradeable. By
             indicating that I have chosen this option, I certify that I have met all the
             requirements pertaining to the conditions for submitting or citing
             existing data to upgrade a study described in the Data Call-in Notice. I
             am indicating on attached correspondence the Master Record
             Identification Number (MRID) that EPA has assigned to the data that I
             am citing as well as the MRID of the study I am attempting to upgrade.

Option 6.     ON BOTH FORMS: rCiting a Study) I am citing an existing study
             that has been previously classified by EPA  as acceptable, core, core
             minimum, or a study that has not yet been reviewed by the Agency. If
             reviewed, I am providing the Agency's classification of the study.

                                   196

-------
                   However, for Product Specific Data, I am citing another
             registrant's study. I understand that this option is available ONLY for
             acute toxicity or certain efficacy data and ONLY if the cited study was
             conducted on my product, an identical product or a product which the
             Agency has "grouped" with one or more other products for purposes of
             depending on the same data. I may also choose this option if I am citing
             my own data. In either case, I will provide the MRID or Accession
             number (s). If I cite another registrant's data, I will submit a completed
             "Certification With Respect To Data Compensation Requirements"
             form.

FOR THE GENERIC DATA FORM ONLY The following three options
(Numbers 7, 8, and 9) are responses thafapplv only to the "Requirements Status
and Registrant's Response Form "for generic data

Option 7.     (Deleting Uses) I am attaching an application for amendment to my
             registration deleting the uses for which the data are required.

Option 8.     (Low Volume/Minor Use Waiver Request) I have read the statements
             concerning low volume-minor use data waivers in the Data  Call-In
             Notice and I request a low-volume minor use waiver of the  data
             requirement. I am attaching a detailed justification to support this
             waiver request including, among other things, all information required
             to support the request. I understand that, unless modified by the Agency
             in writing, the data requirement as stated in the Notice governs.

Option 9.     (Request for Waiver of Data) I have read the statements concerning data
             waivers other than lowvolume minor-use data waivers in the Data
             Call-In Notice and I request a waiver of the data requirement. I am
             attaching a rationale explaining why I believe the data requirements do
             not apply. I am also submitting a copy of my current labels. (You must
             also submit a copy of your Confidential Statement of Formula if not
             already on file with EPA). I understand that, unless modified by the
             Agency in writing, the data requirement as stated in the Notice governs.

FOR PRODUCT SPECIFIC DATA  The following option (number 7)  is a
response that applies to the "Requirements Status and Registrant's  Response
Form" for product specific data.

Option 7.     (Waiver Request)  I request a waiver for this study because it is
             inappropriate for my product. I am attaching a complete justification for
             this request, including technical reasons, data and references to relevant
             EPA regulations, guidelines or policies. [Note: any supplemental data
             must be submitted in the format required by P.R. Notice 86-5]. I
             understand that this is my only opportunity to state the reasons or

                                  197

-------
Item 10.



Item 11.

Item 12.
       provide information in support of my request. If the Agency approves
       my waiver request, I will not be required to supply the data pursuant to
       Section 3(c) (2) (B) of FIFRA. If the Agency denies my waiver request,
       I must choose a method of meeting the data requirements of this Notice
       by the due date stated by this Notice. In this case, I must, within 30
       days-of my receipt of the Agency's written decision, submit a revised
       "Requirements Status" form specifying the option chosen. I also
       understand that the deadline for submission of data as specified by the
       original Data Call-In notice will not change.

ON BOTH FORMS:This item must be signed by an authorized representative
of your company. The person signing must include his/her title, and must initial
and date all other pages of this form.

ON BOTH FORMS:Enter the date of signature.

ON BOTH FORMSrEnter the name of the person EPA should contact with
questions regarding your response.
Item 13.      ON BOTH FORMSrEnter the phone number of your company contact.
   NOTE:   You may provide additional information that does not fit on this form in a signed letter that accompanies this your response. For example, you
          may wish to report that your product has already been transferred to another company or that you have already voluntarily cancelled this
                                           198

-------


**
41
O
* *
0)
Cr
Q








































P-l

o
o

w
FM
S
b *-N
4-* C
1 1
CO 0
.2 ^
Q_
II
55
i"!
C/> (U
z ^







3
o
ซtป
0
01

1 1
0) S
*i Si
Q VI

tr>
















C tH
•H 0
N H
Name
Metribu
and Name 101
T3 % C

•3 II
50 5 I
rl




1
















CD

a
u

H-
'i
Q.
tn
0

Q.


•"•










CD
4-*
CD
0
C
c


: S co
ra ^ *€ ^
til 10 0>
3 4-ป E CO
J CD 4-ป S ••
.C CD I- 4J
C 4-1 M- C
OJ 0) 3 CO
CO H- 4J CU 4J
•-co g: co
4J '4J o ~ "5>
O CD t> 0)
3 ป CO_CB o;
5 0 E T> T3 =_
L** ง *ป CD OJ
0) 0) C CO
K a; _ซ- eu co g
0i'5 E 4J a.
• CO ฃT t. O CO
JO CU.O 4J 0)
- — C.H-O9 CX



2 "5 „ป
"%-gc
a. ฃ co cu
ง*• g CO
O 4J S -
^I CO ^ 4J
C 4J ••- C
CO 0) 3 CD

CO H- 4-ป CU 4-ป
4J *4J g ~ '5
O CD tJ 0)
3 co co oi a:
i o c 4J-n =
L. 4^ qi •*- c •
a. p 4^ a o>
0) W C CO
>. 0) L. O CO C
&:<-•— 3 o
at 3 E 4J S.
• CD O* t- CO CO
CO 0) O 4J CU
r~ — t.t-tacf

ฃ•8-0
C- 4-ป CU
0) CO —
C O 4-ป
>.— 01 CO "•
agree to satis
requirements as
; attached form
irements Status
t rant's Respons
— JC. 3 CO
o 4J trซ-
• 4J CU CD
Si CO C Cฃ CU
OOO=Q:


I am claiming a Generic
a Exemption because I
ain the active ingredient
m the source EPA regis-
tion number listed below.
• 4-> 4J O CO
co CD .a t- t-


O *^ 3
*"*••- 0) "o
JCJC t- >
en 4J
— 4J C

co "^ c; o CD *il
CO • CfJ C. C- CD
JJ . in 0 Q.4J 4J
•a
ซt CO

* p* p
1 ฐ 9
X kl W
s & a
u m CO


II
a. co
U|.p-

^T

• u^

•.-" , - W ^-
^ ^^ ^•;"' •>,-'.• -^ ^
-- ซ, , X * ^
; ' ; 4 * \ ';>'••
^ •" f *v
"" •> ff
•> ^ ""
'' " v

'' *%x
'1

11
'
' •,' , "'
f '
'


t f f :j
,, ""< ^f ^

f f -.v -•••>, *

*X jrt-^ ' ^^^" """• "* %
^^ --X 1^4-

\ f*>f v


^ ^
_,
*

^

,
/*
'

s

'
'w ""'* i" -
^^ -^ f^f ' J "*\\
' "" ,'.A " "
f <•
,v
"%
•A

"v-
•* f f
*• e % > ' ^ x

^^ ^ K
f •**•"*

I '•: ' '

:|
•, • '
} .;:. . '• • _ .

















U

0
3
o*











4J

—
"3.

* W
s-s
4-f C
o> EL
c.
srm and all attachments a
5 leading statement may be
lepresentative
ป'E "S
••- t, N
JC O ••-
4-> 1.
01 O
g^2 15
CO 3
Oil- <
g >. CO
CO? - ฅ
4-ป •*- 3 CO
C 3 CO g
S 2 ^^ g
01 -^ O CJ
CO >ป^ **-

"* ra." o>
0)4-'—' — '
^ ffl Q. -M
c -M^: Q. ••-
O 4J (0 H-
4^ CO 0) L. T3
x o en













S
5
as
i;
5

Q.
^J



























4J
CO
4-*
g
U
1

U
o
i
z
o



-------
-1
c
r-


0)
cr
fl
ft


















































-i
LI
3
J
J
5
H
i!
t!
3


f
to
oin co
^•o cu
oo c.
TJ i i f
> ฐ.f2 S~
O OO Ul
J- CMCM __
CL • co
<ฃ 0 5
Z O
E "
C. CD Q.
S. iง ซt
















^i Efl
U 01
 O O
* 3
n> n

1 R *
VX _|__1
&J W*. CO
-r3 8
^ B

W "m H
™™ m
ra S
Q) ^ ra

ClS SI
CO g
0) H



















E
O
M-
CO
ซ=
C
o
1
CO
1
<-
c.
o




0
c
o

>+
g-
co
"O
CO
g
4-f
u
3
t
4-ป
CO
C;

•a
CD
U
CD
4J
a
01
-C
4.^

*~^
3
a>
L.
CO
U
•o

L.
01
CO
CO
"el
4
s >ป
c_
4^ CD
C CO
Q. O
M-
OJ •—
ฃ• ^
0) *J
CO CU
co a>
0 JZ
— • 0)
a.
STRUCT IONS:
e additiona
Z CO









CJ
H_
o

x-U
•D PH
g W
I 0
M















H
O
rH
-H 0
N H
.Q a,
•H E

ง_l i
d) c
535 S ffl

ro . -a 'i
at t~l o JJ
eo ~% g c-

CM












CO
c.
2 CO
< CO
i *8
co PJ Q
i 83
CD
c w w
X iJ J
0 CO CO

*™





4V
C
CO
ฃ_
en cu
••~ CO
O> C
01 o

CO
ff.ee


_i
V™ E
CO It





0)
u
4-> C
CO CD
CU 4->
1— ป
N- CO








0) (-
CO 01
3 4-*

•0 2

N)
(0
S- t-
58. ~
f- CU













4-*
1—
t
4-*
CO
in



jl

•J-CKZ
;.> >. y /'f ^ r^ -/' ;
•• s *\ ,^ -' ^-\" x
% - •

•• f sS ^ ' f
" ''f
"• r - f f

f •"
"*

•, f
*
-
02 ta tn ta m to ta m oj CQ CQ to CD
c S S g 6 g SSSS SSS
*"
CN < >i - •
'




f
/ f ••

' ""', J''~ '"'"
'^ '
•• • ''
CO O O *"-
- 0 ti. S. '
J - 2 S " '
— • „ CO -O ซ- ,
>tj c a, >ป
"6 1 ฃ -S - 4: J ,
g 1 s 1 l i r s 1
HiijiHhiiili
CJ  VO H H H

U3 >tD rH^iH rH .r! H H















0)
CD
ฐ
JI












^
01 CU
ซl
— • o
Q.CO

?-
raoT

2*4^
CO
3 ."*
O 0)
ป CO
0) _g-

ซl
L.
CO
C CD
cu E
E
o c
CO 01
CD 4-> >
CO ••-
— * 4-ป 4-f
— W CO
ฐ tป c
1E-ฃ S
COT3 0)
S CU p
ฃ— . o
o co ee
a>ฃ "S
i* r
CU O
C CO .C
S X co
col. ฅ
4->M- X CO
C X^co O.
CD X^ H-
4-> C CO O
CO CO U
— 0)
0) 4J— • —
g 55 & ฃ
c— 4-ป CO 1—
4-ป 4-*
co co cu c. TJ
j x: en ID ฃ
^ x-25 "
; ~15 =
J u j<: o a
ซ CJ CO O>
O t- M-
ซ- •-• ~ o w













L,
z
41
c
o
.ฃ=
CL
fO








































J
0
5
CJ
D
1
3
i

M

-------
0)

I
CM
     g
     n
    -H
              PJ
                          d
                         -H
                          N
                          3
                         ฃ1
                         -H
                          5-1
          N
          3
         43
         -H
          5,
         4J
          0)
                                t~l


                          H IS H
•>ซ •  •

                                            4-) -H ,d  0) 5-1
                                            0)  0)
                                                     0)
                                                     CQ
                               5-1
                                                      Q)
                                               >i 0)  ra
                                             1)  5-1 rH
                                            H  3 3 4->   •
                                               4-> o  nj  ra
                                            H  O O &  4->
                                            3  -•
                               0)  5-1
                                            ns 0) o\ฐ  4-> a
                                            3 -H r-1 -H a
                                               4->   •  0) 3
                                            0) -H O
                                            0) 5-1
                                                      4J 0)
                                            5-1 3  d  ra *d
                                            0)
                                                      4J  5,
                •H  4-) 5-1  5-1
             5-1  5-1  OS 4J  O
             O  3  0) m

                 o  CD tno-T
                                            ofl
                               CD
                                                          O
                      0)     Q)     d
                     ,€  o> m     Cn
                         Q) 0)   • -H
                         5-i 5-i  d  ra

                      b  4J     o)  >i
                     in     0)  o rH
                         0) 5-1  d rH

                      Q)  4-)     O  O
                      5H     -d    -H
                      H  4-> d in  tn
                      3  nJ oj  oS  O
                         m N
                      ra d 3
                        o -H
                        H  H
                 Q)-HO4->
              njOO)
              pog
OO
4Jd
                                               in
                                               O
                                                                 .  3 0
                                                               m  4J o
                                                               0)  O O
                                                               -H  3

                                                               -H  4-) 4->
                                         g  5, O
                                        -H  Oj 5-1
                                            _ a
                                         ra  fi
                                         m  o o)
                                            ra
                                         tn 0) oV>
                                         3 5,
                                         4J 3  d
                                 in -H 4-)
                                 3

                                 as d  o)
                                 g -H 4J
                                    5-1  (ti
                                 Q) 3  0)
                                 0) 4->  5-1
                                                                0)
                                             3  03
                                             d
                0)

          O  0) 0)

             43 a

                0
         oV  0) 5-1
         o  ,d nj

         m     -d
                                 4->,d

                                 5-1
                                 o  ra
                                 M-I  d
                                     5-1
                                 •d  0)
                                 0)  O
                                 5-i  d
                                 -H  o
                                 3  o
                -H  5-1
                 N  0)
                 3  O
                43  d
                -H  O
                 5,
                4J
                 Q)  iH
                 S  (ti
                                                                          o
                                                                 0)  m o -H
                                                                 m
                                     O4-JO
                                                                m
                                                                 i
                                                                VD
                                                    ra
                                                    nj  0)
                                                     0)
                                                    -H  H  m

                                                    -H m-  5
                                                     m o
                                                     m     cti
                                                     nj 4J  4J

                                                     o     "d
                                                                                      rH-H
                                                     Q)     ns
                                                    4J  m 4-)
                                                     nj  nj ra

                                                    rH     0)
                                                     nj  Q) tn
                                                     >  o nj

                                                        nj O
                                                      -4-> 4J
                                                    T3  ra ra
                                                    4-)  43
                                                    4J  3 O
                                                                                       4J-d
                                                                                    m     ci
                                                                                -H
                                                                                 3 oo
                                                            nj

                                                        0)  O
                                                          5n  o 3
                                                             <* nj  0)
                                                          ra     o 43
                                                         -H  p Q)  _
                                                                                 >i
                                                                    nJ
                                                  4J    H 43
                                                  m >,43  o
                                                     "d  nj -H
d  m  5-1
O     en m

4->  nj  a O
nj  d  3 5-1
4J  O     O
O -H  4J
5-1  4J  O 5-1

•d  4-)     4H
0)  O   -•
                           o  d Q)    -d
                           o -H g  g  o)
 cuo a-H  >
 doa^o
       3nJ5-i
                           H

                           in

                           H
                                                4J
                                                 tti
                                                 d
                                                 3
                                                 o  m
                                                 k-H

                                                 ^d
                                                 Q)  O

                                                -H  4->

                                                 O  g
                                                 0)  SH
                                                 a o
                                                 m  4-1
                                                 o  d
                                                 5H  -H
                                                rH 4->
                                                 nj nj

                                                 ra
                                                  '  -d

                                                rH 3
                                                 nj O
                                                 g 5-1
                                                 m tn
                                                                                                        ft

                                                 -H  dฐ
                                                 SH -H

                                                 "3  o
                                                                                                        (Ur-l
                                                                                                        5-1O
 O  0)

    4->
 m
-H  5-1
    0)
 >1>
 O  Q)
                                                                                                        tn,d
                                                                                                          5
                                    Oj  O
                                    5  0)
                                        5H

                                    oT-d
                                                                                                                    -rl N  d
                                       -H
                                      •  5-1 cxi
                                     0)  4J H

                                    —  id
                                     o

                                     4J  O
 d  nS  4J
 o  d  4->
 O -H  -H
    S  g
                          r\ jj
                          4J
                             •d
                          Q)  0)
                          CO  5-1
                          nj -H
                          0)  3
                          5-1  D1
                          O  Q)
                          0) {*!
                          •d



                          Id

                          4-> -H
                          OS 4J

                          4J  O
                             -H
                          4J  (ti


                           |d


                           O  N
                                                                                                           38
                                                                                                           -Sg
                                                                                                           4J  O
                                                                                                           nj  5,
                                                                                                           Q)  O
                           0) d
                           O "H
                          -H g

                           O 4J
                           d  d  03
                           nj  3  H

                               5-t  d
 o  d m
,d  o       .u  OI-H
4->  o o)     m     ,d
       43     0)  5-1 4J
                                                                                                                      H  5 -d    -H  nJ Q)
                                                                                                                      0)   i  0)     O -rl 4J
                                                               •
                                                               0)d'H
                                                               QSS.,
                                                                      &1
                               .U43
                           ^-~O3
                           cxiara

-------
o
CM

CD
CJ
rd
f-M

































































































O
d
CD
CD

w
d K
O ฃJ(
•H Q
jj gj
ฐ o 2
2 ^ H
5-1 rvi Sf
CU S
PS
	 j *
fd ES
a d 1
g - H
ง Cj Q
ง o a
H CD ง
ฃ -H 0!
[VI rM O
CQ h
CD t2
/T i j*^ 01
4-> feJ
rd S
4-3 M
TO S

T3 S
CD w
-H *
d




























































































r-i
-rl
d N
-H 3
N f)
d -H

-H i 4->
5-1 z CD
E "^ "D *^<
to d) c
s: *ฃi ca
•g *= H
	 . (U 	 .
% i— 1 o r-l
a, CO "g H
w H a; o
S 0 5 H







































































z
LU
O
CJ



LU
~
111
t_i
3
0)
i — i •*
rd rd
O 4-) rH
CQ rd fd rd
' T3 "d d
rH CD T3 O 5-1
rH 5n 4-) d -rl O
rd d) rd rd 4-) in
g -c! 3 -H
CQ 4J rH CQ "d CQ
O fd rH -d 4J
cu t* fd rd d
4-) >i CL> }> CD
CD d 5-1 ~ g
rH rd >i CD fd 0)
ft rH 4J 4J 5-1
g 5-i CQ d rd -H
O O 3 -H -d ^
o o tr1
d -H CD CD CD
fd O > CD4-) 5-1
-H CD fd rd
5-1 4J 5^ 5H d d
O rd ft O D1 O
^^* g 4-1 CD -H
"d 5-1 CD CQ "d 4-)
SO xl rd fd
rd f-i 4-J CD 5-i
d .d >i 4.)
rd -H g 4-) ฃ3 to
4J 0 -H
rd CQ 5^ 4-1 >d CD
T) -H m H 0) CD
ฃl 4J5-I
rH 4-J CQ M Q)
fd CD • O 5-1
O O ft CD ft CD
-H g 5^ d xl
4-) -d fd -H CQ 4J
-H CD CQ 3
T) CQ di4J rH
T3 rd >i CD O rH
rd X! 4-) 5^ d -H
CD >i TJ CD CD rH
5-1 -d O 5-1 5-1 3
-H 3 g rrj rd in
D1 CQ O CQ CQ O
CD O CD CD 4J
5-1 CD -H -H
d rH -d 4-) 'd
O -H (d d -H CD
4-> M g 4J -d CQ
O -rl CQ O d
4J 4J d g •
,d -H rd CD g "d CD
tDd d o CD ft
•HO 5-1 -H 0 5-1
5-1 g • O -d -H J>,
CQ tH 0 id d rrj •
-SmS rrttunnf ^
4->4-)CD 4-) 4->5-l fdd
(dO fd 4J CQ 4-) 4-)
CQ&d -ddCDCD fdCQ
CD -d o rd > ft -d
5 d o >,d-H en
5^d 4-l-HrH>-i CDd
CD O 5-1 -H g rd d -H
CQ5-1O rHS5-)g -HCQ
• CD CD . -H 5-1 O CQ CQ
5-i ft u-i rd CQ CD
CD d td "d 4.) CD u
^*i [> Q 4_) J^ (]Q '(^ y Q
O-H-H CQfdd-d O5-1
d 4J 4-1 O 5-1 ft
o> o fd 0 >I-H en ft
(^) (J) ^ ฃj") J_( 4_J J^ ^4 ^|
I^ft5-l fd4J-H-H [i!4-)a)
CQO 5-JrH'd'd fJrdrH
CDOt-l OddCD C^CD5^
435-id 4JOOCD ^.drd
E-) ft-H 03 ft O 4H CQ ง ft

„ 	 s ^— ^,
CD rH

i i
H H
I> 0
H H

-------

-------












(U
u
JJ
o
B
H
i
H
rt
O
ttf
4J

Q
CQ
-H
EH
4J
0
CO
CQ
fl
rt

jj
CQ
-H
0)
^H
rH
0
4J
CQ
-H































n
|

rH
K"1
4->
Q)
, — |

4J
S
-H
•d
H
-.
H
*• — '
i
i
o
d
-H
a
ซ
a)
o
in
fl i
-H fl
N -H
J3 N
ฃ! ai nS
-H E -H
^ = M

SS S
^ * H

-------

-------
EPA'S BATCHING OF METRIBUZIN PRODUCTS FOR MEETING REREGISTRATION
ACUTE TOXICITY DATA REQUIREMENTS

       In an effort to reduce the time, resources and number of animals needed to fulfill the
acute toxicity data requirements for reregistration of products containing metribuzin as an
active ingredient, the Agency has batched products which can be considered similar for
purposes of acute toxicity. Factors considered in the sorting process include each product's
active and inert ingredients (identity, percent composition and biological activity), type of
formulation (e.g., emulsifiable concentrate, aerosol, wettable powder, granular, etc.), and
labeling (e.g., signal word, use classification, precautionary labeling, etc.).  Note that the
Agency is not describing batched products as "substantially similar" since some products
within a batch may not be considered chemically similar or have identical use patterns.

       Using available information, batching has been accomplished by the process described
in the preceding paragraph. Notwithstanding the batching process, the Agency reserves the
right to require, at any time, acute toxicity data for an individual product should the need
arise.

       Registrants of products within a batch may choose to cooperatively generate, submit or
cite a single battery of six acute toxicological studies to represent all the products within that
batch. It is the registrant's option to participate in the process with all other registrants, only
some of the other registrants, or only their own products within a batch, or to generate all the
required acute toxicological studies for each of their own products. If a registrant chooses to
generate the data for a batch, he/she must use one of the products within the batch as the test
material. If a registrant chooses to rely upon previously submitted acute toxicity data, he/she
may do so provided that the data base is complete and valid by today's standards (see
acceptance criteria attached), the formulation tested is considered by EPA to be similar for
acute toxicity, and the formulation has not been significantly altered since submission and
acceptance of the acute toxicity data. Regardless of whether new data is generated or existing
data is referenced, registrants must clearly identify the test material by EPA Registration
Number. If more than one confidential statement of formula (CSF) exists for a product, the
registrant must indicate the formulation actually tested by identifying the corresponding CSF.

       In deciding how to meet the product specific data requirements, registrants must
follow the directions given in the Data Call-In Notice and its attachments appended to the
RED. The DCI Notice contains two response forms which are to be completed and submitted
to the Agency within 90 days of receipt.  The first form, "Data Call-In Response," asks
whether the registrant will meet the data requirements for each product. The second form,
"Requirements Status and Registrant's Response," lists the product specific data required for
each product, including the standard six acute toxicity tests. A registrant who wishes to
participate  in a batch must decide whether he/she will provide the data or depend on someone
else to do so. If a registrant supplies the data to support a batch of products, he/she must
select one of the following options: Developing Data (Option 1), Submitting an Existing
                                         199

-------
Study (Option 4), Upgrading an Existing Study (Option 5) or Citing an Existing Study
(Option 6). If a registrant depends on another's data, he/she must choose among: Cost Sharing
(Option 2), Offers to Cost Share (Option 3) or Citing an Existing Study (Option 6). If a
registrant does not want to participate in a batch, the choices are Options 1, 4, 5 or 6.
However, a registrant should know that choosing not to participate in a batch does not
preclude other registrants in the batch from citing his/her studies and offering to cost share
(Option 3) those studies.

       Eighty-six products were found which contain metribuzin as an active ingredient.
These products have been placed into five batches and a "no batch" category in accordance
with the active and inert ingredients, type of formulation and current labeling. Although some
products are not batched together, acute data requirements may still be satisfied through
bridging or citing data on a product in another batch or in the "no batch" category. With
batching, acute data on any product in a batch will support all other product within that batch.
Bridging, however, is a "one-way" citation from a more acutely toxic to a less acutely toxic
product Acceptable bridging strategies are described prior to the following tables. Table 1
identifies the products in each batch. Table 2 lists the products which have been placed in the
"no batch" category.

       With the exception  of eye irritation, batch 1, 3, 4 or 5 products may be supported by
       acute data on the technical active ingredient.
       With the exception  of eye irritation, products in batch 3 may be supported by  acute
       data on products in batch 4 and products in batch 4 may be supported by acute data on
       products in batch 3.
       With the exception of eye irritation, EPA Reg. No. 3125-294 (no batch) may be
       supported by acute  data supporting any batch  4 product.
       Products hi batch 5 may be supported by any category III or IV acute data supporting
       any batch 1  product.
Batch
1


2

EPA Reg. No.
3125-277
3125-305
CA79023400
352-444
352-448
% active ingredient
50.0
50.0
50.0
Metribuzin 64.3
Chlorimuron ethyl 10.7
Metribuzin 68.5
Chlorimuron ethvl 6.5
Formulation Type
Solid
Solid
Solid
Solid
Solid
                                           200

-------
Batch

3
EPA Reg. No.
352-549
352-390
352-550
LA8 1003200
OR90002600
OR90002800
WA90003700
WA96000100
% active ingredient
Metribuzin 68.5
Chlorimuron ethyl 6.5
75.0
75.0
75.0
75.0
75.0
75.0
75.0
Formulation Type
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
201

-------
Batch
•••••••
4






EPA Reg. No.
3125-325
3125-402
AL81002500
AZ88002800
CA87003900
CA89000400
GA84000600
IA91000100
IA92000200
IA92000300
ID81004600
ID87000500
ID87001700
ID95000400
IN93000200
KS92000300
MI9200010'0
MN93000100
MO84000300
MO93000300
MO93000400
NC84000500
NC86000600
ND93000500
ND93000600
	 % active ingredient
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
Formulation Type
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
202

-------
Batch

5
EPA Reg. No.
NE91000400
NE92000400
NE92000500
NM94000200
OH93000200
OH93000300
OK94000200
OR8 1004000
OR85002000
OR87000200
OR90002500
PR90000100
PR90000200
SCSI 00 1800
TX93001700
VA93000800
WA85000500
WA86001500
WA87000800
WA93000300
WA94004100
WY95000300
3125-314
AL81002600
AR79001400
% active ingredient
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
75.0
41.0
41.0
41.0
Formulation Type
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Liquid
Liquid
Liquid
203

-------
Batch
mmmmmmm
EPA Reg. No.
CA79023500
GA80002100
IDS 1004500
ID87000400
ID87001600
ME79000900
MO79001200
MS80000200
ND93000400
OR81003900
OR85001900
OR87000100
WA81004100
WA85000600
WA86001600
WA87000700
% active ingredient
41.0
41.0
41.0
41.0
41.0
41.0
41.0
41.0
41.0
41.0
41.0
41.0
41.0
41.0
41.0
41.0
Formulation Type
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
       The following table lists products that were either considered not to be similar or the
Agency lacked sufficient information for decision making and were not placed in any batch.
The registrants of these producs are responsible for meeting the acute toxicity data
requirements separately or through the accepted bridging scheme presented below.
       Table 2 (No Batch")
EPA Reg. No.
3125-270
3125-294
% active ingredient
90.0
70.0
Formulation
Type
Solid
Solid
                                          204

-------
EPA Reg. No.
3125-366
3125-375
55947-166
CA84000700
ID90000200
% active ingredient
Metribuzin 15.0
Metalochlor 70.0
Metribuzin 14.0
Trifluralin 28.0
Metribuzin 10.0
Dicamba 66.0
75.0
15.0
Formulation
Type
Liquid
Liquid
Solid
Solid
Liquid
205

-------

-------
H
O
H

0)
tn
ns













































































>>i
o
0)
tn


fl
O
-H
4-1
o

fl

CD
CD
4->

4J
CO
Ti
0)
4J
-H
e











































0
o
CM
.
0
ซ
Q

g"
O
4_)
tn
fl
-H
m
1











































H
a
H
o
S
jg
H

1
H™1 Ci
2 N
U 0
rtj -H
E-j 5-)
S 0
co S
H
PH rH
E-< 00
H
Pj O
a
CO (U
c
co ro
P-i ^
g
H "O
K fl
E-i n3
CO
H #
O
W (U
P4 CQ
_ (^
J
rtj

0
EH
CO
H
M



















ft
-H
N


(D
4J
ccS
4J
CQ

y

4J
-H
o








tn
tn
0)
T3
rg
- Qฃ CO
Q. O "- Z
_J 1- 0 3= —
UJ C3 CJ <
O Z CO Qi -J
3ป-<  — 1 Z CO CO
2: >-i 
ISJ Q
-
t— —i :n
CO Q_ Z Z3
o; o
1— _J O f—
LLI _j rn
^ '-' t— CO t—
Qฃ S 3 CM W
- = m QJ
LLJ ซ—
in — i o o
ro a: o x o
fv. < - o o
CJ Z
Cfl 'O O
- CO 2
U- LLJ CQ CQ CO

Os CNJ in 0s r^-
N- in CM vo **
CM ro ^— o o
o o to N- in
C3 o o o in
o o o o o

-------

-------
Instructions for Completing the Confidential Statement of Formula

The Confidential Statement of Formula (CSF) Form 8570-4 must be used. Two legible,
signed copies of the form are required. Following are basic instructions:

      a.     All the blocks on the form must be filled in and answered completely..

      b.     If any block is not applicable, mark it N/A.

      c.     The CSF must be signed, dated and the telephone number of the responsible
             party must be provided.

      d.     All applicable information which is on the product specific data submission
             must also be reported on the CSF.

      e.     All weights reported under item 7 must be in pounds per gallon for liquids and
             pounds per cubic feet for solids.

      f.     Flashpoint must be in degrees Fahrenheit and flame extension in inches.

      g.     For all active ingredients, the EPA Registration Numbers for the currently
             registered source products must be reported under column 12.

      h.     The Chemical Abstracts Service (CAS) Numbers for all actives and inerts and
             all common names for the trade names must be reported.

      i.     For the active ingredients, the percent purity of the source products must be
             reported under column 10 and must be exactly the same as on the source
             product's label.

      j.     All the weights in columns 13.a. and 13.b. must be in pounds, kilograms, or
             grams. In no case will volumes be accepted. Do not mix English and metric
             system units (i.e., pounds and kilograms).

      k.     All the items under column 13.b.  must total 100 percent.

      1.     All items under columns 14.a. and 14.b. for the active ingredients must
             represent pure active form.

      m.    The upper and lower certified limits for ail active and inert ingredients must
             follow the 40 CFR 158.175 instructions. An explanation must be provided if
             the proposed limits are different than standard certified limits.

      n.     When new CSFs are submitted and approved, all previously submitted CSFs
             become obsolete for that specific  formulation.
                                        207

-------

-------

I
CO
ฃ
•p.
Ul

_
i
8
6
z
CO
3
1
I



u?
<0
s
O
UJ
.0
**ป
1
^

1
8
CO
•5
e
•S
CB
5
Contain
on: Does Not
n'ness In format!
2
OQ
(Q
1
a


ro
CO
C
o
CA
c
O
3
•|
en



"o


o
?
oi ฃ

c
o
5 i
3 S

J3 o
S
I i
m <
an
j




2
g

rk
eป~ ฐ
Protection /
•itni(TS-76i
20460
ent of 1
litai Environmental
ca of Pesticide Progi
Washington, DC
tial Statem
United S
Offi
Confiden



^
LU














1
1
^
u
ง
3
|
ฃ
"5
3
2
•o
c
CO
9
Z
CN










^

"5
^c
'ง
"••*
s
CD
IT
LU
i
(P
^5
ง
t"
_
I
ง
i
|
3
(0
I
CO"
ฃ

0
ฃ
ex
c

^


> obsolete.
ilous editions are
i
QL
T-
i
K
** '
2
e
IO
to
e
1
a.
UI
209

-------

-------
                      United States Environmental Protection Agency
                                  Washington, D.C. 20460
                            Certification  of Offer to Cost
                         Share in the Development of Data
  Form Approved
OMB No. 2070-0106,
    2070-0057
 Approval Expires
     3-31-99
 Public reporting burden for this collection of information is estimated to average 15 minutes per response, including
 time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and
 completing and reviewing the collection of information.  Send comments regarding the burden estimate or any othler
 aspect of this collection of information, including suggestions for reducing this burden to, Chief Information Polic
 Branch, PM-233, U.S. Environmental Protection Agency, 401 M St., S.W., Washington, DC 20460; and to the Office <
 Management and Budget, Paperwork Reduction Project (2070-0106), Washington, DC 20503.

 Please fill in blanks below:
Company Name
Product Name
Company Number
EPA Reg. No.
 I Certify that:

 My company is willing to develop and submit the data required by EPA under the authority of the
 Federal Insecticide, Fungicide and Rodenticide Act (FIFRA), if necessary. However my company would
 prefer to enter into an agreement with one or more registrants to develop jointly or share in the cost of
 developing data.

 My firm has offered in writing to enter into such an agreement. That offer was irrevocable and included
 in an offer to be bound by arbitration decision under section 3(c)(2)(B)(iii) of FIFRA if final agreement on
 all terms could not be reached otherwise. This offer was made to the following firms on the following
 date(s):
Name of Flrm(s)
Date of Offer
 Certification:
 I certify that I am duly authorized to represent the company named above, and that the statements that I have made
 on this form and all attachments therein are true, accurate, and complete. I acknowledge that any knowingly false (or
 misleading statement may be punishable by fine or imprisonment or both under applicable law.
Signature of Company's Authorized Representative
Date
 Name and Title (Please Type or Print)
EPA Form 8570-32 (5/91) Replaces EPA form 8580 which is obselete
                                               211

-------

-------
                         United States Environmental Protection Agency
                                     Washington, DC 20460
                         CERTIFICATION WITH RESPECT TO
                      DATA COMPENSATION REQUIREMENTS
Form Approved
OMB No. 2070-0107,
2070-0057
Approval Expires
3-31-99
  Public reporting burden for this collection of information is estimated to average 15 minutes per response, including time for
  reviewing instructipns, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the
  collection of information.  Send comments regarding the burden estimate or any other aspect of this collection of information,
  including suggestions for reducing this burden to, Chief Information Policy Branch,  PM-233, U.S. Environmental Protection
  Agency, 401 M St., S.W., Washington, DC 20460; and to the Office of Management and Budget,  Paperwork Reduction Project
  (2070-0106), Washington, DC 20503.

  Please fill in blanks below.
Company Name
Product Name
Company Number
EPA Reg. No.
  I Certify that:

  1.    For each study cited in support of registration or reregistratiion under the Federal Insecticide, Fungicide and Rodenticide Act
  (FIFRA) that is an exclusive use study, I am the original data submitter, or I have obtained the written permission of the original
  data submitter to cite that study.

  2.    That for each study cited in support of registration or reregistration under FIFRA that is NOT an exclusive use study, I am the
  original data submitter, or I have obtained the written permission of the original data submitter, or I have notified in writing the
  company(ies) that submitted data I have cited and have offered to: (a) Pay compensation for those data in accordance with sections
  3(c)(1)(F) and 3(c)(2)(D) of FIFRA; and (b) Commence negotiation to determine which data are subject to the compensation
  requirement of FIFRA and the amount of compensation due, if any. The companies I have notified are. (check one)

   [  ] The companies who have submitted the studies listed on the back of this form or attached sheets, or indicated on the attached
  "Requirements Status and Registrants' Response Form,"

  3.    That I have previously complied with section 3(c)(1)(F) of FIFRA for the studies I have cited in support of registration or
  reregistration under FIFRA.
Signature
Date
  Name and Title (Please Type or Print)
  GENERAL OFFER TO PAY:  I hereby offer and agree to pay compensation to other persons, with regard to the registration or
  reregistration of my products, to the extent required by FIFRA section 3(c)(1)(F) and 3(c)(2)(D).
Signature
Date
  Name and Title (Please Type or Print)
EPA Form 8570-31 (4-96)

-------

-------
    The following is a list of available documents for Metribuzin that my further assist you in
responding to this Reregistration Eligibility Decision document. These documents may be
obtained by the following methods:

Electronic
File format:   Portable Document Format (.PDF) Requires Adobeฎ Acrobat or  compatible
             reader. Electronic copies are available on the Internet at on WWW.EPA.GOV.,
             or contact Jean Holmes at (703)-308-8008.

    1.        PR Notice 86-5.

    2.        PR Notice 91-2 (pertains to the Label Ingredient Statement).

    3.        A  full copy of this RED document.

    4.        A  copy of the fact sheet for Metribuzin.


    The following documents are part of the Administrative Record for Metribuzin  and may be
included in the EPA's Office of Pesticide Programs Public Docket. Copies of these documents
are not available electronically, but may be obtained by contacting the person listed on the
Chemical Status  Sheet.

    1 .Health and Environmental Effects Science Chapters.

    2.Detailed Label Usage Information System (LUIS) Report.

    The following Agency reference documents are not available electronically,  but may be
obtained by contacting the person listed on the Chemical Status Sheet of this RED  document.

    1.        The Label Review Manual.

    2.        EPA Acceptance Criteria
                                         215

-------

-------

-------

-------